INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10197, 'Sansovit plus syrup 100 ml', 'سانسوفيت بلس شرب 100 مل', '95', '80', 'Vitamins', 'Vitamins(a+d3+b1+b2+b5+b6+b9+b12+c+e)+iron+zinv+copper+selenium', 'Marcyrl co. > aug pharma', 'Syrup', 'شراب', '100 ml', '1', NULL, 'composition for 10 ml : vitamin a .. 450 mcg vitamin d3 .. 400 i.u. vitamin b1 .. 2.5 mg vitamin b2 .. 2.5 mg vitamin b6 .. 2.5 mg vitamin c .. 50 mg vitamin e .. 15 i.u. vitamin b5 .. 7.5 mg vitamin b9 .. 200 mcg vitamin b12 .. 2 mcg iron .. 14 mg zinc .', '6223005465023', NULL, 2005, '2024-09-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10199, 'Sansovit with iron syrup 200 gm', 'سانسوفيت حديد شراب 200 جرام', '26', '26.25', 'Vitamins', 'Vitamins', 'Marcyrl co. > aug pharma', 'Syrup', 'شراب', '200 gm', '1', 'مكمل غذائي لعلاج نقص الفيتامينات.', NULL, '6223005463401', NULL, 12496, '2023-08-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10204, 'Sarcozide 16/12.5mg 20 tabs.', 'ساركوزيد 16/12.5مجم 20 قرص', '82', '60', 'Antihypertensive. combined angiotensin blocker with diuretic', 'Candesartan cilexetil+hydrochlorothiazide', 'October pharma', 'Tab', 'أقراص', '12.5mg', '2', 'علاج ارتفاع ضغط الدم', 'about candesartan cilexetil angiotensin || antagonist antihypertensive agent mechanism of action of candesartan cilexetil it is a antagonist of angiotensin 2 at at-1 receptor.it decreases peripheral resistance and lowers bp in hypertensive individuals. it', '6221088010970', NULL, 4204, '2024-11-26', 0, 'May be used as a first line agent to treat uncomplicated hypertension, isolated systolic hypertension and left ventricular hypertrophy. May be used as a first line agent to delay progression of diabetic nephropathy. Candesartan may be also used as a second line agent in the treatment of congestive heart failure, systolic dysfunction, myocardial infarction and coronary artery disease in those intolerant of ACE inhibitors.', 'Candesartan selectively blocks the binding of angiotensin II to AT1 in many tissues including vascular smooth muscle and the adrenal glands. This inhibits the AT1-mediated vasoconstrictive and aldosterone-secreting effects of angiotensin II and results in an overall decrease in blood pressure. Candesartan is greater than 10,000 times more selective for AT1 than AT2. Inhibition of aldosterone secretion may increase sodium and water excretion while decreasing potassium excretion.', 'Candesartan cilexetil is an ARB prodrug that is rapidly converted to candesartan, its active metabolite, during absorption from the gastrointestinal tract. Candesartan confers blood pressure lowering effects by antagonizing the hypertensive effects of angiotensin II via the RAAS. RAAS is a homeostatic mechanism for regulating hemodynamics, water and electrolyte balance. During sympathetic stimulation or when renal blood pressure or blood flow is reduced, renin is released from granular cells of the juxtaglomerular apparatus in the kidneys. Renin cleaves circulating angiotensinogen to angiotensin I, which is cleaved by angiotensin converting enzyme (ACE) to angiotensin II. Angiotensin II increases blood pressure by increasing total peripheral resistance, increasing sodium and water reabsorption in the kidneys via aldosterone secretion, and altering cardiovascular structure. Angiotensin II binds to two receptors: type-1 angiotensin II receptor (AT1) and type-2 angiotensin II receptor (AT2). AT1 is a G-protein coupled receptor (GPCR) that mediates the vasoconstrictive and aldosterone-secreting effects of angiotensin II. Studies performed in recent years suggest that AT2 antagonizes AT1-mediated effects and directly affects long-term blood pressure control by inducing vasorelaxation and increasing urinary sodium excretion. Angiotensin receptor blockers (ARBs) are non-peptide competitive inhibitors of AT1. ARBs block the ability of angiotensin II to stimulate pressor and cell proliferative effects. Unlike ACE inhibitors, ARBs do not affect bradykinin-induced vasodilation. The overall effect of ARBs is a decrease in blood pressure.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10206, 'Sate cream 50 gm', 'سيت كريم 50 جم', '70', '55', 'Moisturizing topicals', 'Bee propolis+salicylic acid+casein+vitamin e+vitamin a+calendula extract+aloe vera+chamomile+tea trea oil', 'Hi-care > pixel pharmaceutical company', 'Cream', 'كريم', '50 gm', '1', 'مرطب للجلد -- يتستخدم في حالات الصدفية والاكزيما', NULL, '6224001202353', NULL, 2243, '2025-02-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10208, 'Savibleed 500mg/5ml 5 amp.', 'سافيبليد 500مجم/5مل 5 امبولات', '60', '33.75', 'Bleedding.fibrinolytics inhibitors', 'Tranexamic acid', 'Marcyrl co.', 'Amp', 'أمبول', '500mg', '5', NULL, NULL, '6223003579364', NULL, 1268, '2024-11-28', 0, 'Taken orally, tranexamic acid is indicated for the treatment of hereditary angioedema,[L31883] cyclic heavy menstrual bleeding in premenopausal females,[L31858] and other instances of significant bleeding in the context of hyperfibrinolysis.[L31883] Given intravenously, tranexamic acid is indicated for short-term use (2-8 days) in patients with hemophilia to prevent or reduce bleeding following tooth extraction.[L31853]', 'Tranexamic acid competitively and reversibly inhibits the activation of plasminogen via binding at several distinct sites, including four or five low-affinity sites and one high-affinity site, the latter of which is involved in its binding to fibrin. The binding of plasminogen to fibrin induces fibrinolysis - by occupying the necessary binding sites tranexamic acid prevents this dissolution of fibrin, thereby stabilizing the clot and preventing hemorrhage.[L31858]', 'Tranexamic acid is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin.[L31858] At much higher concentrations it behaves as a noncompetitive inhibitor of plasmin similar to [aminocaproic acid], a similar antifibrinolytic which is 10-fold less potent.[L31883] Tranexamic acid binds more strongly than aminocaproic acid to both the strong and weak receptor sites of the plasminogen molecule in a ratio corresponding to the difference in potency between the compounds. In patients with hereditary angioedema, inhibition of the formation and activity of plasmin by tranexamic acid may prevent attacks of angioedema by decreasing plasmin-induced activation of the first complement protein (C1).[A230113] 



Off-target antagonism of GABA(A) receptors may be associated with the development of convulsions and hyperexcitability following tranexamic acid administration[A229383] - the risk appears higher with improper administration or administration during cardiovascular surgery.[L31883] Consider EEG monitoring of patients with a history of seizure.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10213, 'Scadele cream 100 gm', 'سكاديل كريم 100جم', '195', '120', 'Hair care', 'Stearic acid+bees wax+ceteareth 20+triethanolamine+urea+glycerin+isopropyl myristate+panthenol+olive', 'Leader cosmetics > original pharma group', 'Cream', 'كريم', '100 gm', '1', NULL, NULL, NULL, NULL, 998, '2024-04-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10214, 'Scalogen hair shampoo 250 ml', 'سكالوجين شامبو للشعر 250 مل', '170', '150', 'Hair care', 'Saw palmetto extract+ginko biloba extract+ginseng extract+royal jelly extract+aloe vera extract+rose', 'Hi-care > roventis pharma', 'Amp', 'أمبول', '250 ml', '1', 'العناية بالشعر', 'indications adjuvant therapy in: ï- all cases of hair loss. ï- helps increasing length and thickness of hair. ï- maintains healthy growth of damaged and brittle hair. ï- prevents split ends formation. ï- keeps hair beauty and vitality. -directions for use', '6224011042093', NULL, 2665, '2025-01-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10215, 'Scalogen hair serum 120 ml', 'سكالوجين سيرم للشعر 120 مل', '220', '185', 'Hair care', 'Saw palmetto extract+ginko biloba extract+ginseng extract+royal jelly extract+aloe vera extract+rose', 'Hi-care > roventis pharma', 'Serum', 'سيروم', '120 ml', '1', NULL, NULL, '6224007611012', NULL, 1576, '2025-01-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10219, 'Scaro plus cream 50 gm', 'سكارو بلس كريم 50 جرام', '300', NULL, 'Scar therapy', 'Silicon fluid+polydimethylsiloxan copolyol+deodorized onion extract+vitamin e+vitamin a+olive oil+', 'Macro group pharmaceuticals', 'Cream', 'كريم', '50 gm', '1', 'لعلاج ندبات الجلد', NULL, '6224007384350', NULL, 7499, '2023-04-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10222, 'Schizofy 10mg 20 scored f.c.tab.', 'شيزوفاي 10مجم 20 قرص', '114', '85', 'Psychiatric.antipsychotics', 'Aripiprazole', 'Western pharmaceuticals industries', 'Tab', 'أقراص', '10mg', '2', NULL, NULL, '6224007308479', NULL, 1314, '2025-02-02', 0, 'Aripiprazole is indicated for the treatment of acute manic and mixed episodes associated with bipolar I disorder, irritability associated with autism spectrum disorder, schizophrenia, and Tourette''s disorder.[L45859] It is also used as an adjunctive treatment of major depressive disorder.[L45859 An injectable formulation of aripiprazole is indicated for agitation associated with schizophrenia or bipolar mania.[L45859] Finally, an extended-release, bimonthly injection formulation of aripiprazole is indicated for the treatment of adult schizophrenia and maintenance therapy for adult bipolar I disorder.[L46203]', 'The antipsychotic action of aripiprazole is likely due to its partial agonist activity on D2 and 5-HT<sub>1A</sub> receptors as well as its antagonist activity at 5-HT<sub>2A</sub> receptors; however, the exact mechanism has not been fully elucidated.[A4393,L45859,L4620] One of the mechanisms that have been proposed is that aripiprazole both stimulates and inhibits dopamine as it engages the D2 receptor. It lowers dopamine neuronal firing at high dopamine concentrations and increases dopamine firing at low concentrations. Its partial agonist activity gives aripiprazole an intermediate level of dopaminergic neuronal tone between full agonist and antagonist of the D2 receptor.[A258699] In addition, some adverse effects may be due to action on other receptors.[L4620] For example, orthostatic hypotension may be explained by antagonism of the adrenergic alpha-1 receptors.[L4620,A4393]', 'Aripiprazole exhibits high affinity for dopamine D<sub>2</sub> and D<sub>3</sub>, serotonin 5-HT<sub>1a</sub> and 5-HT<sub>2a</sub> receptors (Ki values of 0.34 nM, 0.8 nM, 1.7 nM, and 3.4 nM, respectively), moderate affinity for dopamine D<sub>4</sub>, serotonin 5-HT<sub>2c</sub> and 5-HT<sub>7</sub>, alpha<sub>1</sub>-adrenergic and histamine H<sub>1</sub> receptors (Ki values of 44 nM, 15 nM, 39 nM, 57 nM, and 61 nM, respectively), and moderate affinity for the serotonin reuptake site (Ki=98 nM). Aripiprazole has no appreciable affinity for cholinergic muscarinic receptors (IC<sub>50</sub>>1000 nM).[L45859]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10231, 'Scotts oint', 'مرهم سكوتس', '120', '80', NULL, 'White ppt oint+camphor+olive oil+lanovas', 'Company', 'Oint', 'مرهم', NULL, '1', 'يستخدم مرهم سكوتس في علاج إلتهاب المفاصل الروماتيزمي -- إرتشاح المفاصل والركبة', NULL, NULL, NULL, 1579, '2022-05-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10237, 'Seboral hair shampoo 125ml', 'سيبورال شامبو 125 مل', '75', '51', 'Hair care', 'Aqua+sodium lauryl ether sulphate+cocamide dea+zinc pyrithron+peg-7+glyceryl cocoate+olive oil+panth', 'Mash premiere', 'Amp', 'أمبول', '125ml', '1', NULL, 'anti-dandruff hair shampoo', '6222001403749', NULL, 1488, '2024-02-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10238, 'Secinda misr 500 mg 4 tab', 'سيكندا مصر 500 مجم 4 قرص', '11', NULL, 'Antifungal', 'Secnidazole', 'Misr', 'Tab', 'أقراص', '500 mg', '1', 'مضاد للفطريات', NULL, NULL, NULL, 879, '2022-04-24', 0, 'Secnidazole is indicated for treating trichomoniasis and bacterial vaginosis in patients 12 years of age and older.[L39524] In other countries, it is also available as a combination product with other antibacterial drugs, such as [itraconazole].[L16023]', 'Like other 5-nitroimidazole antimicrobials, the antimicrobial and antiprotozoal activity of secnidazole is accounted for by the nitro group in the

imidazole ring.[A245508] Upon entering the target pathogen, the nitro group of secnidazole is reduced by bacterial or parasitic nitroreductase enzymes, producing radical anions and reactive intermediates. Radical anions and reactive intermediates cause the depletion of thiols, DNA helix damage, disruption of bacterial or parasitic protein synthesis and replication, and ultimately, cell death of susceptible isolates of Gram positive bacteria, Gram negative bacteria and _T. vaginalis_.[A245508, L39524]', 'Secnidazole is a broad-spectrum nitroimidazole antimicrobial drug.[A245503] It is selective against many anaerobic Gram-positive and Gram-negative bacteria and protozoa. According to _in vitro_ studies, secnidazole mediates antibacterial effects against _Bacteroides fragilis_, _Trichomonas vaginalis_, _Entamoeba histolytica_, and _Giardia lamblia_.[A27210] Secnidazole may prolong the QTc interval, but not to a clinically significant extent.[L39524]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10239, 'Secnidazole 500mg 4 tab.', 'سيكنيدازول 500مجم 4 اقراص', '15', '9', 'Antiprotozoal', 'Secnidazole', 'Eipico', 'Tab', 'أقراص', '500mg', '1', 'مضاد للطفيليات', NULL, '6221032115027', NULL, 3274, '2024-12-08', 0, 'Secnidazole is indicated for treating trichomoniasis and bacterial vaginosis in patients 12 years of age and older.[L39524] In other countries, it is also available as a combination product with other antibacterial drugs, such as [itraconazole].[L16023]', 'Like other 5-nitroimidazole antimicrobials, the antimicrobial and antiprotozoal activity of secnidazole is accounted for by the nitro group in the

imidazole ring.[A245508] Upon entering the target pathogen, the nitro group of secnidazole is reduced by bacterial or parasitic nitroreductase enzymes, producing radical anions and reactive intermediates. Radical anions and reactive intermediates cause the depletion of thiols, DNA helix damage, disruption of bacterial or parasitic protein synthesis and replication, and ultimately, cell death of susceptible isolates of Gram positive bacteria, Gram negative bacteria and _T. vaginalis_.[A245508, L39524]', 'Secnidazole is a broad-spectrum nitroimidazole antimicrobial drug.[A245503] It is selective against many anaerobic Gram-positive and Gram-negative bacteria and protozoa. According to _in vitro_ studies, secnidazole mediates antibacterial effects against _Bacteroides fragilis_, _Trichomonas vaginalis_, _Entamoeba histolytica_, and _Giardia lamblia_.[A27210] Secnidazole may prolong the QTc interval, but not to a clinically significant extent.[L39524]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10242, 'Sedalac 3.35gm/5ml syrup 120ml', 'سيدالاك شراب 120 مل', '20', NULL, 'Laxative', 'Lactulose', 'Sedico', 'Syrup', 'شراب', '3.35gm', '1', NULL, 'about lactulose a synthetic disaccharide osmotic laxative ammonium detoxicant. mechanism of action of lactulose laxative: lactulose is a synthetic disaccharide of galactose and fructose that resist intestinal disaccharidase activity. the sugars are joined', '6221042251012', NULL, 2010, '2023-02-06', 0, 'Lactulose is indicated for use as a laxative in the treatment of chronic constipation in adults and geriatric patients.[FDA Label,L6199,L6202]



Additionally, lactulose is also employed as an adjunct to protein restriction and supportive therapy for the prevention and treatment of portal-systemic encephalopathy (PSE), including both the hepatic pre-coma and coma variations.[FDA Label,L6199,L6202] In particular, lactulose solution has been effective at managing PSE resulting from surgical portacaval shunts or from chronic hepatic diseases like cirrhosis.[L6199]



Moreover, there have also been studies demonstrating the capacity for lactulose to minimize the formation of gallstones and even some investigations regarding the experimental use of the agent in developing novel anticancer agents owing to its ability to bind galactin carbohydrates involved in various tumor progressions [L6202].', 'Lactulose is a synthetic disaccharide derivative of lactose that consists of one molecule of galactose and one molecule of fructose.[FDA Label,L6199,L6202] Saccharolytic bacteria present in the large intestine subsequently break the substance down into organic acids like lactic acid and small amounts of formic and acetic acids.[FDA Label,L6199,L6202] Such resultant volatile fatty acid metabolites, in combination with hydrogen and methane that is also generated consequently enhance intraluminal gas formation, peristaltic gut motility, and elicit an osmotic effect that facilitates an increase in the water content of stool as well as associated stool softening.[FDA Label,L6199,L6202] All of these actions ultimately assist in facilitating and increasing the frequency of bowel movements in patients experiencing constipation, although it may take 24 to 48 hours after using the medication for this laxative effect to become evident.[FDA Label,L6199,L6202]



At the same time, the formation of such acids via the metabolism of lactulose by colonic bacteria also acidifies the contents of the colon, thereby contributing to the treatment of portal-systemic encephalopathy (PSE).[FDA Label,L6199,L6202] As one of the principal features of PSE involves the accumulation of nitrogenous waste products like ammonia in the systemic circulation, a state in which the colonic contents become more acidic than blood allows ammonia in the circulation to diffuse into the colon.[FDA Label,L6199,L6202]. Furthermore, ammonia that diffuses into the acidic colon is ionized to ammonium ions that are incapable of being absorbed back into the blood.[FDA Label,L6199,L6202] These effects, combined with the laxative action of lactulose facilitates the excretion of excess ammonia.[FDA Label,L6199,L6202] And finally, it is also believed that an acidic colonic environment results in the elimination of urease-producing bacteria that contribute to the formation of ammonia while surviving colonic bacteria use up any trapped ammonia in the colon as a source of nitrogen for protein synthesis.[L6202]', 'Lactulose formulations are most commonly administered via the oral route or the rectal route.[L6202] Consequently, because the substance experiences minimal absorption by the gut it typically remains localized in the gastrointestinal tract environment and ultimately demonstrates almost all of its pharmacologic effects within the gut.[FDA Label,L6199,L6202] In particular, as lactulose elicits its laxative effects in enhancing stool amounts and softening stool, such biochemical and physiologic activities can cause increased bowel sounds (borborygmi), a feeling of bloatedness, belching, frequent flatus, and diarrhea.[FDA Label,L6199,L6202]   ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10244, 'Pirant facial cleanser 150 ml', 'بيرانت منظف للوجه 150 مل', '135', '90', 'Facial cleanser', 'Vitamin c+hony+glycerin+olive oil+rosemary oli+licorice extract', 'Troya pharma', 'Cleanser', 'منظف', '150 ml', '1', NULL, NULL, '762497204766', NULL, 1193, '2025-11-19', 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10247, 'Sedaneurin 20 tab.', 'سيدانيورين 20 قرص', '60', '50', 'Anxiolytic', 'Hypericum+valerian extract', 'Atos pharma', 'Tab', 'أقراص', NULL, '2', NULL, 'properties and actions: sedaneurin is an anxiolytic drug with a dose-dependent sedative effect. it shows a potentiating effect in enhancement of gaba (gamma amino butyric acid) pathway which is the main inhibitory neurotransmitter in the central nervous s', '6223000471616', NULL, 1459, '2025-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10249, 'Sediproct topical cream 20 gm', 'سيديبروكت كريم 20 جم', '42', '27', 'Haemorrhoids', 'Cinchocaine+hydrocortisone', 'Mup', 'Cream', 'كريم', '20 gm', '1', 'علاج البواسير -- تقليل الالام و الالتهابات --- تقليل الحكة الشرجية', 'about cinchocaine an amide derivative most potent and toxic long-acting local anesthetics a local anaesthetic mechanism of action of cinchocaine cinchocaine is a local anesthetic. it works by blocking the pathway of pain signals along nerves. it inhibits', '6221508121118', NULL, 11500, '2024-11-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10250, 'Sediproct 6 supp.', 'سيديبروكت 6 اقماع لبوس', '26', NULL, 'Haemorrhoids', 'Cinchocaine+esculoside+framycetine+hydrocortisone', 'Mup', 'Supp', 'لبوس', NULL, '1', NULL, NULL, '6221508150118', NULL, 5515, '2022-09-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10252, 'Sedokast 10mg 10 f.c. tab', 'سيدوكاست 10مجم 10 اقراص', '59', '30', 'Asthma.anti-inflammatory.leukotriene antagonist', 'Montelukast', 'Sedico', 'Tab', 'أقراص', '10mg', '1', 'علاج أزمات الصدر وصعوبة وضيق التنفس', NULL, '6221042124019', NULL, 3346, '2024-12-01', 0, 'Montelukast is indicated for:



(a) the prophylaxis and chronic treatment of asthma in adults and pediatric patients who are 12 months of age and older[L6301], although other regional health authorities specifically note this indication for adults and adolescents who are 15 years and older[L6304,L6307] and also include indications for preventing day and night-time symptoms, and the treatment of acetylsalicylic acid-sensitive asthma[L6304];



(b) the prevention of exercise-induced bronchoconstriction (EIB) in patients who are 6 years of age and older[L6301], although other regional health authorities specifically note this indication for adults and adolescents who are 15 years and older[L6304,L6307]; and



(c) the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older[L6301], although other regional health authorities specifically note the relief of seasonal allergic rhinitis symptoms for adults and adolescents who are 15 years and older[L6304,L6307].



Furthermore, some formulations like chewable montelukast tablets may also be specifically indicated by particular regulatory bodies for the prophylaxis and chronic treatment of asthma, including the prevention of day and night-time symptoms, the treatment of acetylsalicylic acid based asthma, and the prevention of exercise-induced bronchoconstriction in adult and pediatric patients aged 2 and older[L6328], between the ages 2 and 5[L6325], or between the ages of 6 and 14 years.[L6331]



Moreover, when employed for such indications montelukast is considered effective as monotherapy or when combined with other medications indicated for the maintenance treatment of chronic asthma.[L6304,L6328] For instance, montelukast and inhaled corticosteroids can be used concomitantly to demonstrate additive effects to control asthma or to decrease the necessary inhaled corticosteroid dose while still maintaining clinical stability.[L6304,L6328]



Additionally, in patients who continue to experience asthma symptoms, montelukast can also be combined with an ''as required'' short-acting beta-agonist, an inhaled corticosteroid, or inhaled corticosteroid paired with a long-acting beta-agonist.[L6304,L6328]', 'Cysteinyl leukotrienes (CysLT) like LTC4, LTD4, and LTE4, among others, are eicosanoids released by a variety of cells like mast cells and eosinophils.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] When such CysLT bind to corresponding CysLT receptors like CysLT type-1 receptors located on respiratory airway smooth muscle cells, airway macrophages, and on various pro-inflammatory cells like eosinophils and some specific myeloid stem cells activities that facilitate the pathophysiology of asthma and allergic rhinitis are stimulated.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



In particular, CysLT-mediated airway bronchoconstriction, occluding mucous secretion, vascular permeability, and eosinophil recruitment are all types of effects that facilitate asthma.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Alternatively, in allergic rhinitis, CysLTs are released by the nasal mucosa when exposed to allergens during both early and late phase reactions and participate in eliciting symptoms of allergic rhinitis like a congested nose and airway.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



Subsequently, montelukast is a leukotriene receptor antagonist that binds with high affinity and selectivity to the CysLT type 1 receptor, which consequently assists in inhibiting any physiological actions of CysLTs like LTC4, LTD4, and LTE4 at the receptor that may facilitate asthma or allergic rhinitis.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]', 'Montelukast is a leukotriene receptor antagonist that demonstrates a marked affinity and selectivity to the cysteinyl leukotriene receptor type-1 in preference to many other crucial airway receptors like the prostanoid, cholinergic, or beta-adrenergic receptors.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] As a consequence, the agent can elicit substantial blockage of LTD4 leukotriene-mediated bronchoconstriction with doses as low as 5 mg.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Moreover, a placebo-controlled, crossover study (n=12) demonstrated that montelukast is capable of inhibiting early and late phase bronchoconstriction caused by antigen challenge by 75% and 57% respectively.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



In particular, it has been documented that montelukast can cause bronchodilation as soon as within 2 hours of oral administration.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] This action can also be additive to the bronchodilation caused by the concomitant use of a beta agonist.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Nevertheless, clinical investigations performed with adults 15 years of age and older revealed that no additional clinical benefit is obtained when doses of montelukast greater than 10 mg a day are used.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



Additionally, in clinical trials with adults and pediatric asthmatic patients aged 6 to 14 years, it was also determined that montelukast can reduce mean peripheral blood eosinophils by about 13% to 15% from baseline in comparison to placebo during double-blind treatment periods.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] At the same time, in patients aged 15 years and older who were experiencing seasonal allergic rhinitis, the use of montelukast caused a median reduction of 13% in peripheral blood eosinophil counts when compared to placebo as well.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10253, 'Sedokast 4mg 7 chewable tabs', 'سيدوكاست 4مجم 7 اقراص مضغ', '22', '11', 'Asthma.anti-inflammatory.leukotriene antagonist', 'Montelukast', 'Sedico', 'Tab', 'أقراص', '4mg', '1', 'علاج للربو.', NULL, '6221042121162', NULL, 2006, '2024-12-23', 0, 'Montelukast is indicated for:



(a) the prophylaxis and chronic treatment of asthma in adults and pediatric patients who are 12 months of age and older[L6301], although other regional health authorities specifically note this indication for adults and adolescents who are 15 years and older[L6304,L6307] and also include indications for preventing day and night-time symptoms, and the treatment of acetylsalicylic acid-sensitive asthma[L6304];



(b) the prevention of exercise-induced bronchoconstriction (EIB) in patients who are 6 years of age and older[L6301], although other regional health authorities specifically note this indication for adults and adolescents who are 15 years and older[L6304,L6307]; and



(c) the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older[L6301], although other regional health authorities specifically note the relief of seasonal allergic rhinitis symptoms for adults and adolescents who are 15 years and older[L6304,L6307].



Furthermore, some formulations like chewable montelukast tablets may also be specifically indicated by particular regulatory bodies for the prophylaxis and chronic treatment of asthma, including the prevention of day and night-time symptoms, the treatment of acetylsalicylic acid based asthma, and the prevention of exercise-induced bronchoconstriction in adult and pediatric patients aged 2 and older[L6328], between the ages 2 and 5[L6325], or between the ages of 6 and 14 years.[L6331]



Moreover, when employed for such indications montelukast is considered effective as monotherapy or when combined with other medications indicated for the maintenance treatment of chronic asthma.[L6304,L6328] For instance, montelukast and inhaled corticosteroids can be used concomitantly to demonstrate additive effects to control asthma or to decrease the necessary inhaled corticosteroid dose while still maintaining clinical stability.[L6304,L6328]



Additionally, in patients who continue to experience asthma symptoms, montelukast can also be combined with an ''as required'' short-acting beta-agonist, an inhaled corticosteroid, or inhaled corticosteroid paired with a long-acting beta-agonist.[L6304,L6328]', 'Cysteinyl leukotrienes (CysLT) like LTC4, LTD4, and LTE4, among others, are eicosanoids released by a variety of cells like mast cells and eosinophils.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] When such CysLT bind to corresponding CysLT receptors like CysLT type-1 receptors located on respiratory airway smooth muscle cells, airway macrophages, and on various pro-inflammatory cells like eosinophils and some specific myeloid stem cells activities that facilitate the pathophysiology of asthma and allergic rhinitis are stimulated.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



In particular, CysLT-mediated airway bronchoconstriction, occluding mucous secretion, vascular permeability, and eosinophil recruitment are all types of effects that facilitate asthma.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Alternatively, in allergic rhinitis, CysLTs are released by the nasal mucosa when exposed to allergens during both early and late phase reactions and participate in eliciting symptoms of allergic rhinitis like a congested nose and airway.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



Subsequently, montelukast is a leukotriene receptor antagonist that binds with high affinity and selectivity to the CysLT type 1 receptor, which consequently assists in inhibiting any physiological actions of CysLTs like LTC4, LTD4, and LTE4 at the receptor that may facilitate asthma or allergic rhinitis.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]', 'Montelukast is a leukotriene receptor antagonist that demonstrates a marked affinity and selectivity to the cysteinyl leukotriene receptor type-1 in preference to many other crucial airway receptors like the prostanoid, cholinergic, or beta-adrenergic receptors.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] As a consequence, the agent can elicit substantial blockage of LTD4 leukotriene-mediated bronchoconstriction with doses as low as 5 mg.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Moreover, a placebo-controlled, crossover study (n=12) demonstrated that montelukast is capable of inhibiting early and late phase bronchoconstriction caused by antigen challenge by 75% and 57% respectively.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



In particular, it has been documented that montelukast can cause bronchodilation as soon as within 2 hours of oral administration.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] This action can also be additive to the bronchodilation caused by the concomitant use of a beta agonist.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Nevertheless, clinical investigations performed with adults 15 years of age and older revealed that no additional clinical benefit is obtained when doses of montelukast greater than 10 mg a day are used.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



Additionally, in clinical trials with adults and pediatric asthmatic patients aged 6 to 14 years, it was also determined that montelukast can reduce mean peripheral blood eosinophils by about 13% to 15% from baseline in comparison to placebo during double-blind treatment periods.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] At the same time, in patients aged 15 years and older who were experiencing seasonal allergic rhinitis, the use of montelukast caused a median reduction of 13% in peripheral blood eosinophil counts when compared to placebo as well.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10268, 'Sekem baby calm herbs 15 filter bags', 'سيكم بيبي كالم 15 فلتر', '28', '25', 'Antispasmodic', 'Anise-caraway-chamomile-fennel fruit-liq', 'Atos pharma', 'Unknown', 'غير محدد', NULL, '1', 'اعشاب للرضع -- تخفيف تقلصات المعدة -- تخفيف الغازات والانتفاخات', NULL, '6223000471012', NULL, 1231, '2025-05-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10269, 'Sekem laxative 10 filter bags', 'سيكم اعشاب ملينة 10 اكياس', '25', '20', 'Drinks', 'Senna+liquorice+chamomile+fennel+dill+coriander+anise', 'Atos pharma', 'Unknown', 'غير محدد', NULL, '1', 'ملين -- علاج الامساك الشديد -- تقليل تقلصات المعدة', NULL, NULL, NULL, 1116, '2025-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10270, 'Sekem calm 15 filter bags', 'سيكم اعشاب مهدئة 15 فلتر', '28', '20', 'Drinks', 'Chamomile+marjoram+fennel+dill+anise+caraway+liquorice', 'Atos pharma', 'Unknown', 'غير محدد', NULL, '1', 'اعشاب مهدئة للمعدة -- تقليل الانتفاخات والغازات -- استرخاء الجسم -- تساعد علي النوم', NULL, NULL, NULL, 862, '2025-07-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10271, 'Sekem baby calm drink 200 gm jar', 'سيكم بيبي كالم درينك 200 جم برطمان', '100', NULL, 'Drinks', 'Fennel+chamomile+anise+caraway+lactose+maltodextrin', 'Atos pharma', 'Unknown', 'غير محدد', '200 gm', '1', NULL, NULL, NULL, NULL, 702, '2022-12-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10275, 'Sekem diarrhoea herbs 10 filter bags', 'سيكم اعشاب للاسهال 10 فلتر', '8', NULL, 'Drinks', 'Achillea+basil+chamomile+chicory+hibiscus+verbascum+vine leaves', 'Atos pharma', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, '6223000470527', NULL, 820, '2022-12-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10284, 'Sekem lactagogue mother herbs 15 filter bags', 'سيكم اعشاب لادرار اللبن للام 15 كيس', '28', '20', 'Drinks', 'Anise+caraway+chamomile+dill+fennel+fenugreek+nettle', 'Atos pharma', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 813, '2025-06-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10298, 'Sildenamax 100mg 24 tablet', 'سيلديناماكس 100مجم 24 قرص', '258', NULL, 'Tonic for men', 'Sildenafil', 'Egpi > heropharm', 'Tablet', 'أقراص', '100mg', '3', 'مقوي للرجال', NULL, NULL, NULL, 1122, '2022-05-21', 0, 'Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor that is predominantly employed for two primary indications:



(1) the treatment of erectile dysfunction [A175582, L5611, F3853, F3856, F3886]; and



(2) treatment of pulmonary hypertension, where:

a) the US FDA specifically indicates sildenafil for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical worsening [F3850]. The delay in clinical worsening was demonstrated when sildenafil was added to background epoprostenol therapy [F3850]. Studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with New York Heart Association (NYHA) Functional Class II-III symptoms and idiopathic etiology (71%) or associated with connective tissue disease (CTD) (25%) [F3850];



b) the Canadian product monograph specifically indicates sildenafil for the treatment of primary pulmonary arterial hypertension (PPH) or pulmonary hypertension secondary to connective tissue disease (CTD) in adult patients with WHO functional class II or III who have not responded to conventional therapy [F3859]. In addition, improvement in exercise ability and delay in clinical worsening was demonstrated in adult patients who were already stabilized on background epoprostenol therapy [F3859]; and



c) the EMA product information specifically indicates sildenafil for the treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity [F3883]. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease [F3883]. The EMA label also indicates sildenafil for the treatment of pediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension [F3883]. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease [F3883].', 'Sildenafil is an oral therapy for erectile dysfunction [A175582, F3853, F3856, F3886, L5611]. In the natural setting, i.e. with sexual stimulation, it restores impaired erectile function by increasing blood flow to the penis [A175582, F3853, F3856, F3886, L5611].



The physiological mechanism responsible for the erection of the penis involves the release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation [A175582, F3853, F3856, F3886, L5611]. Nitric oxide then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood [A175582, F3853, F3856, F3886, L5611].



Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) in the corpus cavernosum, where PDE5 is responsible for degradation of cGMP [A175582, F3853, F3856, F3886, L5611]. Sildenafil has a peripheral site of action on erections [A175582, F3853, F3856, F3886, L5611]. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum but potently enhances the relaxant effect of NO on this tissue [A175582, F3853, F3856, F3886, L5611]. When the NO/cGMP pathway is activated, as occurs with sexual stimulation, inhibition of PDE5 by sildenafil results in increased corpus cavernosum levels of cGMP [A175582, F3853, F3856, F3886, L5611]. Therefore sexual stimulation is required in order for sildenafil to produce its intended beneficial pharmacological effects [A175582, F3853, F3856, F3886, L5611].



Moreover, apart from the presence of PDE5 in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature [A175579, F3850, F3859, F3883, L5614]. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation [A175579, F3850, F3859, F3883, L5614]. In patients with pulmonary arterial hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemic circulation [A175579, F3850, F3859, F3883, L5614].', 'In vitro studies have shown that sildenafil is selective for phosphodiesterase-5 (PDE5) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Its effect is more potent on PDE5 than on other known phosphodiesterases [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. In particular, there is a 10-times selectivity over PDE6 which is involved in the phototransduction pathway in the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. There is an 80-times selectivity over PDE1, and over 700-times over PDE 2, 3, 4, 7, 8, 9, 10 and 11 [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. And finally, sildenafil has greater than 4,000-times selectivity for PDE5 over PDE3, the cAMP-specific phosphodiesterase isoform involved in the control of cardiac contractility [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In eight double-blind, placebo-controlled crossover studies of patients with either organic or psychogenic erectile dysfunction, sexual stimulation resulted in improved erections, as assessed by an objective measurement of hardness and duration of erections (via the use of RigiScan®), after sildenafil administration compared with placebo [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Most studies assessed the efficacy of sildenafil approximately 60 minutes post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The erectile response, as assessed by RigiScan®, generally increased with increasing sildenafil dose and plasma concentration [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The time course of effect was examined in one study, showing an effect for up to 4 hours but the response was diminished compared to 2 hours [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Sildenafil causes mild and transient decreases in systemic blood pressure which, in the majority of cases, do not translate into clinical effects [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with systemic hypertension the mean change from baseline in systolic and diastolic blood pressure was a decrease of 9.4 mmHg and 9.1 mmHg respectively [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with pulmonary arterial hypertension lesser effects in blood pressure reduction were observed (a reduction in both systolic and diastolic pressure of 2 mmHg)[F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614] . At the recommended dose of 20 mg three times a day no reductions in systolic or diastolic pressure were seen [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Single oral doses of sildenafil up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg three times a day to patients with pulmonary arterial hypertension no clinically relevant effects on the ECG were reported either [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In a study of the hemodynamic effects of a single oral 100 mg dose of sildenafil in 14 patients with severe coronary artery disease (CAD) (> 70 % stenosis of at least one coronary artery), the mean resting systolic and diastolic blood pressures decreased by 7 % and 6 % respectively compared to baseline [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Mean pulmonary systolic blood pressure decreased by 9% [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil showed no effect on cardiac output and did not impair blood flow through the stenosed coronary arteries [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Mild and transient differences in color discrimination (blue/green) were detected in some subjects using the Farnsworth-Munsell 100 hue test at 1 hour following a 100 mg dose, with no effects evident after 2 hours post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The postulated mechanism for this change in color discrimination is related to inhibition of PDE6, which is involved in the phototransduction cascade of the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil has no effect on visual acuity or contrast sensitivity. In a small size placebo-controlled study of patients with documented early age-related macular degeneration (n = 9), sildenafil (single dose, 100 mg) demonstrated no significant changes in visual tests conducted (which included visual acuity, Amsler grid, color discrimination simulated traffic light, and the Humphrey perimeter and photostress test) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10299, 'Selectival 20 capsules', 'سيليكتيفال 20 كبسولة', '100', '30', 'Liver support supplements', 'Vitamin c+vitamin e+selenium+zinc+vitamin b12+silymarin+dandelion+folic acid', 'Egyphar', 'Capsule', 'كبسولة', NULL, '2', NULL, 'selectival is formulated of different highly selected components each of them individually and i or together with other components of selectival plays an essential role in preserving and protecting liver cells from different harmful and threatening factor', '6224001026423', NULL, 2907, '2024-06-01', 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10301, 'Selenium vit 30 tablets', 'سيلينيوم فيت 30 قرص', '100', NULL, 'Multivitamins', 'Vitamin A+vitamin E+vitamin C+selenium', 'Jedco', 'Tablet', 'أقراص', NULL, '3', 'فيتامينات متعددة', NULL, NULL, NULL, 5020, '2023-02-05', 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10302, 'Selenium daily vit 30 tabs', 'سيلنيوم ديلي فيت 30 قرص', '100', '95', 'Multivitamins', 'Selenium+vitamin a+vitamin e+vitamin c', 'Zoser pharma', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 1468, '2024-07-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10303, 'Selgon 40mg/ml oral drops 15 ml', 'سيلجون نقط فم 15 مل', '16', NULL, 'Anti-cough', 'Pipazethate', 'Eipico', 'Drops', 'نقط', '40mg', '1', NULL, 'indication for the treatment of cough. pharmacodynamics antitussive agents act centrally on the medullary cough center.', '6221032230188', NULL, 1229, '2022-12-13', 0, 'For the treatment of cough.', NULL, 'Antitussive agents act centrally on the medullary cough center.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10304, 'Selgon 20mg 20 tabs.', 'سيلجون 20مجم 20 قرص', '30', '18', 'Anti-cough', 'Pipazethate', 'Eipico', 'Tab', 'أقراص', '20mg', '2', 'حالات الكحة الجافة', NULL, '6221032115058', NULL, 9945, '2024-10-24', 0, 'For the treatment of cough.', NULL, 'Antitussive agents act centrally on the medullary cough center.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10309, 'Selsun blue 118 ml balanced shampoo (n/a)', 'سيلسن بلو 118 مل شامبو', '35', NULL, 'Hair care', 'Selenium sulfide', 'Famar > ramco', 'Amp', 'أمبول', '118 ml', '1', 'شامبو لنظافة الشعر --الحفاظ علي الشعر من التلف', 'anti-dandruff shampoo', NULL, NULL, 851, '2023-04-28', 0, 'For treatment of tinea versicolor, tinea capitis, dandruff and seborrheic dermatitis of the scalp.', 'Topical selenium sulfide may act by an antimitotic action, resulting in a reduction in the turnover of epidermal cells. It also has local irritant, antibacterial, and mild antifungal activity, which may contribute to its effectiveness. An antimitotic mechanism of action is suggested by data showing that selenium sulfide decreases the rate of incorporation of radioactively labeled thymidine into the DNA of dermal epithelial cells. The following organisms are generally considered susceptible to selenium sulfide in vitro: <i>Malassezia furfur</i>, <i>Microsporum sp.</i> including <i>Microsporum audouinii</i> and <i>Microsporum canis</i>, <i>Pityrosporon sp.</i>, <i>Trichophyton sp.</i> including <i>Trichophyton schoenleinii</i> and <i>Trichophyton tonsurans</i>. Selenium sulfide has been shown to be sporicidal to <i>T. tonsurans</i>, the most common etiologic agent of tinea capitis. One in-vitro study demonstrated that 2.5% selenium sulfide was equivalent in sporicidal activity to both 1% and 2% zinc pyrithione.', 'Selenium sulfide is an antifungal agent often used in shampoos for the treatment of dandruff and seborrheic dermatitis. Selenium sulfide is highly active in inhibiting the growth of <i>P. ovale</i>. It is also a proven cytostatic agent, slowing the growth of both hyperproliferative and normal cells in dandruff and seborrheic dermatitis. A 0.6% micronized form of selenium sulfide is also safe and effective for dandruff.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10310, 'Selsun blue 207 ml dual action shampoo (n/a)', 'سيلسن بلو 207 مل شامبو', '48', NULL, 'Hair care', 'Selenium sulfide', 'Famar > ramco', 'Amp', 'أمبول', '207 ml', '1', NULL, 'anti-dandruff shampoo', NULL, NULL, 837, '2023-04-28', 0, 'For treatment of tinea versicolor, tinea capitis, dandruff and seborrheic dermatitis of the scalp.', 'Topical selenium sulfide may act by an antimitotic action, resulting in a reduction in the turnover of epidermal cells. It also has local irritant, antibacterial, and mild antifungal activity, which may contribute to its effectiveness. An antimitotic mechanism of action is suggested by data showing that selenium sulfide decreases the rate of incorporation of radioactively labeled thymidine into the DNA of dermal epithelial cells. The following organisms are generally considered susceptible to selenium sulfide in vitro: <i>Malassezia furfur</i>, <i>Microsporum sp.</i> including <i>Microsporum audouinii</i> and <i>Microsporum canis</i>, <i>Pityrosporon sp.</i>, <i>Trichophyton sp.</i> including <i>Trichophyton schoenleinii</i> and <i>Trichophyton tonsurans</i>. Selenium sulfide has been shown to be sporicidal to <i>T. tonsurans</i>, the most common etiologic agent of tinea capitis. One in-vitro study demonstrated that 2.5% selenium sulfide was equivalent in sporicidal activity to both 1% and 2% zinc pyrithione.', 'Selenium sulfide is an antifungal agent often used in shampoos for the treatment of dandruff and seborrheic dermatitis. Selenium sulfide is highly active in inhibiting the growth of <i>P. ovale</i>. It is also a proven cytostatic agent, slowing the growth of both hyperproliferative and normal cells in dandruff and seborrheic dermatitis. A 0.6% micronized form of selenium sulfide is also safe and effective for dandruff.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10313, 'Zofatrone 4 mg 5 orodispersible films', 'زوفاترون 4 مجم 5 افلام ذائبة بالفم', '160', '112.5', 'Antiemetic', 'Ondansetron', 'Eva pharma', 'Film', 'فيلم', '4 mg', '5', NULL, NULL, '6223007353861', NULL, 883, '2024-08-15', 0, 'In the adult patient population:

i) orally administered ondansetron tablets and orally disintegrating tablets (ODT) are indicated for:

- the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, including high dose (ie. greater than or equal to 50 mg/m2) cisplatin therapy, and radiotherapy, and

- the prevention and treatment of postoperative nausea and vomiting



ii) intravenously administered ondansetron injection formulations are indicated for:

- the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, including high dose (ie. greater than or equal to 50 mg/m2) cisplatin therapy, and

- the prevention and treatment of postoperative nausea and vomiting



In the pediatric (4-18 years of age) patient population:

i) ondansetron was effective and well tolerated when given to children 4-12 years of age for the treatment of post-chemotherapy induced nausea and vomiting,

ii) ondansetron tablets, ondansetron ODT, ondansetron injection are not indicated for the treatment of children 3 years of age or younger,

iii) ondansetron tablets, ondansetron ODT, ondansetron injection are not indicated for use in any age group of the pediatric population for the treatment of post-radiotherapy induced nausea and vomiting, and

iV) ondansetron tablets, ondansetron ODT, ondansetron injection are not indicated for use in any age group of the pediatric population for the treatment of postoperative nausea and vomiting



In the geriatric (>65 years of age) patient population:

i) efficacy and tolerance of ondansetron were similar to that observed in younger adults for the treatment of post-chemotherapy and radiotherapy-induced nausea and vomiting, and

ii) clinical experience in the use of ondansetron in the prevention and treatment of postoperative nausea and vomiting is limited and is not indicated for use in the geriatric patient population ', 'Ondansetron is a selective antagonist of the serotonin receptor subtype, 5-HT3 [F3178, F3181, F3184].



Cytotoxic chemotherapy and radiotherapy are associated with the release of serotonin (5-HT) from enterochromaffin cells of the small intestine, presumably initiating a vomiting reflex through stimulation of 5-HT3 receptors located on vagal afferents [F3178, F3181, F3184]. Ondansetron may block the initiation of this reflex. Activation of vagal afferents may also cause a central release of serotonin from the chemoreceptor trigger zone of the area postrema, located on the floor of the fourth ventricle [F3178, F3181, F3184]. Thus, the antiemetic effect of ondansetron is probably due to the selective antagonism of 5-HT3 receptors on neurons located in either the peripheral or central nervous systems, or both [F3178, F3181, F3184].



Although the mechanisms of action of ondansetron in treating postoperative nausea and vomiting and cytotoxic induced nausea and vomiting may share similar pathways, the role of ondansetron in opiate-induced emesis has not yet been formally established [F3181, F3184].', 'Ondansetron is a highly specific and selective serotonin 5-HT<sub>3</sub> receptor antagonist, not shown to have activity at other known serotonin receptors and with low affinity for dopamine receptors [FDA Label], [A1160, A1161]. The serotonin 5-HT<sub>3</sub> receptors are located on the nerve terminals of the vagus in the periphery, and centrally in the chemoreceptor trigger zone of the area postrema [FDA Label], [A1160, A1161]. The temporal relationship between the emetogenic action of emetogenic drugs and the release of serotonin, as well as the efficacy of antiemetic agents, suggest that chemotherapeutic agents release serotonin from the enterochromaffin cells of the small intestine by causing degenerative changes in the GI tract [FDA Label], [A1160, A1161]. The serotonin then stimulates the vagal and splanchnic nerve receptors that project to the medullary vomiting center, as well as the 5-HT<sub>3</sub> receptors in the area postrema, thus initiating the vomiting reflex, causing nausea and vomiting [FDA Label], [A1160, A1161].



Moreover, the effect of ondansetron on the QTc interval was evaluated in a double-blind, randomized, placebo and positive (moxifloxacin) controlled, crossover study in 58 healthy adult men and women [F3181, F3184]. Ondansetron was tested at single doses of 8 mg and 32 mg infused intravenously over 15 minutes [F3181, F3184]. At the highest tested dose of 32 mg, prolongation of the Fridericia-corrected QTc interval (QT/RR0.33=QTcF) was observed from 15 min to 4 h after the start of the 15 min infusion, with a maximum mean (upper limit of 90% CI) difference in QTcF from placebo after baseline-correction of 19.6 (21.5) msec at 20 min [F3181, F3184]. At the lower tested dose of 8 mg, QTc prolongation was observed from 15 min to 1 h after the start of the 15-minute infusion, with a maximum mean (upper limit of 90% CI) difference in QTcF from placebo after baseline-correction of 5.8 (7.8) msec at 15 min [F3181, F3184]. The magnitude of QTc prolongation with ondansetron is expected to be greater if the infusion rate is faster than 15 minutes [F3181, F3184]. The 32 mg intravenous dose of ondansetron must not be administered [F3181, F3184]. No treatment-related effects on the QRS duration or the PR interval were observed at either the 8 or 32 mg dose [F3181, F3184].



An ECG assessment study has not been performed for orally administered ondansetron [F3181, F3184]. On the basis of pharmacokinetic-pharmacodynamic modelling, an 8 mg oral dose of ondansetron is predicted to cause a mean QTcF increase of 0.7 ms (90% CI -2.1, 3.3) at steady-state, assuming a mean maximal plasma concentration of 24.7 ng/mL (95% CI 21.1, 29.0) [F3181, F3184]. The magnitude of QTc prolongation at the recommended 5 mg/m2 dose in pediatrics has not been studied, but pharmacokinetic-pharmacodynamic modeling predicts a mean increase of 6.6 ms (90% CI 2.8, 10.7) at maximal plasma concentrations [F3181, F3184]. 



In healthy subjects, single intravenous doses of 0.15 mg/kg of ondansetron had no effect on esophageal motility, gastric motility, lower esophageal sphincter pressure, or small intestinal transit time [F3178]. Multiday administration of ondansetron has been shown to slow colonic transit in healthy subjects [F3178]. Ondansetron has no effect on plasma prolactin concentrations [F3178].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10314, 'Semprex 8mg 24 caps.', 'سيمبريكس 8مجم 24 كبسولة', '19', NULL, 'Antihistamine.second-generation', 'Acrivastine', 'Glaxo smithkline', 'Cap', 'كبسولة', '8mg', '2', NULL, 'description: a non-sedating antihistamine indication : relieving the symptoms of nasal allergies (allergic rhinitis) such as hay fever. relieving the symptoms of an itchy skin rash with no known cause (chronic idiopathic urticaria). mechanism of action :', '6221045000471', NULL, 871, '2022-12-26', 0, 'For the relief of symptoms associated with seasonal allergic rhinitis such as sneezing, rhinorrhea, pruritus, lacrimation, and nasal congestion.', NULL, NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10318, 'Senna-lax 30 tab.', 'سنالاكس 30 قرص', '48', '29.25', 'Laxative', 'Sennoside', 'El nile.', 'Tab', 'أقراص', NULL, '3', NULL, NULL, '6221077020218', NULL, 3493, '2025-12-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10319, 'Narji hair tonic lotion 120 ml', 'نارجي لوشن مقوي للشعر 120 مل', '247', '190', 'Hair tonic.hair fall', 'Keratin+panthenol+lactic acid+tea tree oil+caffeine', 'Egyptian co. for cosmetics', 'Lotion', 'لوشن', '120 ml', '1', NULL, NULL, NULL, NULL, 1247, '2024-09-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10320, 'Sensicare cream 50 gm', 'سينسيكير كريم 50 جم', '98', '85', 'Topical care', 'Propolis+panthenol+soya protein+chamomile', 'Leader cosmetics > original pharma group', 'Cream', 'كريم', '50 gm', '1', 'يستخدم بشكل موضعي لتحسين شكل وملمس الجلد كي يعود لملمسه الطبيعي', 'for normal skin structure', NULL, NULL, 1322, '2025-02-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10321, 'Strakopina 2.5 mg 30 f.c. tabs.', 'ستراكوبينا 2.5 مجم 30 قرص', '444', '336', 'Anticoagulant', 'Apixaban', 'Global napi pharmaceuticals > global advanced pharmaceutical (gap)', 'Tab', 'أقراص', '2.5 mg', '3', NULL, NULL, '6223005940155', NULL, 1294, '2024-07-20', 0, 'Apixaban is indicated for reducing the risk of stroke and systemic embolism in patients who have nonvalvular atrial fibrillation, prophylaxis of deep vein thrombosis(DVT) leading to pulmonary embolism(PE) in patients after a hip or knee replacement surgery, and treatment of DVT and PE to reduce the risk of recurrence[Label,A177565,A6897].', 'Apixaban selectively inhibits factor Xa in its free and bound forms, independant of antithrombin III[Label]. Apixaban also inhibits prothrominase[Label]. These effects prevent the formation of a thrombus[Label].', 'Apixaban selectively inhibits factor Xa in its free and bound forms, independant of antithrombin III[Label]. Apixaban also inhibits prothrominase[Label]. These effects prevent the formation of a thrombus[Label].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10324, 'Septazole 1 strip', 'سبتازول 1 شريط', '17', '11.45', 'Antibiotic', 'Sulphamethoxazole+trimethoprim', 'Alexandria', 'Unknown', 'غير محدد', NULL, '1', 'مضاد حيوى يستخدم لعلاج حالات عدوى الجهاز البولي. التهاب الأذن الوسطى الحاد في الأطفال. المضاعفات الحادة لحالات التهاب القصبات المزمن في البالغين', NULL, NULL, NULL, 21503, '2025-05-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10325, 'Protopan 40 mg 14 caps.', 'بروتوبان 40مجم 14 كبسولة', '49', NULL, 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Pharopharma', 'Cap', 'كبسولة', '40 mg', '2', NULL, NULL, '6221094000583', NULL, 1152, '2023-04-24', 0, 'Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome. ', 'Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect that persists longer than 24 hours.[FDA Label]

', 'Esomeprazole is a compound that inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and <i>H. pylori</i> eradication to reduce the risk of duodenal ulcer recurrence. Esomeprazole belongs to a new class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonistic properties, but that suppress gastric acid secretion by specific inhibition of the H<sup>+</sup>/K<sup>+</sup> ATPase at the secretory surface of the gastric parietal cell. By doing so, it inhibits acid secretion into the gsatric lumen. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.



Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 



PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10326, 'Septazole forte 800/160mg 20 tab.', 'سيبتازول فورت 20 قرص', '18', NULL, 'Antibiotic', 'Sulphamethoxazole+trimethoprim', 'Alexandria', 'Tab', 'أقراص', '160mg', '2', 'مضاد حيوي . أدوية السلفا', NULL, NULL, NULL, 2774, '2022-12-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10329, 'Septocid antiseptic solution 120 ml', 'سيبتوسيد محلول مطهر 120مل', '4', NULL, 'Antiseptic', 'Cetrimide+dichloroxylenol', 'Cid', 'Solution', 'محلول', '120 ml', '1', NULL, NULL, '6221043012025', NULL, 956, '2022-12-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10333, 'Septoral gargle 120 ml', 'سيبتورال مضمضة 120مل', '4', NULL, 'Oral care', 'Cetrimide+lidocaine', 'Cid', 'Gargle', 'غرغرة', '120 ml', '1', NULL, 'is used to obtain a local anaesthesia of the lining of the inside of the mouth (buccal mucosa). it contains two active ingredients: ï- lidocaine a local anaesthetic which numbs the painful area temporarily ï- cetrimide an antiseptic which kills any micro?', '6221043012117', NULL, 1028, '2022-12-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10334, 'Septrin d.s 10 coated tab.', 'سبترين دي اس اقراص مضاعف قوة 10 قرص', '28', '18', 'Antibiotic', 'Sulphamethoxazole+trimethoprim', 'Glaxo smithkline', 'Tab', 'أقراص', NULL, '1', 'مضاد حيوي من عائلة السلفا', NULL, '6091403220397', NULL, 15174, '2024-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10335, 'Septrin paediatric 200/40 susp. 120ml', 'سبترين معلق للاطفال 120 مل', '32', '16', 'Antibiotic', 'Sulphamethoxazole+trimethoprim', 'Glaxo smithkline', 'Susp', 'معلق', '120ml', '1', 'مضاد حيوي', NULL, '6091403220403', NULL, 4420, '2024-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10337, 'Seralone -e 30 capsules', 'سيرالون - اي 30 كبسولة', '26', NULL, 'Liver support', 'Milk thistle+vitamin e', 'Hochster pharmaceutical industries', 'Capsule', 'كبسولة', NULL, '3', NULL, NULL, '6224007751053', NULL, 699, '2022-12-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10339, 'Hanza 2 in 1 correcting eye cream 30 gm', 'هانزا 2 في 1 كريم تصحيح لمحيط العين 30 جم', '130', NULL, NULL, NULL, 'Hanza pharma', 'Cream', 'كريم', '30 gm', '1', NULL, NULL, NULL, NULL, 620, '2022-08-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10340, 'Lodi-rose whitening cream 100gram', 'لودي روز كريم تبييض وتفتيح البشرة 100 جم', '195', NULL, 'Whitening cream', 'Alpha-arbutin+vit e+vit c+vit a+licorice extract+kojic acid+vit b3+glycerin+caviar extract+bearberry extract+hyaluronic acid+collagen+titanuim dioxide+zinc oxide+shea butter+sodium hydroxide+caffeine', 'Optavit pharma', 'Cream', 'كريم', NULL, '1', NULL, NULL, NULL, NULL, 693, '2022-08-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10341, 'Grantochizan 400 mg 20 caps', 'جرانتوشيزان 400مجم 20 كبسولة', '135', NULL, 'Dietary supplement', 'Chromium+chitosan', 'Grand egypt pharma', 'Cap', 'كبسولة', '400 mg', '2', NULL, NULL, NULL, NULL, 2419, '2022-08-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10342, 'Eucal herbal oil 75 ml', 'يوكال هيربال اويل 75 مل', '45', NULL, 'Massage', 'Eucalyptus globulus+gaultheria procumbens+salvia officinalis+cassia angustifolia+colchicum+centaureu', 'El-dawlia co. > el-sisi international co.', 'Oil', 'زيت', '75 ml', '1', NULL, NULL, NULL, NULL, 838, '2022-08-16', 0, 'As an active agent, eucalyptus oil has been indicated for relief of the symptoms of catarrhal colds, and/or the relief of the symptoms of minor muscular sprains and cramps [L1857].', 'The general consensus is that the exact mechanism of action of eucalyptus oil is largely unknown at this time but comprises various hypotheses from various studies.



Cineol containing preparations of eucalyptus oil may contain up to 80% (or more) 1,8-cineole [A32243] and is one of the most common types of eucalyptus oil formulations used. As an active agent indicated for relieving certain cold symptoms and/or certain muscular sprains and cramps, it is believed that eucalyptus oil may possess some antimicrobial and anti-inflammatory activities.



Some in vitro studies of human blood monocytes suggest a dose-dependent effect of eucalyptus oil to elicit significant inhibition of multiple cytokines, perhaps in the treatment of airway inflammation [A32244, A32245]. Moreover, other studies in animal models discuss the possibility of eucalyptus oil demonstrating anti-inflammatory and anti-nociceptive effects that potentially account for inhibiting the formation of prostaglandins and cytokines by stimulated monocytes in vitro [A32246, A32247].



Furthermore, additional studies have observed eucalyptus oil anti-viral activity against herpes simplex virus (HSV-1, HSV-2) in cell cultures as well as the demonstration of broad antimicrobial activity of eucalyptus medicinal plant extracts against Alicyclobacillus acidoterretris, Bacillus cereus, E. coli, Enterococcus faecalis, MRSA, Propionibacterium acnes, S. aureus, fungus including C. albicans isolates, Trichophyton mentagrophytes, and other Gram-positive bacteria. Specific activity against periodontopathic bacteria, such as Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans, Fusobacterium nucleatum, Streptococcus mutans, and Streptococcus sobrinus has also been observed [A32250, A32251, A32252, A32253, A32254].', 'Lipophilic monoterpene formulations of eucalyptus oil appear to be readily absorbed orally, with a primarily oxidative metabolism that might necessitate induction of the cytochrome P450 enzyme system and subsequent urinary excretion [A32236]. Gastrointestinal absorption of eucalyptus appears to be rapid and may be enhanced by the intake of lipids and milk. 1,8-cineole (which makes up to as much as 90% of most commonly used cineole-based eucalyptus oils) [A32227] has also been found in vitro and in animals to possess cytochrome P450 inducing activity [A32237, A32238, A32239].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10343, 'Enov nutibutter 200gm 10 sachets', 'اينوف نوتيباتر 200 جم 10 اكياس', '149', '112', 'Multivitamin', 'Vitamins(a+d3+e+c+b1+b2+b6+b12)+folic acid+niacin+iodine+selenium+iron+copper+zinc', 'Zeta pharm', 'Sachet', 'أكياس', '200gm', '1', NULL, NULL, NULL, NULL, 863, '2023-08-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10345, 'Seretide diskus 250/50mcg 28 doses', 'سيريتايد ديسكس 250/50مكجم 28 جرعة', '257', '184', 'Bronchodilator.glucocorticoid steroid and long-acting b2 agonist', 'Fluticasone+salmeterol', 'Glaxo smithkline > modern pharma', 'Unknown', 'غير محدد', '50mcg', '1', NULL, 'about fluticasone synthetic topical glucocorticoid anti inflammatory and antipruritic in corticosteroid-responsive dermatoses; atopic dermatitis. mechanism of action of fluticasone it reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes b', NULL, NULL, 1790, '2025-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10347, 'Seretide diskus 500/50mcg 60 doses', 'سيريتايد ديسكس 500/50مكجم 60 جرعة', '411', '316', 'Bronchodilator.glucocorticoid steroid and long-acting b2 agonist', 'Fluticasone+salmeterol', 'Glaxo smithkline > modern pharma', 'Unknown', 'غير محدد', '50mcg', '1', NULL, 'about fluticasone synthetic topical glucocorticoid anti inflammatory and antipruritic in corticosteroid-responsive dermatoses; atopic dermatitis. mechanism of action of fluticasone it reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes b', NULL, NULL, 8914, '2024-12-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10348, 'Flagoshown 20 mg 5 f.c. tabs.', 'فلاجوشون 20مجم 5 اقراص', '105', NULL, 'Tonic for men', 'Tadalafil', 'Adwia', 'Tab', 'أقراص', '20 mg', '5', 'مقوي للانتصاب للرجال', NULL, '6223002974849', NULL, 10889, '2024-05-16', 0, 'Tadalafil is indicated for the treatment of erectile dysfunction (ED) and either alone or in combination with [finasteride] for the treatment of benign prostatic hypertrophy (BPH).[L39095,L39439] It is also indicated for the treatment of pulmonary arterial hypertension (PAH) both alone and in combination with [macitentan] or other endothelin-1 antagonists.[L39100,L39105,L50622]', 'Tadalafil is a selective phosphodiesterase-5 (PDE5) inhibitor that produces several downstream effects with the most common therapeutic effect being smooth muscle relaxation. [L39095] Patients may experience ED due to a variety of causes including psychogenic, neurogenic, vasculogenic, iatrogenic, or endocrine. [A242392] These causes result in dysfunction of penile smooth muscle relaxation through either disrupted neuronal signaling or direct influence on smooth muscle cells. During sexual arousal, non-adrenergic non-cholinergic (NANC) neurons release nitric oxide (NO). Nitric oxide stimulates guanylate cyclase which converts guanosine triphosphate to cyclic guanosine monophosphate (cGMP).[A242287, A242377] cGMP activates the cGMP-dependent kinase (PKG) in a signal cascade which activates K+ channels leading to inhibition of Ca2+ channels, inhibits platelet activation, and inhibits smooth muscle cell proliferation while inducing apoptosis. This signal cascade is attenuated by PDE5 which breaks the phosphodiester bond of cGMP, converting it to GMP. Inhibition of PDE5 by tadalafil increases signaling via the PKG cascade which supports penile smooth muscle relaxation during sexual arousal by decreasing Ca2+ entry into smooth muscle cells. This smooth muscle relaxation allows blood to fill the corpus cavernosum thereby producing an erection.



In PAH, blood pressure in the pulmonary arteries is raised due to a variety of mechanisms stemming from endothelial dysfunction.[A242377] Decreased production of NO and prostacyclin reduce vasodilatory signaling while overproduction of endothelin-1 and thromboxane increase vasoconstriction. Inflammation, thromboses, and hypoxia later contribute to vascular remodeling which further reduces luminal size. The resultant increase in blood pressure reduces the capacity for gas exchange and increases afterload at the right ventricle, producing symptoms of dyspnea, fatigue, and dizziness as well as leading to right-sided heart failure. Tadalafil exerts its therapeutic effect in PAH through boosting NO-cGMP signaling to contribute to smooth muscle relaxation as with ED.



Lastly, tadalafil is used to treat BPH.[L39095] BPH produces urinary dysfunction through hyperproliferation of the epithelial and smooth muscle layers of the prostate.[A242382] The increased size of the prostate blocks urine flow through the urethra resulting in higher residual volumes due to incomplete emptying. Tadalafil does not appear to exert its benefit via smooth muscle relaxation of the prostate. It may instead exert its effect through a mix of increased oxygenation and decreased inflammation, which decreases tissue remodeling, and inhibition of cell proliferation through the cGMP cascade.



The decreased affinity for PDE6 compared to other PDE5 inhibitors may explain the decreased incidence of visual side effects as PDE6 is present in the eye and contributes to color vision.[L39100, L39105, A242287]', 'Tadalafil exerts a therapeutic effect in ED by increasing sexual stimulation-dependant smooth muscle relaxation in the penis, allowing the corpus cavernosum to fill with blood to produce an erection.[A242287, A242377] Smooth muscle relaxation in the pulmonary vasculature helps to produce vasodilation in PAH which reduces blood pressure in the pulmonary arteries.[A242377] In BPH, tadalafil may contribute to decreased smooth muscle cell proliferation which may reduce the size of the prostate and relieve the anatomical obstruction which produces urinary symptoms of BPH.[A242382] The decreased affinity of tadalafil for PDE6 compared to other PDE5 inhibitors may explain the reduced incidence of visual side effects.[L39100, L39105, A242287]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10349, 'Ogiva cream 60 gm', 'اوجيفا كريم 60 جم', '105', NULL, NULL, NULL, 'Company', 'Cream', 'كريم', '60 gm', '1', 'موسع للشعب الهوائية', NULL, NULL, NULL, 822, '2024-05-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10352, 'Serigabtin 75 mg 20 caps.', 'سيريجابتن 75 مجم 20 قرص', '58', NULL, 'Anti-epileptic.gaba analogs', 'Pregabalin', 'Sedico > serio pharm-egypt', 'Cap', 'كبسولة', '75 mg', '2', 'علاج الصرع -- تقليل التشنجات التي تصاحب الصرع', NULL, '6225000092112', NULL, 1273, '2022-12-08', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10353, 'Serio topical lotion 120ml', 'سيريو لوسيون 120 مل', '20', NULL, 'Soothing', 'Zinc oxide+panthenol+menthol+thymol+chamomile extract+aloe vera extract+glycerin', 'Macro group pharmaceuticals', 'Lotion', 'لوشن', '120ml', '1', 'ملطف للجلد.', NULL, '6224000437596', NULL, 1010, '2022-12-08', 0, 'Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].  



', '**Zinc has three primary biological roles**: _catalytic_, _structural_, and _regulatory_. The catalytic and structural role of zinc is well established, and there are various noteworthy reviews on these functions. For example, zinc is a structural constituent in numerous proteins, inclusive of growth factors, cytokines, receptors, enzymes, and transcription factors for different cellular signaling pathways. It is implicated in numerous cellular processes as a cofactor for approximately 3000 human proteins including enzymes, nuclear factors, and hormones [L2096].



Zinc promotes resistance to epithelial apoptosis through cell protection (cytoprotection) against reactive oxygen species and bacterial toxins, likely through the antioxidant activity of the cysteine-rich metallothioneins [A32419].



In HL-60 cells (promyelocytic leukemia cell line), zinc enhances the up-regulation of A20 mRNA, which, via TRAF pathway, decreases NF-kappaB activation, leading to decreased gene expression and generation of tumor necrosis factor-alpha (TNF-alpha), IL-1beta, and IL-8 [A32418].



There are several mechanisms of action of zinc on acute diarrhea. Various mechanisms are specific to the gastrointestinal system: zinc restores mucosal barrier integrity and enterocyte brush-border enzyme activity, it promotes the production of antibodies and circulating lymphocytes against intestinal pathogens, and has a direct effect on ion channels, acting as a potassium channel blocker of adenosine 3-5-cyclic monophosphate-mediated chlorine secretion. Cochrane researchers examined the evidence available up to 30 September 2016 [L2106].



Zinc deficiency in humans decreases the activity of serum _thymulin_ (a hormone of the thymus), which is necessary for the maturation of T-helper cells. T-helper 1 (Th(1)) cytokines are decreased but T-helper 2 (Th(2)) cytokines are not affected by zinc deficiency in humans [A32417].



The change of _Th(1)_ to _Th(2)_ function leads to cell-mediated immune dysfunction. Because IL-2 production (Th(1) cytokine) is decreased, this causes decreased activity of natural-killer-cell (NK cell) and T cytolytic cells, normally involved in killing viruses, bacteria, and malignant cells [A32424]. 



In humans, zinc deficiency may lead to the generation of new CD4+ T cells, produced in the thymus. In cell culture studies (HUT-78, a Th(0) human malignant lymphoblastoid cell line), as a result of zinc deficiency, nuclear factor-kappaB (NF-kappaB) activation, phosphorylation of IkappaB, and binding of NF-kappaB to DNA are decreased and this results in decreased Th(1) cytokine production [A32417].



In another study, zinc supplementation in human subjects suppressed the gene expression and production of pro-inflammatory cytokines and decreased oxidative stress markers [A32424]. In HL-60 cells (a human pro-myelocytic leukemia cell line), zinc deficiency increased the levels of TNF-alpha, IL-1beta, and IL-8 cytokines and mRNA. In such cells, zinc was found to induce A20, a zinc finger protein that inhibited NF-kappaB activation by the tumor necrosis factor receptor-associated factor pathway. This process decreased gene expression of pro-inflammatory cytokines and oxidative stress markers [A32417].



The exact mechanism of zinc in acne treatment is poorly understood. However, zinc is considered to act directly on microbial inflammatory equilibrium and facilitate antibiotic absorption when used in combination with other agents. Topical zinc alone as well as in combination with other agents may be efficacious because of its anti-inflammatory activity and ability to reduce P. acnes bacteria by the inhibition of P. acnes lipases and free fatty acid levels [L2102].', 'Zinc is involved in various aspects of cellular metabolism. It has been estimated that approximately 10% of human proteins may bind zinc, in addition to hundreds of proteins that transport and traffic zinc. It is required for the catalytic activity of more than 200 enzymes, and it plays a role in immune function wound healing, protein synthesis, DNA synthesis, and cell division. Zinc is an essential element for a proper sense of taste and smell and supports normal growth and development during pregnancy, childhood, and adolescence. It is thought to have antioxidant properties, which may be protective against accelerated aging and helps to speed up the healing process after an injury; however, studies differ as to its effectiveness. Zinc ions are effective antimicrobial agents even if administered in low concentrations [L2211].



Studies on oral zinc for specific conditions shows the following evidence in various conditions [L2095]:



**Colds:** Evidence suggests that if zinc lozenges or syrup are taken within 24 hours after cold symptoms start, the supplement may shorten the length of colds. The use intranasal zinc has been associated with the loss of the sense of smell, in some cases long-term or permanently [L2095].



**Wound healing:** Patients with skin ulcers and decreased levels of zinc may benefit from oral zinc supplements [L2095]. 



**Diahrrea**: Oral zinc supplements can reduce the symptoms of diarrhea in children with low levels of zinc, especially in cases of malnutrition [L2095].

', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10355, 'Sermion 10mg 50 tab', 'سيرميون 10مجم 50 قرص', '32', NULL, 'Cerebral vasodilator', 'Nicergoline', 'Pfizer', 'Tab', 'أقراص', '10mg', '5', 'يحسن التدفق الدموي -- علاج الزهايمر', NULL, NULL, NULL, 912, '2022-05-19', 0, 'For the treatment of senile dementia, migraines of vascular origin, transient ischemia, platelet hyper-aggregability, and macular degeneration.', 'Nicergoline acts by inhibiting the postsynaptic alpha(1)-adrenoceptors on vascular smooth muscle. This inhibits the vasoconstrictor effect of circulating and locally released catecholamines (epinephrine and norepinephrine), resulting in peripheral vasodilation. Therefore the mechanism of Nicergoline is to increase vascular circulation in the brain, thereby enhancing the transmission of nerve signals across the nerve fibres, which secrete acetylcholine as a neural transmitter.', 'Nicergoline is a potent vasodilator (improves brain blood flow). On the cerebral level it prompts a lowering of vascular resistance, an increase in arterial flow and stimulates the use of oxygen and glucose. Nicergoline also improves blood circulation in the lungs and limbs and has been shown to inhibit blood platelet aggregation.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10356, 'Memzy 30 h.g cap', 'ميمزى 30 كبسولة جيلاتينية صلبة', '126', '96', 'Multivitamin', 'Iron 28 mg+vitamin c 60 mg+cyanocobalamin 8 mcg', 'Organix for dietary supplements > biotec', 'Cap', 'كبسولة', NULL, '3', NULL, NULL, '6225000603417', NULL, 2396, '2025-02-04', 0, 'For treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Also used to replenish body iron stores in Non-Dialysis Dependent-Chronic Kidney Disease (NDD-CKD) patients receiving or not receiving erythropoietin and in Hemodialysis Dependent (HDD-CKD) and Peritoneal Dialysis Dependent (PDD-CKD) - Chronic Kidney Disease patients receiving an erythropoietin.', 'After iron dextran is injected, the circulating iron dextran is removed from the plasma by cells of the reticuloendothelial system, which split the complex into its components of iron and dextran. The iron is immediately bound to the available protein moieties to form hemosiderin or ferritin, the physiological forms of iron, or to a lesser extent to transferrin. This iron which is subject to physiological control replenishes hemoglobin and depleted iron stores.', 'Iron dextran is a dark brown, slightly viscous sterile liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. It is for treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Iron is essential to the formation of hemoglobin and to the function and formation of other heme and nonheme compounds. Untreated depletion of iron stores leads to iron-deficient erythropoiesis and, in turn, to iron deficiency anemia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10357, 'Seroflo 250/25 mcg inhaler 120 doses', 'سيروفلو 250/25مكجم بخاخ 120 جرعة', '113', '98', 'Bronchodilator.short-acting b2 agonist', 'Fluticasone+salmeterol', 'Cipla ltd. - india > star international company', 'Inhaler', 'جهاز استنشاق', '25 mcg', '1', NULL, 'about fluticasone synthetic topical glucocorticoid anti inflammatory and antipruritic in corticosteroid-responsive dermatoses; atopic dermatitis. mechanism of action of fluticasone it reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes b', '8901117451056', NULL, 2734, '2023-11-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10358, 'Pregnamar plus 60 caps (marnys)', 'برجنامار بلس 60 كبسولة (مارنيز)', '450', NULL, NULL, NULL, 'Marnys', 'Cap', 'كبسولة', NULL, '1', NULL, NULL, NULL, NULL, 797, '2024-06-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10359, 'Seroquel 100mg 10 tab', 'سيروكويل 100مجم 10 اقراص', '117', '89', 'Psychiatric.antipsychotics', 'Quetiapine', 'Astra zeneca', 'Tab', 'أقراص', '100mg', '1', NULL, NULL, '5000455006843', NULL, 2394, '2024-11-25', 0, 'Quetiapine is used in the symptomatic treatment of schizophrenia.  In addition, it may be used for the management of acute manic or mixed episodes in patients with bipolar I disorder, as a monotherapy or combined with other drugs. It may be used to manage depressive episodes in bipolar disorder. In addition to the above indications, quetiapine is used in combination with antidepressant drugs for the treatment of major depression.[L8546]



Some off-label uses for this drug include the management of post-traumatic stress disorder (PTSD), generalized anxiety disorder, and psychosis associated with Parkinson''s disease.[A185438,A185447,T685]

', 'Although the mechanism of action of quetiapine is not fully understood, several proposed mechanisms exist. In schizophrenia, its actions could occur from the antagonism of dopamine type 2 (D2) and serotonin 2A (5HT2A) receptors. In bipolar depression and major depression, quetiapine''s actions may be attributed to the binding of this drug or its metabolite to the norepinephrine transporter. Additional effects of quetiapine, including somnolence, orthostatic hypotension, and anticholinergic effects, may result from the antagonism of H1 receptors, adrenergic α1 receptors, and muscarinic M1 receptors, respectively.[A2189,A185438,L8546]', 'Quetiapine improves the positive and negative symptoms of schizophrenia and major depression by acting on various neurotransmitter receptors, such as the serotonin and dopamine receptors. In bipolar disorder, it improves both depressive and manic symptoms.[A2189,A185441,A185444]



**A note on suicidality in young patients and administration in the elderly**



Quetiapine can cause suicidal thinking or behavior in children and adolescents and should not be given to children under 10 years of age. It is important to monitor for suicidality if this drug is given to younger patients. In addition, this drug is not indicated for the treatment of psychosis related to dementia due to an increased death rate in elderly patients taking this drug.[L8546]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10360, 'Seroquel 100mg 30 tab', 'سيروكويل 100مجم 30 قرص', '350', '267', 'Psychiatric.antipsychotics', 'Quetiapine', 'Astra zeneca', 'Tab', 'أقراص', '100mg', '3', NULL, NULL, '6223003270162', NULL, 1049, '2023-11-26', 0, 'Quetiapine is used in the symptomatic treatment of schizophrenia.  In addition, it may be used for the management of acute manic or mixed episodes in patients with bipolar I disorder, as a monotherapy or combined with other drugs. It may be used to manage depressive episodes in bipolar disorder. In addition to the above indications, quetiapine is used in combination with antidepressant drugs for the treatment of major depression.[L8546]



Some off-label uses for this drug include the management of post-traumatic stress disorder (PTSD), generalized anxiety disorder, and psychosis associated with Parkinson''s disease.[A185438,A185447,T685]

', 'Although the mechanism of action of quetiapine is not fully understood, several proposed mechanisms exist. In schizophrenia, its actions could occur from the antagonism of dopamine type 2 (D2) and serotonin 2A (5HT2A) receptors. In bipolar depression and major depression, quetiapine''s actions may be attributed to the binding of this drug or its metabolite to the norepinephrine transporter. Additional effects of quetiapine, including somnolence, orthostatic hypotension, and anticholinergic effects, may result from the antagonism of H1 receptors, adrenergic α1 receptors, and muscarinic M1 receptors, respectively.[A2189,A185438,L8546]', 'Quetiapine improves the positive and negative symptoms of schizophrenia and major depression by acting on various neurotransmitter receptors, such as the serotonin and dopamine receptors. In bipolar disorder, it improves both depressive and manic symptoms.[A2189,A185441,A185444]



**A note on suicidality in young patients and administration in the elderly**



Quetiapine can cause suicidal thinking or behavior in children and adolescents and should not be given to children under 10 years of age. It is important to monitor for suicidality if this drug is given to younger patients. In addition, this drug is not indicated for the treatment of psychosis related to dementia due to an increased death rate in elderly patients taking this drug.[L8546]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10361, 'Seroquel 200mg 30 tab', 'سيروكويل 200مجم 30 قرص', '429', '300', 'Psychiatric.antipsychotics', 'Quetiapine', 'Astra zeneca', 'Tab', 'أقراص', '200mg', '3', NULL, NULL, '6223003270179', NULL, 2366, '2024-04-09', 0, 'Quetiapine is used in the symptomatic treatment of schizophrenia.  In addition, it may be used for the management of acute manic or mixed episodes in patients with bipolar I disorder, as a monotherapy or combined with other drugs. It may be used to manage depressive episodes in bipolar disorder. In addition to the above indications, quetiapine is used in combination with antidepressant drugs for the treatment of major depression.[L8546]



Some off-label uses for this drug include the management of post-traumatic stress disorder (PTSD), generalized anxiety disorder, and psychosis associated with Parkinson''s disease.[A185438,A185447,T685]

', 'Although the mechanism of action of quetiapine is not fully understood, several proposed mechanisms exist. In schizophrenia, its actions could occur from the antagonism of dopamine type 2 (D2) and serotonin 2A (5HT2A) receptors. In bipolar depression and major depression, quetiapine''s actions may be attributed to the binding of this drug or its metabolite to the norepinephrine transporter. Additional effects of quetiapine, including somnolence, orthostatic hypotension, and anticholinergic effects, may result from the antagonism of H1 receptors, adrenergic α1 receptors, and muscarinic M1 receptors, respectively.[A2189,A185438,L8546]', 'Quetiapine improves the positive and negative symptoms of schizophrenia and major depression by acting on various neurotransmitter receptors, such as the serotonin and dopamine receptors. In bipolar disorder, it improves both depressive and manic symptoms.[A2189,A185441,A185444]



**A note on suicidality in young patients and administration in the elderly**



Quetiapine can cause suicidal thinking or behavior in children and adolescents and should not be given to children under 10 years of age. It is important to monitor for suicidality if this drug is given to younger patients. In addition, this drug is not indicated for the treatment of psychosis related to dementia due to an increased death rate in elderly patients taking this drug.[L8546]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10363, 'Seroquel 25mg 10 tab', 'سيروكويل 25مجم 10 اقراص', '45', '30', 'Psychiatric.antipsychotics', 'Quetiapine', 'Astra zeneca', 'Tab', 'أقراص', '25mg', '1', 'علاج انفصام الشخصية.', NULL, '6223003270247', NULL, 4627, '2024-07-29', 0, 'Quetiapine is used in the symptomatic treatment of schizophrenia.  In addition, it may be used for the management of acute manic or mixed episodes in patients with bipolar I disorder, as a monotherapy or combined with other drugs. It may be used to manage depressive episodes in bipolar disorder. In addition to the above indications, quetiapine is used in combination with antidepressant drugs for the treatment of major depression.[L8546]



Some off-label uses for this drug include the management of post-traumatic stress disorder (PTSD), generalized anxiety disorder, and psychosis associated with Parkinson''s disease.[A185438,A185447,T685]

', 'Although the mechanism of action of quetiapine is not fully understood, several proposed mechanisms exist. In schizophrenia, its actions could occur from the antagonism of dopamine type 2 (D2) and serotonin 2A (5HT2A) receptors. In bipolar depression and major depression, quetiapine''s actions may be attributed to the binding of this drug or its metabolite to the norepinephrine transporter. Additional effects of quetiapine, including somnolence, orthostatic hypotension, and anticholinergic effects, may result from the antagonism of H1 receptors, adrenergic α1 receptors, and muscarinic M1 receptors, respectively.[A2189,A185438,L8546]', 'Quetiapine improves the positive and negative symptoms of schizophrenia and major depression by acting on various neurotransmitter receptors, such as the serotonin and dopamine receptors. In bipolar disorder, it improves both depressive and manic symptoms.[A2189,A185441,A185444]



**A note on suicidality in young patients and administration in the elderly**



Quetiapine can cause suicidal thinking or behavior in children and adolescents and should not be given to children under 10 years of age. It is important to monitor for suicidality if this drug is given to younger patients. In addition, this drug is not indicated for the treatment of psychosis related to dementia due to an increased death rate in elderly patients taking this drug.[L8546]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10364, 'Seroquel xr 300mg 30 tab', 'سيروكويل اكس ار 300مجم 30 قرص', '759', '540', 'Psychiatric.antipsychotics', 'Quetiapine', 'Astra zeneca', 'Tab', 'أقراص', '300mg', '3', 'علاج الأمراض النفسية العصبية', NULL, '7321839781582', NULL, 1511, '2024-08-01', 0, 'Quetiapine is used in the symptomatic treatment of schizophrenia.  In addition, it may be used for the management of acute manic or mixed episodes in patients with bipolar I disorder, as a monotherapy or combined with other drugs. It may be used to manage depressive episodes in bipolar disorder. In addition to the above indications, quetiapine is used in combination with antidepressant drugs for the treatment of major depression.[L8546]



Some off-label uses for this drug include the management of post-traumatic stress disorder (PTSD), generalized anxiety disorder, and psychosis associated with Parkinson''s disease.[A185438,A185447,T685]

', 'Although the mechanism of action of quetiapine is not fully understood, several proposed mechanisms exist. In schizophrenia, its actions could occur from the antagonism of dopamine type 2 (D2) and serotonin 2A (5HT2A) receptors. In bipolar depression and major depression, quetiapine''s actions may be attributed to the binding of this drug or its metabolite to the norepinephrine transporter. Additional effects of quetiapine, including somnolence, orthostatic hypotension, and anticholinergic effects, may result from the antagonism of H1 receptors, adrenergic α1 receptors, and muscarinic M1 receptors, respectively.[A2189,A185438,L8546]', 'Quetiapine improves the positive and negative symptoms of schizophrenia and major depression by acting on various neurotransmitter receptors, such as the serotonin and dopamine receptors. In bipolar disorder, it improves both depressive and manic symptoms.[A2189,A185441,A185444]



**A note on suicidality in young patients and administration in the elderly**



Quetiapine can cause suicidal thinking or behavior in children and adolescents and should not be given to children under 10 years of age. It is important to monitor for suicidality if this drug is given to younger patients. In addition, this drug is not indicated for the treatment of psychosis related to dementia due to an increased death rate in elderly patients taking this drug.[L8546]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10365, 'Pranoso brandy spray 30 ml', 'برانوسو براندي سبراي 30 مل', '75', '70', 'Soothing.moisturizing', NULL, 'Company', 'Spray', 'بخاخ', '30 ml', '1', 'مضاد اكتئاب', NULL, NULL, NULL, 1166, '2025-07-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10366, 'Seroxat cr 12.5mg 30 f.c. tab', 'سيروكسات 12.5مجم 30 قرص', '242', '157.5', 'Psychiatric.antidepressants', 'Paroxetine', 'Glaxo smithkline', 'Tab', 'أقراص', '12.5mg', '3', NULL, NULL, NULL, NULL, 2360, '2024-10-24', 0, 'Paroxetine is indicated for the management of depression, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, posttraumatic stress disorder.[L3358] One form of paroxetine, commercially known as Brisdelle, is used to manage mild to moderate vasomotor symptoms of menopause.[L7703] Off-label, paroxetine may be used for the treatment of premature ejaculation or irritable bowel syndrome (IBS).[A1093,A181754,A181904]', 'Paroxetine enhances serotonergic activity via the inhibition presynaptic reuptake of serotonin by the serotonin (SERT) receptor.[A5492,A181772] This inhibition raises the level of serotonin in the synaptic cleft, relieving various symptoms. This drug has been demonstrated to be a stronger inhibitor of serotonin reuptake than other members of the same drug class, including [Citalopram], [Fluoxetine], and [Fluvoxamine].[A31914] The mechanism of action of paroxetine in relieving the vasomotor symptoms of menopause is unknown, according to the Brisdelle prescribing information[L7703], but may occur due to its effects on thermoregulation.[A181973]



Paroxetine shows a clinically insignificant affinity for adrenergic alpha-1 and alpha-2 receptors and β-adrenergic receptors, dopamine D1 and D2 receptors, histamine H1 receptors and serotonin 5-HT1A, 5-HT2A and 5-HT2C receptors.[A31914] This drug shows some affinity for muscarinic cholinergic receptors and 5-H2B receptors.[A181829,A181847] The delayed onset of paroxetine therapeutic effects may be explained by the initial paroxetine actions on the 5-HT neurons.  In rats, paroxetine activates 5-HT1A receptors when it is first administered, inhibiting the stimulation of the  5-HT neurons and subsequent release of serotonin at the synaptic cleft.[A31914]', 'Paroxetine treats the symptoms of depression, various anxiety disorders, posttraumatic stress disorder, obsessive-compulsive disorder, and the vasomotor symptoms of menopause via the inhibition of serotonin reuptake.[T653,L3358,L7703] The onset of action of paroxetine is reported to be approximately 6 weeks.[A181874]



Due its serotonergic activity, paroxetine, like other SSRI drugs, may potentiate serotonin syndrome. This risk is especially high when monoamine oxidase (MAO) inhibitors are given within 2 weeks of paroxetine administration. Upon cessation of MAO inhibitors, a 2-week interval before paroxetine administration is recommended. Do not coadminister these agents.[T656]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10367, 'Seroxat cr 25mg 30 f.c. tab', 'سيروكسات سي ار 25مجم 30 قرص', '321', '210', 'Psychiatric.antidepressants', 'Paroxetine', 'Glaxo smithkline', 'Tab', 'أقراص', '25mg', '3', 'مضاد للاكتئاب', NULL, NULL, NULL, 6965, '2024-10-24', 0, 'Paroxetine is indicated for the management of depression, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, posttraumatic stress disorder.[L3358] One form of paroxetine, commercially known as Brisdelle, is used to manage mild to moderate vasomotor symptoms of menopause.[L7703] Off-label, paroxetine may be used for the treatment of premature ejaculation or irritable bowel syndrome (IBS).[A1093,A181754,A181904]', 'Paroxetine enhances serotonergic activity via the inhibition presynaptic reuptake of serotonin by the serotonin (SERT) receptor.[A5492,A181772] This inhibition raises the level of serotonin in the synaptic cleft, relieving various symptoms. This drug has been demonstrated to be a stronger inhibitor of serotonin reuptake than other members of the same drug class, including [Citalopram], [Fluoxetine], and [Fluvoxamine].[A31914] The mechanism of action of paroxetine in relieving the vasomotor symptoms of menopause is unknown, according to the Brisdelle prescribing information[L7703], but may occur due to its effects on thermoregulation.[A181973]



Paroxetine shows a clinically insignificant affinity for adrenergic alpha-1 and alpha-2 receptors and β-adrenergic receptors, dopamine D1 and D2 receptors, histamine H1 receptors and serotonin 5-HT1A, 5-HT2A and 5-HT2C receptors.[A31914] This drug shows some affinity for muscarinic cholinergic receptors and 5-H2B receptors.[A181829,A181847] The delayed onset of paroxetine therapeutic effects may be explained by the initial paroxetine actions on the 5-HT neurons.  In rats, paroxetine activates 5-HT1A receptors when it is first administered, inhibiting the stimulation of the  5-HT neurons and subsequent release of serotonin at the synaptic cleft.[A31914]', 'Paroxetine treats the symptoms of depression, various anxiety disorders, posttraumatic stress disorder, obsessive-compulsive disorder, and the vasomotor symptoms of menopause via the inhibition of serotonin reuptake.[T653,L3358,L7703] The onset of action of paroxetine is reported to be approximately 6 weeks.[A181874]



Due its serotonergic activity, paroxetine, like other SSRI drugs, may potentiate serotonin syndrome. This risk is especially high when monoamine oxidase (MAO) inhibitors are given within 2 weeks of paroxetine administration. Upon cessation of MAO inhibitors, a 2-week interval before paroxetine administration is recommended. Do not coadminister these agents.[T656]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10368, 'Iron-sq 20 capsules', 'ايرون اس كيو 20 كبسولة', '98', '66', 'Anemia-iron supplement combined with folic acid and vitamins', 'Iron+zinc+copper+folic acid+vitamin b6+vitamin b12', 'S and q pharma', 'Capsule', 'كبسولة', NULL, '2', NULL, NULL, NULL, NULL, 989, '2025-11-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10369, 'Sertral 50mg 10 tab.', 'سيرترال 50مجم 10 اقراص', '22', NULL, 'Psychiatric.antidepressants', 'Sertraline', 'Pharco', 'Tab', 'أقراص', '50mg', '1', NULL, NULL, '6223000013366', NULL, 961, '2022-12-08', 0, 'Sertraline is indicated for the management of major depressive disorder (MDD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), panic disorder (PD), premenstrual dysphoric disorder (PMDD), and social anxiety disorder (SAD).[L9016] Common off-label uses for sertraline include the prevention of post stroke depression[A187078], generalized anxiety disorder (GAD), fibromyalgia, premature ejaculation, migraine prophylaxis, diabetic neuropathy, and neurocardiogenic syncope.[L5227]

', 'Sertraline selectively inhibits the reuptake of serotonin (5-HT) at the presynaptic neuronal membrane, thereby increasing serotonergic activity. This results in an increased synaptic concentration of serotonin in the CNS, which leads to numerous functional changes associated with enhanced serotonergic neurotransmission.[T28,L9016] These changes are believed to be responsible for the antidepressant action and beneficial effects in obsessive-compulsive (and other anxiety related disorders). It has been hypothesized that obsessive-compulsive disorder, like depression, is also caused by the disregulation of serotonin.[A187165]



In animal studies, chronic administration of sertraline results in down-regulation of brain norepinephrine receptors.[L9016] Sertraline displays affinity for sigma-1 and 2 receptor binding sites[A31941], but binds with stronger affinity to sigma-1 binding sites.[A31940] In vitro, sertraline shows little to no affinity for GABA, dopaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors.[L9016] It exerts weak inhibitory actions on the neuronal uptake of norepinephrine and dopamine[A1844] and exhibits no inhibitory effects on the monoamine oxidase enzyme.[L9016]', 'Sertraline improves or relieves the symptoms of depression, OCD, post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder, and premenstrual dysphoric disorder via the inhibition of serotonin reuptake.[A187075,L9016] Clinical studies have shown that it improves cognition in depressed patients.[A1846] It has less sedative, anticholinergic, and cardiovascular effects than the tricyclic antidepressant drugs because it does not exert significant anticholinergic, antihistamine, or adrenergic (alpha1, alpha2, beta) blocking activity.[A1844] The onset of action and beneficial effects are usually noticed after 4-6 weeks, for reasons that are not fully understood and currently under investigation.[A188493,L10677]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10372, 'Sanso potassium 28 tabs', 'سانسو بوتاسيوم 28 قرص', '120', NULL, 'Potassium', 'Potassium', 'Aug pharma', 'Tab', 'أقراص', NULL, '4', NULL, NULL, '6223005465856', NULL, 1672, '2022-12-08', 0, 'For use as an electrolyte replenisher and in the treatment of hypokalemia.', 'Supplemental potassium in the form of high potassium food or potassium chloride may be able to restore normal potassium levels.', 'The potassium ion is in the principle intracellular cation of most body tissues. Potassium ions participate in a number of essential physiological processes including the maintenance of intracellular tonicity, the transmission of nerve impulses, the contraction of cardiac, skeletal and smooth muscle, and the maintenance of normal renal function. The intracellular concentration of potassium is approximately 150 to 160 mEq per liter. The normal adult plasma concentration is 3.5 to 5 mEq per liter. An active ion transport system maintains this gradient across the plasma membrane. Potassium is a normal dietary constituent and under steady-state conditions the amount of potassium absorbed from the gastrointestinal tract is equal to the amount excreted in the urine. The usual dietary intake of potassium is 50 to 100 mEq per day. Potassium depletion will occur whenever the rate of potassium loss through renal excretion and/or loss from the gastrointestinal tract exceeds the rate of potassium intake. Such depletion usually develops as a consequence of therapy with diuretics, primarily or secondary hyperaldosteronism, diabetic ketoacidosis, or inadequate replacement of potassium in patients on prolonged parenteral nutrition. Depletion can develop rapidly with severe diarrhea, especially if associated with vomiting. Potassium depletion due to these causes is usually accompanied by concomitant loss of chloride and is manifested by hypokalemia and metabolic alkalosis. Potassium depletion may produce weakness, fatigue, disturbances of cardiac rhythm (primarily ectopic beats), prominent U-waves in the electrocardiogram, and, in advanced cases, flaccid paralysis and/or impaired ability to concentrate urine. If potassium depletion associated with metabolic alkalosis cannot be managed by correcting the fundamental cause of the deficiency, e.g., where the patient requires long-term diuretic therapy, supplemental potassium in the form of high potassium food or potassium chloride may be able to restore normal potassium levels. In rare circumstances (e.g., patients with renal tubular acidosis) potassium depletion may be associated with metabolic acidosis and hyperchloremia. In such patients, potassium replacement should be accomplished with potassium salts other than the chloride, such as potassium bicarbonate, potassium citrate, potassium acetate, or potassium gluconate.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10377, 'Serviflox 250 mg 10 f.c.tab.', 'سرفيفلوكس 250مجم 10 اقراص', '18', NULL, 'Antibiotic.quinolone', 'Ciprofloxacin', 'Novartis', 'Tab', 'أقراص', '250 mg', '1', 'مضاد حيوي', 'about ciprofloxacin it is a broad spectrum fluoroquinolone with activity against pseudomonas aeruginosa. indications for ciprofloxacin 1.urinary tract infection 2.respiratory tract infection 3.bone and joint infections 4.infectious diarrhoea 5.gonorrhoea', '6223002640164', NULL, 1245, '2023-06-02', 0, 'Ciprofloxacin is only indicated in infections caused by susceptible bacteria.[L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493]



Ciprofloxacin immediate release tablets, oral suspensions, and intravenous injections are indicated for the treatment of skin and skin structure infections, bone and joint infections, complicated intra-abdominal infections, nosocomial pneumonia, febrile neutropenia, adults who have inhaled anthrax, plague, chronic bacterial prostatitis, lower respiratory tract infections including acute exacerbations of chronic bronchitis, urinary tract infections, complicated urinary tract infections in pediatrics, complicated pyelonephritis in pediatrics, and acute sinusitis.[L6481,L6478]



A ciprofloxacin otic solution and otic suspension with hydrocortisone are indicated for acute otitis externa.[L6469,L6484] Ciprofloxacin suspension with dexamethasone is indicated for acute otitis media in pediatric patients with tympanostomy tubes or acute otitis externa.[L6490] A ciprofloxacin intratympanic injection is indicated for pediatric patients with bilateral otitis media with effusion who are having tympanostomy tubes placed or pediatric patients 6 months or older with acute otitis externa.[L6493]



A ciprofloxacin eye drop is indicated for bacterial corneal ulcers and conjunctivitis.[L6472] A ciprofloxacin eye ointment is indicated for bacterial conjunctivitis.[L6475]



A ciprofloxacin extended release tablet is indicated for uncomplicated urinary tract infections, complicated urinary tract infections, and acute uncomplicated pyelonephritis.[L6487]', 'Ciprofloxacin acts on bacterial topoisomerase II (DNA gyrase) and topoisomerase IV.[A178885] Ciprofloxacin''s targeting of the alpha subunits of DNA gyrase prevents it from supercoiling the bacterial DNA which prevents DNA replication.[A178876,A178882]', 'Ciprofloxacin is a second generation fluoroquinolone that is active against many Gram negative and Gram positive bacteria.[A178870,L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493] It produces its action through inhibition of bacterial DNA gyrase and topoisomerase IV.[A178885] Ciprofloxacin binds to bacterial DNA gyrase with 100 times the affinity of mammalian DNA gyrase.[A178894] There is no cross resistance between fluoroquinolones and other classes of antibiotics, so it may be of clinical value when other antibiotics are no longer effective.[A178894] Ciprofloxain and its derivatives are also being investigated for its action against malaria, cancers, and AIDS.[A178885]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10378, 'Serviflox 500mg 10 f.c.tab.', 'سرفيفلوكس 500مجم 10 اقراص', '34', NULL, 'Antibiotic.quinolone', 'Ciprofloxacin', 'Novartis', 'Tab', 'أقراص', '500mg', '1', 'مضاد حيوي', 'about ciprofloxacin it is a broad spectrum fluoroquinolone with activity against pseudomonas aeruginosa. indications for ciprofloxacin 1.urinary tract infection 2.respiratory tract infection 3.bone and joint infections 4.infectious diarrhoea 5.gonorrhoea', '6223002640171', NULL, 2612, '2023-06-02', 0, 'Ciprofloxacin is only indicated in infections caused by susceptible bacteria.[L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493]



Ciprofloxacin immediate release tablets, oral suspensions, and intravenous injections are indicated for the treatment of skin and skin structure infections, bone and joint infections, complicated intra-abdominal infections, nosocomial pneumonia, febrile neutropenia, adults who have inhaled anthrax, plague, chronic bacterial prostatitis, lower respiratory tract infections including acute exacerbations of chronic bronchitis, urinary tract infections, complicated urinary tract infections in pediatrics, complicated pyelonephritis in pediatrics, and acute sinusitis.[L6481,L6478]



A ciprofloxacin otic solution and otic suspension with hydrocortisone are indicated for acute otitis externa.[L6469,L6484] Ciprofloxacin suspension with dexamethasone is indicated for acute otitis media in pediatric patients with tympanostomy tubes or acute otitis externa.[L6490] A ciprofloxacin intratympanic injection is indicated for pediatric patients with bilateral otitis media with effusion who are having tympanostomy tubes placed or pediatric patients 6 months or older with acute otitis externa.[L6493]



A ciprofloxacin eye drop is indicated for bacterial corneal ulcers and conjunctivitis.[L6472] A ciprofloxacin eye ointment is indicated for bacterial conjunctivitis.[L6475]



A ciprofloxacin extended release tablet is indicated for uncomplicated urinary tract infections, complicated urinary tract infections, and acute uncomplicated pyelonephritis.[L6487]', 'Ciprofloxacin acts on bacterial topoisomerase II (DNA gyrase) and topoisomerase IV.[A178885] Ciprofloxacin''s targeting of the alpha subunits of DNA gyrase prevents it from supercoiling the bacterial DNA which prevents DNA replication.[A178876,A178882]', 'Ciprofloxacin is a second generation fluoroquinolone that is active against many Gram negative and Gram positive bacteria.[A178870,L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493] It produces its action through inhibition of bacterial DNA gyrase and topoisomerase IV.[A178885] Ciprofloxacin binds to bacterial DNA gyrase with 100 times the affinity of mammalian DNA gyrase.[A178894] There is no cross resistance between fluoroquinolones and other classes of antibiotics, so it may be of clinical value when other antibiotics are no longer effective.[A178894] Ciprofloxain and its derivatives are also being investigated for its action against malaria, cancers, and AIDS.[A178885]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10379, 'Serviflox 750 mg 10 f.c. tab.', 'سرفيفلوكس 750 مجم 10 اقراص', '39', NULL, 'Antibiotic.quinolone', 'Ciprofloxacin', 'Novartis', 'Tab', 'أقراص', '750 mg', '1', 'مضاد حيوي لعلاج التهابات الجهاز البولي والتنفسي والعظام', 'about ciprofloxacin it is a broad spectrum fluoroquinolone with activity against pseudomonas aeruginosa. eye drops: it is a fluroquinolone antibacterial having broad spectrum of activity. indications for ciprofloxacin 1.urinary tract infection 2.respirato', '6223002640676', NULL, 1953, '2023-06-02', 0, 'Ciprofloxacin is only indicated in infections caused by susceptible bacteria.[L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493]



Ciprofloxacin immediate release tablets, oral suspensions, and intravenous injections are indicated for the treatment of skin and skin structure infections, bone and joint infections, complicated intra-abdominal infections, nosocomial pneumonia, febrile neutropenia, adults who have inhaled anthrax, plague, chronic bacterial prostatitis, lower respiratory tract infections including acute exacerbations of chronic bronchitis, urinary tract infections, complicated urinary tract infections in pediatrics, complicated pyelonephritis in pediatrics, and acute sinusitis.[L6481,L6478]



A ciprofloxacin otic solution and otic suspension with hydrocortisone are indicated for acute otitis externa.[L6469,L6484] Ciprofloxacin suspension with dexamethasone is indicated for acute otitis media in pediatric patients with tympanostomy tubes or acute otitis externa.[L6490] A ciprofloxacin intratympanic injection is indicated for pediatric patients with bilateral otitis media with effusion who are having tympanostomy tubes placed or pediatric patients 6 months or older with acute otitis externa.[L6493]



A ciprofloxacin eye drop is indicated for bacterial corneal ulcers and conjunctivitis.[L6472] A ciprofloxacin eye ointment is indicated for bacterial conjunctivitis.[L6475]



A ciprofloxacin extended release tablet is indicated for uncomplicated urinary tract infections, complicated urinary tract infections, and acute uncomplicated pyelonephritis.[L6487]', 'Ciprofloxacin acts on bacterial topoisomerase II (DNA gyrase) and topoisomerase IV.[A178885] Ciprofloxacin''s targeting of the alpha subunits of DNA gyrase prevents it from supercoiling the bacterial DNA which prevents DNA replication.[A178876,A178882]', 'Ciprofloxacin is a second generation fluoroquinolone that is active against many Gram negative and Gram positive bacteria.[A178870,L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493] It produces its action through inhibition of bacterial DNA gyrase and topoisomerase IV.[A178885] Ciprofloxacin binds to bacterial DNA gyrase with 100 times the affinity of mammalian DNA gyrase.[A178894] There is no cross resistance between fluoroquinolones and other classes of antibiotics, so it may be of clinical value when other antibiotics are no longer effective.[A178894] Ciprofloxain and its derivatives are also being investigated for its action against malaria, cancers, and AIDS.[A178885]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10381, 'Servipep 40mg 14 f.c. tab.', 'سيرفيبيب 40مجم 14 قرص', '18', NULL, 'Peptic ulcer.anti-histamine.h2 antagonist', 'Famotidine', 'Novartis', 'Tab', 'أقراص', '40mg', '2', NULL, NULL, '6223002640126', NULL, 963, '2022-12-08', 0, 'Famotidine is indicated in pediatric and adult patients (with the bodyweight of 40 kg and above) for the management of active duodenal ulcer (DU), active gastric ulcer, symptomatic non-erosive gastroesophageal reflux disease (GERD), and erosive esophagitis due to GERD, diagnosed by biopsy.[L11139]



It is also indicated in adult patients for the treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison Syndrome, multiple endocrine neoplasias) and reduction of the risk of DU recurrence.[L11139]



The intravenous formulation of famotidine is available for some hospitalized patients with pathological hypersecretory conditions or intractable ulcers or as an alternative to the oral dosage form for short-term use in patients who are unable to take oral medication.[L11142]



Over-the-counter famotidine is used for the management and prevention of heartburn caused by gastroesophageal reflux in children and adults. Off-label uses of famotidine include the reduction of NSAIDs-associated gastrointestinal effects, treatment of refractory urticarial, prevention of stress ulcer in critically-ill patients, and symptomatic relief of gastritis.[L11166,L11172]', 'Histamine acts as a local hormone that stimulates the acid output by parietal cells via a paracrine mechanism. Neuroendocrine cells called enterochromaffin-like (ECL) cells lie close to the parietal cells and regulate the basal secretion of histamine. Histamine release is also promoted from stimulation by acetylcholine and gastrin, a peptide hormone. Gastrin (G) cells release gastrin, which works on CCK<sub>2</sub> receptors on ECL cells. This action promotes the release of histamine from ECL cells. Upon release, histamine acts on H<sub>2</sub> receptors expressed on the basolateral membrane of parietal cells, leading to increased intracellular cAMP levels and activated proton pumps on parietal cells. Proton pump releases more protons into the stomach, thereby increasing the secretion of acid. [T28] In conditions that are associated with acid hypersecretion such as ulcers, there is a loss of regulation of acid secretion. Famotidine works on H<sub>2</sub> receptors and blocks the actions of histamine.[L11166]', 'Famotidine decreases the production of gastric acid, suppresses acid concentration and pepsin content, and decreases the volume of gastric secretion. Famotidine inhibits both basal and nocturnal gastric acid secretion, as well as acid secretion stimulated by food, caffeine, insulin, and pentagastrin.[L11139,L11142]



Famotidine has a dose-dependent therapeutic action, with the highest dose having the most extended duration of action and the highest inhibitory effect on gastric acid secretion. Following oral administration, the onset of action is within one hour, and the peak effect is reached within 1-3 hours. The duration of effect is about 10-12 hours.[A189459]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10386, 'Carnizonex 60 ml syrup', 'كارنيزونكس شراب 60 مل', '165', NULL, 'Multivitamin', 'L carnitine+co enzyme q 10+vitamin b5', 'Zoonix pharm', 'Syrup', 'شراب', '60 ml', '1', NULL, NULL, NULL, NULL, 1467, '2024-08-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10387, 'Seserine 50mg 30 tab.', 'سيسيرين 50مجم 30 قرص', '75', '60', 'Psychiatric.antidepressants', 'Sertraline', 'Adwia', 'Tab', 'أقراص', '50mg', '3', NULL, 'about sertraline selective serotonin reuptake inhibitor (ssri) antidepressant antidepressant mechanism of action of sertraline sertraline blocks the re-uptake of neurotransmitter serotonin from the synapse in to the presynaptic nerve terminal in the cns.', '6223002978106', NULL, 2547, '2024-11-09', 0, 'Sertraline is indicated for the management of major depressive disorder (MDD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), panic disorder (PD), premenstrual dysphoric disorder (PMDD), and social anxiety disorder (SAD).[L9016] Common off-label uses for sertraline include the prevention of post stroke depression[A187078], generalized anxiety disorder (GAD), fibromyalgia, premature ejaculation, migraine prophylaxis, diabetic neuropathy, and neurocardiogenic syncope.[L5227]

', 'Sertraline selectively inhibits the reuptake of serotonin (5-HT) at the presynaptic neuronal membrane, thereby increasing serotonergic activity. This results in an increased synaptic concentration of serotonin in the CNS, which leads to numerous functional changes associated with enhanced serotonergic neurotransmission.[T28,L9016] These changes are believed to be responsible for the antidepressant action and beneficial effects in obsessive-compulsive (and other anxiety related disorders). It has been hypothesized that obsessive-compulsive disorder, like depression, is also caused by the disregulation of serotonin.[A187165]



In animal studies, chronic administration of sertraline results in down-regulation of brain norepinephrine receptors.[L9016] Sertraline displays affinity for sigma-1 and 2 receptor binding sites[A31941], but binds with stronger affinity to sigma-1 binding sites.[A31940] In vitro, sertraline shows little to no affinity for GABA, dopaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors.[L9016] It exerts weak inhibitory actions on the neuronal uptake of norepinephrine and dopamine[A1844] and exhibits no inhibitory effects on the monoamine oxidase enzyme.[L9016]', 'Sertraline improves or relieves the symptoms of depression, OCD, post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder, and premenstrual dysphoric disorder via the inhibition of serotonin reuptake.[A187075,L9016] Clinical studies have shown that it improves cognition in depressed patients.[A1846] It has less sedative, anticholinergic, and cardiovascular effects than the tricyclic antidepressant drugs because it does not exert significant anticholinergic, antihistamine, or adrenergic (alpha1, alpha2, beta) blocking activity.[A1844] The onset of action and beneficial effects are usually noticed after 4-6 weeks, for reasons that are not fully understood and currently under investigation.[A188493,L10677]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10388, 'Setavlon antiseptic solution 120ml', 'سيتافلون محلول مطهر 120 مل', '20', '15', 'Antiseptic', 'Cetrimide+chlorhexidine', 'Kahira', 'Solution', 'محلول', '120ml', '1', NULL, NULL, '6221068402771', NULL, 1879, '2025-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10399, 'Sex forte for men 50 tab', 'سيكس فورت للرجال 50 قرص', '35', NULL, NULL, 'Yohimbine+vit e', 'Company', 'Tab', 'أقراص', NULL, '5', 'علاج ضعف الانتصاب -- زيادة الرغبة الجنسية', NULL, NULL, NULL, 2046, '2022-05-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10400, 'Yarnax massage gel 50 gm', 'يارناكس مساج جل 50 جم', '50', NULL, 'Massage', NULL, 'Great pharma group', 'Gel', 'جل', '50 gm', '1', NULL, NULL, '6224008232100', NULL, 798, '2022-02-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10401, 'Sham 300mg 24 cap', 'شام 300مجم 24 كبسولة', '18', NULL, 'Urolithiac', 'Salicylhydroxyamic acid', 'Elnasr', 'Cap', 'كبسولة', '300mg', '2', 'مضاد للالتهاب -- خافض للحرارة -- مسكن عام للالام', NULL, '6221067003467', NULL, 1084, '2022-07-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10403, 'Shark cartilage 740mg 20 tab', 'شارك كارتليدج 740مجم 20 قرص', '35', NULL, 'Calcium', 'Calcium', 'Company', 'Tab', 'أقراص', '740mg', '2', NULL, NULL, NULL, NULL, 794, '2022-12-02', 0, 'Calcium acetate is one of a number of calcium salts used to treat hyperphosphatemia (too much phosphate in the blood) in patients with kidney disease.', 'Calcium acetate and other calcium salts are phosphate binders. They work by binding with the phosphate in the food you eat, so that it is eliminated from the body without being absorbed.', 'Patients with advanced renal insufficiency (creatinine clearance less than 30 ml/min) exhibit phosphate retention and some degree of hyperphosphatemia. The retention of phosphate plays a pivotal role in causing secondary hyperparathyroidism associated with osteodystrophy, and soft-tissue calcification. The mechanism by which phosphate retention leads to hyperparathyroidism is not clearly delineated. Therapeutic efforts directed toward the control of hyperphosphatemia include reduction in the dietary intake of phosphate, inhibition of absorption of phosphate in the intestine with phosphate binders, and removal of phosphate from the body by more efficient methods of dialysis. The rate of removal of phosphate by dietary manipulation or by dialysis is insufficient. Dialysis patients absorb 40% to 80% of dietary phosphorus. Therefore, the fraction of dietary phosphate absorbed from the diet needs to be reduced by using phosphate binders in most renal failure patients on maintenance dialysis. Calcium acetate when taken with meals combines with dietary phosphate to form insoluble calcium phosphate which is excreted in the feces. Maintenance of serum phosphorus below 6.0 mg/dl is generally considered as a clinically acceptable outcome of treatment with phosphate binders. Calcium acetate is highly soluble at neutral pH, making the calcium readily available for binding to phosphate in the proximal small intestine.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10405, 'Shark liver oil 1000mg 10 caps.', 'شارك ليفر اويل 1000مجم 10 كبسولات', '31', NULL, 'Omega 3', 'Shark liver oil', 'Sigma > ibn sina', 'Cap', 'كبسولة', '1000mg', '1', NULL, NULL, NULL, NULL, 961, '2022-12-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10406, 'Shark liver oil 500 mg 20 caps.', 'شارك ليفر اويل 500مجم 20 كبسولة', '123', '78', 'Omega 3', 'Shark liver oil', 'Arab caps > golden queen company', 'Cap', 'كبسولة', '500 mg', '2', 'مكمل غذائي يعمل على تعزيز المناعة -- تقليل مستوى الدهون الثلاثية بالدم وكذلك نسبة الكوليسترول الضار -- يزيد نسبة الكوليسترول النافع بالدم -- يساعد على تحسين عملية التذكر -- يستخدم في الحمل حيث يساعد الجنين على النمو الصحي للجهاز العصبي و البصري', NULL, '6224009104017', NULL, 2760, '2024-07-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10413, 'Sibelium 5mg 18 caps', 'سيبليوم 5مجم 18 كبسولة', '8', NULL, 'Antimigraine', 'Flunarizine', 'Janssen cling', 'Cap', 'كبسولة', '5mg', '3', 'يستخدم في علاج الصداع النصفي __ يقلل الالام الناتجة من الصداع', NULL, '6222003700686', NULL, 3095, '2023-01-20', 0, 'Used in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.', 'Flunarizine inhibits the influx of extracellular calcium through myocardial and vascular membrane pores by physically plugging the channel. The decrease in intracellular calcium inhibits the contractile processes of smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.', 'Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10416, 'Sibotrim 15mg 30 cap', 'سيبوترم 15مجم 30 كبسولة', '45', NULL, 'Weight loss.narcotic', 'Sibutramine hydrochloride monohydrate', 'EVA PHARMA', 'Cap', 'كبسولة', '15mg', '3', 'كبسولات لانقاص الوزن -- الحفاظ علي الوزن المثالي للجسم', NULL, NULL, NULL, 3932, '2023-05-22', 0, 'For the treatment of obesity.', 'Sibutramine produces its therapeutic effects by inhibition of norepinephrine (NE), serotonin (5-hydroxytryptamine, 5-HT), and to a lesser extent, dopamine reuptake at the neuronal synapse. By inhibiting the reuptake of these neurotransmitters, sibutramine promotes a sense of satiety and decrease in appetite, thereby reducing food intake. Data from animal studies also suggest that sibutramine may also increase energy expenditure through thermogenic effects in both the basal and fed states, but this has not been confirmed in humans. Sibutramine and its major pharmacologically active metabolites (M1 and M2) do not act via release of monoamines. ', 'Sibutramine is an orally administered agent for the treatment of obesity. Sibutramine exerts its pharmacological actions predominantly via its secondary (M1) and primary (M2) amine metabolites. The parent compound, sibutramine, is a potent inhibitor of serotonin and norepinephrine reuptake <i>in vivo</i>, but not <i>in vitro</i>. However, metabolites M1 and M2 inhibit the reuptake of these neurotransmitters both <i>in vitro</i> and <i>in vivo</i>. In human brain tissue, M1 and M2 also inhibit dopamine reuptake <i>in vitro</i>, but with ~3-fold lower potency than for the reuptake inhibition of serotonin or norepinephrine. Sibutramine, M1 and M2 exhibit no evidence of anticholinergic or antihistaminergic actions. In addition, receptor binding profiles show that sibutramine, M1 and M2 have low affinity for serotonin (5-HT<sub>1</sub>, 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>2C</sub>), norepinephrine (b, b1, b3, a1 and a2), dopamine (D1 and D2), benzodiazepine, and glutamate (NMDA) receptors. These compounds also lack monoamine oxidase inhibitory activity <i>in vitro</i> and <i>in vivo</i>.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10429, 'Sigmadone 3mg 10 tab.', 'سيجمادون 3مجم 10 اقراص', '34', NULL, 'Psychiatric.antipsychotics', 'Risperidone', 'Sigma', 'Tab', 'أقراص', '3mg', '1', NULL, 'about risperidone second-generation antipsychotic benzisoxazole derivative antimanic atypical antipsychotic. mechanism of action of risperidone risperidone exerts its antipsychotic activity by blocking dopamine and serotonin (5ht2) receptors. the drug has', '6221051011171', NULL, 1080, '2022-12-08', 0, 'Risperidone is indicated for the treatment of schizophrenia [L12885,L44692,L46297] and irritability associated with autistic disorder.[L12885] It is also indicated as monotherapy, or adjunctly with lithium or valproic acid, for the treatment of acute mania or mixed episodes associated with bipolar I disorder.[L12885,L44692]



Risperidone is additionally indicated in Canada for the short-term symptomatic management of aggression or psychotic symptoms in patients with severe dementia of the Alzheimer type unresponsive to nonpharmacological approaches.[L12906]



Risperidone is also used off-label for a number of conditions including as an adjunct to antidepressants in treatment-resistant depression.[A177226]', 'Though its precise mechanism of action is not fully understood, current focus is on the ability of risperidone to inhibit the D2 dopaminergic receptors and 5-HT2A serotonergic receptors in the brain. Schizophrenia is thought to result from an excess of dopaminergic D2 and serotonergic 5-HT2A activity, resulting in overactivity of central mesolimbic pathways and mesocortical pathways, respectively.[A1115, A1116, A1117]



D2 dopaminergic receptors are transiently inhibited by risperidone, reducing dopaminergic neurotransmission, therefore decreasing positive symptoms of schizophrenia, such as delusions and hallucinations.[A251765] Risperidone binds transiently and with loose affinity to the dopaminergic D2 receptor, with an ideal receptor occupancy of 60-70% for optimal effect.[A1119,A31773] Rapid dissociation of risperidone from the D2 receptors contributes to decreased risk of extrapyramidal symptoms (EPS), which occur with permanent and high occupancy blockade of D2 dopaminergic receptors.[A1118,A1119] Low-affinity binding and rapid dissociation from the D2 receptor distinguish risperidone from the traditional antipsychotic drugs. A higher occupancy rate of D2 receptors is said to increase the risk of extrapyramidal symptoms and is therefore to be avoided.[A1118,A1119,A31771] 

 

Increased serotonergic mesocortical activity in schizophrenia results in negative symptoms, such as depression and decreased motivation. The high-affinity binding of risperidone to 5-HT2A receptors leads to a decrease in serotonergic activity. In addition, 5-HT2A receptor blockade results in decreased risk of extrapyramidal symptoms, likely by increasing dopamine release from the frontal cortex, and not the nigrostriatal tract. Dopamine level is therefore not completely inhibited.[A1117,A1119] Through the above mechanisms, both serotonergic and D2 blockade by risperidone are thought to synergistically work to decrease the risk of extrapyramidal symptoms. 

 

Risperidone has also been said to be an antagonist of alpha-1 (α1), alpha-2 (α2), and histamine (H1) receptors.[A37034] Blockade of these receptors is thought to improve symptoms of schizophrenia, however the exact mechanism of action on these receptors is not fully understood at this time.[L12885]', 'The primary action of risperidone is to decrease dopaminergic and serotonergic pathway activity in the brain, therefore decreasing symptoms of schizophrenia and mood disorders.[A1115,A1116]



Risperidone has a high binding affinity for serotonergic 5-HT2A receptors when compared to dopaminergic D2 receptors in the brain.[A1114,A1115] Risperidone binds to D2 receptors with a lower affinity than first-generation antipsychotic drugs, which bind with very high affinity. A reduction in extrapyramidal symptoms with risperidone, when compared to its predecessors, is likely a result of its moderate affinity for dopaminergic D2 receptors.[A1119,A1117]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10435, 'Sigmacortin 500mg pd. for i.m./i.v.', 'سيجماكورتين 500مجم باودر فيال', '34', NULL, 'Glucocorticoid', 'Hydrocortisone sodium succinate', 'Sigma', 'Unknown', 'غير محدد', '500mg', '1', NULL, NULL, '6221172002034', NULL, 1166, '2022-12-08', 0, 'Otic solutions are indicated for infections of the external auditory canal caused by susceptible organisms and with inflammation.[L10529,L10532] Hydrocortisone tablets are indicated for certain endocrine, rheumatic, collagen, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, gastrointestinal, and other conditions.[L10535] A hydrocortisone enema is indicated for ulcerative colitis,[L10538] a topical ointment with antibiotics is indicated for corticosteroid responsive dermatoses with infections,[L7772] and a topical cream with [acyclovir] is indicated to treat cold sores.[L7321] Oral granules of hydrocortisone are used as a replacement therapy for Adrenocortical Insufficiency (AI) in children under 17 years of age.[L16533]', 'The short-term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation.[A187463] Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days.[A187463]



Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10.[A187463]



Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.[A187463] High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.[A187463]', 'Hydrocortisone binds to the glucocorticoid receptor leading to downstream effects such as inhibition of phospholipase A2, NF-kappa B, other inflammatory transcription factors, and the promotion of anti-inflammatory genes.[A187463] Hydrocortisone has a wide therapeutic index[A188405] and a moderate duration of action.[A188354,A188381] Patients should stop taking the medication if irritation or sensitization occurs.[L10529,L10532,L10535,L10538,L7772,L7321]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10436, 'Sigmataxim 500mg i.v. / i.m. vial', 'سيجماتاكسيم 500مجم فيال', '14', NULL, 'Antibiotic.cephalosporin.third-generation', 'Cefotaxime', 'Rameda > sigma', 'Vial', 'فيال', '500mg', '1', NULL, NULL, '6221172002287', NULL, 784, '2023-04-11', 0, 'Used to treat gonorrhoea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery.', 'The bactericidal activity of cefotaxime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cefotaxime shows high affinity for penicillin-binding proteins in the cell wall including PBP Ib and PBP III.', 'Cefotaxime is a third generation intravenous cephalosporin antibiotic. It has broad spectrum activity against Gram positive and Gram negative bacteria. It does not have activity against <i>Pseudomonas aeruginosa</i>. Cefotaxime works by inhibiting bacterial cell wall biosynthesis. A positive feature of cefotaxime is that it display a resistance to penicillinases and is useful to treat infections that are resistant to penicillin derivatives.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10437, 'Sigmataxim 1 gm i.v/i.m vial', 'سيجماتاكسيم 1جم وريد/عضل فيال', '43', '30', 'Antibiotic.cephalosporin.third-generation', 'Cefotaxime', 'Rameda > sigma', 'Vial', 'فيال', '1 gm', '1', NULL, 'about cefotaxime third generation cephalosporin parenteral antibiotic. mechanism of action of cefotaxime cefotaxime is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & aerobic gram negative organisms by inhi', '6221172002270', NULL, 988, '2025-02-07', 0, 'Used to treat gonorrhoea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery.', 'The bactericidal activity of cefotaxime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cefotaxime shows high affinity for penicillin-binding proteins in the cell wall including PBP Ib and PBP III.', 'Cefotaxime is a third generation intravenous cephalosporin antibiotic. It has broad spectrum activity against Gram positive and Gram negative bacteria. It does not have activity against <i>Pseudomonas aeruginosa</i>. Cefotaxime works by inhibiting bacterial cell wall biosynthesis. A positive feature of cefotaxime is that it display a resistance to penicillinases and is useful to treat infections that are resistant to penicillin derivatives.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10438, 'Sigmazidim 1 gm vial for i.v./i.m. inj.', 'سيجمازيديم 1جم فيال', '41', '15', 'Antibiotic.cephalosporin.third-generation', 'Ceftazidime', 'Pharco b > sigma tec', 'Inj', 'حقن', '1 gm', '1', NULL, NULL, '6221172002447', NULL, 1495, '2024-11-17', 0, 'Ceftazidime is indicated for the treatment of lower respiratory tract infections, skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections (including peritonitis), and central nervous system infections (including meningitis) caused by susceptible bacteria.[L32935]



Ceftazidime is indicated in combination with [avibactam] to treat infections caused by susceptible Gram-negative organisms, including complicated intra-abdominal infections (cIAI), in conjunction with [metronidazole], and complicated urinary tract infections (cUTI), including pyelonephritis, in patients aged three months and older. This combination is also indicated to treat hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older.[L45128]



In all cases, to mitigate the risk of bacterial resistance and preserve clinical efficacy, ceftazidime should only be used for infections that are confirmed or strongly suspected to be caused by susceptible bacterial strains.[L32935, L45128]', 'The bacterial cell wall, which is located at the periphery of Gram-positive bacteria and within the periplasm of Gram-negative bacteria, comprises a glycopeptide polymer synthesized through cross-linking of glycans to peptide stems on alternating saccharides, which is known commonly as peptidoglycan.[A232920] Cell wall formation, recycling, and remodelling require numerous enzymes, including a family of enzymes with similar active site character despite distinct and sometimes overlapping roles as carboxypeptidases, endopeptidases, transpeptidases, and transglycosylases, known as "penicillin-binding proteins" (PBPs). The number of PBPs differs between bacteria, in which some are considered essential and others redundant. In general, inhibition of one or more essential PBPs results in impaired cell wall homeostasis, loss of cell integrity, and is ultimately bactericidal.[A232920, A232925, A232930]



Ceftazidime is a semisynthetic third-generation cephalosporin with broad activity against numerous Gram-negative and some Gram-positive bacteria.[L32935] Like other β-lactam antibiotics, ceftazidime exhibits its bactericidal effect primarily through direct inhibition of specific PBPs in susceptible bacteria.[A232935] _In vitro_ experiments in Gram-negative bacteria such as _Escherichia coli_, _Pseudomonas aeruginosa_, _Acinetobacter baumannii_, and _Klebsiella pneumoniae_ suggest that ceftazidime primarily binds to PBP3, with weaker binding to PBP1a/1b and PBP2 as well; although binding to other PBPs, such as PBP4, is detectable, the concentrations required are much greater than those achieved clinically.[A232935, A16721, A232940, A232945, A232950] Similarly, ceftazidime showed binding to _Staphylococcus aureus_ PBP 1, 2, and 3 with a much lower affinity for PBP4.[A16721] Recent data for _Mycobacterium abcessus_ suggest that ceftazidime can inhibit PonA1, PonA2, and PbpA at intermediate concentrations.[A232930]', 'Ceftazidime is a semisynthetic, broad-spectrum, third-generation cephalosporin antibiotic that is bactericidal through inhibition of enzymes responsible for cell-wall synthesis, primarily penicillin-binding protein 3 (PBP3).[L32935] Among cephalosporins, ceftazidime is notable for its resistance to numerous β-lactamases and its broad spectrum of activity against Gram-negative bacteria, including _Pseudomonas aeruginosa_.[A232935] However, it is less active than first- and second-generation cephalosporins against _Staphylococcus aureus_ and other Gram-positive bacteria and also has low activity against anaerobes.[A232935, A233160] Ceftazidime has confirmed activity against clinically relevant Gram-negative bacteria including _Citrobacter_ spp., _Enterobacter_ spp., _Klebsiella_ spp., _Proteus_ spp., _Serratia spp., _Escherichia coli_, _Haemophilus influenzae_, _Neisseria meningitidis_, _Pseudomonas aeruginosa_, and some Gram-positive bacteria including _Staphylococcus_ spp. and _Streptococcus_ spp. There are also _in vitro_ data for ceftazidime efficacy against a wide variety of other bacteria, such as _Acinetobacter baumannii_ and _Neisseria gonorrhoeae_, but no clear clinical studies to support the use of ceftazidime for infections caused by these bacteria.[L32935]



Although β-lactam antibiotics like ceftazidime are generally well tolerated, there remains a risk of serious acute hypersensitivity reactions, which is higher in patients with a known allergy to ceftazidime or any other β-lactam antibiotic. As with all antibiotics, ceftazidime may result in the overgrowth of non-susceptible organisms and potentially serious effects including _Clostridium difficile_-associated diarrhea (CDAD); CDAD should be considered in patients who develop diarrhea and, in confirmed cases, supportive care initiated immediately. Ceftazidime is primarily renally excreted such that high and prolonged serum concentrations can occur in patients with renal insufficiency, leading to seizures, nonconvulsive status epilepticus (NCSE), encephalopathy, coma, asterixis, neuromuscular excitability, and myoclonia. Treatment may lead to the development or induction of resistance with a risk of treatment failure. Periodic susceptibility testing should be considered, and monotherapy failure may necessitate the addition of another antibiotic such as an aminoglycoside. Cephalosporin use may decrease prothrombin activity, which may be improved by exogenous vitamin K. Inadvertent intra-arterial administration of ceftazidime may result in distal necrosis.[L32935]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10439, 'Sigmazidim 500 mg vial for i.v./i.m. inj.', 'سيجمازيديم 500 مجم فيال', '10', NULL, 'Antibiotic.cephalosporin.third-generation', 'Ceftazidime', 'Pharco b > sigma tec', 'Inj', 'حقن', '500 mg', '1', NULL, NULL, '6221172002430', NULL, 965, '2022-12-08', 0, 'Ceftazidime is indicated for the treatment of lower respiratory tract infections, skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections (including peritonitis), and central nervous system infections (including meningitis) caused by susceptible bacteria.[L32935]



Ceftazidime is indicated in combination with [avibactam] to treat infections caused by susceptible Gram-negative organisms, including complicated intra-abdominal infections (cIAI), in conjunction with [metronidazole], and complicated urinary tract infections (cUTI), including pyelonephritis, in patients aged three months and older. This combination is also indicated to treat hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older.[L45128]



In all cases, to mitigate the risk of bacterial resistance and preserve clinical efficacy, ceftazidime should only be used for infections that are confirmed or strongly suspected to be caused by susceptible bacterial strains.[L32935, L45128]', 'The bacterial cell wall, which is located at the periphery of Gram-positive bacteria and within the periplasm of Gram-negative bacteria, comprises a glycopeptide polymer synthesized through cross-linking of glycans to peptide stems on alternating saccharides, which is known commonly as peptidoglycan.[A232920] Cell wall formation, recycling, and remodelling require numerous enzymes, including a family of enzymes with similar active site character despite distinct and sometimes overlapping roles as carboxypeptidases, endopeptidases, transpeptidases, and transglycosylases, known as "penicillin-binding proteins" (PBPs). The number of PBPs differs between bacteria, in which some are considered essential and others redundant. In general, inhibition of one or more essential PBPs results in impaired cell wall homeostasis, loss of cell integrity, and is ultimately bactericidal.[A232920, A232925, A232930]



Ceftazidime is a semisynthetic third-generation cephalosporin with broad activity against numerous Gram-negative and some Gram-positive bacteria.[L32935] Like other β-lactam antibiotics, ceftazidime exhibits its bactericidal effect primarily through direct inhibition of specific PBPs in susceptible bacteria.[A232935] _In vitro_ experiments in Gram-negative bacteria such as _Escherichia coli_, _Pseudomonas aeruginosa_, _Acinetobacter baumannii_, and _Klebsiella pneumoniae_ suggest that ceftazidime primarily binds to PBP3, with weaker binding to PBP1a/1b and PBP2 as well; although binding to other PBPs, such as PBP4, is detectable, the concentrations required are much greater than those achieved clinically.[A232935, A16721, A232940, A232945, A232950] Similarly, ceftazidime showed binding to _Staphylococcus aureus_ PBP 1, 2, and 3 with a much lower affinity for PBP4.[A16721] Recent data for _Mycobacterium abcessus_ suggest that ceftazidime can inhibit PonA1, PonA2, and PbpA at intermediate concentrations.[A232930]', 'Ceftazidime is a semisynthetic, broad-spectrum, third-generation cephalosporin antibiotic that is bactericidal through inhibition of enzymes responsible for cell-wall synthesis, primarily penicillin-binding protein 3 (PBP3).[L32935] Among cephalosporins, ceftazidime is notable for its resistance to numerous β-lactamases and its broad spectrum of activity against Gram-negative bacteria, including _Pseudomonas aeruginosa_.[A232935] However, it is less active than first- and second-generation cephalosporins against _Staphylococcus aureus_ and other Gram-positive bacteria and also has low activity against anaerobes.[A232935, A233160] Ceftazidime has confirmed activity against clinically relevant Gram-negative bacteria including _Citrobacter_ spp., _Enterobacter_ spp., _Klebsiella_ spp., _Proteus_ spp., _Serratia spp., _Escherichia coli_, _Haemophilus influenzae_, _Neisseria meningitidis_, _Pseudomonas aeruginosa_, and some Gram-positive bacteria including _Staphylococcus_ spp. and _Streptococcus_ spp. There are also _in vitro_ data for ceftazidime efficacy against a wide variety of other bacteria, such as _Acinetobacter baumannii_ and _Neisseria gonorrhoeae_, but no clear clinical studies to support the use of ceftazidime for infections caused by these bacteria.[L32935]



Although β-lactam antibiotics like ceftazidime are generally well tolerated, there remains a risk of serious acute hypersensitivity reactions, which is higher in patients with a known allergy to ceftazidime or any other β-lactam antibiotic. As with all antibiotics, ceftazidime may result in the overgrowth of non-susceptible organisms and potentially serious effects including _Clostridium difficile_-associated diarrhea (CDAD); CDAD should be considered in patients who develop diarrhea and, in confirmed cases, supportive care initiated immediately. Ceftazidime is primarily renally excreted such that high and prolonged serum concentrations can occur in patients with renal insufficiency, leading to seizures, nonconvulsive status epilepticus (NCSE), encephalopathy, coma, asterixis, neuromuscular excitability, and myoclonia. Treatment may lead to the development or induction of resistance with a risk of treatment failure. Periodic susceptibility testing should be considered, and monotherapy failure may necessitate the addition of another antibiotic such as an aminoglycoside. Cephalosporin use may decrease prothrombin activity, which may be improved by exogenous vitamin K. Inadvertent intra-arterial administration of ceftazidime may result in distal necrosis.[L32935]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10442, 'Silagra 25 mg 10 f.c. tab.', 'سيلاجرا 25مجم 10 اقراص', '18', NULL, 'Tonic for men', 'Sildenafil', 'Arab drug company.', 'Tab', 'أقراص', '25 mg', '1', NULL, 'about sildenafil citrate phosphodiesterase-5 enzyme inhibitor anti-erectile dysfunction agent. mechanism of action of sildenafil citrate sildenafil is a phosphodiesterase enzyme (pde5) inhibitor. this enzyme is responsible for the degradation cyclic guano', NULL, NULL, 1633, '2023-06-02', 0, 'Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor that is predominantly employed for two primary indications:



(1) the treatment of erectile dysfunction [A175582, L5611, F3853, F3856, F3886]; and



(2) treatment of pulmonary hypertension, where:

a) the US FDA specifically indicates sildenafil for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical worsening [F3850]. The delay in clinical worsening was demonstrated when sildenafil was added to background epoprostenol therapy [F3850]. Studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with New York Heart Association (NYHA) Functional Class II-III symptoms and idiopathic etiology (71%) or associated with connective tissue disease (CTD) (25%) [F3850];



b) the Canadian product monograph specifically indicates sildenafil for the treatment of primary pulmonary arterial hypertension (PPH) or pulmonary hypertension secondary to connective tissue disease (CTD) in adult patients with WHO functional class II or III who have not responded to conventional therapy [F3859]. In addition, improvement in exercise ability and delay in clinical worsening was demonstrated in adult patients who were already stabilized on background epoprostenol therapy [F3859]; and



c) the EMA product information specifically indicates sildenafil for the treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity [F3883]. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease [F3883]. The EMA label also indicates sildenafil for the treatment of pediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension [F3883]. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease [F3883].', 'Sildenafil is an oral therapy for erectile dysfunction [A175582, F3853, F3856, F3886, L5611]. In the natural setting, i.e. with sexual stimulation, it restores impaired erectile function by increasing blood flow to the penis [A175582, F3853, F3856, F3886, L5611].



The physiological mechanism responsible for the erection of the penis involves the release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation [A175582, F3853, F3856, F3886, L5611]. Nitric oxide then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood [A175582, F3853, F3856, F3886, L5611].



Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) in the corpus cavernosum, where PDE5 is responsible for degradation of cGMP [A175582, F3853, F3856, F3886, L5611]. Sildenafil has a peripheral site of action on erections [A175582, F3853, F3856, F3886, L5611]. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum but potently enhances the relaxant effect of NO on this tissue [A175582, F3853, F3856, F3886, L5611]. When the NO/cGMP pathway is activated, as occurs with sexual stimulation, inhibition of PDE5 by sildenafil results in increased corpus cavernosum levels of cGMP [A175582, F3853, F3856, F3886, L5611]. Therefore sexual stimulation is required in order for sildenafil to produce its intended beneficial pharmacological effects [A175582, F3853, F3856, F3886, L5611].



Moreover, apart from the presence of PDE5 in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature [A175579, F3850, F3859, F3883, L5614]. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation [A175579, F3850, F3859, F3883, L5614]. In patients with pulmonary arterial hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemic circulation [A175579, F3850, F3859, F3883, L5614].', 'In vitro studies have shown that sildenafil is selective for phosphodiesterase-5 (PDE5) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Its effect is more potent on PDE5 than on other known phosphodiesterases [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. In particular, there is a 10-times selectivity over PDE6 which is involved in the phototransduction pathway in the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. There is an 80-times selectivity over PDE1, and over 700-times over PDE 2, 3, 4, 7, 8, 9, 10 and 11 [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. And finally, sildenafil has greater than 4,000-times selectivity for PDE5 over PDE3, the cAMP-specific phosphodiesterase isoform involved in the control of cardiac contractility [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In eight double-blind, placebo-controlled crossover studies of patients with either organic or psychogenic erectile dysfunction, sexual stimulation resulted in improved erections, as assessed by an objective measurement of hardness and duration of erections (via the use of RigiScan®), after sildenafil administration compared with placebo [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Most studies assessed the efficacy of sildenafil approximately 60 minutes post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The erectile response, as assessed by RigiScan®, generally increased with increasing sildenafil dose and plasma concentration [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The time course of effect was examined in one study, showing an effect for up to 4 hours but the response was diminished compared to 2 hours [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Sildenafil causes mild and transient decreases in systemic blood pressure which, in the majority of cases, do not translate into clinical effects [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with systemic hypertension the mean change from baseline in systolic and diastolic blood pressure was a decrease of 9.4 mmHg and 9.1 mmHg respectively [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with pulmonary arterial hypertension lesser effects in blood pressure reduction were observed (a reduction in both systolic and diastolic pressure of 2 mmHg)[F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614] . At the recommended dose of 20 mg three times a day no reductions in systolic or diastolic pressure were seen [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Single oral doses of sildenafil up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg three times a day to patients with pulmonary arterial hypertension no clinically relevant effects on the ECG were reported either [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In a study of the hemodynamic effects of a single oral 100 mg dose of sildenafil in 14 patients with severe coronary artery disease (CAD) (> 70 % stenosis of at least one coronary artery), the mean resting systolic and diastolic blood pressures decreased by 7 % and 6 % respectively compared to baseline [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Mean pulmonary systolic blood pressure decreased by 9% [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil showed no effect on cardiac output and did not impair blood flow through the stenosed coronary arteries [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Mild and transient differences in color discrimination (blue/green) were detected in some subjects using the Farnsworth-Munsell 100 hue test at 1 hour following a 100 mg dose, with no effects evident after 2 hours post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The postulated mechanism for this change in color discrimination is related to inhibition of PDE6, which is involved in the phototransduction cascade of the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil has no effect on visual acuity or contrast sensitivity. In a small size placebo-controlled study of patients with documented early age-related macular degeneration (n = 9), sildenafil (single dose, 100 mg) demonstrated no significant changes in visual tests conducted (which included visual acuity, Amsler grid, color discrimination simulated traffic light, and the Humphrey perimeter and photostress test) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10445, 'Sildava 100mg 12 f.c. tab.', 'سيلدافا 100مجم 12 قرص', '144', '91.5', 'Tonic for men', 'Sildenafil', 'Mash premiere', 'Tab', 'أقراص', '100mg', '12', 'مقوي للرجال', NULL, '6222001401318', NULL, 12049, '2025-08-03', 0, 'Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor that is predominantly employed for two primary indications:



(1) the treatment of erectile dysfunction [A175582, L5611, F3853, F3856, F3886]; and



(2) treatment of pulmonary hypertension, where:

a) the US FDA specifically indicates sildenafil for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical worsening [F3850]. The delay in clinical worsening was demonstrated when sildenafil was added to background epoprostenol therapy [F3850]. Studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with New York Heart Association (NYHA) Functional Class II-III symptoms and idiopathic etiology (71%) or associated with connective tissue disease (CTD) (25%) [F3850];



b) the Canadian product monograph specifically indicates sildenafil for the treatment of primary pulmonary arterial hypertension (PPH) or pulmonary hypertension secondary to connective tissue disease (CTD) in adult patients with WHO functional class II or III who have not responded to conventional therapy [F3859]. In addition, improvement in exercise ability and delay in clinical worsening was demonstrated in adult patients who were already stabilized on background epoprostenol therapy [F3859]; and



c) the EMA product information specifically indicates sildenafil for the treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity [F3883]. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease [F3883]. The EMA label also indicates sildenafil for the treatment of pediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension [F3883]. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease [F3883].', 'Sildenafil is an oral therapy for erectile dysfunction [A175582, F3853, F3856, F3886, L5611]. In the natural setting, i.e. with sexual stimulation, it restores impaired erectile function by increasing blood flow to the penis [A175582, F3853, F3856, F3886, L5611].



The physiological mechanism responsible for the erection of the penis involves the release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation [A175582, F3853, F3856, F3886, L5611]. Nitric oxide then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood [A175582, F3853, F3856, F3886, L5611].



Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) in the corpus cavernosum, where PDE5 is responsible for degradation of cGMP [A175582, F3853, F3856, F3886, L5611]. Sildenafil has a peripheral site of action on erections [A175582, F3853, F3856, F3886, L5611]. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum but potently enhances the relaxant effect of NO on this tissue [A175582, F3853, F3856, F3886, L5611]. When the NO/cGMP pathway is activated, as occurs with sexual stimulation, inhibition of PDE5 by sildenafil results in increased corpus cavernosum levels of cGMP [A175582, F3853, F3856, F3886, L5611]. Therefore sexual stimulation is required in order for sildenafil to produce its intended beneficial pharmacological effects [A175582, F3853, F3856, F3886, L5611].



Moreover, apart from the presence of PDE5 in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature [A175579, F3850, F3859, F3883, L5614]. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation [A175579, F3850, F3859, F3883, L5614]. In patients with pulmonary arterial hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemic circulation [A175579, F3850, F3859, F3883, L5614].', 'In vitro studies have shown that sildenafil is selective for phosphodiesterase-5 (PDE5) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Its effect is more potent on PDE5 than on other known phosphodiesterases [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. In particular, there is a 10-times selectivity over PDE6 which is involved in the phototransduction pathway in the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. There is an 80-times selectivity over PDE1, and over 700-times over PDE 2, 3, 4, 7, 8, 9, 10 and 11 [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. And finally, sildenafil has greater than 4,000-times selectivity for PDE5 over PDE3, the cAMP-specific phosphodiesterase isoform involved in the control of cardiac contractility [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In eight double-blind, placebo-controlled crossover studies of patients with either organic or psychogenic erectile dysfunction, sexual stimulation resulted in improved erections, as assessed by an objective measurement of hardness and duration of erections (via the use of RigiScan®), after sildenafil administration compared with placebo [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Most studies assessed the efficacy of sildenafil approximately 60 minutes post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The erectile response, as assessed by RigiScan®, generally increased with increasing sildenafil dose and plasma concentration [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The time course of effect was examined in one study, showing an effect for up to 4 hours but the response was diminished compared to 2 hours [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Sildenafil causes mild and transient decreases in systemic blood pressure which, in the majority of cases, do not translate into clinical effects [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with systemic hypertension the mean change from baseline in systolic and diastolic blood pressure was a decrease of 9.4 mmHg and 9.1 mmHg respectively [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with pulmonary arterial hypertension lesser effects in blood pressure reduction were observed (a reduction in both systolic and diastolic pressure of 2 mmHg)[F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614] . At the recommended dose of 20 mg three times a day no reductions in systolic or diastolic pressure were seen [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Single oral doses of sildenafil up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg three times a day to patients with pulmonary arterial hypertension no clinically relevant effects on the ECG were reported either [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In a study of the hemodynamic effects of a single oral 100 mg dose of sildenafil in 14 patients with severe coronary artery disease (CAD) (> 70 % stenosis of at least one coronary artery), the mean resting systolic and diastolic blood pressures decreased by 7 % and 6 % respectively compared to baseline [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Mean pulmonary systolic blood pressure decreased by 9% [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil showed no effect on cardiac output and did not impair blood flow through the stenosed coronary arteries [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Mild and transient differences in color discrimination (blue/green) were detected in some subjects using the Farnsworth-Munsell 100 hue test at 1 hour following a 100 mg dose, with no effects evident after 2 hours post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The postulated mechanism for this change in color discrimination is related to inhibition of PDE6, which is involved in the phototransduction cascade of the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil has no effect on visual acuity or contrast sensitivity. In a small size placebo-controlled study of patients with documented early age-related macular degeneration (n = 9), sildenafil (single dose, 100 mg) demonstrated no significant changes in visual tests conducted (which included visual acuity, Amsler grid, color discrimination simulated traffic light, and the Humphrey perimeter and photostress test) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10447, 'Silden 100 mg 8 f.c. tabs', 'سيلدين 100مجم 8 قرص', '66', '46', 'Tonic for men', 'Sildenafil', 'Eipico', 'Tab', 'أقراص', '100 mg', '8', NULL, NULL, '6221032119872', NULL, 2041, '2024-10-16', 0, 'Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor that is predominantly employed for two primary indications:



(1) the treatment of erectile dysfunction [A175582, L5611, F3853, F3856, F3886]; and



(2) treatment of pulmonary hypertension, where:

a) the US FDA specifically indicates sildenafil for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical worsening [F3850]. The delay in clinical worsening was demonstrated when sildenafil was added to background epoprostenol therapy [F3850]. Studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with New York Heart Association (NYHA) Functional Class II-III symptoms and idiopathic etiology (71%) or associated with connective tissue disease (CTD) (25%) [F3850];



b) the Canadian product monograph specifically indicates sildenafil for the treatment of primary pulmonary arterial hypertension (PPH) or pulmonary hypertension secondary to connective tissue disease (CTD) in adult patients with WHO functional class II or III who have not responded to conventional therapy [F3859]. In addition, improvement in exercise ability and delay in clinical worsening was demonstrated in adult patients who were already stabilized on background epoprostenol therapy [F3859]; and



c) the EMA product information specifically indicates sildenafil for the treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity [F3883]. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease [F3883]. The EMA label also indicates sildenafil for the treatment of pediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension [F3883]. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease [F3883].', 'Sildenafil is an oral therapy for erectile dysfunction [A175582, F3853, F3856, F3886, L5611]. In the natural setting, i.e. with sexual stimulation, it restores impaired erectile function by increasing blood flow to the penis [A175582, F3853, F3856, F3886, L5611].



The physiological mechanism responsible for the erection of the penis involves the release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation [A175582, F3853, F3856, F3886, L5611]. Nitric oxide then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood [A175582, F3853, F3856, F3886, L5611].



Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) in the corpus cavernosum, where PDE5 is responsible for degradation of cGMP [A175582, F3853, F3856, F3886, L5611]. Sildenafil has a peripheral site of action on erections [A175582, F3853, F3856, F3886, L5611]. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum but potently enhances the relaxant effect of NO on this tissue [A175582, F3853, F3856, F3886, L5611]. When the NO/cGMP pathway is activated, as occurs with sexual stimulation, inhibition of PDE5 by sildenafil results in increased corpus cavernosum levels of cGMP [A175582, F3853, F3856, F3886, L5611]. Therefore sexual stimulation is required in order for sildenafil to produce its intended beneficial pharmacological effects [A175582, F3853, F3856, F3886, L5611].



Moreover, apart from the presence of PDE5 in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature [A175579, F3850, F3859, F3883, L5614]. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation [A175579, F3850, F3859, F3883, L5614]. In patients with pulmonary arterial hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemic circulation [A175579, F3850, F3859, F3883, L5614].', 'In vitro studies have shown that sildenafil is selective for phosphodiesterase-5 (PDE5) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Its effect is more potent on PDE5 than on other known phosphodiesterases [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. In particular, there is a 10-times selectivity over PDE6 which is involved in the phototransduction pathway in the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. There is an 80-times selectivity over PDE1, and over 700-times over PDE 2, 3, 4, 7, 8, 9, 10 and 11 [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. And finally, sildenafil has greater than 4,000-times selectivity for PDE5 over PDE3, the cAMP-specific phosphodiesterase isoform involved in the control of cardiac contractility [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In eight double-blind, placebo-controlled crossover studies of patients with either organic or psychogenic erectile dysfunction, sexual stimulation resulted in improved erections, as assessed by an objective measurement of hardness and duration of erections (via the use of RigiScan®), after sildenafil administration compared with placebo [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Most studies assessed the efficacy of sildenafil approximately 60 minutes post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The erectile response, as assessed by RigiScan®, generally increased with increasing sildenafil dose and plasma concentration [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The time course of effect was examined in one study, showing an effect for up to 4 hours but the response was diminished compared to 2 hours [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Sildenafil causes mild and transient decreases in systemic blood pressure which, in the majority of cases, do not translate into clinical effects [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with systemic hypertension the mean change from baseline in systolic and diastolic blood pressure was a decrease of 9.4 mmHg and 9.1 mmHg respectively [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with pulmonary arterial hypertension lesser effects in blood pressure reduction were observed (a reduction in both systolic and diastolic pressure of 2 mmHg)[F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614] . At the recommended dose of 20 mg three times a day no reductions in systolic or diastolic pressure were seen [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Single oral doses of sildenafil up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg three times a day to patients with pulmonary arterial hypertension no clinically relevant effects on the ECG were reported either [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In a study of the hemodynamic effects of a single oral 100 mg dose of sildenafil in 14 patients with severe coronary artery disease (CAD) (> 70 % stenosis of at least one coronary artery), the mean resting systolic and diastolic blood pressures decreased by 7 % and 6 % respectively compared to baseline [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Mean pulmonary systolic blood pressure decreased by 9% [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil showed no effect on cardiac output and did not impair blood flow through the stenosed coronary arteries [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Mild and transient differences in color discrimination (blue/green) were detected in some subjects using the Farnsworth-Munsell 100 hue test at 1 hour following a 100 mg dose, with no effects evident after 2 hours post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The postulated mechanism for this change in color discrimination is related to inhibition of PDE6, which is involved in the phototransduction cascade of the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil has no effect on visual acuity or contrast sensitivity. In a small size placebo-controlled study of patients with documented early age-related macular degeneration (n = 9), sildenafil (single dose, 100 mg) demonstrated no significant changes in visual tests conducted (which included visual acuity, Amsler grid, color discrimination simulated traffic light, and the Humphrey perimeter and photostress test) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10448, 'Silden 50 mg 4 orodispersible tabs', 'سيلدين 50مجم 4 اقراص ذائبة فموية', '19', NULL, 'Tonic for men', 'Sildenafil', 'Eipico', 'Tab', 'أقراص', '50 mg', '4', NULL, NULL, NULL, NULL, 975, '2022-09-30', 0, 'Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor that is predominantly employed for two primary indications:



(1) the treatment of erectile dysfunction [A175582, L5611, F3853, F3856, F3886]; and



(2) treatment of pulmonary hypertension, where:

a) the US FDA specifically indicates sildenafil for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical worsening [F3850]. The delay in clinical worsening was demonstrated when sildenafil was added to background epoprostenol therapy [F3850]. Studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with New York Heart Association (NYHA) Functional Class II-III symptoms and idiopathic etiology (71%) or associated with connective tissue disease (CTD) (25%) [F3850];



b) the Canadian product monograph specifically indicates sildenafil for the treatment of primary pulmonary arterial hypertension (PPH) or pulmonary hypertension secondary to connective tissue disease (CTD) in adult patients with WHO functional class II or III who have not responded to conventional therapy [F3859]. In addition, improvement in exercise ability and delay in clinical worsening was demonstrated in adult patients who were already stabilized on background epoprostenol therapy [F3859]; and



c) the EMA product information specifically indicates sildenafil for the treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity [F3883]. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease [F3883]. The EMA label also indicates sildenafil for the treatment of pediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension [F3883]. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease [F3883].', 'Sildenafil is an oral therapy for erectile dysfunction [A175582, F3853, F3856, F3886, L5611]. In the natural setting, i.e. with sexual stimulation, it restores impaired erectile function by increasing blood flow to the penis [A175582, F3853, F3856, F3886, L5611].



The physiological mechanism responsible for the erection of the penis involves the release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation [A175582, F3853, F3856, F3886, L5611]. Nitric oxide then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood [A175582, F3853, F3856, F3886, L5611].



Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) in the corpus cavernosum, where PDE5 is responsible for degradation of cGMP [A175582, F3853, F3856, F3886, L5611]. Sildenafil has a peripheral site of action on erections [A175582, F3853, F3856, F3886, L5611]. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum but potently enhances the relaxant effect of NO on this tissue [A175582, F3853, F3856, F3886, L5611]. When the NO/cGMP pathway is activated, as occurs with sexual stimulation, inhibition of PDE5 by sildenafil results in increased corpus cavernosum levels of cGMP [A175582, F3853, F3856, F3886, L5611]. Therefore sexual stimulation is required in order for sildenafil to produce its intended beneficial pharmacological effects [A175582, F3853, F3856, F3886, L5611].



Moreover, apart from the presence of PDE5 in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature [A175579, F3850, F3859, F3883, L5614]. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation [A175579, F3850, F3859, F3883, L5614]. In patients with pulmonary arterial hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemic circulation [A175579, F3850, F3859, F3883, L5614].', 'In vitro studies have shown that sildenafil is selective for phosphodiesterase-5 (PDE5) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Its effect is more potent on PDE5 than on other known phosphodiesterases [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. In particular, there is a 10-times selectivity over PDE6 which is involved in the phototransduction pathway in the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. There is an 80-times selectivity over PDE1, and over 700-times over PDE 2, 3, 4, 7, 8, 9, 10 and 11 [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. And finally, sildenafil has greater than 4,000-times selectivity for PDE5 over PDE3, the cAMP-specific phosphodiesterase isoform involved in the control of cardiac contractility [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In eight double-blind, placebo-controlled crossover studies of patients with either organic or psychogenic erectile dysfunction, sexual stimulation resulted in improved erections, as assessed by an objective measurement of hardness and duration of erections (via the use of RigiScan®), after sildenafil administration compared with placebo [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Most studies assessed the efficacy of sildenafil approximately 60 minutes post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The erectile response, as assessed by RigiScan®, generally increased with increasing sildenafil dose and plasma concentration [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The time course of effect was examined in one study, showing an effect for up to 4 hours but the response was diminished compared to 2 hours [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Sildenafil causes mild and transient decreases in systemic blood pressure which, in the majority of cases, do not translate into clinical effects [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with systemic hypertension the mean change from baseline in systolic and diastolic blood pressure was a decrease of 9.4 mmHg and 9.1 mmHg respectively [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with pulmonary arterial hypertension lesser effects in blood pressure reduction were observed (a reduction in both systolic and diastolic pressure of 2 mmHg)[F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614] . At the recommended dose of 20 mg three times a day no reductions in systolic or diastolic pressure were seen [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Single oral doses of sildenafil up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg three times a day to patients with pulmonary arterial hypertension no clinically relevant effects on the ECG were reported either [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In a study of the hemodynamic effects of a single oral 100 mg dose of sildenafil in 14 patients with severe coronary artery disease (CAD) (> 70 % stenosis of at least one coronary artery), the mean resting systolic and diastolic blood pressures decreased by 7 % and 6 % respectively compared to baseline [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Mean pulmonary systolic blood pressure decreased by 9% [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil showed no effect on cardiac output and did not impair blood flow through the stenosed coronary arteries [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Mild and transient differences in color discrimination (blue/green) were detected in some subjects using the Farnsworth-Munsell 100 hue test at 1 hour following a 100 mg dose, with no effects evident after 2 hours post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The postulated mechanism for this change in color discrimination is related to inhibition of PDE6, which is involved in the phototransduction cascade of the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil has no effect on visual acuity or contrast sensitivity. In a small size placebo-controlled study of patients with documented early age-related macular degeneration (n = 9), sildenafil (single dose, 100 mg) demonstrated no significant changes in visual tests conducted (which included visual acuity, Amsler grid, color discrimination simulated traffic light, and the Humphrey perimeter and photostress test) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10449, 'Silden 25 mg 10 f.c.tab.', 'سيلدين 25مجم 10 اقراص', '42', '20', 'Tonic for men', 'Sildenafil', 'Eipico', 'Tab', 'أقراص', '25 mg', '2', 'مقوي للرجال', 'about sildenafil citrate phosphodiesterase-5 enzyme inhibitor anti-erectile dysfunction agent. mechanism of action of sildenafil citrate sildenafil is a phosphodiesterase enzyme (pde5) inhibitor. this enzyme is responsible for the degradation cyclic guano', NULL, NULL, 3152, '2024-12-06', 0, 'Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor that is predominantly employed for two primary indications:



(1) the treatment of erectile dysfunction [A175582, L5611, F3853, F3856, F3886]; and



(2) treatment of pulmonary hypertension, where:

a) the US FDA specifically indicates sildenafil for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical worsening [F3850]. The delay in clinical worsening was demonstrated when sildenafil was added to background epoprostenol therapy [F3850]. Studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with New York Heart Association (NYHA) Functional Class II-III symptoms and idiopathic etiology (71%) or associated with connective tissue disease (CTD) (25%) [F3850];



b) the Canadian product monograph specifically indicates sildenafil for the treatment of primary pulmonary arterial hypertension (PPH) or pulmonary hypertension secondary to connective tissue disease (CTD) in adult patients with WHO functional class II or III who have not responded to conventional therapy [F3859]. In addition, improvement in exercise ability and delay in clinical worsening was demonstrated in adult patients who were already stabilized on background epoprostenol therapy [F3859]; and



c) the EMA product information specifically indicates sildenafil for the treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity [F3883]. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease [F3883]. The EMA label also indicates sildenafil for the treatment of pediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension [F3883]. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease [F3883].', 'Sildenafil is an oral therapy for erectile dysfunction [A175582, F3853, F3856, F3886, L5611]. In the natural setting, i.e. with sexual stimulation, it restores impaired erectile function by increasing blood flow to the penis [A175582, F3853, F3856, F3886, L5611].



The physiological mechanism responsible for the erection of the penis involves the release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation [A175582, F3853, F3856, F3886, L5611]. Nitric oxide then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood [A175582, F3853, F3856, F3886, L5611].



Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) in the corpus cavernosum, where PDE5 is responsible for degradation of cGMP [A175582, F3853, F3856, F3886, L5611]. Sildenafil has a peripheral site of action on erections [A175582, F3853, F3856, F3886, L5611]. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum but potently enhances the relaxant effect of NO on this tissue [A175582, F3853, F3856, F3886, L5611]. When the NO/cGMP pathway is activated, as occurs with sexual stimulation, inhibition of PDE5 by sildenafil results in increased corpus cavernosum levels of cGMP [A175582, F3853, F3856, F3886, L5611]. Therefore sexual stimulation is required in order for sildenafil to produce its intended beneficial pharmacological effects [A175582, F3853, F3856, F3886, L5611].



Moreover, apart from the presence of PDE5 in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature [A175579, F3850, F3859, F3883, L5614]. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation [A175579, F3850, F3859, F3883, L5614]. In patients with pulmonary arterial hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemic circulation [A175579, F3850, F3859, F3883, L5614].', 'In vitro studies have shown that sildenafil is selective for phosphodiesterase-5 (PDE5) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Its effect is more potent on PDE5 than on other known phosphodiesterases [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. In particular, there is a 10-times selectivity over PDE6 which is involved in the phototransduction pathway in the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. There is an 80-times selectivity over PDE1, and over 700-times over PDE 2, 3, 4, 7, 8, 9, 10 and 11 [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. And finally, sildenafil has greater than 4,000-times selectivity for PDE5 over PDE3, the cAMP-specific phosphodiesterase isoform involved in the control of cardiac contractility [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In eight double-blind, placebo-controlled crossover studies of patients with either organic or psychogenic erectile dysfunction, sexual stimulation resulted in improved erections, as assessed by an objective measurement of hardness and duration of erections (via the use of RigiScan®), after sildenafil administration compared with placebo [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Most studies assessed the efficacy of sildenafil approximately 60 minutes post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The erectile response, as assessed by RigiScan®, generally increased with increasing sildenafil dose and plasma concentration [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The time course of effect was examined in one study, showing an effect for up to 4 hours but the response was diminished compared to 2 hours [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Sildenafil causes mild and transient decreases in systemic blood pressure which, in the majority of cases, do not translate into clinical effects [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with systemic hypertension the mean change from baseline in systolic and diastolic blood pressure was a decrease of 9.4 mmHg and 9.1 mmHg respectively [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with pulmonary arterial hypertension lesser effects in blood pressure reduction were observed (a reduction in both systolic and diastolic pressure of 2 mmHg)[F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614] . At the recommended dose of 20 mg three times a day no reductions in systolic or diastolic pressure were seen [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Single oral doses of sildenafil up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg three times a day to patients with pulmonary arterial hypertension no clinically relevant effects on the ECG were reported either [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In a study of the hemodynamic effects of a single oral 100 mg dose of sildenafil in 14 patients with severe coronary artery disease (CAD) (> 70 % stenosis of at least one coronary artery), the mean resting systolic and diastolic blood pressures decreased by 7 % and 6 % respectively compared to baseline [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Mean pulmonary systolic blood pressure decreased by 9% [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil showed no effect on cardiac output and did not impair blood flow through the stenosed coronary arteries [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Mild and transient differences in color discrimination (blue/green) were detected in some subjects using the Farnsworth-Munsell 100 hue test at 1 hour following a 100 mg dose, with no effects evident after 2 hours post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The postulated mechanism for this change in color discrimination is related to inhibition of PDE6, which is involved in the phototransduction cascade of the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil has no effect on visual acuity or contrast sensitivity. In a small size placebo-controlled study of patients with documented early age-related macular degeneration (n = 9), sildenafil (single dose, 100 mg) demonstrated no significant changes in visual tests conducted (which included visual acuity, Amsler grid, color discrimination simulated traffic light, and the Humphrey perimeter and photostress test) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10451, 'Silicar skin serum 50 gm', 'سيليكار سيروم للجلد 50 جرام', '550', '500', 'Scar therapy', 'Polydimethylsiloxane+cyclopentasiloxane', 'Macro group pharmaceuticals', 'Serum', 'سيروم', '50 gm', '1', 'يستخدم لترطيب البشرة-- إزالة آثار تشققات الحمل-- إزالة آثار الحروق والجروح ما بعد العملية الجراحية-- كذلك يحد من ظهور التجاعيد.', NULL, '6224000437572', NULL, 4634, '2025-03-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10452, 'Silipex 30 capsules', 'سيليبكس 30 كبسولة', '90', '60', 'Liver support supplements', 'Silymarin-lecithin complex', 'Future pharmaceutical industries (fpi) > ema pharm', 'Capsule', 'كبسولة', NULL, '3', 'علاج امراض الكبد -- علاج التهاب الكبد الوبائي -- حماية الكبد من التليف', 'silipex is a new lipophilic complex of silybin (the main active constituents of silymarin) with phosphatidylcholin (form lecithin) this complex exhibits relative bioavailibility 10 folds higher than that of regular silymarin. silipex allows silybin to rea', '6224000912079', NULL, 2579, '2025-03-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10461, 'Silvazine 1% cream 30 gm', 'سيلفازين كريم 30 جرام', '28', '19.5', 'Antibiotic topical', 'Silver sulfadiazine', 'Unipharma co.', 'Cream', 'كريم', '1%', '1', 'كريم مضاد حيوى طبق كريم سالفاديازين موضعياً على الجلد لعلاج أو منع العدوى الناتجة عن الحروق الخطيرة من الدرجة الثانية أو الثالثة', 'indication indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns. mechanism of action studies utilizing radioactive micronized silver sulfadiazine electron microscopy and biochemical techn', '6224000784676', NULL, 14540, '2025-02-24', 0, 'Indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns.', 'Studies utilizing radioactive micronized silver sulfadiazine, electron microscopy, and biochemical techniques have revealed that the mechanism of action of silver sulfadiazine on bacteria differs from silver nitrate and sodium sulfadiazine. Silver sulfadiazine acts only on the cell membrane and cell wall to produce its bactericidal effect. A specific mechanism of action has not been determined, but silver sulfadiazine''s effectiveness may possibly be from a synergistic interaction, or the action of each component. Silver is a biocide, which binds to a broad range of targets. Silver ions bind to nucleophilic amino acids, as well as sulfhydryl, amino, imidazole, phosphate, and carboxyl groups in proteins, causing protein denaturation and enzyme inhibition. 

Silver binds to surface membranes and proteins, causing proton leaks in the membrane, leading to cell death. 

Sulfadiazine is a competitive inhibitor of bacterial para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid.', 'Silver sulfadiazine has broad antimicrobial activity. It is bactericidal for many gram- negative and gram-positive bacteria as well as being effective against yeast. Silver sulfadiazine is not a carbonic anhydrase inhibitor and may be useful in situations where such agents are contraindicated.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10463, 'Silverhyalo cream 100 gm', 'سيلفرهيالو كريم 100 جم', '104', NULL, 'Topical bactericidal', 'Silver sulfadiazine+sodium hyaluronate', 'Debeiky > philo pharm pharmaceuticals', 'Cream', 'كريم', '100 gm', '1', NULL, 'indications: it is indicated for the management of skin lesions especially those at high risk of infection. in particular it is intended to cover acute and chronic wounds (first and second degree burns vascular and metabolic ulcers and pressure sores) and', NULL, NULL, 1715, '2022-10-29', 0, 'Indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns.', 'Studies utilizing radioactive micronized silver sulfadiazine, electron microscopy, and biochemical techniques have revealed that the mechanism of action of silver sulfadiazine on bacteria differs from silver nitrate and sodium sulfadiazine. Silver sulfadiazine acts only on the cell membrane and cell wall to produce its bactericidal effect. A specific mechanism of action has not been determined, but silver sulfadiazine''s effectiveness may possibly be from a synergistic interaction, or the action of each component. Silver is a biocide, which binds to a broad range of targets. Silver ions bind to nucleophilic amino acids, as well as sulfhydryl, amino, imidazole, phosphate, and carboxyl groups in proteins, causing protein denaturation and enzyme inhibition. 

Silver binds to surface membranes and proteins, causing proton leaks in the membrane, leading to cell death. 

Sulfadiazine is a competitive inhibitor of bacterial para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid.', 'Silver sulfadiazine has broad antimicrobial activity. It is bactericidal for many gram- negative and gram-positive bacteria as well as being effective against yeast. Silver sulfadiazine is not a carbonic anhydrase inhibitor and may be useful in situations where such agents are contraindicated.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10465, 'Silybum 3gm 10 sachets', 'سيليبوم 3جم 10 اكياس', '8', NULL, 'Liver support supplements', 'Silybum marianum fruit extract+curcumin', 'Debeiky', 'Sachet', 'أكياس', '3gm', '1', NULL, '*indication: an adjuvant therapy for hepatic disorders *contra-indications: -pregnancy -uncontrolled hypertention -bile duct obstruction *dose: 1 sachet to be diluted in a cup of water twice daily', NULL, NULL, 936, '2023-04-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10466, 'Silymarin plus 140mg 10 sachets', 'سيليمارين بلس 140 مجم 20 اكياس', '45', NULL, 'Liver support supplements', 'Silymarin+acetylcistein+vitamin (a+e+c)+zinc', 'Sedico', 'Sachet', 'أكياس', '140mg', '1', NULL, 'about silymarin a polyphenolic flavonoid hepatoprotective(antihepatotoxic) antioxidant. mechanism of action of silymarin silymarin stimulates rna polymerase a and results in an increase in ribosomal protein synthesis and leads to the synthesis of new hepa', '6221042211016', NULL, 2197, '2023-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10470, 'Silymarin plus 20 caps.', 'سيليمارين بلس 140مجم 20 كبسولة', '56', NULL, 'Liver support supplements', 'Silymarin+vitamin a+vitamin e+selenium+zinc', 'Sedico', 'Cap', 'كبسولة', NULL, '2', 'مدعم لصحة الكبد', 'about silymarin a polyphenolic flavonoid hepatoprotective(antihepatotoxic) antioxidant. mechanism of action of silymarin silymarin stimulates rna polymerase a and results in an increase in ribosomal protein synthesis and leads to the synthesis of new hepa', '6221042185027', NULL, 11246, '2023-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10471, 'Simedill emulsion 120 ml', 'سايميدل مستحلب 120 مل', '50', '34', 'Antispasmodic', 'Dill seed oil+simethicone', 'Saja pharmaceuticals', 'Unknown', 'غير محدد', '120 ml', '1', 'التقلصات المعوية والمغص في الاطفال', 'antiflatulant - antispasmodic', '6221126000529', NULL, 8477, '2024-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10473, 'Simethicone 2% oral drops (30ml)', 'سايميثيكون 2% نقط فم 30 مل', '24', '14', 'Antiflatulent', 'Simethicone', 'Amriya', 'Drops', 'نقط', '2%', '1', 'علاج الانتفاخات -- تقليل الالام المعدة -- علاج الغازات في المعدة', NULL, '6221075200315', NULL, 3807, '2024-07-24', 0, 'Simethicone is indicated for the treatment of bloating, pressure, and cramps caused by gas.[L31533] Simethicone is also used as part of bowel preparation for colonoscopies.[A228343] ', 'Simethicone is a surfactant that decreases the surface tension of gas bubbles in the gastrointestinal tract, more easily allowing gas to exit the body.[A228308]', 'Simethicone decreases the surface tension of gas bubbles in the gastrointestinal tract, facilitating their expulsion.[A228308] It has a short duration of action as it is generally given as needed, and a wide therapeutic index as it is not systemically absorbed.[A228308]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10474, 'Simethicone emulsion 120 ml', 'سايمثيكون مستحلب 120 مل', '28', '20', 'Antiflatulent', 'Simethicone', 'Mup', 'Unknown', 'غير محدد', '120 ml', '1', 'مضاد للانتفاخ والغازات', NULL, '6221508210119', NULL, 3285, '2023-08-13', 0, 'Simethicone is indicated for the treatment of bloating, pressure, and cramps caused by gas.[L31533] Simethicone is also used as part of bowel preparation for colonoscopies.[A228343] ', 'Simethicone is a surfactant that decreases the surface tension of gas bubbles in the gastrointestinal tract, more easily allowing gas to exit the body.[A228308]', 'Simethicone decreases the surface tension of gas bubbles in the gastrointestinal tract, facilitating their expulsion.[A228308] It has a short duration of action as it is generally given as needed, and a wide therapeutic index as it is not systemically absorbed.[A228308]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10477, 'Similac total comfort gold 2 milk 360 gm', 'سيميلاك توتال كومفرت جولد 2 لبن اطفال 360 جم', '480', '458.3', 'Extra care milk', 'Extra care milk formula', 'Ibn sina', 'Unknown', 'غير محدد', '360 gm', '1', NULL, NULL, '8427030008240', NULL, 1135, '2024-10-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10481, 'Simvacor 20mg 7 f.c. tab.', 'سيمفاكور 20مجم 7 اقراص', '24', NULL, 'Antihyperlipidemic.statins', 'Simvastatin', 'Sigma', 'Tab', 'أقراص', '20mg', '1', NULL, NULL, '6221051010105', NULL, 1032, '2022-12-08', 0, 'Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDL‑C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).[F4655, F4658]



This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH).[F4655, F4658]



Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease.[F4655, F4658]



Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.[A181087, A181406]', 'Simvastatin is a prodrug in which the 6-membered lactone ring of simvastatin is hydrolyzed <i>in vivo</i> to generate the beta,delta-dihydroxy acid, an active metabolite structurally similar to HMG-CoA (hydroxymethylglutaryl CoA). Once hydrolyzed, simvastatin competes with HMG-CoA for HMG-CoA reductase, a hepatic microsomal enzyme, which catalyzes the conversion of HMG-CoA to mevalonate, an early rate-limiting step in cholesterol biosynthesis.[A181421] Simvastatin acts primarily in the liver, where decreased hepatic cholesterol concentrations stimulate the upregulation of hepatic low density lipoprotein (LDL) receptors which increases hepatic uptake of LDL. Simvastatin also inhibits hepatic synthesis of very low density lipoprotein (VLDL).[F4655, F4658] The overall effect is a decrease in plasma LDL and VLDL. 



At therapeutic doses, the HMG-CoA enzyme is not completely blocked by simvastatin activity, thereby allowing biologically necessary amounts of mevalonate to remain available. As mevalonate is an early step in the biosynthetic pathway for cholesterol, therapy with simvastatin would also not be expected to cause any accumulation of potentially toxic sterols. In addition, HMG-CoA is metabolized readily back to acetyl-CoA, which participates in many biosynthetic processes in the body.[F4658]



In vitro and in vivo animal studies also demonstrate that simvastatin exerts vasculoprotective effects independent of its lipid-lowering properties, also known as the pleiotropic effects of statins.[A181424] This includes improvement in endothelial function, enhanced stability of atherosclerotic plaques, reduced oxidative stress and inflammation, and inhibition of the thrombogenic response.



Statins have also been found to bind allosterically to β2 integrin function-associated antigen-1 (LFA-1), which plays an important role in leukocyte trafficking and in T cell activation.[A181559]', 'Simvastatin is an oral antilipemic agent which inhibits HMG-CoA reductase. It is used to lower total cholesterol, low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apoB), non-high density lipoprotein-cholesterol (non-HDL-C), and trigleride (TG) plasma concentrations while increasing HDL-C concentrations. High LDL-C, low HDL-C and high TG concentrations in the plasma are associated with increased risk of atherosclerosis and cardiovascular disease. The total cholesterol to HDL-C ratio is a strong predictor of coronary artery disease and high ratios are associated with higher risk of disease. Increased levels of HDL-C are associated with lower cardiovascular risk. By decreasing LDL-C and TG and increasing HDL-C, rosuvastatin reduces the risk of cardiovascular morbidity and mortality.[A181087, A181406]



Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]



**Skeletal Muscle Effects**



Simvastatin occasionally causes myopathy manifested as muscle pain, tenderness or weakness with creatine kinase (CK) above ten times the upper limit of normal (ULN). Myopathy sometimes takes the form of rhabdomyolysis with or without acute renal failure secondary to myoglobinuria, and rare fatalities have occurred. Predisposing factors for myopathy include advanced age (≥65 years), female gender, uncontrolled hypothyroidism, and renal impairment. Chinese patients may also be at increased risk for myopathy. In most cases, muscle symptoms and CK increases resolved when treatment was promptly discontinued.[F4655, F4658]



In a clinical trial database of 41,413 patients, the incidence of myopathy was approximately 0.03% and 0.08% at 20 and 40 mg/day, respectively, while the risk of myopathy with simvastatin 80 mg (0.61%) was disproportionately higher than that observed at the lower doses. It''s therefore recommended that the 80mg dose of simvastatin should be used only in patients who have been taking simvastatin 80 mg chronically (e.g., for 12 months or more) without evidence of muscle toxicity. As well, patients already stabilized on simvastatin 80mg should be monitored closely for evidence of muscle toxicity; if they need to be initiated on an interacting drug that is contraindicated or is associated with a dose cap for simvastatin, that patient should be switched to an alternative statin with less potential for the drug-drug interaction.[F4655, F4658]



The risk of myopathy during treatment with simvastatin may be increased with concurrent administration of interacting drugs such as [fenofibrate], [niacin], [gemfibrozil], [cyclosporine], and strong inhibitors of the CYP3A4 enzyme.  Cases of myopathy, including rhabdomyolysis, have been reported with HMG-CoA reductase inhibitors coadministered with [colchicine], and caution should therefore be exercised when prescribing these two medications together.[F4655, F4658]



**Liver Enzyme Abnormalities**



Persistent increases (to more than 3X the ULN) in serum transaminases have occurred in approximately 1% of patients who received simvastatin in clinical studies. When drug treatment was interrupted or discontinued in these patients, the transaminase levels usually fell slowly to pretreatment levels. The increases were not associated with jaundice or other clinical signs or symptoms. [F4655, F4658]



In the Scandinavian Simvastatin Survival Study (4S),[A181538] the number of patients with more than one transaminase elevation to >3 times the ULN, over the course of the study, was not significantly different between the simvastatin and placebo groups (14 [0.7%] vs. 12 [0.6%]). The frequency of single elevations of ALT to 3 times the ULN was significantly higher in the simvastatin group in the first year of the study (20 vs. 8, p=0.023), but not thereafter. In the HPS (Heart Protection Study),[A181475] in which 20,536 patients were randomized to receive simvastatin 40 mg/day or placebo, the incidences of elevated transaminases (>3X ULN confirmed by repeat test) were 0.21% (n=21) for patients treated with simvastatin and 0.09% (n=9) for patients treated with placebo.[F4655, F4658] 



**Endocrine Effects**



Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including simvastatin.[F4655]



Although cholesterol is the precursor of all steroid hormones, studies with simvastatin have suggested that this agent has no clinical effect on steroidogenesis. Simvastatin caused no increase in biliary lithogenicity and, therefore, would not be expected to increase the incidence of gallstones.[F4658]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10487, 'Simvastat 20mg 7 tab.', 'سيمفاستات 20مجم 7 اقراص', '31', NULL, 'Antihyperlipidemic.statins', 'Simvastatin', 'T3a pharma > rexcel', 'Tab', 'أقراص', '20mg', '1', NULL, 'about simvastatin statins hmg-coa reductase inhibitor a hypolipidemic agent. mechanism of action of simvastatin it is a precursor lactone converted in to active form in the body which competitively inhibits the conversion of 3-hydroxy-3-methyl glutaryl co', NULL, NULL, 1060, '2022-10-24', 0, 'Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDL‑C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).[F4655, F4658]



This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH).[F4655, F4658]



Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease.[F4655, F4658]



Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.[A181087, A181406]', 'Simvastatin is a prodrug in which the 6-membered lactone ring of simvastatin is hydrolyzed <i>in vivo</i> to generate the beta,delta-dihydroxy acid, an active metabolite structurally similar to HMG-CoA (hydroxymethylglutaryl CoA). Once hydrolyzed, simvastatin competes with HMG-CoA for HMG-CoA reductase, a hepatic microsomal enzyme, which catalyzes the conversion of HMG-CoA to mevalonate, an early rate-limiting step in cholesterol biosynthesis.[A181421] Simvastatin acts primarily in the liver, where decreased hepatic cholesterol concentrations stimulate the upregulation of hepatic low density lipoprotein (LDL) receptors which increases hepatic uptake of LDL. Simvastatin also inhibits hepatic synthesis of very low density lipoprotein (VLDL).[F4655, F4658] The overall effect is a decrease in plasma LDL and VLDL. 



At therapeutic doses, the HMG-CoA enzyme is not completely blocked by simvastatin activity, thereby allowing biologically necessary amounts of mevalonate to remain available. As mevalonate is an early step in the biosynthetic pathway for cholesterol, therapy with simvastatin would also not be expected to cause any accumulation of potentially toxic sterols. In addition, HMG-CoA is metabolized readily back to acetyl-CoA, which participates in many biosynthetic processes in the body.[F4658]



In vitro and in vivo animal studies also demonstrate that simvastatin exerts vasculoprotective effects independent of its lipid-lowering properties, also known as the pleiotropic effects of statins.[A181424] This includes improvement in endothelial function, enhanced stability of atherosclerotic plaques, reduced oxidative stress and inflammation, and inhibition of the thrombogenic response.



Statins have also been found to bind allosterically to β2 integrin function-associated antigen-1 (LFA-1), which plays an important role in leukocyte trafficking and in T cell activation.[A181559]', 'Simvastatin is an oral antilipemic agent which inhibits HMG-CoA reductase. It is used to lower total cholesterol, low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apoB), non-high density lipoprotein-cholesterol (non-HDL-C), and trigleride (TG) plasma concentrations while increasing HDL-C concentrations. High LDL-C, low HDL-C and high TG concentrations in the plasma are associated with increased risk of atherosclerosis and cardiovascular disease. The total cholesterol to HDL-C ratio is a strong predictor of coronary artery disease and high ratios are associated with higher risk of disease. Increased levels of HDL-C are associated with lower cardiovascular risk. By decreasing LDL-C and TG and increasing HDL-C, rosuvastatin reduces the risk of cardiovascular morbidity and mortality.[A181087, A181406]



Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]



**Skeletal Muscle Effects**



Simvastatin occasionally causes myopathy manifested as muscle pain, tenderness or weakness with creatine kinase (CK) above ten times the upper limit of normal (ULN). Myopathy sometimes takes the form of rhabdomyolysis with or without acute renal failure secondary to myoglobinuria, and rare fatalities have occurred. Predisposing factors for myopathy include advanced age (≥65 years), female gender, uncontrolled hypothyroidism, and renal impairment. Chinese patients may also be at increased risk for myopathy. In most cases, muscle symptoms and CK increases resolved when treatment was promptly discontinued.[F4655, F4658]



In a clinical trial database of 41,413 patients, the incidence of myopathy was approximately 0.03% and 0.08% at 20 and 40 mg/day, respectively, while the risk of myopathy with simvastatin 80 mg (0.61%) was disproportionately higher than that observed at the lower doses. It''s therefore recommended that the 80mg dose of simvastatin should be used only in patients who have been taking simvastatin 80 mg chronically (e.g., for 12 months or more) without evidence of muscle toxicity. As well, patients already stabilized on simvastatin 80mg should be monitored closely for evidence of muscle toxicity; if they need to be initiated on an interacting drug that is contraindicated or is associated with a dose cap for simvastatin, that patient should be switched to an alternative statin with less potential for the drug-drug interaction.[F4655, F4658]



The risk of myopathy during treatment with simvastatin may be increased with concurrent administration of interacting drugs such as [fenofibrate], [niacin], [gemfibrozil], [cyclosporine], and strong inhibitors of the CYP3A4 enzyme.  Cases of myopathy, including rhabdomyolysis, have been reported with HMG-CoA reductase inhibitors coadministered with [colchicine], and caution should therefore be exercised when prescribing these two medications together.[F4655, F4658]



**Liver Enzyme Abnormalities**



Persistent increases (to more than 3X the ULN) in serum transaminases have occurred in approximately 1% of patients who received simvastatin in clinical studies. When drug treatment was interrupted or discontinued in these patients, the transaminase levels usually fell slowly to pretreatment levels. The increases were not associated with jaundice or other clinical signs or symptoms. [F4655, F4658]



In the Scandinavian Simvastatin Survival Study (4S),[A181538] the number of patients with more than one transaminase elevation to >3 times the ULN, over the course of the study, was not significantly different between the simvastatin and placebo groups (14 [0.7%] vs. 12 [0.6%]). The frequency of single elevations of ALT to 3 times the ULN was significantly higher in the simvastatin group in the first year of the study (20 vs. 8, p=0.023), but not thereafter. In the HPS (Heart Protection Study),[A181475] in which 20,536 patients were randomized to receive simvastatin 40 mg/day or placebo, the incidences of elevated transaminases (>3X ULN confirmed by repeat test) were 0.21% (n=21) for patients treated with simvastatin and 0.09% (n=9) for patients treated with placebo.[F4655, F4658] 



**Endocrine Effects**



Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including simvastatin.[F4655]



Although cholesterol is the precursor of all steroid hormones, studies with simvastatin have suggested that this agent has no clinical effect on steroidogenesis. Simvastatin caused no increase in biliary lithogenicity and, therefore, would not be expected to increase the incidence of gallstones.[F4658]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10489, 'Simvastimibe 10/20mg 30 tabs.', 'سيمفاستيميب 10/20مجم 30 اقراص', '69', NULL, 'Antihyperlipidemic.cholesterol absorption inhibitors.combined with statin', 'Ezetimibe+simvastatin', 'Eva pharma', 'Tab', 'أقراص', '20mg', '3', NULL, 'about ezetimibe cholesterol absorption inhibitor 2-azetidinone derivative hypolipidemic agent. mechanism of action of ezetimibe it reduces the absorption of cholesterol from the intestine by localising at the brush border of the small intestine where it i', '6223002450688', NULL, 955, '2022-12-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10496, 'Sina seas digestion 20 caps.', 'سينا سيز للهضم 20 كبسولة', '23', NULL, 'Git disturbances', 'Caraway oil+fennel oil+chamomile extract+peppermint oil', 'Arab caps', 'Cap', 'كبسولة', NULL, '2', NULL, NULL, '6221051840047', NULL, 1102, '2023-04-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10497, 'Ivylife syrup 120 ml', 'ايفي لايف شراب 120 مل', '40', NULL, 'Anti.couph', 'IVY EXTRACT + THYME EXTRACT', 'LIFE LINE', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 848, '2022-08-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10502, 'Chancy 30 sublingual tabs.', 'شانسي 30 قرص تحت اللسان', '90', '54', 'Dietary supplement', 'Folic acid+vitamin b12', 'Neutra', 'Tab', 'أقراص', NULL, '1', 'لعلاج حالات الانيميا والضعف العام ويدعم تكوين كرات الدم الحمراء', NULL, '6225000486751', NULL, 6787, '2025-05-16', 0, 'Folic acid is indicated for the treatment of folic acid deficiency, megaloblastic anemia, and in anemias of nutritional origins, pregnancy, infancy, or childhood.', 'Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase (DHFR). These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate. Using vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by remethylation of homocysteine to methionine via methionine synthetase.', 'Folic acid is a water-soluble B-complex vitamin found in foods such as liver, kidney, yeast, and leafy, green vegetables. Also known as folate or Vitamin B9, folic acid is an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is the precursor of tetrahydrofolic acid, which is involved as a cofactor for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids. Impairment of thymidylate synthesis in patients with folic acid deficiency is thought to account for the defective deoxyribonucleic acid (DNA) synthesis that leads to megaloblast formation and megaloblastic and macrocytic anemias. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. In order to function properly within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as [DB00563] as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. 



In general, folate serum levels below 5 ng/mL indicate folate deficiency, and levels below 2 ng/mL usually result in megaloblastic anemia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10504, 'Sinecod 0.15% syrup 100 ml', 'ساينيكود شراب 100 مل', '14', '6.5', 'Antitussive', 'Butamirate citrate', 'Novartis > glaxo smithkline', 'Syrup', 'شراب', '0.15%', '1', NULL, NULL, '6221045999904', NULL, 1877, '2022-12-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10505, 'Siliskin gel 50 gram', 'سيليسكين جل 50 جم', '165', NULL, NULL, 'Polysiliconase+silicone dioxide', 'Vitality international', 'Gel', 'جل', NULL, '1', NULL, NULL, NULL, NULL, 929, '2022-10-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10508, 'Sinemet 25/250 mg 20 tabs.', 'سينميت 25/250مجم 20 قرص', '122', '90', 'Parkinson s disease.dopamine agonist', 'Carbidopa+levodopa', 'Merck sharp & dohme', 'Tab', 'أقراص', '250 mg', '2', 'علاج اعراض مرض الشلل الرعاش', 'about carbidopa a noncompetitive dopa decarboxylase inhibitor antidyskinetics anti-parkinson`s agent. mechanism of action of carbidopa carbidopa inhibits the peripheral decarboxylation of levodopa and thus slowing its conversion to dopamine in extra cereb', '6223002146109', NULL, 9827, '2024-08-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10510, 'Movarest gel 60 gm', 'موفاريست جل 60 جم', '65', '55', 'Massage gel', 'Eucalyptus oil+menthol+avocado oil+camphor oil+clove extract+peppermint oil', 'Ix pharma', 'Gel', 'جل', '60 gm', '1', 'كريم مساج مضاد للالتهابات ومسكن للالام وباسط للعضلات وينشط الدورة الدموية', NULL, '6225000505414', NULL, 1092, '2025-06-23', 0, 'As an active agent, eucalyptus oil has been indicated for relief of the symptoms of catarrhal colds, and/or the relief of the symptoms of minor muscular sprains and cramps [L1857].', 'The general consensus is that the exact mechanism of action of eucalyptus oil is largely unknown at this time but comprises various hypotheses from various studies.



Cineol containing preparations of eucalyptus oil may contain up to 80% (or more) 1,8-cineole [A32243] and is one of the most common types of eucalyptus oil formulations used. As an active agent indicated for relieving certain cold symptoms and/or certain muscular sprains and cramps, it is believed that eucalyptus oil may possess some antimicrobial and anti-inflammatory activities.



Some in vitro studies of human blood monocytes suggest a dose-dependent effect of eucalyptus oil to elicit significant inhibition of multiple cytokines, perhaps in the treatment of airway inflammation [A32244, A32245]. Moreover, other studies in animal models discuss the possibility of eucalyptus oil demonstrating anti-inflammatory and anti-nociceptive effects that potentially account for inhibiting the formation of prostaglandins and cytokines by stimulated monocytes in vitro [A32246, A32247].



Furthermore, additional studies have observed eucalyptus oil anti-viral activity against herpes simplex virus (HSV-1, HSV-2) in cell cultures as well as the demonstration of broad antimicrobial activity of eucalyptus medicinal plant extracts against Alicyclobacillus acidoterretris, Bacillus cereus, E. coli, Enterococcus faecalis, MRSA, Propionibacterium acnes, S. aureus, fungus including C. albicans isolates, Trichophyton mentagrophytes, and other Gram-positive bacteria. Specific activity against periodontopathic bacteria, such as Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans, Fusobacterium nucleatum, Streptococcus mutans, and Streptococcus sobrinus has also been observed [A32250, A32251, A32252, A32253, A32254].', 'Lipophilic monoterpene formulations of eucalyptus oil appear to be readily absorbed orally, with a primarily oxidative metabolism that might necessitate induction of the cytochrome P450 enzyme system and subsequent urinary excretion [A32236]. Gastrointestinal absorption of eucalyptus appears to be rapid and may be enhanced by the intake of lipids and milk. 1,8-cineole (which makes up to as much as 90% of most commonly used cineole-based eucalyptus oils) [A32227] has also been found in vitro and in animals to possess cytochrome P450 inducing activity [A32237, A32238, A32239].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10513, 'Singulair 10mg 14 f.c. tab', 'سنجولير 10مجم 14 قرص', '192', '144', 'Asthma.anti-inflammatory.leukotriene antagonist', 'Montelukast', 'Global napi pharmaceuticals > merck sharp & dohme', 'Tab', 'أقراص', '10mg', '2', 'علاج أزمات الصدر وصعوبة وضيق التنفس', NULL, '6223002146475', NULL, 9366, '2024-06-13', 0, 'Montelukast is indicated for:



(a) the prophylaxis and chronic treatment of asthma in adults and pediatric patients who are 12 months of age and older[L6301], although other regional health authorities specifically note this indication for adults and adolescents who are 15 years and older[L6304,L6307] and also include indications for preventing day and night-time symptoms, and the treatment of acetylsalicylic acid-sensitive asthma[L6304];



(b) the prevention of exercise-induced bronchoconstriction (EIB) in patients who are 6 years of age and older[L6301], although other regional health authorities specifically note this indication for adults and adolescents who are 15 years and older[L6304,L6307]; and



(c) the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older[L6301], although other regional health authorities specifically note the relief of seasonal allergic rhinitis symptoms for adults and adolescents who are 15 years and older[L6304,L6307].



Furthermore, some formulations like chewable montelukast tablets may also be specifically indicated by particular regulatory bodies for the prophylaxis and chronic treatment of asthma, including the prevention of day and night-time symptoms, the treatment of acetylsalicylic acid based asthma, and the prevention of exercise-induced bronchoconstriction in adult and pediatric patients aged 2 and older[L6328], between the ages 2 and 5[L6325], or between the ages of 6 and 14 years.[L6331]



Moreover, when employed for such indications montelukast is considered effective as monotherapy or when combined with other medications indicated for the maintenance treatment of chronic asthma.[L6304,L6328] For instance, montelukast and inhaled corticosteroids can be used concomitantly to demonstrate additive effects to control asthma or to decrease the necessary inhaled corticosteroid dose while still maintaining clinical stability.[L6304,L6328]



Additionally, in patients who continue to experience asthma symptoms, montelukast can also be combined with an ''as required'' short-acting beta-agonist, an inhaled corticosteroid, or inhaled corticosteroid paired with a long-acting beta-agonist.[L6304,L6328]', 'Cysteinyl leukotrienes (CysLT) like LTC4, LTD4, and LTE4, among others, are eicosanoids released by a variety of cells like mast cells and eosinophils.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] When such CysLT bind to corresponding CysLT receptors like CysLT type-1 receptors located on respiratory airway smooth muscle cells, airway macrophages, and on various pro-inflammatory cells like eosinophils and some specific myeloid stem cells activities that facilitate the pathophysiology of asthma and allergic rhinitis are stimulated.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



In particular, CysLT-mediated airway bronchoconstriction, occluding mucous secretion, vascular permeability, and eosinophil recruitment are all types of effects that facilitate asthma.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Alternatively, in allergic rhinitis, CysLTs are released by the nasal mucosa when exposed to allergens during both early and late phase reactions and participate in eliciting symptoms of allergic rhinitis like a congested nose and airway.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



Subsequently, montelukast is a leukotriene receptor antagonist that binds with high affinity and selectivity to the CysLT type 1 receptor, which consequently assists in inhibiting any physiological actions of CysLTs like LTC4, LTD4, and LTE4 at the receptor that may facilitate asthma or allergic rhinitis.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]', 'Montelukast is a leukotriene receptor antagonist that demonstrates a marked affinity and selectivity to the cysteinyl leukotriene receptor type-1 in preference to many other crucial airway receptors like the prostanoid, cholinergic, or beta-adrenergic receptors.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] As a consequence, the agent can elicit substantial blockage of LTD4 leukotriene-mediated bronchoconstriction with doses as low as 5 mg.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Moreover, a placebo-controlled, crossover study (n=12) demonstrated that montelukast is capable of inhibiting early and late phase bronchoconstriction caused by antigen challenge by 75% and 57% respectively.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



In particular, it has been documented that montelukast can cause bronchodilation as soon as within 2 hours of oral administration.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] This action can also be additive to the bronchodilation caused by the concomitant use of a beta agonist.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Nevertheless, clinical investigations performed with adults 15 years of age and older revealed that no additional clinical benefit is obtained when doses of montelukast greater than 10 mg a day are used.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



Additionally, in clinical trials with adults and pediatric asthmatic patients aged 6 to 14 years, it was also determined that montelukast can reduce mean peripheral blood eosinophils by about 13% to 15% from baseline in comparison to placebo during double-blind treatment periods.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] At the same time, in patients aged 15 years and older who were experiencing seasonal allergic rhinitis, the use of montelukast caused a median reduction of 13% in peripheral blood eosinophil counts when compared to placebo as well.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10515, 'Singulair 5mg 14 chewable tab', 'سينجولير 5مجم 14 قرص مضغ', '174', '131', 'Asthma.anti-inflammatory.leukotriene antagonist', 'Montelukast', 'Global napi pharmaceuticals > merck sharp & dohme', 'Tab', 'أقراص', '5mg', '2', 'علاج أزمات الصدر وصعوبة وضيق التنفس', NULL, '6223002143276', NULL, 5592, '2024-06-14', 0, 'Montelukast is indicated for:



(a) the prophylaxis and chronic treatment of asthma in adults and pediatric patients who are 12 months of age and older[L6301], although other regional health authorities specifically note this indication for adults and adolescents who are 15 years and older[L6304,L6307] and also include indications for preventing day and night-time symptoms, and the treatment of acetylsalicylic acid-sensitive asthma[L6304];



(b) the prevention of exercise-induced bronchoconstriction (EIB) in patients who are 6 years of age and older[L6301], although other regional health authorities specifically note this indication for adults and adolescents who are 15 years and older[L6304,L6307]; and



(c) the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older[L6301], although other regional health authorities specifically note the relief of seasonal allergic rhinitis symptoms for adults and adolescents who are 15 years and older[L6304,L6307].



Furthermore, some formulations like chewable montelukast tablets may also be specifically indicated by particular regulatory bodies for the prophylaxis and chronic treatment of asthma, including the prevention of day and night-time symptoms, the treatment of acetylsalicylic acid based asthma, and the prevention of exercise-induced bronchoconstriction in adult and pediatric patients aged 2 and older[L6328], between the ages 2 and 5[L6325], or between the ages of 6 and 14 years.[L6331]



Moreover, when employed for such indications montelukast is considered effective as monotherapy or when combined with other medications indicated for the maintenance treatment of chronic asthma.[L6304,L6328] For instance, montelukast and inhaled corticosteroids can be used concomitantly to demonstrate additive effects to control asthma or to decrease the necessary inhaled corticosteroid dose while still maintaining clinical stability.[L6304,L6328]



Additionally, in patients who continue to experience asthma symptoms, montelukast can also be combined with an ''as required'' short-acting beta-agonist, an inhaled corticosteroid, or inhaled corticosteroid paired with a long-acting beta-agonist.[L6304,L6328]', 'Cysteinyl leukotrienes (CysLT) like LTC4, LTD4, and LTE4, among others, are eicosanoids released by a variety of cells like mast cells and eosinophils.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] When such CysLT bind to corresponding CysLT receptors like CysLT type-1 receptors located on respiratory airway smooth muscle cells, airway macrophages, and on various pro-inflammatory cells like eosinophils and some specific myeloid stem cells activities that facilitate the pathophysiology of asthma and allergic rhinitis are stimulated.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



In particular, CysLT-mediated airway bronchoconstriction, occluding mucous secretion, vascular permeability, and eosinophil recruitment are all types of effects that facilitate asthma.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Alternatively, in allergic rhinitis, CysLTs are released by the nasal mucosa when exposed to allergens during both early and late phase reactions and participate in eliciting symptoms of allergic rhinitis like a congested nose and airway.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



Subsequently, montelukast is a leukotriene receptor antagonist that binds with high affinity and selectivity to the CysLT type 1 receptor, which consequently assists in inhibiting any physiological actions of CysLTs like LTC4, LTD4, and LTE4 at the receptor that may facilitate asthma or allergic rhinitis.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]', 'Montelukast is a leukotriene receptor antagonist that demonstrates a marked affinity and selectivity to the cysteinyl leukotriene receptor type-1 in preference to many other crucial airway receptors like the prostanoid, cholinergic, or beta-adrenergic receptors.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] As a consequence, the agent can elicit substantial blockage of LTD4 leukotriene-mediated bronchoconstriction with doses as low as 5 mg.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Moreover, a placebo-controlled, crossover study (n=12) demonstrated that montelukast is capable of inhibiting early and late phase bronchoconstriction caused by antigen challenge by 75% and 57% respectively.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



In particular, it has been documented that montelukast can cause bronchodilation as soon as within 2 hours of oral administration.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] This action can also be additive to the bronchodilation caused by the concomitant use of a beta agonist.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Nevertheless, clinical investigations performed with adults 15 years of age and older revealed that no additional clinical benefit is obtained when doses of montelukast greater than 10 mg a day are used.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



Additionally, in clinical trials with adults and pediatric asthmatic patients aged 6 to 14 years, it was also determined that montelukast can reduce mean peripheral blood eosinophils by about 13% to 15% from baseline in comparison to placebo during double-blind treatment periods.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] At the same time, in patients aged 15 years and older who were experiencing seasonal allergic rhinitis, the use of montelukast caused a median reduction of 13% in peripheral blood eosinophil counts when compared to placebo as well.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10518, 'Freshme 50 ml spray', 'فريش مي سبراي 50 مل', '55', '45', 'Mouth refresgener spray', 'Clove oil + chlorohexedine + vit e + vit c + propolis extract + grape seed', 'Mpco', 'Spray', 'بخاخ', '50 ml', '1', NULL, NULL, NULL, NULL, 1028, '2025-08-03', 0, 'Clove oil is primarily indicated in conditions like colic, flatulence, and toothache [L2849].', 'The chief constituent present in clove oil is the phenol "_eugenol_" which is present in amounts up to 85%. Clove oil acts as a germicide [L2849] to Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa [A24841]. 



Clove oil is thought to inhibit prostaglandin synthesis, thereby reducing painful symptoms [A33145].



Eugenol, the main constituent of clove oil is purported to have anticancer action. In one study, eugenol-treated HL-60 cells showed features of apoptosis including DNA fragmentation and formation of DNA ladders in agarose gel electrophoresis. It was observed that eugenol transduced the apoptotic signal via reactive oxygen species (ROS) generation, inducing mitochondrial permeability transition (MPT), decreasing anti-apoptotic protein _bcl-2_ level, inducing _cytochrome c_ release to the cytosol, and subsequent apoptotic cell death. When taken together, the study showed that ROS plays a critical role in eugenol-induced apoptosis in _HL-60_, and this is the first report on the mechanism of the anticancer effect of eugenol [A33146].', 'Clove (Eugenia caryophyllata Thunb. [Myrtaceae]) essential oil (CEO) has been demonstrated to possess antimicrobial, antifungal, antiviral, antioxidant, anti-inflammatory, anti-histamine, and anticancer properties. However, few studies have focused on its topical use [A33133], [L2850].



Clove essential oil, used as an antiseptic in oral infections, inhibits gram-negative and gram-positive bacteria as well as yeast [A24841].



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10519, 'Naturest gel 100 gm', 'ناتشوريست جل 100 جم', '95', NULL, 'Analgesic anti inflammatory massage gel', 'Vitamin e+omega 3+omega 6+panthenol+eucalyptus oil+menthol oil+camphor oil+peppermint oil', 'Nature pharmasutical.co', 'Gel', 'جل', '100 gm', '1', NULL, NULL, NULL, NULL, 1138, '2022-08-15', 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10522, 'Sinomarin mini nasal spray 30ml', 'سينومارين ميني بخاخ للانف 30 مل', '280', '255', 'Nasal decongestant spray', 'Hypertonic seawater', 'Gerolymatos > eva pharma', 'Spray', 'بخاخ', '30ml', '1', NULL, '*relieves nasal congestion - cleanses and moisturises.', '5206892100148', NULL, 3756, '2025-03-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10523, 'Rosmira 60 ml spray', 'روزميرا سبراي 60 مل', '49', NULL, 'Mouth spray', 'Clove + menthol + chamomile', 'Green chemist', 'Spray', 'بخاخ', '60 ml', '1', NULL, NULL, NULL, NULL, 886, '2023-01-21', 0, 'Clove oil is primarily indicated in conditions like colic, flatulence, and toothache [L2849].', 'The chief constituent present in clove oil is the phenol "_eugenol_" which is present in amounts up to 85%. Clove oil acts as a germicide [L2849] to Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa [A24841]. 



Clove oil is thought to inhibit prostaglandin synthesis, thereby reducing painful symptoms [A33145].



Eugenol, the main constituent of clove oil is purported to have anticancer action. In one study, eugenol-treated HL-60 cells showed features of apoptosis including DNA fragmentation and formation of DNA ladders in agarose gel electrophoresis. It was observed that eugenol transduced the apoptotic signal via reactive oxygen species (ROS) generation, inducing mitochondrial permeability transition (MPT), decreasing anti-apoptotic protein _bcl-2_ level, inducing _cytochrome c_ release to the cytosol, and subsequent apoptotic cell death. When taken together, the study showed that ROS plays a critical role in eugenol-induced apoptosis in _HL-60_, and this is the first report on the mechanism of the anticancer effect of eugenol [A33146].', 'Clove (Eugenia caryophyllata Thunb. [Myrtaceae]) essential oil (CEO) has been demonstrated to possess antimicrobial, antifungal, antiviral, antioxidant, anti-inflammatory, anti-histamine, and anticancer properties. However, few studies have focused on its topical use [A33133], [L2850].



Clove essential oil, used as an antiseptic in oral infections, inhibits gram-negative and gram-positive bacteria as well as yeast [A24841].



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10524, 'Carty 30 pieces', 'كارتي 30 قطعة', '150', '110', 'Calcium supplement', 'Calcium+magnesium+vitamin d3', 'Company', 'Piece', 'قطعة', NULL, '1', NULL, NULL, NULL, NULL, 2720, '2025-06-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10525, 'Keranty conditioner 250 ml', 'كيرانتي كوندشنر 250 مل', '220', '200', 'Hair care', NULL, 'Prime pharma', 'Conditioner', 'بلسم', '250 ml', '1', 'علاج لمرض ارتفاع ضغط الدم', NULL, NULL, NULL, 980, '2025-08-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10526, 'Roaivy 120 ml syrup', 'روايفي شراب 120 مل', '45', '40', 'Supports respiratory system health', 'Ivy+thyme+locoriche', 'Roaya', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 856, '2024-08-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10527, 'Sinopril 5mg 20 tab.', 'سينوبريل 5مجم 20 قرص', '20', '12', 'Antihypertensive.ace', 'Lisinopril', 'Global napi pharmaceuticals', 'Tab', 'أقراص', '5mg', '2', NULL, 'about lisinopril dicarboxylate-containing angiotensin-converting enzyme (ace) inhibitor antihypertensive. mechanism of action of lisinopril it is an angiotensin converting enzyme inhibitor prevents the conversion of angiotensin-1 to angiotensin-2 and abol', '6223002140251', NULL, 1874, '2024-08-22', 0, 'Lisinopril is indicated for the treatment of acute myocardial infarction, hypertension in patients ≥6 years, and as an adjunct therapy for heart failure.[L8384,L8387] A combination product with hydrochlorothiazide is indicated for the treatment of hypertension.[L8390]', 'Angiotensin II constricts coronary blood vessels and is positively inotropic, which under normal circumstances, would increase vascular resistance and oxygen consumption.[A184781] This action can eventually lead to myocyte hypertrophy and vascular smooth muscle cell proliferation.[A184781]



Lisinopril is an angiotensin converting enzyme inhibitor (ACEI), preventing the conversion of angiotensin I to angiotensin II.[A184781,A184808] This action prevents myocyte hypertrophy and vascular smooth muscle cell proliferation seen in untreated patients.[A184808] Increased levels of bradykinin also exhibit vasodilating effects for patients taking ACEIs.[A184808] Lisinopril also inhibits renin''s conversion of angiotensin to angiotensin I.[A184817]', 'Lisinopril is an angiotensin converting enzyme inhibitor used to treat hypertension, heart failure, and myocardial infarction.[L8384,L8387,L8390] Lisinopril is not a prodrug, and functions by inhibition of angiotensin converting enzyme as well as the renin angiotensin aldosterone system.[A184781,A184808,A184817] It has a wide therapeutic index and a long duration of action as patients are generally given 10-80mg daily.[L8384,L8387,L8390]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10528, 'Sinopril-co 12.5/20mg 30 tab.', 'سينوبريل كو 12.5/20مجم 30 قرص', '105', '79.5', 'Antihypertensive.combined ace with diuretic', 'Hydrochlorothiazide+lisinopril', 'Global napi pharmaceuticals', 'Tab', 'أقراص', '20mg', '3', 'علاج ارتفاع ضغط الدم', 'warning: this drug can cause serious (possibly fatal) harm to an unborn baby if used during pregnancy. therefore it is important to prevent pregnancy while taking this medication. uses: this medication is used to treat high blood pressure (hypertension).', '6223002142286', NULL, 4559, '2024-08-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10532, 'Sinupret forte 50 sugar c.tabs.', 'سينوبريت فورت 50 قرص', '210', '154', 'Decongestant', 'Elder flowers+gentian root+primose flowers+shop vervain wort+sorrel herb', 'Bionorica ag-germany > technomed group-egypt', 'Tab', 'أقراص', NULL, '2', 'مضاد للاحتقان -- تقليل الالام بالحلق -- تقليل الالتهابات', NULL, '4029799166243', NULL, 7592, '2025-08-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10536, 'Sirdalud 2mg 20 tab', 'سيردالود 2مجم 20 قرص', '54', '31', 'Cns.analgesic.skeletal muscle relaxant.alpha2 agonist', 'Tizanidine', 'Novartis > sandoz', 'Tab', 'أقراص', '2mg', '2', 'مسكن عام -- تقليل الشد العضلي -- تقليل الالتهابات -- الاحساس بالراحة والاسترخاء -- يساعد علي النوم', NULL, '6223002641932', NULL, 9938, '2024-11-05', 0, 'Tizanidine is indicated for the relief of muscle spasticity, which can interfere with daily activities.  The general recommendation is to reserve tizanidine use for periods of time when there is a particular need for relief, as it has a short duration of action [FDA label, F4471]. ', 'Tizanidine reduces spasticity by causing presynaptic inhibition of motor neurons via agonist actions at Alpha-2 adrenergic receptor sites.

This drug is centrally acting and leads to a reduction in the release of excitatory amino acids like glutamate and aspartate, which cause neuronal firing that leads to muscle spasm. The above reduction and excitatory neurotransmitter release results in presynaptic inhibition of motor neurons. The strongest effect of tizanidine has been shown to occur on spinal polysynaptic pathways.   The anti-nociceptive and anticonvulsant activities of tizanidine may also be attributed to agonist action on Alpha-2 receptors.  Tizanidine also binds with weaker affinity to the Alpha-1 receptors, explaining its slight and temporary effect on the cardiovascular system [T574]. ', '**A note on spasticity**



Spasticity is an increase in muscle accompanied by uncontrolled, repetitive contractions of skeletal muscles which are involuntary.

The patient suffering from muscle spasticity may have reduced mobility and high levels of pain, contributing to poor quality of life and problems performing activities of personal hygiene and care [A177640]. 



**General effects**



Tizanidine is a rapidly acting drug used for the relief of muscle spasticity when it is required for performing specific activities. It acts as an agonist at Alpha-2 adrenergic receptor sites and relieves symptoms of muscle spasticity, allowing the continuation of normal daily activities. In animal models, tizanidine has not been shown to exert direct effects on skeletal muscle fibers or the neuromuscular junction, and has shown no significant effect on monosynaptic spinal reflexes (consisting of the communication between only 1 sensory neuron and 1 motor neuron) [L6064]. The frequency of muscle spasm and clonus are shown to be decreased by tizanidine [T574]. Tizanidine shows a stronger action on polysynaptic reflexes, which involve several interneurons (relay neurons) communicating with motor neurons stimulating muscle movement [L6064].



**Effects on blood pressure and heart rate**



This drug decreases heart rate and blood pressure in humans [A177559, A177589].  Despite this, rebound hypertension and tachycardia along with increased spasticity can occur when tizanidine is abruptly discontinued [A177643]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10537, 'Sirdalud 4mg 20 tab', 'سيردالود 4مجم 20 قرص', '70', '41', 'Cns.analgesic.skeletal muscle relaxant.alpha2 agonist', 'Tizanidine', 'Novartis > sandoz', 'Tab', 'أقراص', '4mg', '2', 'باسط للعضلات -- مسكن عام -- تقليل الشد العضلي -- تقليل الالتهابات -- الاحساس بالراحة والاسترخاء -- يساعد علي النوم', NULL, '6223002641918', NULL, 13596, '2024-09-28', 0, 'Tizanidine is indicated for the relief of muscle spasticity, which can interfere with daily activities.  The general recommendation is to reserve tizanidine use for periods of time when there is a particular need for relief, as it has a short duration of action [FDA label, F4471]. ', 'Tizanidine reduces spasticity by causing presynaptic inhibition of motor neurons via agonist actions at Alpha-2 adrenergic receptor sites.

This drug is centrally acting and leads to a reduction in the release of excitatory amino acids like glutamate and aspartate, which cause neuronal firing that leads to muscle spasm. The above reduction and excitatory neurotransmitter release results in presynaptic inhibition of motor neurons. The strongest effect of tizanidine has been shown to occur on spinal polysynaptic pathways.   The anti-nociceptive and anticonvulsant activities of tizanidine may also be attributed to agonist action on Alpha-2 receptors.  Tizanidine also binds with weaker affinity to the Alpha-1 receptors, explaining its slight and temporary effect on the cardiovascular system [T574]. ', '**A note on spasticity**



Spasticity is an increase in muscle accompanied by uncontrolled, repetitive contractions of skeletal muscles which are involuntary.

The patient suffering from muscle spasticity may have reduced mobility and high levels of pain, contributing to poor quality of life and problems performing activities of personal hygiene and care [A177640]. 



**General effects**



Tizanidine is a rapidly acting drug used for the relief of muscle spasticity when it is required for performing specific activities. It acts as an agonist at Alpha-2 adrenergic receptor sites and relieves symptoms of muscle spasticity, allowing the continuation of normal daily activities. In animal models, tizanidine has not been shown to exert direct effects on skeletal muscle fibers or the neuromuscular junction, and has shown no significant effect on monosynaptic spinal reflexes (consisting of the communication between only 1 sensory neuron and 1 motor neuron) [L6064]. The frequency of muscle spasm and clonus are shown to be decreased by tizanidine [T574]. Tizanidine shows a stronger action on polysynaptic reflexes, which involve several interneurons (relay neurons) communicating with motor neurons stimulating muscle movement [L6064].



**Effects on blood pressure and heart rate**



This drug decreases heart rate and blood pressure in humans [A177559, A177589].  Despite this, rebound hypertension and tachycardia along with increased spasticity can occur when tizanidine is abruptly discontinued [A177643]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10538, 'Mol-sun sunscreen cream spf50+ - 75 gm', 'مول صن صنسكرين كريم اس بي اف 50+ - 75 جم', '220', '150', 'Sun block', NULL, 'Safe life', 'Cream', 'كريم', '75 gm', '1', 'مسكن عام -- تقليل الشد العضلي -- تقليل الالتهابات -- الاحساس بالراحة والاسترخاء -- يساعد علي النوم', NULL, NULL, NULL, 927, '2024-08-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10540, 'Alkapress trio 10/320/25mg 14 f.c. tabs.', 'الكابرس تريو 10/320/25مجم 14 قرص', '118', '62', 'Antihypertensive. combined angiotensin blocker with calcium channel blocker', 'Amlodipine+hydrochlorothiazide+valsartan', 'Hikma pharma', 'Tab', 'أقراص', '25mg', '2', NULL, NULL, '6221000010798', NULL, 1993, '2024-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10542, 'Siwa germ 20 caps.', 'سيوة جيرم 20كبسولة', '37', NULL, 'Multivitamins', 'Wheat germ oil+bee pollen', 'Arab caps', 'Cap', 'كبسولة', NULL, '2', NULL, NULL, NULL, NULL, 842, '2022-12-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10546, 'Herorash cream 60 gm', 'هيرو راش كريم 60 جم', '70', NULL, 'Soothing topical', 'Zinc oxide+benzyl alcohol+benzyl benzoate+benzyl cinnamate+lanolin', 'Hero pharm', 'Cream', 'كريم', '60 gm', '1', 'يستخدم للعناية بالبشرة والوجه والإبط كريم معالج مطهر لطيف، يستخدم للوقاية من التهابات الحفاض للأطفال، يساعد على علاج الجروح ، وله خصائص متعددة مطهرة ومضادة للعدوي، ويحتوي أيضا على مخدر موضعي معتدل لتهدئة الانزعاج.', NULL, NULL, NULL, 881, '2023-01-13', 0, 'Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].  



', '**Zinc has three primary biological roles**: _catalytic_, _structural_, and _regulatory_. The catalytic and structural role of zinc is well established, and there are various noteworthy reviews on these functions. For example, zinc is a structural constituent in numerous proteins, inclusive of growth factors, cytokines, receptors, enzymes, and transcription factors for different cellular signaling pathways. It is implicated in numerous cellular processes as a cofactor for approximately 3000 human proteins including enzymes, nuclear factors, and hormones [L2096].



Zinc promotes resistance to epithelial apoptosis through cell protection (cytoprotection) against reactive oxygen species and bacterial toxins, likely through the antioxidant activity of the cysteine-rich metallothioneins [A32419].



In HL-60 cells (promyelocytic leukemia cell line), zinc enhances the up-regulation of A20 mRNA, which, via TRAF pathway, decreases NF-kappaB activation, leading to decreased gene expression and generation of tumor necrosis factor-alpha (TNF-alpha), IL-1beta, and IL-8 [A32418].



There are several mechanisms of action of zinc on acute diarrhea. Various mechanisms are specific to the gastrointestinal system: zinc restores mucosal barrier integrity and enterocyte brush-border enzyme activity, it promotes the production of antibodies and circulating lymphocytes against intestinal pathogens, and has a direct effect on ion channels, acting as a potassium channel blocker of adenosine 3-5-cyclic monophosphate-mediated chlorine secretion. Cochrane researchers examined the evidence available up to 30 September 2016 [L2106].



Zinc deficiency in humans decreases the activity of serum _thymulin_ (a hormone of the thymus), which is necessary for the maturation of T-helper cells. T-helper 1 (Th(1)) cytokines are decreased but T-helper 2 (Th(2)) cytokines are not affected by zinc deficiency in humans [A32417].



The change of _Th(1)_ to _Th(2)_ function leads to cell-mediated immune dysfunction. Because IL-2 production (Th(1) cytokine) is decreased, this causes decreased activity of natural-killer-cell (NK cell) and T cytolytic cells, normally involved in killing viruses, bacteria, and malignant cells [A32424]. 



In humans, zinc deficiency may lead to the generation of new CD4+ T cells, produced in the thymus. In cell culture studies (HUT-78, a Th(0) human malignant lymphoblastoid cell line), as a result of zinc deficiency, nuclear factor-kappaB (NF-kappaB) activation, phosphorylation of IkappaB, and binding of NF-kappaB to DNA are decreased and this results in decreased Th(1) cytokine production [A32417].



In another study, zinc supplementation in human subjects suppressed the gene expression and production of pro-inflammatory cytokines and decreased oxidative stress markers [A32424]. In HL-60 cells (a human pro-myelocytic leukemia cell line), zinc deficiency increased the levels of TNF-alpha, IL-1beta, and IL-8 cytokines and mRNA. In such cells, zinc was found to induce A20, a zinc finger protein that inhibited NF-kappaB activation by the tumor necrosis factor receptor-associated factor pathway. This process decreased gene expression of pro-inflammatory cytokines and oxidative stress markers [A32417].



The exact mechanism of zinc in acne treatment is poorly understood. However, zinc is considered to act directly on microbial inflammatory equilibrium and facilitate antibiotic absorption when used in combination with other agents. Topical zinc alone as well as in combination with other agents may be efficacious because of its anti-inflammatory activity and ability to reduce P. acnes bacteria by the inhibition of P. acnes lipases and free fatty acid levels [L2102].', 'Zinc is involved in various aspects of cellular metabolism. It has been estimated that approximately 10% of human proteins may bind zinc, in addition to hundreds of proteins that transport and traffic zinc. It is required for the catalytic activity of more than 200 enzymes, and it plays a role in immune function wound healing, protein synthesis, DNA synthesis, and cell division. Zinc is an essential element for a proper sense of taste and smell and supports normal growth and development during pregnancy, childhood, and adolescence. It is thought to have antioxidant properties, which may be protective against accelerated aging and helps to speed up the healing process after an injury; however, studies differ as to its effectiveness. Zinc ions are effective antimicrobial agents even if administered in low concentrations [L2211].



Studies on oral zinc for specific conditions shows the following evidence in various conditions [L2095]:



**Colds:** Evidence suggests that if zinc lozenges or syrup are taken within 24 hours after cold symptoms start, the supplement may shorten the length of colds. The use intranasal zinc has been associated with the loss of the sense of smell, in some cases long-term or permanently [L2095].



**Wound healing:** Patients with skin ulcers and decreased levels of zinc may benefit from oral zinc supplements [L2095]. 



**Diahrrea**: Oral zinc supplements can reduce the symptoms of diarrhea in children with low levels of zinc, especially in cases of malnutrition [L2095].

', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10558, 'Sleep-aid 10mg 10 tab.', 'سليب-ايد 10مجم 10 اقراص', '12', '8', 'Psychiatric.anxiolytics-hypnotics', 'Zaleplon', 'October pharma', 'Tab', 'أقراص', '10mg', '1', NULL, 'about zaleplon pyrazolopyrimidine derivative( a nonbenzodiazepine sedative-hypnotic. mechanism of action of zaleplon zaleplon is a non benzodiazepine sedative-hypnotic drug. it binds to the benzodiazepine binding site on gaba-a receptors containing the al', '6221088010840', NULL, 1741, '2025-08-04', 0, 'For the treatment of short-term treatment of insomnia in adults.', 'Zaleplon exerts its action through subunit modulation of the GABA<sub>B</sub>Z receptor chloride channel macromolecular complex. Zaleplon also binds selectively to the brain omega-1 receptor located on the alpha subunit of the GABA-A/chloride ion channel receptor complex and potentiates t-butyl-bicyclophosphorothionate (TBPS) binding.', 'Zaleplon is a nonbenzodiazepine hypnotic from the pyrazolopyrimidine class and is indicated for the short-term treatment of insomnia. While Zaleplon is a hypnotic agent with a chemical structure unrelated to benzodiazepines, barbiturates, or other drugs with known hypnotic properties, it interacts with the gamma-aminobutyric acid-benzodiazepine (GABA<sub>B</sub>Z) receptor complex. Subunit modulation of the GABA<sub>B</sub>Z receptor chloride channel macromolecular complex is hypothesized to be responsible for some of the pharmacological properties of benzodiazepines, which include sedative, anxiolytic, muscle relaxant, and anticonvulsive effects in animal models. Zaleplon also binds selectively to the CNS GABA<sub>A</sub>-receptor chloride ionophore complex at benzodiazepine(BZ) omega-1 (BZ1, ο1) receptors. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10559, 'Calfacto massage gel 50 gm', 'كالفاكتو مساج جل 50 جم', '48', NULL, 'Massage', 'Camphor+eucalyptus+clove+menthol', 'Company', 'Gel', 'جل', '50 gm', '1', NULL, NULL, NULL, NULL, 780, '2022-10-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10561, 'Sleepez 2mg 20 f.c. tabs.', 'سليبيز 2مجم 20 قرص', '40', '27', 'Psychiatric.anxiolytics-hypnotics', 'Eszopiclone', 'Chemipharm', 'Tab', 'أقراص', '2mg', '2', NULL, NULL, '6222006500610', NULL, 2243, '2025-08-04', 0, 'Eszopiclone is indicated for the treatment of insomnia.[L6769]', 'The exact mechanism of action of eszopiclone is unknown at this time but is thought to occur via binding with the GABA receptor complexes at binding sites located near benzodiazepine receptors, possibly explaining its hypnotic and sedative effects.[A179659,L6769] It has particular affinity for GABA-A (or GABAA) receptor subunits 1, 3 and 5.[A179788,A15625,A15626] Eszopiclone increases GABA-A channel currents significantly.[A179788] GABA-A channels are major inhibitory channels that cause CNS depression when their receptors are activated.[A179800]', 'Eszopiclone rapidly induces sleep and decreases sleep latency. It also aids in the maintenance of sleep, preventing frequent awakenings.[A179659,A179662,L6769] This drug has shown anticonvulsant and muscle relaxant properties in animals but is used in humans for its sedating effects.[A179827]



Eszopiclone is a central nervous system depressant with various effects. These include changes in alertness and motor coordination and the risk of next morning impairment, increasing with the amount of eszopiclone administered.  Exercise caution and advise against driving a motor vehicle or activities that require full mental alertness the next morning.[L6769] Complex sleep behaviors may result from eszopiclone use. Eszopiclone should be discontinued in these cases.[L6874] Avoid the use of alcohol and other CNS depressants when eszopiclone is administered. Advise patients to skip the eszopiclone dose if alcohol has been consumed before bed or during the evening. Use the smallest dose of eszopiclone as possible, especially in elderly patients, who may experience exaggerated drug effects. Though the potential for dependence and abuse with eszopiclone is lower than for other hypnotic drugs, this drug has been abused and is known to cause dependence.[L6868]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10562, 'Sleepez 3 mg 30 f.c.tabs.', 'سليبيز 3مجم 30 قرص', '81', '57', 'Psychiatric.anxiolytics.hypnotics', 'Eszopiclone', 'Chemipharm', 'Tab', 'أقراص', '3 mg', '3', NULL, NULL, '6222006500627', NULL, 8948, '2024-08-15', 0, 'Eszopiclone is indicated for the treatment of insomnia.[L6769]', 'The exact mechanism of action of eszopiclone is unknown at this time but is thought to occur via binding with the GABA receptor complexes at binding sites located near benzodiazepine receptors, possibly explaining its hypnotic and sedative effects.[A179659,L6769] It has particular affinity for GABA-A (or GABAA) receptor subunits 1, 3 and 5.[A179788,A15625,A15626] Eszopiclone increases GABA-A channel currents significantly.[A179788] GABA-A channels are major inhibitory channels that cause CNS depression when their receptors are activated.[A179800]', 'Eszopiclone rapidly induces sleep and decreases sleep latency. It also aids in the maintenance of sleep, preventing frequent awakenings.[A179659,A179662,L6769] This drug has shown anticonvulsant and muscle relaxant properties in animals but is used in humans for its sedating effects.[A179827]



Eszopiclone is a central nervous system depressant with various effects. These include changes in alertness and motor coordination and the risk of next morning impairment, increasing with the amount of eszopiclone administered.  Exercise caution and advise against driving a motor vehicle or activities that require full mental alertness the next morning.[L6769] Complex sleep behaviors may result from eszopiclone use. Eszopiclone should be discontinued in these cases.[L6874] Avoid the use of alcohol and other CNS depressants when eszopiclone is administered. Advise patients to skip the eszopiclone dose if alcohol has been consumed before bed or during the evening. Use the smallest dose of eszopiclone as possible, especially in elderly patients, who may experience exaggerated drug effects. Though the potential for dependence and abuse with eszopiclone is lower than for other hypnotic drugs, this drug has been abused and is known to cause dependence.[L6868]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10565, 'Slimax 10mg 30 cap', 'سليماكس 10مجم 30 كبسولة', '45', NULL, 'Monoamine oxidase inhibitor', 'Sibutramine hydrochloride monohydrate', 'Multi apex pharm', 'Cap', 'كبسولة', '10mg', '3', 'تقليل الشهية -- انقاص الوزن -- تقليل الكوليسترول في الدم', NULL, '6223003201654', NULL, 2188, '2022-12-15', 0, 'For the treatment of obesity.', 'Sibutramine produces its therapeutic effects by inhibition of norepinephrine (NE), serotonin (5-hydroxytryptamine, 5-HT), and to a lesser extent, dopamine reuptake at the neuronal synapse. By inhibiting the reuptake of these neurotransmitters, sibutramine promotes a sense of satiety and decrease in appetite, thereby reducing food intake. Data from animal studies also suggest that sibutramine may also increase energy expenditure through thermogenic effects in both the basal and fed states, but this has not been confirmed in humans. Sibutramine and its major pharmacologically active metabolites (M1 and M2) do not act via release of monoamines. ', 'Sibutramine is an orally administered agent for the treatment of obesity. Sibutramine exerts its pharmacological actions predominantly via its secondary (M1) and primary (M2) amine metabolites. The parent compound, sibutramine, is a potent inhibitor of serotonin and norepinephrine reuptake <i>in vivo</i>, but not <i>in vitro</i>. However, metabolites M1 and M2 inhibit the reuptake of these neurotransmitters both <i>in vitro</i> and <i>in vivo</i>. In human brain tissue, M1 and M2 also inhibit dopamine reuptake <i>in vitro</i>, but with ~3-fold lower potency than for the reuptake inhibition of serotonin or norepinephrine. Sibutramine, M1 and M2 exhibit no evidence of anticholinergic or antihistaminergic actions. In addition, receptor binding profiles show that sibutramine, M1 and M2 have low affinity for serotonin (5-HT<sub>1</sub>, 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>2C</sub>), norepinephrine (b, b1, b3, a1 and a2), dopamine (D1 and D2), benzodiazepine, and glutamate (NMDA) receptors. These compounds also lack monoamine oxidase inhibitory activity <i>in vitro</i> and <i>in vivo</i>.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10566, 'Jackodan facial wash 150 ml', 'جاكودان غسول للوجه 150 مل', '160', '130', NULL, 'Anti-acne', 'Kmt pharma', 'Facial wash', 'غسول للوجه', '150 ml', '1', NULL, NULL, '6224011031219', NULL, 1699, '2024-05-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10570, 'Mepadrenal 50 carpules', 'ميبادرينال 50 كربوله', '480', NULL, 'Analgesic.local anesthetic', 'Adrenaline+mepivacaine', 'Alexandria', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, '6221025017109', NULL, 713, '2023-01-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10584, 'Sunseiz 500 mg 30 f.c.tabs.', 'صن سيز 500 مجم 30 قرص', '171', '126', 'Anti-epileptic.pyrrolidine', 'Levetiracetam', 'Sun pharma egypt limited', 'Tab', 'أقراص', '500 mg', '3', NULL, NULL, NULL, NULL, 1287, '2025-02-04', 0, 'Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606]



Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]', 'The exact mechanism through which levetiracetam exerts its anti-epileptic effects is unclear, but is thought to be unique amongst other anti-epileptic medications. Current knowledge suggests that levetiracetam’s binding to synaptic vesicle protein 2A (SV2A) is a key driver of its action. SV2A is a membrane-bound protein that is found on synaptic vesicles and is ubiquitous throughout the CNS[A12546] - it appears to play a role in vesicle exocytosis[L8606,L8615] and in the modulation of synaptic transmission by increasing the available amount of secretory vesicles available for neurotransmission.[A12552] Stimulation of pre-synaptic SV2A by levetiracetam may inhibit neurotransmitter release,[A12551] but this action does not appear to affect normal neurotransmission. This has led to the suggestion that levetiracetam exclusively modulates the function of SV2A only under pathophysiological conditions.[A12546] Levetiracetam and related analogues showed a correlation between affinity for SV2A and anti-epileptic potency, further suggesting that action at this site contributes to the anti-epileptic activity of the drug.[L8606,L8615]



Levetiracetam has also been shown to indirectly affect GABAergic neurotransmission (despite having no direct effect on GABAergic or glutamatergic receptors) and modulate ionic currents.[A12552] Similarly, levetiracetam has been shown in vitro to inhibit N-type calcium channels.[A16562] How, or even if, these actions are implicated in its anti-epileptic action have yet to be elucidated.', 'Levetiracetam appears to prevent seizure activity via the selective inhibition of hypersynchronized epileptiform burst firing without affecting normal neuronal transmission, though the exact mechanism through which this occurs is unclear.[L8606,L8615] The therapeutic index of levetiracetam is wide,[L8615,A185918] making it relatively unique amongst other anti-epileptic medications.



Anti-epileptic drugs, including levetiracetam, may increase the risk of suicidal ideation or behaviour - patients taking levetiracetam should be monitored for the emergence or worsening of depressive symptoms, suicidal ideation, and behavioural abnormalities.[L8606,L8600,L8615]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10585, 'Comeciar sunscreen cream spf +30 - 60 gm', 'كومسيار صن سكرين كريم اس بي اف 30+ 60 جم', '70', NULL, 'Sun block', 'Sun protection formula', 'Company', 'Cream', 'كريم', '60 gm', '1', NULL, NULL, '6221075200070', NULL, 712, '2023-04-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10589, 'Sonidair 1 mg/2ml 30 susp. amp. for inh.', 'سونيدير 1مجم/2 مل 30 امبول للاستنشاق', '612', '420', 'Bronchodilator.anti-inflammatory.glucocorticoid steroid', 'Budesonide', 'Mdi pharma', 'Susp', 'معلق', '1 mg', '1', NULL, NULL, '6224002249043', NULL, 2154, '2024-06-27', 0, 'Budesonide extended-release capsules are indicated for the treatment and maintenance of mild to moderate Crohn’s disease.[L10601,L10604] Various inhaled budesonide products are indicated for prophylactic therapy in asthma [L10607,L10613,L10619] and to reduce exacerbations of COPD.[L10619] A budesonide nasal spray is available over the counter for symptoms of hay fever and upper respiratory allergies.[L10616] Extended-release capsules are indicated to induce remission of mild to moderate ulcerative colitis[L10622] and a rectal foam is used for mild to moderate distal ulcerative colitis.[L10625] In addition, a delayed-release capsule formulation of budesonide is indicated to reduce proteinuria in adults with IgA nephropathy at risk of rapid disease progression.[L42515,L49540] Budesonide is indicated to treat eosinophilic esophagitis (EoE): For this indication, it is only approved for use in adults in Europe [L42525] while it is approved for short-term use (12 weeks) in patients 11 years of age and older in the US.[L50161]', 'The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation.[A187463] Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days.[A187463]



Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10.[A187463]



Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.[A187463] High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.[A187463]', 'Budesonide is a glucocorticoid used to treat respiratory and digestive conditions by reducing inflammation.[L10601,L10604,L10607,L10613,L10619,L10622,L10625] It has a wide therapeutic index, as dosing varies highly from patient to patient.[L10601,L10604,L10607,L10613,L10619,L10622,L10625] Patients should be counselled regarding the risk of hypercorticism and adrenal axis suppression.[L10601,L10604,L10607,L10613,L10619,L10622,L10625]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10590, 'Averocoxib 90 mg 20 f.c. tabs.', 'افيروكوكسيب 90مجم 20 قرص', '228', '159', 'Nsaid.selective cox-2 inhibitors', 'Etoricoxib', 'Arab caps > averroes pharma-egypt', 'Tab', 'أقراص', '90 mg', '2', 'مسكن قوي ومضاد التهاب', NULL, '6224008179566', NULL, 63887, '2025-04-07', 0, 'For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.', 'Like any other COX-2 selective inhibitor Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2), preventing production of prostaglandins (PGs) from arachidonic acid.', 'Etoricoxib is a COX-2 selective inhibitor (approximately 106 times more selective for COX-2 inhibition over COX-1).', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10592, 'Ranxapin 10 mg 10 tabs.', 'رانكسابين 10مجم 10 اقراص', '49', NULL, 'Psychiatric.antipsychotics', 'Olanzapine', 'future pharmaceutical industries(fpi) > sun pharma egypt limited', 'Tab', 'أقراص', '10 mg', '1', NULL, NULL, NULL, NULL, 819, '2022-08-15', 0, 'Olanzapine was initially used orally and intramuscularly for the chronic treatment of schizophrenia in patients over 13 years old and other psychiatric disorders such as bipolar I disorder including mixed or manic episodes.[A177014] 



Olanzapine is also indicated, in combination with lithium or valproate for the short-term treatment of acute manic or mixed episodes associated with bipolar I disorder in adults.[FDA label]



As well, olanzapine is indicated, in combination with fluoxetine for the treatment of episodes of depression associated with bipolar disorder type 1 and treatment-resistant depression in patients over 10 years old.[A177014]



Olanzapine is also approved for the management of psychomotor agitation associated with schizophrenia and bipolar I mania.[FDA label]



Schizophrenia is a complex biochemical brain disorder that affects the person''s ability to differentiate reality. It is usually observed as the presence of delusions, hallucinations, social withdrawal and disturbed thinking.[L5936]



Bipolar disorder is a mental health condition defined by periods of extreme mood disturbances. It is categorized in different types from which type 1 is known to involve episodes of severe mania and often depression while type 2 presents less severe forms of mania.[L5939]



Olanzapine is also indicated in combination with [samidorphan] for the treatment of bipolar I disorder, either as an adjunct to lithium or valproate or as monotherapy for the acute treatment of manic or mixed episodes or as maintenance therapy, and for the treatment of schizophrenia in adults.[L34359]', 'The activity of olanzapine is achieved by the antagonism of multiple neuronal receptors including the dopamine receptor D1, D2, D3 and D4 in the brain, the serotonin receptors 5HT2A, 5HT2C, 5HT3 and 5HT6, the alpha-1 adrenergic receptor, the histamine receptor H1 and multiple muscarinic receptors.[A176993, A176999]



As abovementioned, olanzapine presents a wide profile of targets, however, its antagonistic effect towards the dopamine D2 receptor in the mesolimbic pathway is key as it blocks dopamine from having a potential action at the post-synaptic receptor. The binding of olanzapine to the dopamine D2 receptors is easily dissociable and hence, it allows for a certain degree of dopamine neurotransmission.[A177014]



On the other hand, olanzapine acts in the serotonin 5HT2A receptors in the frontal cortex in a similar manner than the reported on dopamine D2 receptors. This determined effect allows for a decrease in adverse effects.[A177014]', 'The effect of olanzapine in the D2 receptor is reported to produce the positive effects of this drug such as a decrease in hallucinations, delusions, disorganized speech, disorganized thought, and disorganized behavior. On the other hand, its effect on the serotonin 5HT2A receptor prevents the onset of anhedonia, flat affect, alogia, avolition and poor attention.[A177014] Based on the specific mechanism of action, olanzapine presents a higher affinity for the dopamine D2 receptor when compared to the rest of the dopamine receptor isotypes. This characteristic significantly reduces the presence of side effects.[T554]



Clinical trials for the original use of olanzapine demonstrated significant effectiveness in the treatment of schizophrenia and bipolar disorder in adults and acute manic or mixed episodes associated with bipolar disorder in adolescents.[A177008]



The effect of olanzapine on dopamine and serotonin receptors has been suggested to reduce chemotherapy-induced nausea and vomiting as those receptors are suggested to be involved in this process. For this effect, several clinical trials have been conducted and it has been shown that olanzapine can produce a significant increase in total control of nausea and vomiting.[A176993] In a high-level study of the effect of olanzapine for this condition, a complete response on the delay phase was observed in 84% of the individual and control of emesis of over 80% despite the phase.[A176999]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10599, 'Snafi 20 mg 4 f.c.tab', 'سنافي 20مجم 4 قرص', '204', '78', 'Tonic for men', 'Tadalafil', 'Spimaco > eimc', 'Tab', 'أقراص', '20 mg', '4', 'مقوي للرجال', NULL, '6251001155358', NULL, 11311, '2024-03-30', 0, 'Tadalafil is indicated for the treatment of erectile dysfunction (ED) and either alone or in combination with [finasteride] for the treatment of benign prostatic hypertrophy (BPH).[L39095,L39439] It is also indicated for the treatment of pulmonary arterial hypertension (PAH) both alone and in combination with [macitentan] or other endothelin-1 antagonists.[L39100,L39105,L50622]', 'Tadalafil is a selective phosphodiesterase-5 (PDE5) inhibitor that produces several downstream effects with the most common therapeutic effect being smooth muscle relaxation. [L39095] Patients may experience ED due to a variety of causes including psychogenic, neurogenic, vasculogenic, iatrogenic, or endocrine. [A242392] These causes result in dysfunction of penile smooth muscle relaxation through either disrupted neuronal signaling or direct influence on smooth muscle cells. During sexual arousal, non-adrenergic non-cholinergic (NANC) neurons release nitric oxide (NO). Nitric oxide stimulates guanylate cyclase which converts guanosine triphosphate to cyclic guanosine monophosphate (cGMP).[A242287, A242377] cGMP activates the cGMP-dependent kinase (PKG) in a signal cascade which activates K+ channels leading to inhibition of Ca2+ channels, inhibits platelet activation, and inhibits smooth muscle cell proliferation while inducing apoptosis. This signal cascade is attenuated by PDE5 which breaks the phosphodiester bond of cGMP, converting it to GMP. Inhibition of PDE5 by tadalafil increases signaling via the PKG cascade which supports penile smooth muscle relaxation during sexual arousal by decreasing Ca2+ entry into smooth muscle cells. This smooth muscle relaxation allows blood to fill the corpus cavernosum thereby producing an erection.



In PAH, blood pressure in the pulmonary arteries is raised due to a variety of mechanisms stemming from endothelial dysfunction.[A242377] Decreased production of NO and prostacyclin reduce vasodilatory signaling while overproduction of endothelin-1 and thromboxane increase vasoconstriction. Inflammation, thromboses, and hypoxia later contribute to vascular remodeling which further reduces luminal size. The resultant increase in blood pressure reduces the capacity for gas exchange and increases afterload at the right ventricle, producing symptoms of dyspnea, fatigue, and dizziness as well as leading to right-sided heart failure. Tadalafil exerts its therapeutic effect in PAH through boosting NO-cGMP signaling to contribute to smooth muscle relaxation as with ED.



Lastly, tadalafil is used to treat BPH.[L39095] BPH produces urinary dysfunction through hyperproliferation of the epithelial and smooth muscle layers of the prostate.[A242382] The increased size of the prostate blocks urine flow through the urethra resulting in higher residual volumes due to incomplete emptying. Tadalafil does not appear to exert its benefit via smooth muscle relaxation of the prostate. It may instead exert its effect through a mix of increased oxygenation and decreased inflammation, which decreases tissue remodeling, and inhibition of cell proliferation through the cGMP cascade.



The decreased affinity for PDE6 compared to other PDE5 inhibitors may explain the decreased incidence of visual side effects as PDE6 is present in the eye and contributes to color vision.[L39100, L39105, A242287]', 'Tadalafil exerts a therapeutic effect in ED by increasing sexual stimulation-dependant smooth muscle relaxation in the penis, allowing the corpus cavernosum to fill with blood to produce an erection.[A242287, A242377] Smooth muscle relaxation in the pulmonary vasculature helps to produce vasodilation in PAH which reduces blood pressure in the pulmonary arteries.[A242377] In BPH, tadalafil may contribute to decreased smooth muscle cell proliferation which may reduce the size of the prostate and relieve the anatomical obstruction which produces urinary symptoms of BPH.[A242382] The decreased affinity of tadalafil for PDE6 compared to other PDE5 inhibitors may explain the reduced incidence of visual side effects.[L39100, L39105, A242287]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10601, 'Snello plus 7 gm 10 sachets', 'سنيلو بلس 7جم 10 اكياس', '50', NULL, 'Weight loss', 'Psyllium husks powder+diet sugar+colour(sunset yellow)+orange flavour', 'Lemaco egypt > aglan pharma', 'Sachet', 'أكياس', '7 gm', '1', 'اعشاب للتخسيس', 'soluble fibre that is used in weight loss use: 1 sachet twice daily 30 minutes before meals taken with plenty of water.', '6224007331019', NULL, 2422, '2022-12-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10604, 'Ferramino syrup 100 ml', 'فيرامينو شراب 100 مل', '45', '31', 'Iron supplement', 'Ferrous bisglycinate', 'Incandesce', 'Syrup', 'شراب', '100 ml', '1', NULL, NULL, '6771504490409', NULL, 862, '2024-10-28', 0, 'Ferrous sulfate is used for the prevention and treatment of iron deficiency anemia in adults and children.[A190804,L2240,L11800]

', 'Iron is required to maintain optimal health, particularly for helping to form red blood cells (RBC) that carry oxygen around the body. A deficiency in iron indicates that the body cannot produce enough normal red blood cells.[A32514,L11800] Iron deficiency anemia occurs when body stores of iron decrease to very low levels, and the stored iron is insufficient to support normal red blood cell (RBC) production. Insufficient dietary iron, impaired iron absorption, bleeding, pregnancy, or loss of iron through the urine can lead to iron deficiency.[A32514,L11794]  Symptoms of iron deficiency anemia include fatigue, breathlessness, palpitations, dizziness, and headache.



Taking iron in supplement form, such as ferrous sulfate, allows for more rapid increases in iron levels when dietary supply and stores are not sufficient.[L2175] Iron is transported by the divalent metal transporter 1 (DMT1) across the endolysosomal membrane to enter the macrophage. It can then can be incorporated into ferritin and be stored in the macrophage or carried of the macrophage by ferroportin. This exported iron is  oxidized by the enzyme to ceruloplasmin to Fe3+, followed by sequestration by transferrin for transport in the serum to various sites, including the bone marrow for hemoglobin synthesis or into the liver.[A32524] Iron combines with porphyrin and globin chains to form hemoglobin, which is critical for oxygen delivery from the lungs to other tissues.[L2263]', 'Ferrous sulfate replenishes iron, an essential component in hemoglobin, myoglobin, and various enzymes. It replaces the iron that is usually found in hemoglobin and myoglobin. Iron participates in oxygen transport and storage, electron transport and energy metabolism, antioxidant and beneficial pro-oxidant functions, oxygen sensing, tissue proliferation and growth, as well as DNA replication and repair.[A32524,A32514]



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10619, 'Sodium bicarbonate 8.4% (otsuka) i.v. inf. 5 ml', 'صوديوم بيكربونات 8.4% محلول وريدي اوتسوكا 5 مل', '5', '3.5', 'Alkalinizer', 'Sodium bicarbonate', 'Otsuka', 'Unknown', 'غير محدد', '8.4%', '1', NULL, NULL, NULL, NULL, 2194, '2025-07-31', 0, 'Sodium bicarbonate is used for the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturateprotein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments.', 'Sodium bicarbonate is a systemic alkalizer, which increases plasma bicarbonate, buffers excess hydrogen ion concentration, and raises blood pH, thereby reversing the clinical manifestations of acidosis. It is also a urinary alkalizer, increasing the excretion of free bicarbonate ions in the urine, thus effectively raising the urinary pH. By maintaining an alkaline urine, the actual dissolution of uric acid stones may be accomplished. Sodium bicarbonate acts as an antacid and reacts chemically to neutralize or buffer existing quantities of stomach acid but has no direct effect on its output. This action results in increased pH value of stomach contents, thus providing relief of hyperacidity symptoms. [PharmGKB]', 'Intravenous sodium bicarbonate therapy increases plasma bicarbonate, buffers excess hydrogen ion concentration, raises blood pH and reverses the clinical manifestations of acidosis.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10620, 'Sodium chloride 2.7% (el nasr) i.v. inf. 500 ml (rubber cap)', 'صوديوم كلورايد 2.7% النصر محلول ملح وريدي 500 مل بغطاء مطاطي', '6', NULL, 'Sterile solution', 'Sodium chloride', 'El nasr', 'Cap', 'كبسولة', '2.7%', '1', 'يعمل على زيادة القلوية', NULL, NULL, NULL, 1062, '2022-05-20', 0, 'This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives. ', 'Sodium and chloride — major electrolytes of the fluid compartment outside of cells (i.e., extracellular) — work together to control extracellular volume and blood pressure. Disturbances in sodium concentrations in the extracellular fluid are associated with disorders of water balance.', 'Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid.

Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10622, 'Sodium chloride 3% (mottahedoon) i.v. inf. 500 ml', 'صوديوم كلورايد 3% المتحدون محلول ملح وريدي 500 مل', '14', NULL, 'Sterile solution', 'Sodium chloride', 'Al mottahedoon pharma', 'Unknown', 'غير محدد', '3%', '1', 'تستخدم في حالات الجفاف الشديد -- مضاد سريع المفعول للحموضة -- حالات تسمم المخدرات', NULL, '6223003950941', NULL, 2433, '2022-05-30', 0, 'This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives. ', 'Sodium and chloride — major electrolytes of the fluid compartment outside of cells (i.e., extracellular) — work together to control extracellular volume and blood pressure. Disturbances in sodium concentrations in the extracellular fluid are associated with disorders of water balance.', 'Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid.

Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10624, 'Sodium chloride 0.9% (mottahedoon) i.v. inf. 500 ml', 'صوديوم كلورايد 0.9% محلول ملح وريدي المتحدون 500 مل', '24', '13.5', 'Sterile solution', 'Sodium chloride', 'Al mottahedoon pharma', 'Unknown', 'غير محدد', '0.9%', '1', 'محلول ملح معقم للحقن الوريدي', NULL, '6223003950286', NULL, 39490, '2022-11-07', 0, 'This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives. ', 'Sodium and chloride — major electrolytes of the fluid compartment outside of cells (i.e., extracellular) — work together to control extracellular volume and blood pressure. Disturbances in sodium concentrations in the extracellular fluid are associated with disorders of water balance.', 'Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid.

Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10625, 'Sodium chloride 0.9% & dextrose 5% (fipco) i.v. inf. 500 ml (rubber cap)', 'صوديوم كلوريد 0.9% و ديكستروز 5% فيبكو محلول وريدي بغطاء مطاطي 500 مل', '11', NULL, 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'El-fath (fipco)', 'Cap', 'كبسولة', '0.9%', '1', 'مانع تخثر للدم أثناء عمليات نقل الدم -- يساعد في تقليل حمضية البول -- لعلاج النقرس و حصوات الكلى', NULL, NULL, NULL, 1278, '2022-05-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10627, 'Blincorest plus 125/500mg 30 chew. tabs.', 'بلنكورست بلس 125/500مجم 30 قرص مضغ', '99', '66', 'Antiflatulent', 'Simethicone', 'P & c labs', 'Tab', 'أقراص', '500mg', '3', 'مضاد للانتفاخ', NULL, NULL, NULL, 3950, '2024-07-28', 0, 'Simethicone is indicated for the treatment of bloating, pressure, and cramps caused by gas.[L31533] Simethicone is also used as part of bowel preparation for colonoscopies.[A228343] ', 'Simethicone is a surfactant that decreases the surface tension of gas bubbles in the gastrointestinal tract, more easily allowing gas to exit the body.[A228308]', 'Simethicone decreases the surface tension of gas bubbles in the gastrointestinal tract, facilitating their expulsion.[A228308] It has a short duration of action as it is generally given as needed, and a wide therapeutic index as it is not systemically absorbed.[A228308]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10628, 'Sodium chloride 0.9% (otsuka) i.v. amp. 25 ml', 'صوديوم كلورايد 0.9% اوتوسوكا امبول وريدي 25 مل', '10', '3.5', 'Sterile solution', 'Sodium chloride', 'Otsuka', 'Amp', 'أمبول', '0.9%', '1', 'محلول لعلاج الجروح -- تطهير الجلد', NULL, NULL, NULL, 791, '2025-11-17', 0, 'This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives. ', 'Sodium and chloride — major electrolytes of the fluid compartment outside of cells (i.e., extracellular) — work together to control extracellular volume and blood pressure. Disturbances in sodium concentrations in the extracellular fluid are associated with disorders of water balance.', 'Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid.

Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10630, 'Sodium chloride 0.9% (el nasr) i.v. inf. 500 ml (rubber cap)', 'صوديوم كلورايد 0.9% محلول ملح وريدي النصر 500 مل بغطاء مطاطي', '11', NULL, 'Normal saline', 'Sodium chloride', 'El nasr', 'Cap', 'كبسولة', '0.9%', '1', 'مضاد للفطريات -- علاج النخالة المبرقشة', NULL, NULL, NULL, 1218, '2022-05-28', 0, 'This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives. ', 'Sodium and chloride — major electrolytes of the fluid compartment outside of cells (i.e., extracellular) — work together to control extracellular volume and blood pressure. Disturbances in sodium concentrations in the extracellular fluid are associated with disorders of water balance.', 'Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid.

Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10631, 'Sodium chloride 0.9% (el nasr) i.v. inf. 500 ml', 'صوديوم كلورايد 0.9% محلول ملح وريدي النصر 500 مل', '13', NULL, 'Normal saline', 'Sodium chloride', 'El nasr', 'Unknown', 'غير محدد', '0.9%', '1', 'مضاد للفطريات', NULL, NULL, NULL, 806, '2022-06-02', 0, 'This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives. ', 'Sodium and chloride — major electrolytes of the fluid compartment outside of cells (i.e., extracellular) — work together to control extracellular volume and blood pressure. Disturbances in sodium concentrations in the extracellular fluid are associated with disorders of water balance.', 'Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid.

Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10632, 'Sofenacin 1mg/ml oral susp. 120 ml', 'سوفيناسين 1مجم/مل معلق بالفم 120 مل', '88', '67', 'Urinary incontinence.antispasmodics.muscarinic antagonists', 'Solifenacin succinate', 'Marcyrl co.', 'Susp', 'معلق', '1mg', '1', 'مضاد لتقلصات الجهاز البولي -- علاج سلس البول', NULL, '6223003572457', NULL, 1786, '2024-07-30', 0, 'Solifenacin tablets are indicated to treat an overactive bladder with urinary incontinence, urgency, and frequency.[L7511]', 'Solifenacin is a competitive muscarinic receptor antagonist.[L7511] It has the highest affinity for M3, M1, and M2 muscarinic receptors.[A181247] 80% of the muscarinic receptors in the bladder are M2, while 20% are M3.[A181262] Solifenacin''s antagonism of the M3 receptor prevents contraction of the detrusor muscle, while antagonism of the M2 receptor may prevent contraction of smooth muscle in the bladder.[A181262]', 'Solifenacin antagonizes the M2 and M3 muscarinic receptors in the bladder to treat an overactive bladder.[L7511,A181262] It has a long duration of action as it is usually taken once daily.[L7511] Patients taking solifenacin should be aware of the risks of angioedema and anaphylaxis.[L7511]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10633, 'Sofenacin 5mg 30 f.c. tab', 'سوفيناسين 5مجم 30 قرص', '141', '106.5', 'Urinary incontinence.antispasmodics.muscarinic antagonists', 'Solifenacin succinate', 'Marcyrl co.', 'Tab', 'أقراص', '5mg', '3', 'علاج التبول اللاارادي -- تقليل تقلصات المثانة --ارتخاء عضلا المثانة', NULL, '6223003570231', NULL, 10651, '2024-07-13', 0, 'Solifenacin tablets are indicated to treat an overactive bladder with urinary incontinence, urgency, and frequency.[L7511]', 'Solifenacin is a competitive muscarinic receptor antagonist.[L7511] It has the highest affinity for M3, M1, and M2 muscarinic receptors.[A181247] 80% of the muscarinic receptors in the bladder are M2, while 20% are M3.[A181262] Solifenacin''s antagonism of the M3 receptor prevents contraction of the detrusor muscle, while antagonism of the M2 receptor may prevent contraction of smooth muscle in the bladder.[A181262]', 'Solifenacin antagonizes the M2 and M3 muscarinic receptors in the bladder to treat an overactive bladder.[L7511,A181262] It has a long duration of action as it is usually taken once daily.[L7511] Patients taking solifenacin should be aware of the risks of angioedema and anaphylaxis.[L7511]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10634, 'Sofenacin plus 5/50mg 30 f.c. tab', 'سوفيناسين بلس 5/50مجم 30 قرص', '408', NULL, 'Urinary incontinence.antispasmodics.muscarinic antagonists', 'Solifenacin succinate+mirabegron', 'Marcyrl co.', 'Tab', 'أقراص', '50mg', '3', 'علاج التبول اللارادي', NULL, '6223003573188', NULL, 4951, '2024-07-14', 0, 'Solifenacin tablets are indicated to treat an overactive bladder with urinary incontinence, urgency, and frequency.[L7511]', 'Solifenacin is a competitive muscarinic receptor antagonist.[L7511] It has the highest affinity for M3, M1, and M2 muscarinic receptors.[A181247] 80% of the muscarinic receptors in the bladder are M2, while 20% are M3.[A181262] Solifenacin''s antagonism of the M3 receptor prevents contraction of the detrusor muscle, while antagonism of the M2 receptor may prevent contraction of smooth muscle in the bladder.[A181262]', 'Solifenacin antagonizes the M2 and M3 muscarinic receptors in the bladder to treat an overactive bladder.[L7511,A181262] It has a long duration of action as it is usually taken once daily.[L7511] Patients taking solifenacin should be aware of the risks of angioedema and anaphylaxis.[L7511]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10642, 'Limitless vitamin b12 30 oro disspersible film', 'ليمتلس فيتامين ب12 افلام ذائبة بالفم 30 فيلم', '135', '125', 'Vitamin b12', 'Vitamin b12', 'Eva pharma', 'Film', 'فيلم', NULL, '1', NULL, NULL, '6223012480668', NULL, 6380, '2025-07-25', 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10646, 'Solarine 18 spf sun block lotion 50 ml', 'سولارين 18+ للحماية من الشمس 50 مل', '85', '59', 'Sun block', 'Sun protection formula', 'Weiser', 'Lotion', 'لوشن', '50 ml', '1', NULL, NULL, NULL, NULL, 1060, '2024-06-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10648, 'Solarine 18 spf sun block lotion 120 ml', 'سولارين 18+ للحماية من الشمس 120 مل', '70', '59', 'Sun block', 'Sun protection formula', 'Weiser', 'Lotion', 'لوشن', '120 ml', '1', NULL, NULL, '6223002260942', NULL, 1260, '2024-06-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10649, 'Solarine 36 spf sun block lotion 50 ml', 'سولارين 18+ للحماية من الشمس 120 مل', '120', NULL, 'Sun block', 'Sun protection formula', 'Weiser', 'Lotion', 'لوشن', '50 ml', '1', NULL, NULL, NULL, NULL, 753, '2022-12-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10650, 'Solarine 36 spf sun block lotion 120 ml', 'سولارين 36+ للحماية من الشمس 120 مل', '115', NULL, 'Sun block', 'Sun protection formula', 'Weiser', 'Lotion', 'لوشن', '120 ml', '1', NULL, NULL, NULL, NULL, 662, '2022-08-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10651, 'Solarine 18 spf sun block lotion 100 ml', 'سولارين 18+ للحماية من الشمس 100 مل', '155', NULL, 'Sun block', 'Sun protection formula', 'Weiser', 'Lotion', 'لوشن', '100 ml', '1', NULL, NULL, NULL, NULL, 854, '2022-12-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10653, 'Sly citicoline 250 mg 30 ml oral drops', 'سلي سيتيكولين 250 مجم نقط فم 30 مل', '130', NULL, 'Support cerebrovascular disease', 'Citicoline 250 mg+potassium+stevia leaf', 'Elsaid saliy pharma', 'Drops', 'نقط', '250 mg', '1', NULL, NULL, NULL, NULL, 749, '2023-05-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10654, 'Enaro k 60 cap', 'اينارو كيه 60 كبسولة', '170', NULL, 'Urinary alkalinizing agent', 'Magnesium citrate+potassium citrate+sodium citrate 15 meq /serving+b6', 'Enar pharma', 'Cap', 'كبسولة', NULL, '1', NULL, NULL, '6224001568060', NULL, 4426, '2023-05-03', 0, 'Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.', 'Magnesium is the second most plentiful cation of the intracellular fluids. It is essential for the activity of many enzyme systems and plays an important role with regard to neurochemical transmission and muscular excitability. Magnesium sulfate reduces striated muscle contractions and blocks peripheral neuromuscular transmission by reducing acetylcholine release at the myoneural junction. Additionally, Magnesium inhibits Ca<sup>2+</sup> influx through dihydropyridine-sensitive, voltage-dependent channels. This accounts for much of its relaxant action on vascular smooth muscle.', 'Magnesium sulfate is a small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. Magnesium sulfate is gaining popularity as an initial treatment in the management of various dysrhythmias, particularly torsades de pointes, and dyrhythmias secondary to TCA overdose or digitalis toxicity.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10656, 'Yarnax massage spray 120ml', 'يارناكس مساج سبراي 120 مل', '75', NULL, 'Massage', NULL, 'Great pharma group', 'Spray', 'بخاخ', '120ml', '1', NULL, NULL, NULL, NULL, 849, '2023-05-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10657, 'Solcoseryl 5 % top. oint. 20 gm', 'سولكوسيريل 5% مرهم 20 جم', '7', NULL, NULL, 'Extract free from calves blood', 'Misr > solco-switzerland', 'Oint', 'مرهم', '5 %', '1', 'علاج الجروح التي تصيب الجلد -- علاج الحروق', 'a protein-free standardized dialysate ultrafiltrate derived from calf blood it has demonstrated to be effective to enhance corneal epithelial wounds healing in both experimental animal studies and human beings. calf blood extract protein-free eye gel had', '6221035007114', NULL, 1595, '2023-05-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10665, 'Solo sept foamin skin cleanser 14 sachets x 10 ml', 'سولو سبت اكياس 14 كيس', '84', '75', 'Antiseptic', 'Chlorhexidine+hexamine+chlorocresol', 'City pharma > cosmo pack', 'Sol', 'محلول', '10 ml', '1', 'غسول للجلد مضاد للبكتيريا -- تقليل الالتهابات -- تقليل الاحمرار', NULL, '1342129266127', NULL, 2776, '2024-09-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10666, 'Solpadeine 24 cap', 'سولبادين 24 كبسوله *مستورد', '160', NULL, 'Antipyretic', 'Paracetamol(acetaminophen)', 'Chefaro ireland dac', 'Cap', 'كبسولة', NULL, '2', NULL, NULL, '018653002111', NULL, 4274, '2022-12-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10667, 'Solpadeine soluble 24 tab', 'سولبادين فوار 24 قرص', '200', NULL, 'Analgesic', 'Paracetamol(acetaminophen)', 'Chefaro ireland dac', 'Tab', 'أقراص', NULL, '2', 'مسكن -- لتخفيف الصداع', NULL, '018653001732', NULL, 4640, '2023-02-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10668, 'Solpadol 5mg 6 oro-dispersible tablets', 'سولبادول 5مجم 6 اقراص ذائبة بالفم', '77', '54', 'Antimigraine.vasoconstrictor agents.selective serotonin agonist', 'Zolmitriptan', 'Global napi pharmaceuticals', 'Tablet', 'أقراص', '5mg', '3', 'لعلاج حالات الصداع النصفي', 'about zolmitriptan selective serotonin (5ht1) agonists anti migraine mechanism of action of zolmitriptan zolmitriptan is a selective agonist for serotonin (5ht1 receptors). it relieves migraine by selective constriction of intracranial blood vessels', '6223002140756', NULL, 2486, '2024-03-06', 0, 'Zolmitriptan is indicated for the acute treatment of migraine with or without auras in patients aged 18 and over.[L12978]', 'Migraines are complex physiological events characterized by unilateral throbbing headaches combined with photophobia and other aversions to sensory input. Migraine attacks are generally divided into phases: the premonitory phase, which typically involves irritability, fatigue, yawning, and stiff neck; the headache phase, which lasts for between four and 72 hours; and the postdrome phase, which lasts for up to a day following resolution of pain and whose symptoms are similar to those of the premonitory phase. In addition, neurological deficits, collectively termed migraine aura, may precede the headache phase.[A193797, A193794]



The underlying pathophysiology of migraines is a matter of active research but involves both neurological and vascular components. The head pain associated with migraine is thought to be a consequence of activation of the nociceptive nerves comprising the trigeminocervical complex (TCC).[A193794] Terminals of nociceptive nerves that innervate the dura matter release vasoactive peptides, such as calcitonin gene-related peptide (CGRP), resulting in cranial vasodilation. Finally, when present, migraine aura appears to correlate with a transient wave(s) of cortical depolarization, termed cortical spreading depression (CSD).[A193794,A193851]



Triptans, including zolmitriptan, are proposed to act in three ways. The main mechanism is through modulation of nociceptive nerve signalling in the central nervous system through 5-HT<sub>1B/1D</sub> receptors throughout the TCC and associated areas of the brain. In addition, triptans can enhance vasoconstriction, both through direct 5-HT<sub>1B</sub>-mediated dilation of cranial blood vessels,[A462, A198741] as well as through 5-HT<sub>1D</sub>-mediated suppression of CGRP release.[A193794, L12978]



Although triptans are classically described solely in terms of their effects on 5-HT<sub>1B/1D</sub> receptors, they also act as 5-HT<sub>1F</sub> agonists as well. This 5-HT subtype is also found throughout the TCC, but is not present appreciably in cerebral vasculature; the significance of triptan-mediated 5-HT<sub>1F</sub> activation is currently not well described.[A193791] Additionally, CSD that initiates in the ipsilateral parietal region may exert its effects in a manner that relies on 5-HT<sub>1B/1D</sub> receptor activation, suggesting that triptans may have some effect on CSD-mediated symptoms.[A193794, A198738]', 'Zolmitriptan, like other triptans, is a serotonin (5-hydroxytryptamine; 5-HT) receptor agonist, with enhanced specificity for the 5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> receptor subtypes. It is through the downstream effects of 5-HT<sub>1B/1D</sub> activation that triptans are proposed to provide acute relief of migraines.[L12978,A462,A193791] Zolmitriptan is also a vasoconstrictor,[A193803] leading to possible adverse cardiovascular effects such as myocardial ischemia/infarction, arrhythmias, cerebral and subarachnoid hemorrhage, stroke, gastrointestinal ischemia, and peripheral vasospastic reactions. In addition, chest/throat/neck/jaw pain, tightness, and/or pressure has been reported, along with the possibility of medication overuse headaches and serotonin syndrome. Patients with phenylketonuria should be advised that ZOMIG-ZMT contains phenylalanine.[L12978]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10672, 'Solu-cortef 100mg/2ml vial', 'سوليوكورتيف 100مجم/2مل فيال', '16', NULL, 'Glucocorticoid', 'Hydrocortisone sodium succinate', 'Eipico > pfizer', 'Vial', 'فيال', '100mg', '1', NULL, 'about hydrocortisone systemic synthetic glucocorticoid anti-inflammatory mechanism of action of hydrocortisone the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and causes a structural change in steroid', '6221032311931', NULL, 3463, '2023-04-25', 0, 'Otic solutions are indicated for infections of the external auditory canal caused by susceptible organisms and with inflammation.[L10529,L10532] Hydrocortisone tablets are indicated for certain endocrine, rheumatic, collagen, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, gastrointestinal, and other conditions.[L10535] A hydrocortisone enema is indicated for ulcerative colitis,[L10538] a topical ointment with antibiotics is indicated for corticosteroid responsive dermatoses with infections,[L7772] and a topical cream with [acyclovir] is indicated to treat cold sores.[L7321] Oral granules of hydrocortisone are used as a replacement therapy for Adrenocortical Insufficiency (AI) in children under 17 years of age.[L16533]', 'The short-term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation.[A187463] Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days.[A187463]



Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10.[A187463]



Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.[A187463] High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.[A187463]', 'Hydrocortisone binds to the glucocorticoid receptor leading to downstream effects such as inhibition of phospholipase A2, NF-kappa B, other inflammatory transcription factors, and the promotion of anti-inflammatory genes.[A187463] Hydrocortisone has a wide therapeutic index[A188405] and a moderate duration of action.[A188354,A188381] Patients should stop taking the medication if irritation or sensitization occurs.[L10529,L10532,L10535,L10538,L7772,L7321]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10673, 'Solu-medrol 1gm i.m./i.v. vial', 'سوليو ميدرول 1 جم فيال', '360', '180', 'Glucocorticoid', 'Methylprednisolone sodium succinate', 'Pfizer', 'Vial', 'فيال', '1gm', '1', 'مضاد التهاب وحساسية كورتيزوني', NULL, NULL, NULL, 12618, '2024-11-07', 0, 'Oral and intramuscular methylprednisolone are indicated for a number of endocrine,  rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, gastrointestinal, nervous system, and other disorders.[L10785,L10788] Intra-articular and soft tissue injections are indicated for short term treatment of acute gouty arthritis, acute and subactute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, and synovitis of osteoarthritis.[L10788] Intralesional injections are indicated for alopecia areata, discoid lupus erythematosus, keloids, lichen planus, lichen simplex chronicus and psoriatic plaques, necrobiosis lipoidica diabeticorum, and localized hypertrophic infiltrated inflammatory lesions of granuloma annulare.[L10788]', 'The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation.[A187463] Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days.[A187463]



Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10.[A187463]



Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.[A187463] High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.[A187463]', 'Corticosteroids bind to the glucocorticoid receptor, inhibiting pro-inflammatory signals, and promoting anti-inflammatory signals.[A187463] Corticosteroids have a wide therapeutic window as patients may require doses that are multiples of what the body naturally produces.[A187463] Patients taking corticosteroids should be counselled regarding the risk of hypothalamic-pituitary-adrenal axis suppression and increased susceptibility to infections.[A187463]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10677, 'Solupred oro 20mg 20 orodispersible tabs.', 'سوليوبريد 20مجم 20 قرص ذائب بالفم', '142', '90', 'Glucocorticoid', 'Prednisolone', 'Sanofi winthrop > sanofi', 'Tab', 'أقراص', '20mg', '2', 'يستخدم لتثبيط المناعة', NULL, '42607477231740', NULL, 14137, '2025-08-04', 0, 'Prednisolone is indicated to treat endocrine, rheumatic, and hematologic disorders; collagen, dermatologic, ophthalmic, respiratory, and gastrointestinal diseases; allergic and edematous states; and other conditions like tuberculous meningitis.[L9542]', 'The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation.[A187463] Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days.[A187463]



Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10.[A187463]



Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.[A187463] High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.[A187463]', 'Corticosteroids bind to the glucocorticoid receptor, inhibiting pro-inflammatory signals, and promoting anti-inflammatory signals.[A187463] Prednisolone has a short duration of action as the half life is 2.1-3.5 hours.[A187394] Corticosteroids have a wide therapeutic window as patients make require doses that are multiples of what the body naturally produces.[A187463] Patients taking corticosteroids should be counselled regarding the risk of hypothalamic-pituitary-adrenal axis suppression and increased susceptibility to infections.[A187463]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10684, 'Solvetra 20mg 4 f.c. tabs.', 'سولفيترا 20مجم 4 اقراص', '43', NULL, 'Tonic for men', 'Vardenafil', 'Eva pharma > next pharma', 'Tab', 'أقراص', '20mg', '2', 'مقوى للرجال', NULL, '6223004519888', NULL, 2942, '2023-01-24', 0, 'Vardenafil is indicated for the treatment of erectile dysfunction.[L45563,L45568,L45573]', 'Vardenafil inhibits cyclic guanosine monophosphate (GMP) specific phosphodiesterase type 5 (PDE5), which is responsible for the degradation of cyclic GMP in the corpus cavernosum located around the penis. Penile erection during sexual stimulation is caused by increased penile blood flow resulting from the relaxation of penile arteries and corpus cavernosal smooth muscle. This response is mediated by the release of nitric oxide (NO) from nerve terminals and endothelial cells, which stimulates the synthesis of cyclic GMP in smooth muscle cells. Cyclic GMP causes smooth muscle relaxation and increased blood flow into the corpus cavernosum. The tissue concentration of cyclic GMP is regulated by both the rates of synthesis and degradation via phosphodiesterases (PDEs), and the most abundant PDE in the human corpus cavernosum is PDE5. Therefore, the inhibition of PDE5 by vardenafil enhances erectile function by increasing the amount of cyclic GMP.[L45563]', 'Vardenafil is a potent and selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5), an enzyme responsible for the degradation of cGMP in the corpus cavernosum. The presence of cGMP in the corpus cavernosum leads to smooth muscle relaxation, an increased inflow of blood and an erection. Therefore, in patients with erectile dysfunction given vardenafil, normal sexual stimulation will increase cGMP levels in the corpus cavernosum. Without sexual stimulation and no cGMP production, vardenafil should not cause an erection.[L45563,L45568] 



Vardenafil should not be used in men for whom sexual activity is not recommended due to their underlying cardiovascular status. There is also a risk of developing prolonged erections that last longer than 4 hours, as well as priapism. In the event of a sudden loss of vision in one or both eyes, patients should stop using vardenafil. Patients taking PDE5 inhibitors, such as vardenafil, may also develop sudden hearing loss and experience a prolonged QT interval.[L45563,L45568]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10687, 'Solvin 80mg/100ml syrup 120ml', 'سولفين 80مجم/100مل شراب 120 مل', '6', NULL, 'Mucolytic', 'Bromhexine+ipeca tincture+senega extract+tolu syrup', 'Arab drug company.', 'Syrup', 'شراب', '80mg', '1', NULL, NULL, '6221060003266', NULL, 1210, '2023-01-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10688, 'Solvin 2mg/ml oral drops 15 ml', 'سولفين 2مجم/مل نقط للفم 15مل', '14', '5.5', 'Mucolytic', 'Bromhexine', 'Arab drug company.', 'Sol', 'محلول', '2mg', '1', NULL, NULL, '6221060001354', NULL, 1462, '2025-10-25', 0, 'Bromohexine is used alone or with other ingredients such as [diphenhydramine], [dextromethorphan], and [guaifenesin] to reduce mucus viscosity and clear mucus in conditions associated with mucus hypersecretion, including the common cold, influenza, respiratory tract infections, or other conditions.[L29975,L24819,L33060]', 'Inflammation of the airways, increased mucus secretion, and altered mucociliary clearance are the hallmarks of various diseases of the respiratory tract. Mucus clearance is necessary for lung health; bromhexine aids in mucus clearance by reducing the viscosity of mucus and activating the ciliary epithelium[L33060], allowing secretions to be expelled from the respiratory tract.[A233240]



Recent have studies have demonstrated that bromhexine inhibits the transmembrane serine protease 2 receptor (TMPRSS2) in humans. Activation of TMPRSS2 plays an important role in viral respiratory diseases such as influenza A and Middle East Respiratory Syndrome (MERS). Inhibition of receptor activation and viral entry by bromhexine may be effective in preventing or treating various respiratory illnesses, including COVID-19.[A233345,A233350] In vitro studies have suggested the action of ambroxol (a metabolite of bromhexine) on the angiogensin-converting enzyme receptor 2 (ACE2), prevents entry of the viral envelope-anchored spike glycoprotein of SARS-Cov-2 into alveolar cells or increases the secretion of surfactant, preventing viral entry.[A233365 ,A233370]', 'Bromhexine thins airway secretions, improving breathing and discomfort associated with thick mucus in airways associated with a variety of respiratory conditions.[A233240,L26346,L33060]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10690, 'Solvinal 10 sachets eff', 'سولفينال 10 اكياس فوار', '5', NULL, 'Antigout.analgesic', 'Atropine sulphate+colchicine+piperazine', 'Memphis', 'Sol', 'محلول', NULL, '1', 'علاج حالات املاح حمض اليوريك', NULL, '6221050070063', NULL, 2138, '2023-01-05', 0, 'The intravenous, intramuscular, subcutaneous, intraosseous and endotracheal use of atropine is indicated for the temporary blockade of severe or life-threatening muscarinic effects.[L42815,L42835] The intramuscular use of atropine in the form of a pen injector is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having cholinesterase activity as well as organophosphorus or carbamate insecticides in adult and pediatric patients.[L42825] The ophthalmic use of atropine is indicated for mydriasis, cycloplegia, and penalization of the healthy eye in the treatment of amblyopia.[L42830] 



In combination with difenoxin or diphenoxylate (tablets for oral use), atropine is indicated as adjunctive therapy in the management of acute nonspecific diarrhea.[L42840,L42865]', 'Atropine binds to and inhibits muscarinic acetylcholine receptors, competitively blocking the effects of acetylcholine and other choline esters.[L42815,L42825,L42835] It acts as a reversible non-specific antagonist of muscarinic receptors, showing affinity for the M1, M2, M3, M4 and M5 receptor subtypes.[A251665] Atropine antagonizes the effects of acetylcholine on tissues innervated by postganglionic cholinergic nerves, such as smooth muscle, cardiac tissue, exocrine glands and the central nervous system. Also, it acts in less innervated smooth muscle that responds to endogenous acetylcholine.[A251670,L42815] The actions of atropine can be overcome by increasing the concentration of acetylcholine at receptor sites (for instance, the use of anticholinesterase agents that inhibit the hydrolysis of acetylcholine).[L42835]', 'Atropine is an antimuscarinic agent that antagonizes the effects of acetylcholine.[L42815,L42825,L42835] In small doses, atropine slows heart rate, and tachycardia develops due to paralysis of vagal control. Compared to [scopolamine], atropine has a more potent and prolonged effect on the heart, intestine and bronchial muscle, but a weaker effect on the iris, ciliary body and certain secretory glands. Atropine leads to increased respiratory rate and depth of respiration, possibly due to the drug-induced bronchiolar dilatation rather than its mild effect on vagal excitation.[L42835]



At an adequate dose, atropine abolishes different types of reflex vagal cardiac slowing or asystole. Atropine can be used to prevent or abolish bradycardia or asystole induced by the injection of choline esters, anticholinesterase agents or other parasympathomimetic drugs, and cardiac arrest produced by stimulation of the vagus.[L42835] When vagal activity is an etiologic factor, atropine may also lessen the degree of partial heart block. In clinical doses, atropine counteracts the peripheral dilatation and abrupt decrease in blood pressure produced by choline esters. However, when given by itself, atropine does not exert a striking or uniform effect on blood vessels or blood pressure.[L42835] The use of topical atropine in the eye induces mydriasis by inhibiting the contraction of the circular pupillary sphincter muscle normally stimulated by acetylcholine. This results in the contraction of the countering radial pupillary dilator muscle and pupil dilation.[L42830]



The use of atropine may precipitate acute glaucoma and convert partial organic pyloric stenosis into complete obstruction. Atropine may also lead to complete urinary retention in patients with prostatic hypertrophy and cause the thickening of bronchial secretions and formation of viscid plugs in patients with chronic lung disease.[L42835]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10696, 'Somatropin 4 i.u./ vial', 'سوماتروبين 4وحدة دولية / فيال', '321', '228', 'Human growth hormone', 'Somatropin', 'Sedico', 'Vial', 'فيال', NULL, '1', 'هرمون نمو بشري', NULL, '6221042593402', NULL, 16499, '2024-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10698, 'Somazina supra 100mg/ml oral drops 30 ml', 'سومازينا سوبرا 100مجم/مل نقط للفم 30 مل', '250', '210', 'Cerebral circulatory inhancer', 'Citicholine', 'October pharma > ferrer international sa -spain', 'Drops', 'نقط', '100mg', '1', 'لتحفيز الدورة الدموية بالمخ', 'citicoline is a brain chemical that occurs naturally in the body. as a medicine it is taken by mouth as a supplement or given by iv or as a shot. citicoline is used for alzheimer s disease and other types of dementia head trauma cerebrovascular disease su', '6224009165285', NULL, 8201, '2025-11-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10704, 'Sominaletta 15mg 60 tabs.', 'سومنياليتا 15مجم 60 قرص', '30', '3.5', 'Anti-epileptic.barbiturates', 'Phenobarbitone', 'Alexandria', 'Tab', 'أقراص', '15mg', '6', NULL, NULL, NULL, NULL, 720, '2024-11-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10711, 'Soral 20mg 5 supp.', 'سورال 20مجم 5 اقماع لبوس', '30', '20.5', 'Nsaid.oxicam', 'Tenoxicam', 'Global napi pharmaceuticals', 'Supp', 'لبوس', '20mg', '1', NULL, 'mechanism of action of tenoxicam the anti-inflammatory effects of tenoxicam may result from the inhibition of the enzyme cyclooxygenase and the subsequent peripheral inhibition of prostaglandin synthesis (prostaglandins sensitize pain receptors their inhi', '6223002149339', NULL, 1902, '2024-10-30', 0, 'For the treatment of rheumatoid arthritis, osteoarthritis, backache, and pain.', 'The antiinflammatory effects of tenoxicam may result from the inhibition of the enzyme cycooxygenase and the subsequent peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, their inhibition accounts for the peripheral analgesic effects of tenoxicam. Antipyresis may occur by central action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat loss.', 'Tenoxicam, an antiinflammatory agent with analgesic and antipyretic properties, is used to treat osteoarthritis and control acute pain.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10712, 'Soral 20mg 3 vial i.m./i.v.', 'سورال 20مجم 3 فيال', '38', '16.5', 'Nsaid.oxicam', 'Tenoxicam', 'Global napi pharmaceuticals', 'Vial', 'فيال', '20mg', '3', NULL, 'mechanism of action of tenoxicam the anti-inflammatory effects of tenoxicam may result from the inhibition of the enzyme cyclooxygenase and the subsequent peripheral inhibition of prostaglandin synthesis (prostaglandins sensitize pain receptors their inhi', '6223002149650', NULL, 1319, '2024-04-24', 0, 'For the treatment of rheumatoid arthritis, osteoarthritis, backache, and pain.', 'The antiinflammatory effects of tenoxicam may result from the inhibition of the enzyme cycooxygenase and the subsequent peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, their inhibition accounts for the peripheral analgesic effects of tenoxicam. Antipyresis may occur by central action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat loss.', 'Tenoxicam, an antiinflammatory agent with analgesic and antipyretic properties, is used to treat osteoarthritis and control acute pain.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10713, 'Soral 20 mg 20 caps.', 'سورال 20مجم 20 كبسولة', '86', '59', 'Nsaid.oxicam', 'Tenoxicam', 'Global napi pharmaceuticals', 'Cap', 'كبسولة', '20 mg', '2', 'مضاد للالتهابات يستخدم في علاج الألم والتهاب الفقار اللاصق والتهاب المفاصل الروماتويدي والتهاب المفصل التنكسي و / أو الالتهابات الاخرى', 'mechanism of action of tenoxicam the anti-inflammatory effects of tenoxicam may result from the inhibition of the enzyme cyclooxygenase and the subsequent peripheral inhibition of prostaglandin synthesis (prostaglandins sensitize pain receptors their inhi', '6223002146499', NULL, 3312, '2024-12-06', 0, 'For the treatment of rheumatoid arthritis, osteoarthritis, backache, and pain.', 'The antiinflammatory effects of tenoxicam may result from the inhibition of the enzyme cycooxygenase and the subsequent peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, their inhibition accounts for the peripheral analgesic effects of tenoxicam. Antipyresis may occur by central action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat loss.', 'Tenoxicam, an antiinflammatory agent with analgesic and antipyretic properties, is used to treat osteoarthritis and control acute pain.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10718, 'Sorbit 5 gm 20 sachets', 'سوربيت بودره 20 كيس', '7', NULL, 'Laxative', 'Sorbitol', 'Mup', 'Sachet', 'أكياس', '5 gm', '1', 'ملين -- علاج الامساك -- تنظيم حركة الامعاء -- تقليل الانتفاخات و الغازات', 'about sorbitol a sugar alcohol sweetener non-stimulant laxative osmotic diuretic genitourinary irrigant. mechanism of action of sorbitol sorbitol is hydrolysed in the colon to short chain fatty acids. this fatty acid stimulates colonic propulsive motility', '6221508050319', NULL, 1074, '2022-12-09', 0, 'Used as a non-stimulant laxative via an oral suspension or enema.', 'Sorbitol exerts its laxative effect by drawing water into the large intestine, thereby stimulating bowel movements.', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10731, 'Spara 200mg 11 f.c. tab.', 'سبارا 200مجم 11 قرص', '35', NULL, 'Antibiotic.quinolone', 'Sparfloxacin', 'Global napi pharmaceuticals', 'Tab', 'أقراص', '200mg', '1', NULL, NULL, '6223002140282', NULL, 755, '2023-01-12', 0, 'For the treatment of adults with the following infections caused by susceptible strains microorganisms: community-acquired pneumonia (caused by <i>Chlamydia pneumoniae</i>, <i>Haemophilus influenzae</i>, <i>Haemophilus parainfluenzae</i>, <i>Moraxella catarrhalis</i>, <i>Mycoplasma pneumoniae</i>, or <i>Streptococcus pneumoniae</i>) and acute bacterial exacerbations of chronic bronchitis (caused by <i>Chlamydia pneumoniae</i>, <i>Enterobacter cloacae</i>, <i>Haemophilus influenzae</i>, <i>Haemophilus parainfluenzae</i>, <i>Klebsiella pneumoniae</i>, <i>Moraxella catarrhalis</i>, <i>Staphylococcus aureus</i>, or <i>Streptococcus pneumoniae</i>).', 'The bactericidal action of sparfloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.', 'Sparfloxacin is a synthetic fluoroquinolone broad-spectrum antimicrobial agent in the same class as ofloxacin and norfloxacin. Sparfloxacin has in vitro activity against a wide range of gram-negative and gram-positive microorganisms. Sparfloxacin exerts its antibacterial activity by inhibiting DNA gyrase, a bacterial topoisomerase. DNA gyrase is an essential enzyme which controls DNA topology and assists in DNA replication, repair, deactivation, and transcription. Quinolones differ in chemical structure and mode of action from (beta)-lactam antibiotics. Quinolones may, therefore, be active against bacteria resistant to (beta)-lactam antibiotics. Although cross-resistance has been observed between sparfloxacin and other fluoroquinolones, some microorganisms resistant to other fluoroquinolones may be susceptible to sparfloxacin. In vitro tests show that the combination of sparfloxacin and rifampin is antagonistic against Staphylococcus aureus.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10737, 'Spascolon 100mg 30 f.c.tab.', 'سباسكولون 100مجم 30 قرص', '108', '70.5', 'Smooth muscle relaxant', 'Pinaverium bromide', 'Chemipharm', 'Tab', 'أقراص', '100mg', '3', 'علاج القولون العصبي.', 'about pinaverium bromide a calcium channel blocker for functional gastrointestinal disorder. mechanism of action of pinaverium bromide pinaverium is a calcium channel blocker. it inhibits the calcium influx through voltage-dependent calcium channel in the', '6222006502232', NULL, 6605, '2024-08-08', 0, 'Pinaverium is indicated for the symptomatic treatment of irritable bowel syndrome (IBS) and functional disorders of the biliary tract.', 'Pinaverium interacts with the 1,4-dihydropyridine binding sites on voltage dependent L-type calcium channels located on GI smooth muscle cells in a competitve manner [A19698]. The binding site is located in the alpha 1S subunit and pinaverium most likely antagonizes the action of calcium ions by stabilizing a non-conducting channel state [A19705]. Pinaverium inhibits smooth muscle contractions of the GI tract by inhibiting inward calcium current and calcium influx. It is suggested that pinaverium may be able to bind to both closed or inactivates states of the calcium channel with similar affinity [T37, A19697]. ', 'Pinaverium is a selective and specific voltage-dependent calcium channel blocker located on intestinal smooth muscle cells to inhibit calcium influx. It mediates various effects on the GI tract: it causes oesophageal, gastric and duodenal relaxation, relaxes the colon and intestines, inhibits colonic motility in response to food, hormonal or pharmacological stimuli, accelerates gastric emptying, and reduces contractions of the gallbladder and phasic contractions of sphincter of Oddi [L873, A19702]. At higher concentrations, pinaverium also exhibits very weak anticholinergic effects [L873] but is not shown to display vasodilatory or anti-arrythmic actions [T37]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10741, 'Spasmag 20 caps', 'سبازماج 20 كبسولة', '15', NULL, 'Magnesium', 'Magnesium sulphate+yeast', 'Global napi pharmaceuticals > serolam-france', 'Cap', 'كبسولة', NULL, '2', 'حالات نقص الماغنسيوم -- زيادة المناعة', NULL, '6223002145614', NULL, 2504, '2023-03-15', 0, 'Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.', 'Magnesium is the second most plentiful cation of the intracellular fluids. It is essential for the activity of many enzyme systems and plays an important role with regard to neurochemical transmission and muscular excitability. Magnesium sulfate reduces striated muscle contractions and blocks peripheral neuromuscular transmission by reducing acetylcholine release at the myoneural junction. Additionally, Magnesium inhibits Ca<sup>2+</sup> influx through dihydropyridine-sensitive, voltage-dependent channels. This accounts for much of its relaxant action on vascular smooth muscle.', 'Magnesium sulfate is a small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. Magnesium sulfate is gaining popularity as an initial treatment in the management of various dysrhythmias, particularly torsades de pointes, and dyrhythmias secondary to TCA overdose or digitalis toxicity.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10744, 'Spasmin 5 paed.supp.', 'سبازمين 5 اقماع لبوس اطفال', '3', NULL, 'Antispasmodic', 'Hexahydro-adiphenine+propyphenazone', 'Pharco', 'Supp', 'لبوس', NULL, '1', NULL, NULL, '6223000011829', NULL, 913, '2023-04-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10745, 'Spasmo sterile 20mg/ml i.m./i.v. 6 amp.', 'سبازمو 20مجم/مل 6 امبولات', '15', NULL, 'Antimuscarinic.antispasmodic', 'Hyoscin-n-butylbromid', 'Kahira', 'Amp', 'أمبول', '20mg', '6', NULL, 'about hyoscine butyl bromide anti-cholinergic a tropane alkaloid antispasmodic in gi and gu spasm. mechanism of action of hyoscine butyl bromide hyoscine butyl bromide is an anticholinergic drug. it exerts its action by inhibiting muscarinic (cholinergic)', NULL, NULL, 1026, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10748, 'Spasmo cibalgin 200 tab', 'سبازمو سيبالجين 200 قرص', '26', NULL, 'Antispasmodic', 'Adiphenine+propyphenazone', 'Novartis torre', 'Tab', 'أقراص', NULL, '20', 'مضاد للتقلصات المعدة -- تقليل تقلصات والالام المعدة -- مضاد للالتهاب', NULL, NULL, NULL, 1648, '2023-01-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10749, 'Spasmo-digestin 30 tabs.', 'سبازموديجستين 30 قرص', '78', '52.5', 'Colon.antispasmodic.digestive enzymes', 'Dicyclomine+papain+sanzyme 3500+simethicone+sodium dehydrocholate', 'Pharco', 'Tab', 'أقراص', NULL, '3', 'انزيمات هاضمة ومضاد للتقلصات والام القولون', NULL, '6221151005353', NULL, 26187, '2024-06-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10751, 'Spasmo amrase 20 e.c. tab', 'سبازمو امريز 20 قرص', '18', NULL, 'Colon.antispasmodic.digestive enzymes', 'Pancreatin+papain+ox-bile extract+dimethicone+mebeverine', 'Amriya', 'Tab', 'أقراص', NULL, '2', 'انزيمات هاضمة لعلاج مشاكل وعسر الهضم', NULL, '6221075010051', NULL, 12922, '2023-06-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10752, 'Spasmocanulase_d 30 bitab', 'سبازموكانيولاز د 30 قرص', '13', NULL, 'Digestive enzymes', 'Cellulase+dimethylpolysiloxan+glutamic acid+methixene+pancreatin+pepsin+sodium dehydrocholate', 'Novartis', 'Tab', 'أقراص', NULL, '3', 'مهضم -- حالات عسر الهضم --حالات الانتفاخات -- تقليل الالام المعدة والقولون', NULL, '6223002640348', NULL, 5489, '2023-02-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10753, 'Spasmocin 10mg 20 tab.', 'سبازموسين 10مجم 20 قرص', '5', NULL, 'Antimuscarinic.antispasmodic', 'Hyoscin-n-butylbromid', 'Memphis', 'Tab', 'أقراص', '10mg', '2', NULL, 'hyoscine-n-butylbromide is an antispasmodic drug used to treat conditions associated with spasms of the gastrointestinal tract such as cramping. how does it work? this medication relieves gastrointestinal cramping by relieving smooth muscle contractions.', '6221050030609', NULL, 1201, '2022-09-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10756, 'Troya care hair tonic lotion 120 ml', 'تروياكير لوشن مقوي للشعر 120 مل', '190', '170', 'Hair tonic lotion spray', 'Caffeine + argan + aloe vera + capixyl + garlic + apple stem cells', 'Troya pharma', 'Lotion', 'لوشن', '120 ml', '1', NULL, NULL, NULL, NULL, 1280, '2025-08-04', 0, 'Caffeine is indicated for the short term treatment of apnea of prematurity in infants and off label for the prevention and treatment of bronchopulmonary dysplasia caused by premature birth.[T716,L9851] In addition, it is indicated in combination with sodium benzoate to treat respiratory depression resulting from an overdose with CNS depressant drugs.[L9899] Caffeine has a broad range of over the counter uses, and is found in energy supplements, athletic enhancement products, pain relief products, as well as cosmetic products.[T716,L9854,L9872]', 'The mechanism of action of caffeine is complex, as it impacts several body systems, which are listed below. The effects as they relate to various body systems are described as follows:



**General and cellular actions**



Caffeine exerts several actions on cells, but the clinical relevance is poorly understood. One probable mechanism is the inhibition of nucleotide phosphodiesterase enzymes, adenosine receptors, regulation of calcium handling in cells, and participates in adenosine receptor antagonism.[A187721,L9857] Phosphodiesterase enzymes regulate cell function via actions on second messengers cAMP and cGMP.[A187724] This causes lipolysis through activation of hormone-sensitive lipases, releasing fatty acids and glycerol.[T722]



**Respiratory**



The exact mechanism of action of caffeine in treating apnea related to prematurity is unknown, however, there are several proposed mechanisms, including respiratory center stimulation in the central nervous system, a reduced threshold to hypercapnia with increased response, and increased consumption of oxygen, among others.[L9851] The blocking of the adenosine receptors enhances respiratory drive via an increase in brain medullary response to carbon dioxide, stimulating ventilation and respiratory drive, while increasing contractility of the diaphragm.[T716]



**Central nervous system**



Caffeine demonstrates antagonism of all 4 adenosine receptor subtypes (A1, A2a, A2b, A3) in the central nervous system.[T716,L9851] Caffeine''s effects on alertness and combatting drowsiness are specifically related to the antagonism of the A2a receptor.[T716]



**Renal system**



Caffeine has diuretic effects due to is stimulatory effects on renal blood flow, increase in glomerular filtration, and increase in sodium excretion.[T716]



**Cardiovascular system**



Adenosine receptor antagonism at the A1 receptor by caffeine stimulates inotropic effects in the heart. Blocking of adenosine receptors promotes catecholamine release, leading to stimulatory effects occurring in the heart and the rest of the body.  In the blood vessels, caffeine exerts direct antagonism of adenosine receptors, causing vasodilation. It stimulates the endothelial cells in the blood vessel wall to release nitric oxide, potentiating blood vessel relaxation. Catecholamine release, however, antagonizes this and exerts inotropic and chronotropic effects on the heart, ultimately leading to vasoconstriction. Finally, caffeine is shown to raise systolic blood pressure measurements by 5 to 10 mmHg when it is not taken regularly, versus no effect in those who consume it regularly.[T716] The vasoconstricting effects of caffeine are beneficial in migraines and other types of headache, which are normally caused by vasodilation in the brain.[A187709,L9872]', 'Caffeine stimulates the central nervous system (CNS), heightening alertness, and sometimes causing restlessness and agitation. It relaxes smooth muscle, stimulates the contraction of cardiac muscle, and enhances athletic performance.[A298,T716,L9857] Caffeine promotes gastric acid secretion and increases gastrointestinal motility. It is often combined in products with analgesics and ergot alkaloids, relieving the symptoms of migraine and other types of headaches. Finally, caffeine acts as a mild diuretic.[T716]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10758, 'Spasmocure 60mg 30 tabs', 'سبازموكيور 60مجم 30 قرص', '54', '34', 'Antispasmodic', 'Drotaverine', 'Alfacure pharmaceuticals', 'Tab', 'أقراص', '60mg', '3', NULL, 'about drotaverine drotaverine is an effective spasmolytic drug. mechanism of action of drotaverine drotaverine has spasmolytic and vasodilating action. it exerts its action by inhibiting phosphodiesterase enzyme iv. this will leads to a decrease in cyclic', '6224007711705', NULL, 3140, '2024-09-28', 0, 'Drotaverine is used to alleviate gastrointestinal and genitourinary smooth muscle spasms, such as cholecystitis and gallbladder disorders.[L22689]', 'Drotaverine is a selective inhibitor of phosphodiesterase 4 (PDE4), which is an enzyme responsible for the degradation of cyclic adenosine monophosphate (cAMP). Inhibition of PDE4 leads to elevated levels of cAMP, leading to smooth muscle relaxation. Recent research showed that low levels of cAMP have been associated with brain tumorigenesis, leading to the investigation of PDE4 inhibitors as potential anticancer agents.[A231619]', 'Drotaverine is an e spasmolytic agent with a relaxing effect on smooth muscles. It works to relieve visceral spasms and improve cervical dilation. _In vitro_, drotaverine mediated cytostatic effects on several human tumor cell lines and nonmalignant mouse fibroblasts.[A231619] Drotaverine may have minor allosteric calcium channel blocking properties: _in vitro_, drotaverine behaves like voltage-dependent L-type calcium channel blockers.[A231624]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10760, 'Arzo comp cream', 'ارزو كومب كريم', '50', '40', NULL, 'Panthenol+olive oil', 'Arz pharma', 'Cream', 'كريم', NULL, '1', NULL, NULL, NULL, NULL, 941, '2024-04-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10761, 'Spasmodin 5mg 20 tab.', 'سبازمودين 5مجم 20 قرص', '7', NULL, 'Antispasmodic', 'Oxyphenonium bromide', 'Hi-pharm', 'Tab', 'أقراص', '5mg', '2', 'مضاد لتقلصات المعدة -- يقلل التهابات المعدة -- يقلل الالام المعدة', NULL, '6221009003586', NULL, 1159, '2022-10-06', 0, 'For the treatment of visceral spasms', 'Action is achieved via a dual mechanism: (1) a specific anticholinergic effect (antimuscarinic) at the acetylcholine-receptor sites and (2) a direct effect upon smooth muscle (musculotropic).', 'Oxyphenonium is an anticholinergic drug, a medication that reduces the effect of acetylcholine, a chemical released from nerves that stimulates muscles, by blocking the receptors for acetylcholine on smooth muscle (a type of muscle). It also has a direct relaxing effect on smooth muscle. Oxyphenonium is used to treat or prevent spasm in the muscles of the gastrointestinal tract in the irritable bowel syndrome. In addition, Oxyphenonium inhibits gastrointestinal propulsive motility and decreases gastric acid secretion and controls excessive pharyngeal, tracheal and bronchial secretions.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10762, 'Spasmofen 3 amp. for i.m. inj.', 'سبازموفين 3 امبولات للحقن عضل', '54', '39', 'Antispasmodic', 'Hyoscine+ketoprofen', 'Amriya', 'Inj', 'حقن', NULL, '3', 'مضاد للتقلصا ويعمل على تخفيف الألم خاصة ألم التهاب المفاصل.', 'about hyoscine butyl bromide anti-cholinergic a tropane alkaloid antispasmodic in gi and gu spasm. mechanism of action of hyoscine butyl bromide hyoscine butyl bromide is an anticholinergic drug. it exerts its action by inhibiting muscarinic (cholinergic)', '6221075030028', NULL, 11516, '2025-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10763, 'Spasmofree 5mg/2ml i.v./i.m. 3 amp.', 'سبازموفري 3 امبولات عضل او وريد', '54', '37.5', 'Antispasmodic', 'Tiemonium methylsulphate', 'Adwia', 'Amp', 'أمبول', '5mg', '3', 'مضاد للمغص والتقلصات', 'tiemonium methylsulfate - treatment of acute intense or refractory painful syndromes with a spasmodic component. the use of noramidopyrine is only justified when its activity confers a real advantage over other analgesics. indications: smooth muscle spasm', '6223002975433', NULL, 10136, '2024-07-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10764, 'Spasmofree 50mg 20 f.c. tabs.', 'سبازموفري 50مجم 20 قرص', '42', '29', 'Antispasmodic', 'Tiemonium methylsulphate', 'Adwia', 'Tab', 'أقراص', '50mg', '2', 'مضاد للتقلصات.', NULL, '6223002971770', NULL, 14039, '2024-09-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10765, 'Spasmofree 10mg/5ml syrup 120ml', 'سبازموفري شراب 120 مل', '35', '14', 'Antispasmodic', 'Tiemonium methylsulphate', 'Adwia', 'Syrup', 'شراب', '10mg', '1', NULL, 'tiemonium methylsulfate - treatment of acute intense or refractory painful syndromes with a spasmodic component. the use of noramidopyrine is only justified when its activity confers a real advantage over other analgesics. indications: smooth muscle spasm', '6223002972029', NULL, 2728, '2025-03-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10766, 'Spasmomen 40mg 20 tab.', 'سبازمومين 40مجم 20 قرص', '80', '52', 'Antispasmodic', 'Otilonium bromide', 'Mina pharm > menarini', 'Tab', 'أقراص', '40mg', '2', 'مضاد للتقلصات', NULL, '6222003700501', NULL, 5439, '2025-05-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10769, 'Sudkids cordoba 120 gm cream', 'سودكيدز قرطبة 120 جم كريم', '140', '130', 'Soothing cream for diaper area', 'Zinc oxide + cetearyl alcohol + paraffinum liquid + propylene glycol + dimethicon + lanolin + triethanolamine + panthenol + phenoxyethanol + sodium benzoate', 'CORDOBA PHARMA', 'Cream', 'كريم', '120 gm', '1', 'للمغص والتقلصات', NULL, NULL, NULL, 1056, '2023-11-12', 0, 'Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].  



', '**Zinc has three primary biological roles**: _catalytic_, _structural_, and _regulatory_. The catalytic and structural role of zinc is well established, and there are various noteworthy reviews on these functions. For example, zinc is a structural constituent in numerous proteins, inclusive of growth factors, cytokines, receptors, enzymes, and transcription factors for different cellular signaling pathways. It is implicated in numerous cellular processes as a cofactor for approximately 3000 human proteins including enzymes, nuclear factors, and hormones [L2096].



Zinc promotes resistance to epithelial apoptosis through cell protection (cytoprotection) against reactive oxygen species and bacterial toxins, likely through the antioxidant activity of the cysteine-rich metallothioneins [A32419].



In HL-60 cells (promyelocytic leukemia cell line), zinc enhances the up-regulation of A20 mRNA, which, via TRAF pathway, decreases NF-kappaB activation, leading to decreased gene expression and generation of tumor necrosis factor-alpha (TNF-alpha), IL-1beta, and IL-8 [A32418].



There are several mechanisms of action of zinc on acute diarrhea. Various mechanisms are specific to the gastrointestinal system: zinc restores mucosal barrier integrity and enterocyte brush-border enzyme activity, it promotes the production of antibodies and circulating lymphocytes against intestinal pathogens, and has a direct effect on ion channels, acting as a potassium channel blocker of adenosine 3-5-cyclic monophosphate-mediated chlorine secretion. Cochrane researchers examined the evidence available up to 30 September 2016 [L2106].



Zinc deficiency in humans decreases the activity of serum _thymulin_ (a hormone of the thymus), which is necessary for the maturation of T-helper cells. T-helper 1 (Th(1)) cytokines are decreased but T-helper 2 (Th(2)) cytokines are not affected by zinc deficiency in humans [A32417].



The change of _Th(1)_ to _Th(2)_ function leads to cell-mediated immune dysfunction. Because IL-2 production (Th(1) cytokine) is decreased, this causes decreased activity of natural-killer-cell (NK cell) and T cytolytic cells, normally involved in killing viruses, bacteria, and malignant cells [A32424]. 



In humans, zinc deficiency may lead to the generation of new CD4+ T cells, produced in the thymus. In cell culture studies (HUT-78, a Th(0) human malignant lymphoblastoid cell line), as a result of zinc deficiency, nuclear factor-kappaB (NF-kappaB) activation, phosphorylation of IkappaB, and binding of NF-kappaB to DNA are decreased and this results in decreased Th(1) cytokine production [A32417].



In another study, zinc supplementation in human subjects suppressed the gene expression and production of pro-inflammatory cytokines and decreased oxidative stress markers [A32424]. In HL-60 cells (a human pro-myelocytic leukemia cell line), zinc deficiency increased the levels of TNF-alpha, IL-1beta, and IL-8 cytokines and mRNA. In such cells, zinc was found to induce A20, a zinc finger protein that inhibited NF-kappaB activation by the tumor necrosis factor receptor-associated factor pathway. This process decreased gene expression of pro-inflammatory cytokines and oxidative stress markers [A32417].



The exact mechanism of zinc in acne treatment is poorly understood. However, zinc is considered to act directly on microbial inflammatory equilibrium and facilitate antibiotic absorption when used in combination with other agents. Topical zinc alone as well as in combination with other agents may be efficacious because of its anti-inflammatory activity and ability to reduce P. acnes bacteria by the inhibition of P. acnes lipases and free fatty acid levels [L2102].', 'Zinc is involved in various aspects of cellular metabolism. It has been estimated that approximately 10% of human proteins may bind zinc, in addition to hundreds of proteins that transport and traffic zinc. It is required for the catalytic activity of more than 200 enzymes, and it plays a role in immune function wound healing, protein synthesis, DNA synthesis, and cell division. Zinc is an essential element for a proper sense of taste and smell and supports normal growth and development during pregnancy, childhood, and adolescence. It is thought to have antioxidant properties, which may be protective against accelerated aging and helps to speed up the healing process after an injury; however, studies differ as to its effectiveness. Zinc ions are effective antimicrobial agents even if administered in low concentrations [L2211].



Studies on oral zinc for specific conditions shows the following evidence in various conditions [L2095]:



**Colds:** Evidence suggests that if zinc lozenges or syrup are taken within 24 hours after cold symptoms start, the supplement may shorten the length of colds. The use intranasal zinc has been associated with the loss of the sense of smell, in some cases long-term or permanently [L2095].



**Wound healing:** Patients with skin ulcers and decreased levels of zinc may benefit from oral zinc supplements [L2095]. 



**Diahrrea**: Oral zinc supplements can reduce the symptoms of diarrhea in children with low levels of zinc, especially in cases of malnutrition [L2095].

', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10771, 'Spasmopyralgin-m 10 tabs.', 'سبازموبيرالجين ام 10 اقراص', '21', '14.5', 'Antispasmodic', 'Camylofin+dipyrone', 'Kahira', 'Tab', 'أقراص', NULL, '1', 'مضاد للمغص والتقلصات', NULL, '6221068010334', NULL, 13229, '2024-12-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10773, 'Zinc on lotion 120 ml', 'زنك اون لوشن 120 مل', '65', NULL, NULL, 'Olive oil+vit e+lavander oil+glycerin', 'Amazon pharma', 'Lotion', 'لوشن', '120 ml', '1', NULL, NULL, NULL, NULL, 761, '2023-05-04', 0, 'In a clinical context, olive oil is used as a source of calories and fatty acids in patients requiring parenteral nutrition. A formulation called Clinolipid, comprising olive oil and [soybean oil], is indicated in all age groups, including term and preterm neonates, as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated.[L51013]', 'Fatty acids act as a substrate in energy production through beta-oxidation as well as important components of cell membrane structures and prescursors for bioactive molecules like prostaglandins.', 'Provides a source of calories and fatty acids.[L51013]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10774, 'Spasmorest 10mg 20 tab.', 'سبازمورست 10مجم 20 قرص', '22', '11.5', 'Antimuscarinic.irritable bowel syndrome', 'Dicyclomine', 'Misr', 'Tab', 'أقراص', '10mg', '2', 'علاج المغص والتقلصات والتشنجات،و مشاكل في المعدة أو الأمعاء (الأمعاء) - مثل القولون العصبي.', NULL, '6221035009439', NULL, 2587, '2025-02-18', 0, 'Dicyclomine is indicated for the treatment of functional bowel disorder and irritable bowel syndrome.[L7967]', 'Dicyclomine achieves its action partially through direct antimuscarinic activity of the M1, M3, and M2 receptors; and partially through antagonism of bradykinin and histamine.[A6556,A182555,A234659,L7967] Dicyclomine non-competitively inhibits the action of bradykinin and histamine, resulting in direct action on the smooth muscle, and decreased strength of contractions seen in spasms of the ileum.[A182555]', 'Dicyclomine is an anticholinergic drug used to relax the smooth muscles of the intestines.[L7967] It''s duration of action is not especially long as it is usually taken 4 times daily with individual doses of 20-40mg orally or 10-20mg by intramuscular injection.[L7967] Dicyclomine should not be administered intravenously.[L7967]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10775, 'Spasmorest 10 mg/ml 6 i.m. amp.', 'سبازمورست 10مجم/مل 6 امبولات', '7', NULL, 'Antimuscarinic.irritable bowel syndrome', 'Dicyclomine', 'Misr', 'Amp', 'أمبول', '10 mg', '6', 'مضاد للتقلصات', 'about dicyclomine anticholinergic antimuscarinic antispasmodic and in urinary incontinence. mechanism of action of dicyclomine dicyclomine is an anticholinergic drug. it exerts its action by inhibiting muscarinic (((cholinergic))) receptors on smooth musc', NULL, NULL, 825, '2023-04-27', 0, 'Dicyclomine is indicated for the treatment of functional bowel disorder and irritable bowel syndrome.[L7967]', 'Dicyclomine achieves its action partially through direct antimuscarinic activity of the M1, M3, and M2 receptors; and partially through antagonism of bradykinin and histamine.[A6556,A182555,A234659,L7967] Dicyclomine non-competitively inhibits the action of bradykinin and histamine, resulting in direct action on the smooth muscle, and decreased strength of contractions seen in spasms of the ileum.[A182555]', 'Dicyclomine is an anticholinergic drug used to relax the smooth muscles of the intestines.[L7967] It''s duration of action is not especially long as it is usually taken 4 times daily with individual doses of 20-40mg orally or 10-20mg by intramuscular injection.[L7967] Dicyclomine should not be administered intravenously.[L7967]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10776, 'Zeeshan cream 60 gm', 'زيشان كريم 60 جرام', '45', '40', 'Massage cream', 'Camphor oil+methyl paraben+eucalyptus oil+menthol crystal', 'P pharm', 'Cream', 'كريم', '60 gm', '1', NULL, NULL, NULL, NULL, 958, '2025-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10777, 'Rafada b complex 20 odf', 'رافادا بي مركب 20 او دي اف', '95', '79', 'Multivitamin', 'B12 1000mcg+b6 5mg+folic acid 800mcg+biotin 2500mcg', 'Rafada two rs', 'Unknown', 'غير محدد', NULL, '1', 'مكمل غذائى ويستخدم علاج مساعد لحالات التهاب الأعصاب فى الحمل و مرضى السكر.', NULL, NULL, NULL, 3941, '2025-03-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10778, 'Frieden 30 capsules', 'فرايدن 30 كبسولة', '120', NULL, 'Multivitamin', 'Magnesium + vitamin b12 + vitamin b6 + folic acid + vitamin d', 'Oth pharma', 'Capsule', 'كبسولة', NULL, '3', NULL, NULL, NULL, NULL, 820, '2023-04-27', 0, 'Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.', 'Magnesium is the second most plentiful cation of the intracellular fluids. It is essential for the activity of many enzyme systems and plays an important role with regard to neurochemical transmission and muscular excitability. Magnesium sulfate reduces striated muscle contractions and blocks peripheral neuromuscular transmission by reducing acetylcholine release at the myoneural junction. Additionally, Magnesium inhibits Ca<sup>2+</sup> influx through dihydropyridine-sensitive, voltage-dependent channels. This accounts for much of its relaxant action on vascular smooth muscle.', 'Magnesium sulfate is a small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. Magnesium sulfate is gaining popularity as an initial treatment in the management of various dysrhythmias, particularly torsades de pointes, and dyrhythmias secondary to TCA overdose or digitalis toxicity.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10779, 'Spasmotal inf mouth drops 10 ml', 'سبازموتال نقط فم للاطفال 10 مل', '5', NULL, 'Antispasmodic', 'Pipenzolate bromide+phenobarbitone', 'Misr', 'Drops', 'نقط', '10 ml', '1', 'مضاد لتقلصات المعدة والامعاء للاطفال -- تقليل الالام المعدة -- تقليل الانتفاخات و الغازات', NULL, '6221035018035', NULL, 1320, '2022-12-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10781, 'Spasmotalin forte 135mg 20 f.c. tabs.', 'سبازموتالين فورت 135مجم 20 قرص', '13', NULL, 'Antimuscarinic.irritable bowel syndrome', 'Mebeverine', 'Amriya', 'Tab', 'أقراص', '135mg', '2', NULL, 'about mebeverine reserpine derivative antimuscarinic a musculotropic antispasmodic motility stimulant. mechanism of action of mebeverine mebeverine has a direct relaxant effect on smooth muscle. this will inhibits gastrointestinal propulsive motility and', '6221075014011', NULL, 1343, '2022-12-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10785, 'Spazaway 0.125mg 20 sublingual tab.', 'سبازاواي 0.125مجم 20 قرص', '29', '21', 'Antispasmodic', 'Hyoscyamine sulfate', 'Egpi > jasper for pharmaceutical industries', 'Tab', 'أقراص', '0.125mg', '2', NULL, NULL, '6224007884027', NULL, 1522, '2025-06-12', 0, 'As a drug that is not FDA approved, hyscyamine has no official indications.[L31548,L31553] Intravenous hysocyamine has been used to reduce gastric motility, reduce pancreatic pain and secretions, to facilitate imaging of the gastrointestinal tract, treat anticholinesterase toxicity, treat certain cases of partial heart block, improve visualization of the kidneys, and for symptomatic relief of biliary and renal colic.[L31548] Intravenous hyoscyamine is also used pre-operatively to reduce secretions of the mouth and respiratory tract to facilitate intubation.[L31548] Oral hyoscyamine is used to treat functional intestinal disorders, for symptomatic relief of biliary and renal colic, and symptomatic relief of acute rhinitis.[L31553]', 'Hyoscyamine competitively and non-selectively antagonises muscarinic receptors in the smooth muscle, cardiac muscle, sino-atrial node, atrioventricular node, exocrine nodes, gastrointestinal tract, and respiratory tract.[A228613,L31548,L31553] Antagonism of muscarinic M1, M4, and M5 receptors in the central nervous system lead to cognitive impairment; antagonism of M2 in the sinoatrial and atrioventricular nodes leads to increases in heart rate and atrial contractility; and antagonism of M3 in smooth muscle results in reduced peristalsis, bladder contraction, salivary secretions, gastric secretions, bronchial secretions, sweating, increased bronchodilation, mydriasis, and cycloplegia.[A228613,A228623,A228633]', 'Hyoscyamine is not FDA approved, and so it has not official indications.[L31548,L31553] However, it is used as an antimuscarinic agent in a number of treatments and therapies.[L31548,L31553] Hyoscyamine has a short duration of action as it may need to be given multiple times per day.[L31548,L31553] Patients should be counselled regarding the risks and signs of anticholinergic toxicity.[L31548,L31553]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10787, 'Limitless chromax cut 30 sachets', 'ليميتلس كروماكس كت 30 كيس', '375', '339', NULL, NULL, 'Eva pharma', 'Sachet', 'أكياس', NULL, '30', NULL, 'during weight loss programs', '6223007352857', NULL, 2993, '2025-06-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10788, 'Spectone 100mg 20 tab.', 'سبيكتون 100مجم 20 قرص', '90', '70', 'Diuretic.potassium-sparing diuretics', 'Spironolactone', 'Kahira', 'Tab', 'أقراص', '100mg', '2', 'مدر للبول', NULL, '6221068010983', NULL, 7546, '2025-06-22', 0, 'Spironolactone is indicated for the treatment of the following conditions:



- NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and reduce the need for hospitalization for heart failure. Spironolactone is usually administered in conjunction with other heart failure therapies.[L44602]

- Hypertension, as add-on therapy, in patients not adequately controlled by other agents.[L44602, L47810]

- Edema associated with hepatic cirrhosis when edema is not responsive to fluid and sodium restriction.[L44602, L47810]

- Edema associated with nephrotic syndrome when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics produce an inadequate response.[L44602]

- Refractory edema associated with congestive cardiac failure, malignant ascites, hepatic cirrhosis with ascites, and essential hypertension.[L47810]

- Short-term preoperative treatment of patients with primary hyperaldosteronism.[L44602, L47810]

- Diagnosis of primary aldosteronism.[L47810]

- Long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are not candidates for surgery.[L44602]

- Long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism).[L44602]



As spironolactone has antiandrogenic activity, its off-label uses include the treatment of hirsutism, female pattern hair loss, and adult acne vulgaris.[A178135, A261025]', 'Aldosterone is a key hormone in the renin-angiotensin-aldosterone system. By binding to the mineralocorticoid receptor at the distal tubules and collecting duct, it causes sodium reabsorption and potassium secretion, increases vascular stiffness and remodelling, and activates pro-inflammatory pathways.[A178192, A261025]



Spironolactone and its active metabolites are aldosterone antagonists that produce a potassium-sparing diuretic effect. They competitively bind to receptors at the aldosterone-dependent sodium-potassium exchange site in the distal convoluted renal tubule. Spironolactone causes increased amounts of sodium and water to be excreted while potassium is retained. Spironolactone acts both as a diuretic and as an antihypertensive drug by this mechanism. It may be given alone or with other diuretic agents that act more proximally in the renal tubule.[A178192, L44602]', 'Spironolactone has a potassium-sparing diuretic effect. It promotes sodium and water excretion and potassium retention. It increases renin and aldosterone levels.[A11837] Spironolactone is a mineralocorticoid receptor antagonist and has a low affinity for the glucocorticoid receptor.[A11834] It also exhibits progestogenic and anti-androgenic actions as it binds to the androgen receptor and, to a lesser extent, estrogen and progesterone receptors.[A11837, A178192, A261025] Spironolactone exhibits anti-inflammatory effects.[A178192]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10789, 'Spectone 25mg 20 tab.', 'سبيكتون 25مجم 20 قرص', '36', '27', 'Diuretic.potassium-sparing diuretics', 'Spironolactone', 'Kahira', 'Tab', 'أقراص', '25mg', '2', 'مدر للبول', NULL, '6221068000977', NULL, 10655, '2024-08-15', 0, 'Spironolactone is indicated for the treatment of the following conditions:



- NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and reduce the need for hospitalization for heart failure. Spironolactone is usually administered in conjunction with other heart failure therapies.[L44602]

- Hypertension, as add-on therapy, in patients not adequately controlled by other agents.[L44602, L47810]

- Edema associated with hepatic cirrhosis when edema is not responsive to fluid and sodium restriction.[L44602, L47810]

- Edema associated with nephrotic syndrome when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics produce an inadequate response.[L44602]

- Refractory edema associated with congestive cardiac failure, malignant ascites, hepatic cirrhosis with ascites, and essential hypertension.[L47810]

- Short-term preoperative treatment of patients with primary hyperaldosteronism.[L44602, L47810]

- Diagnosis of primary aldosteronism.[L47810]

- Long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are not candidates for surgery.[L44602]

- Long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism).[L44602]



As spironolactone has antiandrogenic activity, its off-label uses include the treatment of hirsutism, female pattern hair loss, and adult acne vulgaris.[A178135, A261025]', 'Aldosterone is a key hormone in the renin-angiotensin-aldosterone system. By binding to the mineralocorticoid receptor at the distal tubules and collecting duct, it causes sodium reabsorption and potassium secretion, increases vascular stiffness and remodelling, and activates pro-inflammatory pathways.[A178192, A261025]



Spironolactone and its active metabolites are aldosterone antagonists that produce a potassium-sparing diuretic effect. They competitively bind to receptors at the aldosterone-dependent sodium-potassium exchange site in the distal convoluted renal tubule. Spironolactone causes increased amounts of sodium and water to be excreted while potassium is retained. Spironolactone acts both as a diuretic and as an antihypertensive drug by this mechanism. It may be given alone or with other diuretic agents that act more proximally in the renal tubule.[A178192, L44602]', 'Spironolactone has a potassium-sparing diuretic effect. It promotes sodium and water excretion and potassium retention. It increases renin and aldosterone levels.[A11837] Spironolactone is a mineralocorticoid receptor antagonist and has a low affinity for the glucocorticoid receptor.[A11834] It also exhibits progestogenic and anti-androgenic actions as it binds to the androgen receptor and, to a lesser extent, estrogen and progesterone receptors.[A11837, A178192, A261025] Spironolactone exhibits anti-inflammatory effects.[A178192]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10790, 'Limitless woman max 100 tabs.', 'ليميتلس وومان ماكس 100 قرص', '675', '615', 'Multivitamins', NULL, 'Eva pharma', 'Tab', 'أقراص', NULL, '1', NULL, 'vitamin a ... 1050 mcg vitamin c ... 75 mg vitamin d3 .. 25 mcg (1000 iu) vitamin e .. 15.8 mg vitamin k .. 50 mcg thiamine 1.1 mg riboflavin 1.1 mg niacin .. 14 mg vitamin b6 .. 2 mg folic acid ... 400 mcg vitamin b12 .. 6 mcg biotin 40 mg pantothenic ac', '6223012480132', NULL, 1226, '2024-06-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10791, 'Klenken cream 100 gm', 'كلينكن كريم 100 جم', '98', '90', 'Diaper rash', 'Zinc oxide+lanolon+beeswax+tocopherol+aloe vera', 'Ubm', 'Cream', 'كريم', '100 gm', '1', NULL, NULL, '6223014460033', NULL, 1001, '2025-12-01', 0, 'Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].  



', '**Zinc has three primary biological roles**: _catalytic_, _structural_, and _regulatory_. The catalytic and structural role of zinc is well established, and there are various noteworthy reviews on these functions. For example, zinc is a structural constituent in numerous proteins, inclusive of growth factors, cytokines, receptors, enzymes, and transcription factors for different cellular signaling pathways. It is implicated in numerous cellular processes as a cofactor for approximately 3000 human proteins including enzymes, nuclear factors, and hormones [L2096].



Zinc promotes resistance to epithelial apoptosis through cell protection (cytoprotection) against reactive oxygen species and bacterial toxins, likely through the antioxidant activity of the cysteine-rich metallothioneins [A32419].



In HL-60 cells (promyelocytic leukemia cell line), zinc enhances the up-regulation of A20 mRNA, which, via TRAF pathway, decreases NF-kappaB activation, leading to decreased gene expression and generation of tumor necrosis factor-alpha (TNF-alpha), IL-1beta, and IL-8 [A32418].



There are several mechanisms of action of zinc on acute diarrhea. Various mechanisms are specific to the gastrointestinal system: zinc restores mucosal barrier integrity and enterocyte brush-border enzyme activity, it promotes the production of antibodies and circulating lymphocytes against intestinal pathogens, and has a direct effect on ion channels, acting as a potassium channel blocker of adenosine 3-5-cyclic monophosphate-mediated chlorine secretion. Cochrane researchers examined the evidence available up to 30 September 2016 [L2106].



Zinc deficiency in humans decreases the activity of serum _thymulin_ (a hormone of the thymus), which is necessary for the maturation of T-helper cells. T-helper 1 (Th(1)) cytokines are decreased but T-helper 2 (Th(2)) cytokines are not affected by zinc deficiency in humans [A32417].



The change of _Th(1)_ to _Th(2)_ function leads to cell-mediated immune dysfunction. Because IL-2 production (Th(1) cytokine) is decreased, this causes decreased activity of natural-killer-cell (NK cell) and T cytolytic cells, normally involved in killing viruses, bacteria, and malignant cells [A32424]. 



In humans, zinc deficiency may lead to the generation of new CD4+ T cells, produced in the thymus. In cell culture studies (HUT-78, a Th(0) human malignant lymphoblastoid cell line), as a result of zinc deficiency, nuclear factor-kappaB (NF-kappaB) activation, phosphorylation of IkappaB, and binding of NF-kappaB to DNA are decreased and this results in decreased Th(1) cytokine production [A32417].



In another study, zinc supplementation in human subjects suppressed the gene expression and production of pro-inflammatory cytokines and decreased oxidative stress markers [A32424]. In HL-60 cells (a human pro-myelocytic leukemia cell line), zinc deficiency increased the levels of TNF-alpha, IL-1beta, and IL-8 cytokines and mRNA. In such cells, zinc was found to induce A20, a zinc finger protein that inhibited NF-kappaB activation by the tumor necrosis factor receptor-associated factor pathway. This process decreased gene expression of pro-inflammatory cytokines and oxidative stress markers [A32417].



The exact mechanism of zinc in acne treatment is poorly understood. However, zinc is considered to act directly on microbial inflammatory equilibrium and facilitate antibiotic absorption when used in combination with other agents. Topical zinc alone as well as in combination with other agents may be efficacious because of its anti-inflammatory activity and ability to reduce P. acnes bacteria by the inhibition of P. acnes lipases and free fatty acid levels [L2102].', 'Zinc is involved in various aspects of cellular metabolism. It has been estimated that approximately 10% of human proteins may bind zinc, in addition to hundreds of proteins that transport and traffic zinc. It is required for the catalytic activity of more than 200 enzymes, and it plays a role in immune function wound healing, protein synthesis, DNA synthesis, and cell division. Zinc is an essential element for a proper sense of taste and smell and supports normal growth and development during pregnancy, childhood, and adolescence. It is thought to have antioxidant properties, which may be protective against accelerated aging and helps to speed up the healing process after an injury; however, studies differ as to its effectiveness. Zinc ions are effective antimicrobial agents even if administered in low concentrations [L2211].



Studies on oral zinc for specific conditions shows the following evidence in various conditions [L2095]:



**Colds:** Evidence suggests that if zinc lozenges or syrup are taken within 24 hours after cold symptoms start, the supplement may shorten the length of colds. The use intranasal zinc has been associated with the loss of the sense of smell, in some cases long-term or permanently [L2095].



**Wound healing:** Patients with skin ulcers and decreased levels of zinc may benefit from oral zinc supplements [L2095]. 



**Diahrrea**: Oral zinc supplements can reduce the symptoms of diarrhea in children with low levels of zinc, especially in cases of malnutrition [L2095].

', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10798, 'Fusibact oint 30 gm', 'فيوسيباكت مرهم 30 جم', '30', NULL, 'Antibiotic', 'Fucidic acid', 'Jamjom pharma', 'Oint', 'مرهم', '30 gm', '1', NULL, NULL, '6281269105321', NULL, 809, '2022-08-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10799, 'Spika 100mg 12 f.c. tablets', 'سبيكا 100مجم 12 قرص', '45', NULL, 'Tonic for men', 'Sildenafil', 'El-obour > spimaco misr', 'Tablet', 'أقراص', '100mg', '1', 'مقوي لللرجال', NULL, '6224007333341', NULL, 7746, '2023-01-30', 0, 'Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor that is predominantly employed for two primary indications:



(1) the treatment of erectile dysfunction [A175582, L5611, F3853, F3856, F3886]; and



(2) treatment of pulmonary hypertension, where:

a) the US FDA specifically indicates sildenafil for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical worsening [F3850]. The delay in clinical worsening was demonstrated when sildenafil was added to background epoprostenol therapy [F3850]. Studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with New York Heart Association (NYHA) Functional Class II-III symptoms and idiopathic etiology (71%) or associated with connective tissue disease (CTD) (25%) [F3850];



b) the Canadian product monograph specifically indicates sildenafil for the treatment of primary pulmonary arterial hypertension (PPH) or pulmonary hypertension secondary to connective tissue disease (CTD) in adult patients with WHO functional class II or III who have not responded to conventional therapy [F3859]. In addition, improvement in exercise ability and delay in clinical worsening was demonstrated in adult patients who were already stabilized on background epoprostenol therapy [F3859]; and



c) the EMA product information specifically indicates sildenafil for the treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity [F3883]. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease [F3883]. The EMA label also indicates sildenafil for the treatment of pediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension [F3883]. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease [F3883].', 'Sildenafil is an oral therapy for erectile dysfunction [A175582, F3853, F3856, F3886, L5611]. In the natural setting, i.e. with sexual stimulation, it restores impaired erectile function by increasing blood flow to the penis [A175582, F3853, F3856, F3886, L5611].



The physiological mechanism responsible for the erection of the penis involves the release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation [A175582, F3853, F3856, F3886, L5611]. Nitric oxide then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood [A175582, F3853, F3856, F3886, L5611].



Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) in the corpus cavernosum, where PDE5 is responsible for degradation of cGMP [A175582, F3853, F3856, F3886, L5611]. Sildenafil has a peripheral site of action on erections [A175582, F3853, F3856, F3886, L5611]. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum but potently enhances the relaxant effect of NO on this tissue [A175582, F3853, F3856, F3886, L5611]. When the NO/cGMP pathway is activated, as occurs with sexual stimulation, inhibition of PDE5 by sildenafil results in increased corpus cavernosum levels of cGMP [A175582, F3853, F3856, F3886, L5611]. Therefore sexual stimulation is required in order for sildenafil to produce its intended beneficial pharmacological effects [A175582, F3853, F3856, F3886, L5611].



Moreover, apart from the presence of PDE5 in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature [A175579, F3850, F3859, F3883, L5614]. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation [A175579, F3850, F3859, F3883, L5614]. In patients with pulmonary arterial hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemic circulation [A175579, F3850, F3859, F3883, L5614].', 'In vitro studies have shown that sildenafil is selective for phosphodiesterase-5 (PDE5) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Its effect is more potent on PDE5 than on other known phosphodiesterases [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. In particular, there is a 10-times selectivity over PDE6 which is involved in the phototransduction pathway in the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. There is an 80-times selectivity over PDE1, and over 700-times over PDE 2, 3, 4, 7, 8, 9, 10 and 11 [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. And finally, sildenafil has greater than 4,000-times selectivity for PDE5 over PDE3, the cAMP-specific phosphodiesterase isoform involved in the control of cardiac contractility [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In eight double-blind, placebo-controlled crossover studies of patients with either organic or psychogenic erectile dysfunction, sexual stimulation resulted in improved erections, as assessed by an objective measurement of hardness and duration of erections (via the use of RigiScan®), after sildenafil administration compared with placebo [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Most studies assessed the efficacy of sildenafil approximately 60 minutes post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The erectile response, as assessed by RigiScan®, generally increased with increasing sildenafil dose and plasma concentration [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The time course of effect was examined in one study, showing an effect for up to 4 hours but the response was diminished compared to 2 hours [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Sildenafil causes mild and transient decreases in systemic blood pressure which, in the majority of cases, do not translate into clinical effects [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with systemic hypertension the mean change from baseline in systolic and diastolic blood pressure was a decrease of 9.4 mmHg and 9.1 mmHg respectively [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with pulmonary arterial hypertension lesser effects in blood pressure reduction were observed (a reduction in both systolic and diastolic pressure of 2 mmHg)[F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614] . At the recommended dose of 20 mg three times a day no reductions in systolic or diastolic pressure were seen [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Single oral doses of sildenafil up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg three times a day to patients with pulmonary arterial hypertension no clinically relevant effects on the ECG were reported either [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In a study of the hemodynamic effects of a single oral 100 mg dose of sildenafil in 14 patients with severe coronary artery disease (CAD) (> 70 % stenosis of at least one coronary artery), the mean resting systolic and diastolic blood pressures decreased by 7 % and 6 % respectively compared to baseline [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Mean pulmonary systolic blood pressure decreased by 9% [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil showed no effect on cardiac output and did not impair blood flow through the stenosed coronary arteries [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Mild and transient differences in color discrimination (blue/green) were detected in some subjects using the Farnsworth-Munsell 100 hue test at 1 hour following a 100 mg dose, with no effects evident after 2 hours post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The postulated mechanism for this change in color discrimination is related to inhibition of PDE6, which is involved in the phototransduction cascade of the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil has no effect on visual acuity or contrast sensitivity. In a small size placebo-controlled study of patients with documented early age-related macular degeneration (n = 9), sildenafil (single dose, 100 mg) demonstrated no significant changes in visual tests conducted (which included visual acuity, Amsler grid, color discrimination simulated traffic light, and the Humphrey perimeter and photostress test) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10802, 'Spiramycin 1.5 m.i.u. 10 tab.', 'سبيراميسين 1.5 مليون وحدة دولية 10 قرص', '20', NULL, 'Antibiotic.macrolide', 'Spiramycin', 'Pharopharma', 'Tab', 'أقراص', NULL, '1', 'مضاد حيوي', 'about spiramycin macrolide antibiotic antibacterial (systemic antiprotozoal in toxoplasmosis cryptosporidiosis. mechanism of action of spiramycin spiramycin is a member of macrolide antibiotic. it binds to the 50s sub unit of bacterial ribosome and inhibi', '6221094077219', NULL, 1370, '2022-12-09', 0, 'Macrolide antibiotic for treatment of various infections.', 'The mechanism of action of macrolides has been a matter of controversy for some time. Spiramycin, a 16-membered macrolide, inhibits translocation by binding to bacterial 50S ribosomal subunits with an apparent 1 : 1 stoichiometry. This antibiotic is a potent inhibitor of the binding to the ribosome of both donor and acceptor substrates. The primary mechanism of action is done by stimulation of dissociation of peptidyl-tRNA from ribosomes during translocation.I ', 'The absolute bioavailability of oral spiramycin is generally within the range of 30 to 40%. After a 1 g oral dose, the maximum serum drug concentration was found to be within the range 0.4 to 1.4 mg/L.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10803, 'Spiramycin 3 m.i.u. 10 tab.', 'سيبراميسين 3م.و.د 10اقراص', '42', NULL, 'Antibiotic.macrolide', 'Spiramycin', 'Pharopharma', 'Tab', 'أقراص', NULL, '1', 'مضاد حيوي', 'about spiramycin macrolide antibiotic antibacterial (systemic antiprotozoal in toxoplasmosis cryptosporidiosis. mechanism of action of spiramycin spiramycin is a member of macrolide antibiotic. it binds to the 50s sub unit of bacterial ribosome and inhibi', '6221094077233', NULL, 1558, '2022-12-09', 0, 'Macrolide antibiotic for treatment of various infections.', 'The mechanism of action of macrolides has been a matter of controversy for some time. Spiramycin, a 16-membered macrolide, inhibits translocation by binding to bacterial 50S ribosomal subunits with an apparent 1 : 1 stoichiometry. This antibiotic is a potent inhibitor of the binding to the ribosome of both donor and acceptor substrates. The primary mechanism of action is done by stimulation of dissociation of peptidyl-tRNA from ribosomes during translocation.I ', 'The absolute bioavailability of oral spiramycin is generally within the range of 30 to 40%. After a 1 g oral dose, the maximum serum drug concentration was found to be within the range 0.4 to 1.4 mg/L.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10804, 'Spirazole 20 tab.', 'سبيرازول 20 قرص', '50', '21.75', 'Antibiotic.macrolide.combined with nitroimidazoles', 'Metronidazole+spiramycin', 'Pharopharma', 'Tab', 'أقراص', NULL, '2', NULL, 'pregnancy related information use with caution. breast feeding related information contraindicated indications for metronidazole + spiramycin 1.dental abscess 2.cellulites of the jaw 3.pericoronitis 4.gingivitis 5.stomatitis 6.parotitis 7.submaxillaritis', '6221094077257', NULL, 1264, '2024-12-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10806, 'Spirazole forte 20 tab.', 'سبيرازول فورت 20 قرص', '142', '36', 'Antibiotic.macrolide.combined with nitroimidazoles', 'Metronidazole+spiramycin', 'Pharopharma', 'Tab', 'أقراص', NULL, '2', NULL, 'pregnancy related information use with caution. breast feeding related information contraindicated indications for metronidazole + spiramycin 1.dental abscess 2.cellulites of the jaw 3.pericoronitis 4.gingivitis 5.stomatitis 6.parotitis 7.submaxillaritis', '6221094077240', NULL, 2332, '2024-12-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10813, 'Spiriva 18mcg 30 inh. caps.+handihaler', 'سبيريفا 18مكجم 30 كبسولة + جهاز', '416', '403.25', 'Bronchodilator', 'Tiotropium bromide', 'Boehringer ingelheim', 'Cap', 'كبسولة', '18mcg', '3', NULL, NULL, '4048846000507', NULL, 1251, '2022-12-09', 0, 'Tiotropium powder for inhalation is indicated for the maintenance of bronchospasm in COPD and to prevent exacerbations of COPD.[L7084] A combination tiotropium and [olodaterol] metered inhalation spray is indicated for maintenance of COPD.[L7087] A tiotropium inhalation spray is indicated for the maintenance of bronchospasm in COPD, to prevent exacerbations of COPD, and to treat asthma in patients 12 or more years old.[L7090] A tiotropium metered inhalation spray is indicated for the maintenance of bronchospasm in COPD, to prevent exacerbations of COPD, and to treat asthma in patients 6 or more years old.[L7093]', 'Tiotropium is an antagonist of muscarinic receptors M<sub>1</sub> to M<sub>5</sub>.[A180163,L7084,L7087,L7090,L7093] Inhibition of the M<sub>3</sub> receptor in the smooth muscle of the lungs leads to relaxation of smooth muscle and bronchodilation.[A180163,L7084,L7087,L7090,L7093]', 'Tiotropium is a long acting antimuscarinic that causes bronchodilation.[A180163,L7084,L7087,L7090,L7093] The effects of tiotropium last over 24 hours and there is a wide therapeutic index as overdoses are uncommon even at doses well above the recommended maximum.[L7084,L7087,L7090,L7093]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10814, 'Azithrochidia 1% eye drops 15*0.4ml sdu', 'ازيثرو كيديا 1% قطرة عين 15*0.4 مل وحدات مفردة', '66', '45', 'Antibiotic.macrolide', 'Azithromycin', 'Orchidia', 'Drops', 'نقط', '1%', '1', NULL, NULL, NULL, NULL, 928, '2025-08-04', 0, 'Azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria in order to prevent the development antimicrobial resistance and maintain the efficacy of azithromycin [FDA label].



Azithromycin is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the microorganisms listed in the specific conditions below. Recommended dosages, duration of therapy and considerations for various patient populations may vary among these infections. Refer to the FDA label and "Indications" section of this drug entry for detailed information [FDA label]. 



**Adults**:



Acute bacterial exacerbations of chronic obstructive pulmonary disease due to _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Acute bacterial sinusitis due to _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Community-acquired pneumonia due to _Chlamydophila pneumoniae_, _Haemophilus influenzae_, _Mycoplasma pneumoniae_ or _Streptococcus pneumoniae_ in patients appropriate for oral therapy



Pharyngitis/tonsillitis caused by _Streptococcus pyogenes_ as an alternative to first-line therapy in individuals who cannot use first-line therapy.

Uncomplicated skin and skin structure infections due to _Staphylococcus aureus_, _Streptococcus pyogenes_, or _Streptococcus agalactiae_. Abscesses usually require surgical drainage.



Urethritis and cervicitis due to _Chlamydia trachomatis_ or _Neisseria gonorrhoeae_.



Genital ulcer disease in men due to _Haemophilus ducreyi_ (chancroid). Due to the small number of women included in clinical trials, the efficacy of azithromycin in the treatment of chancroid in women has not been established.



**Pediatric Patients**



Acute otitis media caused by _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Community-acquired pneumonia due to _Chlamydophila pneumoniae_, _Haemophilus influenzae_, _Mycoplasma pneumoniae_ or _Streptococcus pneumoniae_ in patients appropriate for oral therapy.



Pharyngitis/tonsillitis caused by _Streptococcus pyogenes_ as an alternative to first-line therapy in individuals who cannot use first-line therapy.', 'In order to replicate, bacteria require a specific process of protein synthesis, enabled by ribosomal proteins [A6505]. Azithromycin binds to the 23S rRNA of the bacterial 50S ribosomal subunit. It stops bacterial protein synthesis by inhibiting the transpeptidation/translocation step of protein synthesis and by inhibiting the assembly of the 50S ribosomal subunit [FDA label], [A14179]. This results in the control of various bacterial infections [A174193], [FDA label].   The strong affinity of macrolides, including azithromycin, for bacterial ribosomes, is consistent with their broad‐spectrum antibacterial activities [A174193].





Azithromycin is highly stable at a low pH, giving it a longer serum half-life and increasing its concentrations in tissues compared to erythromycin [A174175]. 



', 'Macrolides stop bacterial growth by inhibiting protein synthesis and translation, treating bacterial infections [A174175].

Azithromycin has additional immunomodulatory effects and has been used in chronic respiratory inflammatory diseases for this purpose [A174172].



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10816, 'Spironolactone (delta) 100mg 20 tab.', 'سبيرونولاكتون 100مجم 20 قرص', '17', NULL, 'Diuretic.potassium-sparing diuretics', 'Spironolactone', 'Global napi pharmaceuticals > al delta pharmaceuticals trading co.', 'Tab', 'أقراص', '100mg', '2', NULL, 'about spironolactone selective aldosterone antagonist antiandrogen potassium-sparing diuretic. mechanism of action of spironolactone spironolactone is a steroid with structural similarity to aldosterone which exerts it`s pharmacological actions by acting', NULL, NULL, 2980, '2022-10-18', 0, 'Spironolactone is indicated for the treatment of the following conditions:



- NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and reduce the need for hospitalization for heart failure. Spironolactone is usually administered in conjunction with other heart failure therapies.[L44602]

- Hypertension, as add-on therapy, in patients not adequately controlled by other agents.[L44602, L47810]

- Edema associated with hepatic cirrhosis when edema is not responsive to fluid and sodium restriction.[L44602, L47810]

- Edema associated with nephrotic syndrome when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics produce an inadequate response.[L44602]

- Refractory edema associated with congestive cardiac failure, malignant ascites, hepatic cirrhosis with ascites, and essential hypertension.[L47810]

- Short-term preoperative treatment of patients with primary hyperaldosteronism.[L44602, L47810]

- Diagnosis of primary aldosteronism.[L47810]

- Long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are not candidates for surgery.[L44602]

- Long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism).[L44602]



As spironolactone has antiandrogenic activity, its off-label uses include the treatment of hirsutism, female pattern hair loss, and adult acne vulgaris.[A178135, A261025]', 'Aldosterone is a key hormone in the renin-angiotensin-aldosterone system. By binding to the mineralocorticoid receptor at the distal tubules and collecting duct, it causes sodium reabsorption and potassium secretion, increases vascular stiffness and remodelling, and activates pro-inflammatory pathways.[A178192, A261025]



Spironolactone and its active metabolites are aldosterone antagonists that produce a potassium-sparing diuretic effect. They competitively bind to receptors at the aldosterone-dependent sodium-potassium exchange site in the distal convoluted renal tubule. Spironolactone causes increased amounts of sodium and water to be excreted while potassium is retained. Spironolactone acts both as a diuretic and as an antihypertensive drug by this mechanism. It may be given alone or with other diuretic agents that act more proximally in the renal tubule.[A178192, L44602]', 'Spironolactone has a potassium-sparing diuretic effect. It promotes sodium and water excretion and potassium retention. It increases renin and aldosterone levels.[A11837] Spironolactone is a mineralocorticoid receptor antagonist and has a low affinity for the glucocorticoid receptor.[A11834] It also exhibits progestogenic and anti-androgenic actions as it binds to the androgen receptor and, to a lesser extent, estrogen and progesterone receptors.[A11837, A178192, A261025] Spironolactone exhibits anti-inflammatory effects.[A178192]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10817, 'Spironolactone (delta) 25mg 10 tab', 'سبيرونولاكتون 25مجم 10 اقراص', '3', NULL, 'Diuretic.potassium-sparing diuretics', 'Spironolactone', 'Global napi pharmaceuticals > al delta pharmaceuticals trading co.', 'Tab', 'أقراص', '25mg', '1', 'مدر للبول', NULL, NULL, NULL, 3809, '2022-11-07', 0, 'Spironolactone is indicated for the treatment of the following conditions:



- NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and reduce the need for hospitalization for heart failure. Spironolactone is usually administered in conjunction with other heart failure therapies.[L44602]

- Hypertension, as add-on therapy, in patients not adequately controlled by other agents.[L44602, L47810]

- Edema associated with hepatic cirrhosis when edema is not responsive to fluid and sodium restriction.[L44602, L47810]

- Edema associated with nephrotic syndrome when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics produce an inadequate response.[L44602]

- Refractory edema associated with congestive cardiac failure, malignant ascites, hepatic cirrhosis with ascites, and essential hypertension.[L47810]

- Short-term preoperative treatment of patients with primary hyperaldosteronism.[L44602, L47810]

- Diagnosis of primary aldosteronism.[L47810]

- Long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are not candidates for surgery.[L44602]

- Long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism).[L44602]



As spironolactone has antiandrogenic activity, its off-label uses include the treatment of hirsutism, female pattern hair loss, and adult acne vulgaris.[A178135, A261025]', 'Aldosterone is a key hormone in the renin-angiotensin-aldosterone system. By binding to the mineralocorticoid receptor at the distal tubules and collecting duct, it causes sodium reabsorption and potassium secretion, increases vascular stiffness and remodelling, and activates pro-inflammatory pathways.[A178192, A261025]



Spironolactone and its active metabolites are aldosterone antagonists that produce a potassium-sparing diuretic effect. They competitively bind to receptors at the aldosterone-dependent sodium-potassium exchange site in the distal convoluted renal tubule. Spironolactone causes increased amounts of sodium and water to be excreted while potassium is retained. Spironolactone acts both as a diuretic and as an antihypertensive drug by this mechanism. It may be given alone or with other diuretic agents that act more proximally in the renal tubule.[A178192, L44602]', 'Spironolactone has a potassium-sparing diuretic effect. It promotes sodium and water excretion and potassium retention. It increases renin and aldosterone levels.[A11837] Spironolactone is a mineralocorticoid receptor antagonist and has a low affinity for the glucocorticoid receptor.[A11834] It also exhibits progestogenic and anti-androgenic actions as it binds to the androgen receptor and, to a lesser extent, estrogen and progesterone receptors.[A11837, A178192, A261025] Spironolactone exhibits anti-inflammatory effects.[A178192]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10818, 'Spironolactone (delta) 50mg 10 tab.', 'سبيرونولاكتون 50مجم 10 اقراص', '5', NULL, 'Diuretic.potassium-sparing diuretics', 'Spironolactone', 'Global napi pharmaceuticals > al delta pharmaceuticals trading co.', 'Tab', 'أقراص', '50mg', '1', NULL, 'about spironolactone selective aldosterone antagonist antiandrogen potassium-sparing diuretic. mechanism of action of spironolactone spironolactone is a steroid with structural similarity to aldosterone which exerts it`s pharmacological actions by acting', NULL, NULL, 1000, '2022-10-18', 0, 'Spironolactone is indicated for the treatment of the following conditions:



- NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and reduce the need for hospitalization for heart failure. Spironolactone is usually administered in conjunction with other heart failure therapies.[L44602]

- Hypertension, as add-on therapy, in patients not adequately controlled by other agents.[L44602, L47810]

- Edema associated with hepatic cirrhosis when edema is not responsive to fluid and sodium restriction.[L44602, L47810]

- Edema associated with nephrotic syndrome when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics produce an inadequate response.[L44602]

- Refractory edema associated with congestive cardiac failure, malignant ascites, hepatic cirrhosis with ascites, and essential hypertension.[L47810]

- Short-term preoperative treatment of patients with primary hyperaldosteronism.[L44602, L47810]

- Diagnosis of primary aldosteronism.[L47810]

- Long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are not candidates for surgery.[L44602]

- Long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism).[L44602]



As spironolactone has antiandrogenic activity, its off-label uses include the treatment of hirsutism, female pattern hair loss, and adult acne vulgaris.[A178135, A261025]', 'Aldosterone is a key hormone in the renin-angiotensin-aldosterone system. By binding to the mineralocorticoid receptor at the distal tubules and collecting duct, it causes sodium reabsorption and potassium secretion, increases vascular stiffness and remodelling, and activates pro-inflammatory pathways.[A178192, A261025]



Spironolactone and its active metabolites are aldosterone antagonists that produce a potassium-sparing diuretic effect. They competitively bind to receptors at the aldosterone-dependent sodium-potassium exchange site in the distal convoluted renal tubule. Spironolactone causes increased amounts of sodium and water to be excreted while potassium is retained. Spironolactone acts both as a diuretic and as an antihypertensive drug by this mechanism. It may be given alone or with other diuretic agents that act more proximally in the renal tubule.[A178192, L44602]', 'Spironolactone has a potassium-sparing diuretic effect. It promotes sodium and water excretion and potassium retention. It increases renin and aldosterone levels.[A11837] Spironolactone is a mineralocorticoid receptor antagonist and has a low affinity for the glucocorticoid receptor.[A11834] It also exhibits progestogenic and anti-androgenic actions as it binds to the androgen receptor and, to a lesser extent, estrogen and progesterone receptors.[A11837, A178192, A261025] Spironolactone exhibits anti-inflammatory effects.[A178192]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10821, 'Splenda sweetener 100 tablets', 'سبليندا سويتنر 100 قرص', '75', '59', 'Sweetener', 'Sucralose', 'El-gendy trading', 'Tablet', 'أقراص', NULL, '1', NULL, NULL, '722776200025', NULL, 601, '2024-05-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10822, 'Splenda sweetener 50 sachets', 'سبليندا سويتنر 50 كيس', '80', '57', 'Sweetener', 'Sucralose', 'El-gendy trading', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, '722776200018', NULL, 758, '2024-05-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10823, 'Splenda sweetener 300 tablets', 'سبليندا سويتنر 300 قرص', '145', '118', 'Sweetener', 'Sucralose', 'El-gendy trading', 'Tablet', 'أقراص', NULL, '1', NULL, NULL, NULL, NULL, 829, '2024-05-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10825, 'Spondex 30 capsules', 'سبوندكس 30 كبسولة', '90', NULL, 'Bone care', 'D-alpha tocopherol', 'Safe pharma > atos pharma', 'Capsule', 'كبسولة', NULL, '5', NULL, NULL, '6223000470961', NULL, 1731, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10826, 'Spondex 18 capsules', 'سبوندكس 18 كبسولة', '72', '39', 'Bone care', 'D-alpha tocopherol', 'Safe pharma > atos pharma', 'Capsule', 'كبسولة', NULL, '3', NULL, NULL, '6223000471708', NULL, 1261, '2024-09-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10829, 'Sila bone 30 tabs', 'سيلا بون 30 قرص', '120', '60', 'Calcium supplement', 'Calcium+magnesium+zinc+vitamin d3+boron+copper+manganese+selenium', 'Silaj', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 1331, '2025-10-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10830, 'Sporanox 100mg 14 caps.', 'سبورانوكس 100مجم 14 كبسول', '108', NULL, 'Antifungals.triazoles', 'Itraconazole', 'Janssen cilag > soficopharm', 'Cap', 'كبسولة', '100mg', '2', NULL, NULL, NULL, NULL, 1321, '2022-08-01', 0, 'Itraconazole is indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients:[L50051, L50056]



- Blastomycosis, pulmonary and extrapulmonary

- Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, nonmeningeal histoplasmosis, and

- Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy



It is also indicated for the treatment of the following fungal infections in non-immunocompromised patients:[L50051]



- Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium)

- Onychomycosis of the fingernail due to dermatophytes (tinea unguium).



Itraconazole oral solution is indicated for the treatment of oropharyngeal and esophageal candidiasis.[L50061]', 'Itraconazole mediates its antifungal activity by inhibiting 14α-demethylase, a fungal cytochrome P450 enzyme that converts lanosterol to ergosterol, a vital component of fungal cell membranes.[L50051] The azole nitrogen atoms in the chemical structure of itraconazole form a complex with the active site, or the haem iron, of the fungal enzyme to impede its function.[A34257, A263232] The accumulation of lanosterol and 14-methylated sterols results in increased permeability of the fungal cell membrane, and modified membrane-bound enzyme activity, and dysregulated chitin synthesis.[A34257, A263222, A263227] Other proposed mechanisms of action of itraconazole include the inhibition of fungal cytochrome c oxidative and peroxidative enzymes that also lead to the disruption of fungal cell membranes.[A34257]', 'Itraconazole is an antifungal agent that inhibits cell growth and promotes cell death of fungi.[A34257] It exhibits in vitro activity against _Blastomyces dermatitidis_, _Histoplasma capsulatum_, _Histoplasma duboisii_, _Aspergillus flavus_, _Aspergillus fumigatus_, and _Trichophyton_ species.[L50051]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10831, 'Sport drink 6 eff. sachets', 'سبورت درينك 6 اكياس', '7', NULL, 'Multivitamins', 'Multivitamins+minerals', 'Sedico', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, '6221042205046', NULL, 1037, '2023-04-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10837, 'Sprycel 50mg 60 f.c. tabs.', 'سبريسيل 50مجم 60 قرص', '16,300', NULL, 'Antineoplastic', 'Dasatinib', 'Bristol-myers squibb', 'Tab', 'أقراص', '50mg', '6', 'يبطئ نمو وانتشار الخلايا السرطانية -- علاج ابيضاض الدم النقوي -- علاج ابيضاض الارومات اللمفاوية الحاد -- يستخدم في حالة فشل الادوية السرطانية الاخري', NULL, NULL, NULL, 2495, '2023-01-12', 0, 'Dasatinib is indicated for the treatment of newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase, as well as adults with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib, and adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy. Dasatinib is also indicated for the treatment of pediatric patients 1 year of age and older with Ph+ CML in chronic phase or newly diagnosed Ph+ ALL in combination with chemotherapy.[L45171]', 'Dasatinib is a tyrosine kinase inhibitor with several targets. At nanomolar concentrations, it inhibits BCR-ABL, SRC family (SRC, LCK, YES, FYN), c-KIT, EPHA2, and PDGFR&beta;.[A2224,A11377,L45171] In patients with chronic myeloid leukemia (CML), the tyrosine kinase activity of BCR-ABL is deregulated, leading to the growth, proliferation and survival of cancerous hematopoietic cells. Dasatinib binds to the active and inactive conformation of the ABL kinase domain with a higher affinity than imatinib.[A33432] In chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) cell lines overexpressing BCR-ABL, dasatinib inhibits cell growth. Also, dasatinib has _in vitro_ activity against leukemic cell lines that are either sensitive or resistant to imatinib.[L45171] It has been suggested that dasatinib is able to overcome imatinib resistance caused by BCR-ABL kinase domain mutations because it does not require interaction with some of the residues involved in those mutations.[A33432,L45171]', 'Dasatinib is an orally available small-molecule multikinase inhibitor.[A11377] During clinical trials, less than 1% of patients treated with dasatinib had QTc prolongation as an adverse reaction, and 1% experienced a QTcF higher than 500 ms. The use of dasatinib is also associated with myelosuppression, bleeding-related events, fluid retention, cardiovascular toxicity, pulmonary arterial hypertension, severe dermatologic reactions, tumor lysis syndrome and hepatotoxicity. It may also cause embryo-fetal toxicity and lead to adverse reactions associated with bone growth and development in pediatric patients.[L45171]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10838, 'Kativarox 100 mg 30 f.c.tabs.', 'كاتيفاروكس 100 مجم 30 قرص', '258', NULL, 'Anti-epileptic.sv2a ligands', 'Brivaracetam', 'Multi-apex', 'Tab', 'أقراص', '100 mg', '3', NULL, NULL, '6223003208318', NULL, 1550, '2023-01-04', 0, 'Used as adjunctive therapy for partial-onset seizures in patients 16 years of age or older.', 'The precise mechanism of brivaracetam''s anti-epileptogenic activity is unknown.', 'Brivaracetam binds SV2A with high affinity  [A19184]. SV2A is known to play a role in epileptogenesis through modulation of synaptic GABA release [A19185]. It is thought that brivaracetam exerts its anti-epileptogenic effects through its binding to SV2A. Brivaracetam is also known to inhibit Na+ channels which may also contribute to its anti-epileptogenic action [A19186].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10848, 'Stablon 12.5mg 30 sugar coated tab.', 'ستابلون 12.5مجم 30 قرص', '62', NULL, 'Psychiatric.antidepressants', 'Tianeptine sodium salt', 'Servier', 'Tab', 'أقراص', '12.5mg', '3', 'مضاد للاكتئاب -- بعض حالات الامراض النفسية', 'it is a drug used primarily in the treatment of major depressive disorder although it may also be used to treat asthma or irritable bowel syndrome. chemically it is a tricyclic antidepressant (tca) but it has different pharmacological properties than typi', '6223003960001', NULL, 3489, '2022-12-09', 0, 'Used primarily in the treatment of major depressive disorder and anxiety [A31969]. It is currently being studied for fibromyalgia pain treatment [L1426].', 'Recent studies suggest that tianeptine acts as a full agonist at the mu-type opioid receptor (MOR) [A33314], [A33316].   The mu opioid receptors are currently being studied as effective targets for antidepressant therapies [L2947]. It is believed that the clinical effects of tianeptine are owed to its modulation of these receptors  [A33314].  In addition to its actions on the opioid receptor, previous studies have owed its action to its effect on the serotonin receptor [A33317], [A33318], dopamine (D2/3) receptors [A33319], and glutamate receptors [A33315], [F134], as discussed below:



Tianeptine has challenged the monoaminergic hypothesis of depression, as well as the widely supported monoaminergic mechanisms whereby the action of most known antidepressants have been explained [L1414]. Specifically, this drug is thought to persistently alter glutamate receptor bursting of the hippocampal CA3 commissural associational synapse [A31971]. Current research suggests that tianeptine produces its antidepressant effects through the modulation of glutamate receptor activity (for example, AMPA receptors and NMDA receptors) and affect the release of brain-derived neurotrophic factor (BDNF), which impacts neural plasticity [A31986]. More recent studies by support the role of tianeptine in the modulation of glutaminergic activity in the amygdala, the emotional region of the brain associated with memories [A31971]. 



 Tianeptine reduces the hypothalamic-pituitary-adrenal response to stress, and thus prevents stress-related behavioral issues [A31986, A24914].  In rodents, the stress of acute restraint increases extracellular levels of glutamate in the basolateral amygdala an effect that was inhibited by tianeptine [A31971]. Interestingly, the SSRI fluoxetine increased extracellular glutamate levels in the basolateral amygdala regardless of stress conditions. These data demonstrate that the mechanism of action of tianeptine is distinct from SSRIs and support the hypothesis that the mechanism of action of tianeptine relates to alteration of glutaminergic activity in the amygdala and the hippocampus [A31971, A31969, A31986].



In addition to the above mechanisms, tianeptine is a unique antidepressant and anxiolytic medication that stimulates the uptake of serotonin (5-hydroxytryptamine; 5-HT), and 5-hydroxyindoleacetic acid (5-HIAA) in brain tissue [A31971]. 



Although the monoaminergic neurotransmitters serotonin (5-HT), noradrenaline (NA) and dopamine (DA) are proven to be related to the occurrence of depressive disorders, it is now recognized that monoamine deficits are not sufficient to explain the mechanism of action of antidepressant medications [A31971].  

', '



Analyses in large-scale epidemiologic surveys have shown that the anxiety disorders are widely comorbid with major depression. This makes antidepressant with anxiolytic properties particularly unique and attractive [A31971].



Tianeptine is effective in reducing depressive symptoms in mild to severe major depressive disorder and also alleviates anxious symptoms associated with depression without the need for coadministration of an anti-anxiety medication [A31971].   



These findings, however, are met with controversial data.  In a study of healthy volunteers, Tianeptine-treated subjects were less accurate at identifying facial expressions, suggesting a lack of improvement in the psychomotor symptoms of depression. The tianeptine group also showed reduced memory and reduced attentional vigilance to various stimuli [A31987].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10849, 'Chestoleaf syrup 120 ml', 'شيستوليف شراب 120 مل', '55', '45', 'Antitussive', 'Ivy+thyme+licorice', 'Life pharma international', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, '6225000480254', NULL, 1295, '2025-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10850, 'Stalevo 100/25/200 mg 30 tab', 'ستاليفو 100 /25/200مجم 30 قرص', '435', '270', 'Antiparkinsonism', 'Carbidopa+entacapone+levodopa', 'Novartis', 'Tab', 'أقراص', '200 mg', '3', '- لعلاج مرض باركنسون', NULL, NULL, NULL, 2261, '2024-12-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10859, 'Ivy acetyl zinc syrup 120 ml', 'ايفي استيل زنك شراب 120 مل', '45', '45', 'Cough products', 'Acetylcysteine+ivy leaves', 'Copex pharma', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 1811, '2025-05-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10861, 'Doliprane 1 gm 15 tabs.', 'دوليبران 1جم 15 قرص', '48', NULL, 'Analgesic.antipyrteic', 'Paracetamol(acetaminophen)', 'Sanofi', 'Tab', 'أقراص', '1 gm', '3', NULL, NULL, '6223003992248', NULL, 2339, '2023-05-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10866, 'Starlix combi 48 tab', 'ستارليكس كومبي 48 قرص', '40', NULL, 'Antidiabitic drug', 'Nateglinide+metformin', 'Novartis', 'Tab', 'أقراص', NULL, '4', 'لمرضى السكر', NULL, '6223002641093', NULL, 831, '2022-12-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10867, 'Starville whitening facial cleanser 400 ml', 'ستارفيل منظف وجه للتبييض 400 مل', '250', NULL, 'Skin care.whitening', NULL, 'Parkville', 'Cleanser', 'منظف', '400 ml', '1', NULL, NULL, '6224008059790', NULL, 901, '2022-12-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10870, 'Statomain 100mg 30 scored f.c. tabs.', 'ستاتومين 100مجم 30 قرص', '165', '106.5', 'Selective serotonin reuptake inhibitor', 'Fluvoxamine maleate', 'Biomed', 'Tab', 'أقراص', '100mg', '3', 'مضاد للإكتئاب', NULL, '6222001401165', NULL, 5852, '2024-10-21', 0, 'Indicated predominantly for the management of depression and for Obsessive Compulsive Disorder (OCD) [FDA Label]. Has also been used in the management of bulimia nervosa [A250].', 'The exact mechanism of action of fluvoxamine has not been fully determined, but appears to be linked to its inhibition of CNS neuronal uptake of serotonin [FDA Label, A249, A250]. Fluvoxamine blocks the reuptake of serotonin at the serotonin reuptake pump of the neuronal membrane, enhancing the actions of serotonin on 5HT<sub>1A</sub> autoreceptors [FDA Label, A249, A250]. Studies have also demonstrated that fluvoxamine has virtually no affinity for α<sub>1</sub>- or α<sub>2</sub>-adrenergic, β-adrenergic, muscarinic, dopamine D<sub>2</sub>, histamine H<sub>1</sub>, GABA-benzodiazepine, opiate, 5-HT<sub>1</sub>, or 5-HT<sub>2</sub> receptors, despite having an affinity for binding to σ1 receptors [A250].', 'Fluvoxamine, an aralkylketone-derivative agent [FDA Label], is one of a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) that differs structurally from other SSRIs [A249]. It is used to treat the depression associated with mood disorders. It is also used on occassion in the treatment of body dysmorphic disorder and anxiety [A249]. The antidepressant, antiobsessive-compulsive, and antibulimic actions of Fluvoxamine are presumed to be linked to its inhibition of CNS neuronal uptake of serotonin [FDA Label, A249, A250]. <i>In vitro</i> studies show that Fluvoxamine is a potent and selective inhibitor of neuronal serotonin reuptake and has only very weak effects on norepinephrine and dopamine neuronal reuptake [A250]. Moreover, apart from binding to σ1 receptors [A250], fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT<sub>1A</sub>, 5HT<sub>1B</sub>, 5HT<sub>2</sub>), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs [A249]. Furthermore, some studies have demonstrated that the chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors (as has been observed with other drugs effective in the treatment of major depressive disorder), while others suggest the opposite [A31914].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10875, 'Lezberg trio 40/10/25mg 30 f.c.tabs.', 'ليزبيرج تريو 40/10/25مجم 30 قرص', '162', '123', 'Anti-hypertensive.combined angiotensin blocker & ca++ channel blocker & diuretic', 'Amlodipine+olmesartan+hydrochlorothiazide', 'Global advanced pharmaceuticals (gap)', 'Tab', 'أقراص', '25mg', '3', NULL, NULL, '6223005941282', NULL, 1211, '2025-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10876, 'Ojera - skin emollient 50 gm cream', 'اوجيرا كريم ملطف للجلد 50 جم', '45', NULL, 'Skin emollient& moisturizing cream', 'Tea tree oil+honey+panthenol+vit. e+olive oil+beeswax', 'Merk share', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, NULL, NULL, 918, '2024-06-15', 0, 'Indicated for topical use to help protect against infection in minor cuts, scrapes, and burns. No FDA-approved therapeutic indications.', 'The components of tea tree oil, particularly terpinen-4-ol and α-terpineol, mediate antimicrobial actions by disrupting the structural and functional integrity of bacterial membrane. Hydrocarbons are capable of partitioning into the cell and cytoplasmic membrane of microorganisms and disrupt their vital functions, which may result in leakage of ions such as potassium, and the inhibition of respiration [A32439]. Eventually, cell lysis may occur due to weakening of the cell wall, and loss of turgor pressure and subsequent rupture of the cytoplasmic membrane [A32441]. The loss of 260-nm-absorbing material may be indicative of a damaged cytoplasmic membrane and loss of nucleic acids [A32441]. In _E. coli_, perturbed potassium homeostasis, glucose-dependent respiration, cell morphology, and ability to exclude propidium iodide was observed. 



Tea tree oil also mediates its antifungal actions in a similar way, where it alters the permeability of Candida albicans and inhibits its respiration in a dose-dependent manner [A32439]. Plasma and mitochondrial membranes of fungal species are also thought to be negatively affected by inhibition of glucose-induced medium acidification by tea tree oil, which involves inhibition of membrane ATPase responsible for the expulsion of protons [A32439]. Tea tree oil also inhibits the formation of germ tubes, or mycelial conversion, in _C. albicans_, thereby disrupting cell morphogenesis [A32439]. Water-soluble fraction of TTO, terpinen-4-ol, and α-terpineol, can inhibit the lipopolysaccharide-induced production of the inflammatory mediators such as TNF-α, IL-1β and IL-10 by human peripheral monocytes by approximately 50% and that of prostaglandin E2 by about 30% after 40 h [A32439]. These components of tea tree oil may also suppress superoxide production by agonist-stimulated monocytes and decrease the production of reactive oxygen species by both stimulated neutrophils and monocytes [A32439].', 'Tea tree oil exhibits antibacterial, antifungal, antiviral, and antiprotozoal activities [A32439]. It mostly mediates bactericidal actions at concentrations of 1.0% or less in most bacteria such as _Staphylococcus aureus_ and _Escherichia coli_, and causes bacteriostatic effects at lower concentrations [A32439]. Organisms such as commensal skin staphylococci and micrococci, _Enterococcus faecalis_, and Pseudomonas aeruginosa_emphasized text_ were susceptible to tea tree oil concentrations of 2% [A32439]. It is proposed that water-soluble components of tea tree oil are capable in inducing anti-inflammatory actions; terpinen-4-ol attenuates the vasodilation and plasma extravasation associated with histamine-induced inflammation in humans [A32438].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10877, 'Meladodo 3mg 30 tabs', 'ميلادودو 3مجم 30 قرص', '270', '245', 'Sleep aid', 'Melatonin', 'Masenz danya group', 'Tab', 'أقراص', '3mg', '3', NULL, NULL, NULL, NULL, 796, '2025-04-06', 0, 'Used orally for jet lag, insomnia, shift-work disorder, circadian rhythm disorders in the blind (evidence for efficacy), and benzodiazepine and nicotine withdrawal. Evidence indicates that melatonin is likely effective for treating circadian rhythm sleep disorders in blind children and adults. It has received FDA orphan drug status as an oral medication for this use. A number of studies have shown that melatonin may be effective for treating sleep-wake cycle disturbances in children and adolescents with mental retardation, autism, and other central nervous system disorders. It appears to decrease the time to fall asleep in children with developmental disabilities, such as cerebral palsy, autism, and mental retardation. It may also improve secondary insomnia associated with various sleep-wake cycle disturbances. Other possible uses for which there is some evidence for include: benzodiazepine withdrawal, cluster headache, delayed sleep phase syndrome (DSPS), primary insomnia, jet lag, nicotine withdrawal, preoperative anxiety and sedation, prostate cancer, solid tumors (when combined with IL-2 therapy in certain cancers), sunburn prevention (topical use), tardive dyskinesia, thrombocytopenia associated with cancer, chemotherapy and other disorders. ', 'Melatonin is a derivative of tryptophan. It binds to melatonin receptor type 1A, which then acts on adenylate cylcase and the inhibition of a cAMP signal transduction pathway. Melatonin not only inhibits adenylate cyclase, but it also activates phosphilpase C. This potentiates the release of arachidonate. By binding to melatonin receptors 1 and 2, the downstream signallling cascades have various effects in the body. The melatonin receptors are G protein-coupled receptors and are expressed in various tissues of the body. There are two subtypes of the receptor in humans, melatonin receptor 1 (MT1) and melatonin receptor 2 (MT2). Melatonin and melatonin receptor agonists, on market or in clinical trials, all bind to and activate both receptor types.The binding of the agonists to the receptors has been investigated for over two decades or since 1986. It is somewhat known, but still not fully understood. When melatonin receptor agonists bind to and activate their receptors it causes numerous physiological processes.

MT1 receptors are expressed in many regions of the central nervous system (CNS): suprachiasmatic nucleus of the hypothalamus (SNC), hippocampus, substantia nigra, cerebellum, central dopaminergic pathways, ventral tegmental area and nucleus accumbens. MT1 is also expressed in the retina, ovary, testis, mammary gland, coronary circulation and aorta, gallbladder, liver, kidney, skin and the immune system. MT2 receptors are expressed mainly in the CNS, also in the lung, cardiac, coronary and aortic tissue, myometrium and granulosa cells, immune cells, duodenum and adipocytes.

The binding of melatonin to melatonin receptors activates a few signaling pathways. MT1 receptor activation inhibits the adenylyl cyclase and its inhibition causes a rippling effect of non activation; starting with decreasing formation of cyclic adenosine monophosphate (cAMP), and then progressing to less protein kinase A (PKA) activity, which in turn hinders the phosphorilation of cAMP responsive element-binding protein (CREB binding protein) into P-CREB. MT1 receptors also activate phospholipase C (PLC), affect ion channels and regulate ion flux inside the cell. The binding of melatonin to MT2 receptors inhibits adenylyl cyclase which decreases the formation of cAMP.[4] As well it hinders guanylyl cyclase and therefore the forming of cyclic guanosine monophosphate (cGMP). Binding to MT2 receptors probably affects PLC which increases protein kinase C (PKC) activity. Activation of the receptor can lead to ion flux inside the cell.', 'Melatonin is a hormone normally produced in the pineal gland and released into the blood. The essential amino acid L-tryptophan is a precursor in the synthesis of melatonin. It helps regulate sleep-wake cycles or the circadian rhythm. Production of melatonin is stimulated by darkness and inhibited by light. High levels of melatonin induce sleep and so consumption of the drug can be used to combat insomnia and jet lag.

MT1 and MT2 receptors may be a target for the treatment of circadian and non circadian sleep disorders because of their differences in pharmacology and function within the SCN. SCN is responsible for maintaining the 24 hour cycle which regulates many different body functions ranging from sleep to immune functions

', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10878, 'Stellasil 1mg 30 tab.', 'ستلاسيل 1مجم 30 قرص', '27', '19.5', 'Psychiatric.antipsychotics', 'Trifluperazine', 'Kahira', 'Tab', 'أقراص', '1mg', '3', 'علاج الامراض النفسية العصبية', 'indication for the treatment of anxiety disorders depressive symptoms secondary to anxiety and agitation. pharmacodynamics trifluoperazine is a trifluoro-methyl phenothiazine derivative intended for the management of schizophrenia and other psychotic diso', '6221068010839', NULL, 1577, '2024-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10879, 'Rubaru skin cream 40 gm', 'روبارو كريم للجلد 40 جم', '70', NULL, NULL, 'Onion extract+zinc oxide+ascorbic acid+glycerin+d-panthenol+chamomile extract+graperfruit seed ext+nigella sativa aloe vera ext', 'El-helou for perfurmes > cosmetics for sun pharma company', 'Cream', 'كريم', '40 gm', '1', NULL, NULL, NULL, NULL, 848, '2024-06-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10880, 'Stellasil 5 mg 30 tab.', 'ستلاسيل 5مجم 30 قرص', '33', '24', 'Psychiatric.antipsychotics', 'Trifluperazine', 'Kahira', 'Tab', 'أقراص', '5 mg', '3', NULL, 'indication for the treatment of anxiety disorders depressive symptoms secondary to anxiety and agitation. pharmacodynamics trifluoperazine is a trifluoro-methyl phenothiazine derivative intended for the management of schizophrenia and other psychotic diso', '6221068010846', NULL, 1427, '2024-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10885, 'Sterile water for irrigation (el nasr) 3000 ml', 'ماء معقيم للغسيل الجراحي 3000 مل', '47', '17', 'Sterile solutions', 'Purified water', 'El nasr', 'Unknown', 'غير محدد', '3000 ml', '1', NULL, NULL, NULL, NULL, 938, '2025-01-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10887, 'Sterogyl 15 h 600.000 i.u./1.5ml i.m. amp.', 'ستيروجيل 15 اتش 600000 وحدة دولية امبول', '66', NULL, 'Vitamin d', 'Ergocalciferol(vitamin d2)', 'Platinum pharma', 'Amp', 'أمبول', '1.5ml', '1', 'علاج نقص فيتامين د', NULL, NULL, NULL, 5087, '2023-05-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10891, 'Stevia 50 sachets', 'ستيفيا 50 كيس', '99', '75', 'Stevia powder', 'Stevia powder', 'Atos pharma', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, NULL, NULL, 916, '2023-10-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10900, 'Stimulan 1gm/5ml 6 ampoules', 'ستيميولان 1جم/5مل 6 أمبولات', '60', '24', 'Cerebral circulatory inhancer', 'Piracetam', 'Amoun', 'Ampoule', 'أمبول', '1gm', '6', 'لتحسين الدورة الدموية بالمخ - للدوخة والدوار', NULL, '6221025009593', NULL, 2286, '2024-12-07', 0, 'Indicated in adult patients suffering from myoclonus of cortical origin, irrespective of aetiology, and should be used in combination with other anti-myoclonic therapies [L1125].', 'Piracetam interacts with the polar heads in the phospholipids membrane and the resulting mobile drug-lipid complexes are thought to reorganize the lipids and influence membrane function and fluidity [A31532]. Such interaction has been reported in a study that investigated the effects of neuronal outgrowth induced by beta amyloid peptides; while amyloid peptides cause lipid disorganization within the cell membranes leading to neuronal death, piracetam demonstrated to decrease the destabilizing effects of amyloid peptide [A31534]. The authors suggest that piracetam induces a positive curvature of the membrane by occupying the polar groups in the phospholipids to counteract the negative curvature induced by amyloid peptides , which in turn would decrease the likelihood of membrane fusion [A31532]. This mechanism of action is thought to improve membrane stability, allowing the membrane and transmembrane proteins to maintain and recover the three-dimensional structure or folding for normal function [L1124] such as membrane transport, chemical secretion, and receptor binding and stimulation [A31532]. 



Through restored membrane fluidity, piracetam promotes restored neurotransmission such as glutamatergic and cholinergic systems, enhances neuroplasticity and mediates neuroprotective and anticonvulsant effects at the neuronal level [A31532]. It is also demonstrated that piracetam also improves the fluidity of platelet membranes. At the vascular level, piracetam decreases adhesion of erythrocytes to cell wall and reduces vasospasm which in turn improves microcirculation including cerebral and renal blood flow [A31532]. ', 'Piracetam is known to mediate various pharmacodynamic actions:



**Neuronal effects**: 



Piracetam modulates the cholinergic, serotonergic, noradrenergic, and glutamatergic neurotransmission although the drug does not display high affinity to any of the associated receptors (Ki >10μM). Instead, piracetam increases the density of postsynaptic receptors and/or restore the function of these receptors through stabilizing the membrane fluidity [A31532]. In the forebrain of aging mice, the density of NMDA receptors was increased by approximately 20% following 14 days of piracetam treatment. Based on the findings of various animal and human studies, the cognitive processses including learning, memory, attention and consciousness were enhanced from piracetam therapy without inducing sedation and psychostimulant effects [L1125]. Piracetam mediate neuroprotective effects against hypoxia-induced damage, intoxication, and electroconvulsive therapy [L1125]. 



In two studies involving alcohol-treated rats with evidences of withdrawal-related neuronal loss, piracetam was shown to reduce the extent of neuronal loss and increase the numbers of synapses in the hippocampus by up to 20% relative to alcohol-treated or alcohol-withdrawn rats [A31532]. This suggests that piracetam is capable in promoting neuroplasticity when recoverable neural circuits are present [A31532]. Although the mechanism of action is not fully understood, administration of piracetam prior to a convulsant stimulus reduces the seizure severity and enhances the anticonvulsant effectiveness of conventional antiepileptics such as carbamazepine and diazepam [A31535]. 



**Vascular effects**: 



Piracetam is shown to increase the deformability of erythrocytes, reduce platelet aggregation in a dose-dependent manner, reduce the adhesion of erythrocytes to vascular endothelium and capillary vasospasm. In healthy volunteers, piracetam mediated a direct stimulant effect on prostacycline synthesis and reduced the plasma levels of fibrinogen and von Willebrand’s factors (VIII: C; VIII R: AG; VIII R: vW) by 30 to 40% [L1125]. Potentiated microcirculation is thought to arise from a combination of effects on erythrocytes, blood vessels and blood coagulation [A31532]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10901, 'Stimulan 800mg 30 tablets', 'ستيميولان 800مجم 30 قرص', '78', '36', 'Cerebral circulatory inhancer', 'Piracetam', 'Amoun', 'Tablet', 'أقراص', '800mg', '3', 'علاج انخفاض التركيز وضعف الذاكرة', NULL, '6221025008923', NULL, 9109, '2024-12-07', 0, 'Indicated in adult patients suffering from myoclonus of cortical origin, irrespective of aetiology, and should be used in combination with other anti-myoclonic therapies [L1125].', 'Piracetam interacts with the polar heads in the phospholipids membrane and the resulting mobile drug-lipid complexes are thought to reorganize the lipids and influence membrane function and fluidity [A31532]. Such interaction has been reported in a study that investigated the effects of neuronal outgrowth induced by beta amyloid peptides; while amyloid peptides cause lipid disorganization within the cell membranes leading to neuronal death, piracetam demonstrated to decrease the destabilizing effects of amyloid peptide [A31534]. The authors suggest that piracetam induces a positive curvature of the membrane by occupying the polar groups in the phospholipids to counteract the negative curvature induced by amyloid peptides , which in turn would decrease the likelihood of membrane fusion [A31532]. This mechanism of action is thought to improve membrane stability, allowing the membrane and transmembrane proteins to maintain and recover the three-dimensional structure or folding for normal function [L1124] such as membrane transport, chemical secretion, and receptor binding and stimulation [A31532]. 



Through restored membrane fluidity, piracetam promotes restored neurotransmission such as glutamatergic and cholinergic systems, enhances neuroplasticity and mediates neuroprotective and anticonvulsant effects at the neuronal level [A31532]. It is also demonstrated that piracetam also improves the fluidity of platelet membranes. At the vascular level, piracetam decreases adhesion of erythrocytes to cell wall and reduces vasospasm which in turn improves microcirculation including cerebral and renal blood flow [A31532]. ', 'Piracetam is known to mediate various pharmacodynamic actions:



**Neuronal effects**: 



Piracetam modulates the cholinergic, serotonergic, noradrenergic, and glutamatergic neurotransmission although the drug does not display high affinity to any of the associated receptors (Ki >10μM). Instead, piracetam increases the density of postsynaptic receptors and/or restore the function of these receptors through stabilizing the membrane fluidity [A31532]. In the forebrain of aging mice, the density of NMDA receptors was increased by approximately 20% following 14 days of piracetam treatment. Based on the findings of various animal and human studies, the cognitive processses including learning, memory, attention and consciousness were enhanced from piracetam therapy without inducing sedation and psychostimulant effects [L1125]. Piracetam mediate neuroprotective effects against hypoxia-induced damage, intoxication, and electroconvulsive therapy [L1125]. 



In two studies involving alcohol-treated rats with evidences of withdrawal-related neuronal loss, piracetam was shown to reduce the extent of neuronal loss and increase the numbers of synapses in the hippocampus by up to 20% relative to alcohol-treated or alcohol-withdrawn rats [A31532]. This suggests that piracetam is capable in promoting neuroplasticity when recoverable neural circuits are present [A31532]. Although the mechanism of action is not fully understood, administration of piracetam prior to a convulsant stimulus reduces the seizure severity and enhances the anticonvulsant effectiveness of conventional antiepileptics such as carbamazepine and diazepam [A31535]. 



**Vascular effects**: 



Piracetam is shown to increase the deformability of erythrocytes, reduce platelet aggregation in a dose-dependent manner, reduce the adhesion of erythrocytes to vascular endothelium and capillary vasospasm. In healthy volunteers, piracetam mediated a direct stimulant effect on prostacycline synthesis and reduced the plasma levels of fibrinogen and von Willebrand’s factors (VIII: C; VIII R: AG; VIII R: vW) by 30 to 40% [L1125]. Potentiated microcirculation is thought to arise from a combination of effects on erythrocytes, blood vessels and blood coagulation [A31532]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10904, 'Superkids hair mask 300 gm', 'سوبركيدز ماسك للشعر 300 جم', '135', NULL, 'Hair care', NULL, 'Parkville', 'Unknown', 'غير محدد', '300 gm', '1', NULL, NULL, NULL, NULL, 627, '2023-01-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10906, 'Stomahesive cream 56.7gm', 'ستوماهيسف كريم 56.7 جرام', '32', NULL, 'Protective skin barrier', NULL, 'Conavilac', 'Cream', 'كريم', '56.7gm', '1', 'كريم لملئ فراغات الموجودة في الجلد لتجعل شكله افضل', NULL, NULL, NULL, 1635, '2022-07-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10907, 'Stomigas 20/1100 mg 20 caps.', 'ستوميجاز 20/1100مجم 20 كبسولة', '104', '70', 'Peptic ulcer.proton pump inhibitor', 'Omeprazole+sodium bicarbonate', 'International drug agency (idi) > novell pharma', 'Cap', 'كبسولة', '1100 mg', '2', 'علاج الحموضة وارتجاع المريء.-- حرقان المعدة والصدر.-- في علاج قرحة المعدة.-- الانتفاخ والغازات والشعور بالامتلاء.-- الوجع والألم بفم المعدة.', 'about omeprazole proton pump inhibitor substituted benzimidazole anti-secretory antiulcer. mechanism of action of omeprazole omeprazole is a proton pump inhibitor and it is a prodrug. after administration it diffuses in to the parietal cell of the stomach', '6223004071317', NULL, 1102, '2025-09-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10908, 'Stomigas 40/1100 mg 20 caps.', 'ستوميجاز 40/1100مجم 20 كبسولة', '104', '70', 'Peptic ulcer.proton pump inhibitor', 'Omeprazole+sodium bicarbonate', 'International drug agency (idi) > novell pharma', 'Cap', 'كبسولة', '1100 mg', '2', 'علاج الحموضة وارتجاع المريء.', 'about omeprazole proton pump inhibitor substituted benzimidazole anti-secretory antiulcer. mechanism of action of omeprazole omeprazole is a proton pump inhibitor and it is a prodrug. after administration it diffuses in to the parietal cell of the stomach', '6223004071324', NULL, 6797, '2025-06-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10909, 'Stopadol joint 650 mg 30 ext. rel. tabs.', 'ستوبادول جوينت 650 مجم 30 قرص', '75', NULL, 'Mild analgesic', 'Paracetamol(acetaminophen)', 'Eva pharma', 'Tab', 'أقراص', '650 mg', '3', NULL, NULL, NULL, NULL, 884, '2023-01-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10910, 'Periocare mouth wash 120ml', 'بيريوكير غسول للفم 120 مل', '58', '50', 'Mouth wash', 'Chlorohexidine+eucalyptus+clove oil+thymol+tea tree oil+peppermint oil+calendula ectract', 'Ziax', 'Mouth wash', 'غسول للفم', '120ml', '1', NULL, NULL, NULL, NULL, 736, '2025-01-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10912, 'Stopspasm 20 f.c. tabs.', 'ستوب سبازم 20 قرص', '60', '38', 'Antispasmodic', 'Phloroglucinol+trimethylphloroglucinol', 'Chemipharm', 'Tab', 'أقراص', NULL, '2', NULL, 'phloroglucinol is primarily indicated in conditions like biliary spasm dysmenorrhoea gi motality disorder pain smooth muscle spasm urinary spasm uterine spasm. the severe or irreversible adverse effects of phloroglucinol which give rise to further complic', '6222006501013', NULL, 4835, '2024-08-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10919, 'Strepsils lemon sugar free 16 lozenges', 'ستربسيلز ليمون 16 قرص استحلاب', '200', '165', 'Sore throat', 'Dichlorophenylcarbinol+amylmetacresol', 'Reckitt benckiser healthcare > united partners company', 'Lozenges', 'استحلاب', NULL, '2', '1- تخفيف احتقان الحلق في نزلات البرد.', 'soothing effective relief for sore throats', '5000158103580', NULL, 1142, '2024-09-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10923, 'Strepsils original 24 lozenges', 'ستربسلز اوريجينال 24 قطعة', '170', NULL, 'Sore throat', 'Dichlorophenylcarbinol+amylmetacresol', 'Reckitt benckiser healthcare > united partners company', 'Lozenges', 'استحلاب', NULL, '3', '1- تخفيف احتقان الحلق في نزلات البرد.', 'soothing effective relief for sore throats', '5000167019360', NULL, 1409, '2022-12-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10932, 'Streptomycin sulphate-cid 1gm i.m.vial', 'ستربتومايسين سلفات سيد 1جم فيال', '5', NULL, 'Aminoglycoside antibiotic', 'Streptomycin', 'Cid', 'Vial', 'فيال', '1gm', '1', NULL, NULL, '6221077170517', NULL, 2723, '2022-09-11', 0, 'Although streptomycin was the first antibiotic available for the treatment of mycobacterium tuberculosis, it is now largely a second line option due to resistance and toxicity.[A233320] Streptomycin may also be used to treat a variety of other infections caused by susceptible strains of aerobic bacteria where other less toxic agents are ineffective. Examples include: _Yersinia pestis_, _Francisella tularensis_, _Brucella_, _Calymmatobacterium granulomatis_ (donovanosis, granuloma inguinale), _H. ducreyi_ (chancroid), _H. influenzae_ (in respiratory, endocardial, and meningeal infections - concomitantly with another antibacterial agents). _K. pneumoniae_ pneumonia (concomitantly with another antibacterial agent), _E.coli_, _Proteus_, _A.aerogenes_, _K. pneumoniae_, and 

_Enterococcus faecalis_ in urinary tract infections, _Streptococcus viridans_, _Enterococcus faecalis_ (in endocardial infections - concomitantly with penicillin), and Gram-negative bacillary bacteremia (concomitantly with another antibacterial agent).', 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]



The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319]



Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]



Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', 'Although streptomycin originally had broad gram-negative and gram-positive coverage, its spectrum of activity has been significantly narrowed due to antibiotic resistance.[A233320] Streptomycins current spectrum of activity includes susceptible strains of Yersinia pestis, Francisella tularensis, Brucella, Calymmatobacterium granulomatis, H. ducreyi, H. influenza, K. pneumoniae pneumonia, E.coli, Proteus, A. aerogenes, K. pneumoniae, Enterococcus faecalis, Streptococcus viridans, Enterococcus faecalis, and Gram-negative bacillary bacteremia. Streptomycin is not reliably active against pseudomonas aeruginosa.[A233320] 



Similar to other aminoglycosides, streptomycin is considered to have a narrow therapeutic index.[A233769] Characteristic toxicities of streptomycin include nephrotoxicity and ototoxicity.[A233320,A232294] Patients should be carefully monitored for early signs of hearing loss and vestibular dysfunction in order to prevent permanent damage to sensorineural cells. Neuromuscular blockade has also been rarely reported.[A232294]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10937, 'Streptoquin 20 tabs.', 'ستربتوكين 20 قرص', '46', '46', 'Antidiarrheal.antispasmodic', 'Clioquinol+homatropine methylbromide+phthalyl sulfathiazole+streptomycin', 'Mup', 'Tab', 'أقراص', NULL, '2', 'مضاد للمغص والتقلصات --لعلاج الاسهال', NULL, '6221508010726', NULL, 25071, '2025-11-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10942, 'Vitastress 20 f.c.tabs.', 'فيتاسترس 20 قرص', '64', '30.5', 'Multivitamins', 'Vitamins(e+c+b1+b6+b12)+folic acid+nicotinamide+pantothenic acid+copper+zinc', 'Mup > pfizer', 'Tab', 'أقراص', NULL, '1', '1- فيتامينات ومعادن ضرورية هامة.', NULL, '6221508018814', NULL, 26909, '2023-08-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10945, 'Strong b50 20 prolonged release tab.', 'سترونج بي50 20 قرص', '33', NULL, 'Multivitamins', 'Biotin+choline+folic acid+inositol+iron+paba+vitamin(b1+b2+b3+b5+b6+b12+c)', 'Sigma > health aid pharmadass ltd', 'Tab', 'أقراص', NULL, '2', NULL, 'mechanism of action of biotin biotin excerts it`s pharmacological action by influencing metabolic reactions. it acts as a coenzyme for carbohydrate fat and protein metabolism. it is required for cell growth and production of fatty acids. it is required fo', NULL, NULL, 875, '2022-10-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10946, 'Strong (chocolate) 24 pills', 'سترونج 24 قطعة', '44', NULL, 'Calcium supplement', 'Calcium+magnesium+vitamin d3+vitamin e+vitamin c+folic acid', 'Integra pharm', 'Unknown', 'غير محدد', NULL, '2', 'فيتامينات متعددة -- مضاد للأكسدة', '1 pill daily', NULL, NULL, 785, '2022-10-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10950, 'Stugeron 25mg 30 tab', 'ستوجيرون 25مجم 30 قرص', '35', '24', 'Antiemetic.promote cerebral blood flow.antihistamine calcium channel blocker', 'Cinnarizine', 'Mina pharm > janssen cilag', 'Tab', 'أقراص', '25mg', '3', '1- علاج حالات الدوخة ودوار الحركة.', NULL, '6222003701522', NULL, 18345, '2023-09-04', 0, 'For the treatment of vertigo/meniere''s disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.', 'Cinnarizine inhibits contractions of vascular smooth muscle cells by blocking L-type and T-type voltage gated calcium channels. Cinnarizine has also been implicated in binding to dopamine D2 receptors, histamine H1 receptors, and muscarinic acetylcholine receptors. ', 'Cinnarizine is an antihistamine and a calcium channel blocker. Histamines mediate a number of activities such as contraction of smooth muscle of the airways and gastrointestinal tract, vasodilatation, cardiac stimulation, secretion of gastric acid, promotion of interleukin release and chemotaxis of eosinophils and mast cells. Competitive antagonists at histamine H1 receptors may be divided into first (sedating) and second (non-sedating) generation agents. Some, such as Cinnarizine also block muscarinic acetylcholine receptors and are used as anti-emetic agents. Cinnarizine through its calcium channel blocking ability also inhibits stimulation of the vestibular system.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10957, 'Sucralfate 1gm 30 tab', 'سوكرالفيت 1جم 30 قرص', '12', NULL, 'Peptic ulcer', 'Sucralfate', 'Company', 'Tab', 'أقراص', '1gm', '3', 'علاج والوقاية من تقرحات الاثني عشر -- علاج التهاب المعدة', NULL, NULL, NULL, 2934, '2022-05-23', 0, 'The sucralfate suspension [FDA label] and tablet [F4534] are used for the treatment of active duodenal ulcer for up to 8 weeks.  The tablet form may be used at a lower dose for healed duodenal ulcers, for the purpose of maintaining healing and preventing recurrence [F4519, F4534]. 



Sucralfate is also used in the prevention and/or treatment of gastro-esophageal reflux disease (GERD), gastritis, peptic ulcer disease, stress ulcer, in addition to dyspepsia [A177655, F4519].', 'The mechanism of action of this drug in the healing duodenal ulcers is not yet completely defined, however, there are several probable mechanisms that adequately describe the healing activity of sucralfate. There is evidence that sucralfate acts locally to aid in tissue healing, and not systemically [FDA label]. 



Studies in both humans and animals have indicated that sucralfate forms a complex that binds to protein-rich exudate found on the surface of ulcers. It binds to albumin and fibrinogen [A11831, A177685] preventing blood clot lysis by stomach acid (hydrochloric acid). Sucralfate increases the tissue levels of fibroblast growth factors and epidermal growth factors,[A16738, A16741] leading to an increase in prostaglandins at the gastrointestinal tract lining, which promotes the healing of gastrointestinal ulcers.[A177655]



In the laboratory setting, a sucralfate-albumin film provides a barrier against the entry of hydrogen ions, which are a component of gastric acid. In humans, sucralfate, given at therapeutic doses for ulcers, decreases pepsin activity in gastric fluids by 32% [FDA label].  Pepsin has been shown to be damaging to tissues, further aggravating ulcer lesion inflammation [A177667]. Bile salts have been implicated in mucosal injury to the gastrointestinal tract [A177697, A177700]. Sucralfate has also been shown to adsorb bile salts in the laboratory, setting, which could further contribute to its beneficial effects in ulcer healing [FDA label]. ', 'This drug aids in the healing of duodenal ulcers, relieving painful inflammation by creating a protective mechanical barrier between the lining or skin of the gastrointestinal tract and damaging substances [A177655]. In addition, sucralfate acts to increase levels of growth factors locally, and also causes an increase in prostaglandins which are important in the healing of the mucosa (lining) of the gastrointestinal tract [A177655]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10968, 'Sulbin 1500 mg i.m./i.v. vial', 'سالبين 1500مجم فيال', '51', '34.5', 'Penicillins.penicillin with b-lactamase inhibitor', 'Ampicillin+sulbactam', 'Pharco', 'Vial', 'فيال', '1500 mg', '1', 'مضاد حيوي', NULL, '6221151002444', NULL, 6409, '2024-08-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10969, 'Sulbin 375mg vial', 'سالبين 375 مجم فيال', '27', '17.5', 'Penicillins.penicillin with b-lactamase inhibitor', 'Ampicillin+sulbactam', 'Pharco', 'Vial', 'فيال', '375mg', '1', NULL, NULL, '6223000011171', NULL, 1858, '2024-09-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10970, 'Sulbin 750mg vial', 'سالبين 750مجم فيال', '35', '23', 'Penicillins.penicillin with b-lactamase inhibitor', 'Ampicillin+sulbactam', 'Pharco', 'Vial', 'فيال', '750mg', '1', NULL, NULL, '6221151002451', NULL, 1275, '2024-08-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10972, 'Sulfax magnesium cream 120 gm', 'سولفاكس مغنسيوم كريم 120 جرام', '170', '150', 'Massage cream', 'Eucalyptus oil+menthol+camphor oil+cetyl myristoleate', 'Parkville', 'Cream', 'كريم', '120 gm', '1', NULL, 'muscle care', '6224010337732', NULL, 2189, '2025-05-20', 0, 'As an active agent, eucalyptus oil has been indicated for relief of the symptoms of catarrhal colds, and/or the relief of the symptoms of minor muscular sprains and cramps [L1857].', 'The general consensus is that the exact mechanism of action of eucalyptus oil is largely unknown at this time but comprises various hypotheses from various studies.



Cineol containing preparations of eucalyptus oil may contain up to 80% (or more) 1,8-cineole [A32243] and is one of the most common types of eucalyptus oil formulations used. As an active agent indicated for relieving certain cold symptoms and/or certain muscular sprains and cramps, it is believed that eucalyptus oil may possess some antimicrobial and anti-inflammatory activities.



Some in vitro studies of human blood monocytes suggest a dose-dependent effect of eucalyptus oil to elicit significant inhibition of multiple cytokines, perhaps in the treatment of airway inflammation [A32244, A32245]. Moreover, other studies in animal models discuss the possibility of eucalyptus oil demonstrating anti-inflammatory and anti-nociceptive effects that potentially account for inhibiting the formation of prostaglandins and cytokines by stimulated monocytes in vitro [A32246, A32247].



Furthermore, additional studies have observed eucalyptus oil anti-viral activity against herpes simplex virus (HSV-1, HSV-2) in cell cultures as well as the demonstration of broad antimicrobial activity of eucalyptus medicinal plant extracts against Alicyclobacillus acidoterretris, Bacillus cereus, E. coli, Enterococcus faecalis, MRSA, Propionibacterium acnes, S. aureus, fungus including C. albicans isolates, Trichophyton mentagrophytes, and other Gram-positive bacteria. Specific activity against periodontopathic bacteria, such as Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans, Fusobacterium nucleatum, Streptococcus mutans, and Streptococcus sobrinus has also been observed [A32250, A32251, A32252, A32253, A32254].', 'Lipophilic monoterpene formulations of eucalyptus oil appear to be readily absorbed orally, with a primarily oxidative metabolism that might necessitate induction of the cytochrome P450 enzyme system and subsequent urinary excretion [A32236]. Gastrointestinal absorption of eucalyptus appears to be rapid and may be enhanced by the intake of lipids and milk. 1,8-cineole (which makes up to as much as 90% of most commonly used cineole-based eucalyptus oils) [A32227] has also been found in vitro and in animals to possess cytochrome P450 inducing activity [A32237, A32238, A32239].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10976, 'Sulfozinc 20mg/5ml syrup 80ml', 'سلفوزنك 20مجم 80 مل شراب', '24', '15.5', 'Zinc supplement', 'Zinc sulphate', 'Cid', 'Syrup', 'شراب', '20mg', '1', NULL, 'about zinc sulphate zinc compound an astringent adjunctive treatment of wilson?s disease.', '6221043013015', NULL, 3432, '2025-12-10', 0, 'Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].  



', '**Zinc has three primary biological roles**: _catalytic_, _structural_, and _regulatory_. The catalytic and structural role of zinc is well established, and there are various noteworthy reviews on these functions. For example, zinc is a structural constituent in numerous proteins, inclusive of growth factors, cytokines, receptors, enzymes, and transcription factors for different cellular signaling pathways. It is implicated in numerous cellular processes as a cofactor for approximately 3000 human proteins including enzymes, nuclear factors, and hormones [L2096].



Zinc promotes resistance to epithelial apoptosis through cell protection (cytoprotection) against reactive oxygen species and bacterial toxins, likely through the antioxidant activity of the cysteine-rich metallothioneins [A32419].



In HL-60 cells (promyelocytic leukemia cell line), zinc enhances the up-regulation of A20 mRNA, which, via TRAF pathway, decreases NF-kappaB activation, leading to decreased gene expression and generation of tumor necrosis factor-alpha (TNF-alpha), IL-1beta, and IL-8 [A32418].



There are several mechanisms of action of zinc on acute diarrhea. Various mechanisms are specific to the gastrointestinal system: zinc restores mucosal barrier integrity and enterocyte brush-border enzyme activity, it promotes the production of antibodies and circulating lymphocytes against intestinal pathogens, and has a direct effect on ion channels, acting as a potassium channel blocker of adenosine 3-5-cyclic monophosphate-mediated chlorine secretion. Cochrane researchers examined the evidence available up to 30 September 2016 [L2106].



Zinc deficiency in humans decreases the activity of serum _thymulin_ (a hormone of the thymus), which is necessary for the maturation of T-helper cells. T-helper 1 (Th(1)) cytokines are decreased but T-helper 2 (Th(2)) cytokines are not affected by zinc deficiency in humans [A32417].



The change of _Th(1)_ to _Th(2)_ function leads to cell-mediated immune dysfunction. Because IL-2 production (Th(1) cytokine) is decreased, this causes decreased activity of natural-killer-cell (NK cell) and T cytolytic cells, normally involved in killing viruses, bacteria, and malignant cells [A32424]. 



In humans, zinc deficiency may lead to the generation of new CD4+ T cells, produced in the thymus. In cell culture studies (HUT-78, a Th(0) human malignant lymphoblastoid cell line), as a result of zinc deficiency, nuclear factor-kappaB (NF-kappaB) activation, phosphorylation of IkappaB, and binding of NF-kappaB to DNA are decreased and this results in decreased Th(1) cytokine production [A32417].



In another study, zinc supplementation in human subjects suppressed the gene expression and production of pro-inflammatory cytokines and decreased oxidative stress markers [A32424]. In HL-60 cells (a human pro-myelocytic leukemia cell line), zinc deficiency increased the levels of TNF-alpha, IL-1beta, and IL-8 cytokines and mRNA. In such cells, zinc was found to induce A20, a zinc finger protein that inhibited NF-kappaB activation by the tumor necrosis factor receptor-associated factor pathway. This process decreased gene expression of pro-inflammatory cytokines and oxidative stress markers [A32417].



The exact mechanism of zinc in acne treatment is poorly understood. However, zinc is considered to act directly on microbial inflammatory equilibrium and facilitate antibiotic absorption when used in combination with other agents. Topical zinc alone as well as in combination with other agents may be efficacious because of its anti-inflammatory activity and ability to reduce P. acnes bacteria by the inhibition of P. acnes lipases and free fatty acid levels [L2102].', 'Zinc is involved in various aspects of cellular metabolism. It has been estimated that approximately 10% of human proteins may bind zinc, in addition to hundreds of proteins that transport and traffic zinc. It is required for the catalytic activity of more than 200 enzymes, and it plays a role in immune function wound healing, protein synthesis, DNA synthesis, and cell division. Zinc is an essential element for a proper sense of taste and smell and supports normal growth and development during pregnancy, childhood, and adolescence. It is thought to have antioxidant properties, which may be protective against accelerated aging and helps to speed up the healing process after an injury; however, studies differ as to its effectiveness. Zinc ions are effective antimicrobial agents even if administered in low concentrations [L2211].



Studies on oral zinc for specific conditions shows the following evidence in various conditions [L2095]:



**Colds:** Evidence suggests that if zinc lozenges or syrup are taken within 24 hours after cold symptoms start, the supplement may shorten the length of colds. The use intranasal zinc has been associated with the loss of the sense of smell, in some cases long-term or permanently [L2095].



**Wound healing:** Patients with skin ulcers and decreased levels of zinc may benefit from oral zinc supplements [L2095]. 



**Diahrrea**: Oral zinc supplements can reduce the symptoms of diarrhea in children with low levels of zinc, especially in cases of malnutrition [L2095].

', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10983, 'Sulperazon 1.5 mg 1 vial', 'سلبيرازون 1.5 مجم 1 فيال', '59', NULL, 'Antibiotic third generation ceohalosporin with beta lactamase inhibitor', 'Cefoperazone sodium 1 g-sulbactam', 'Pfizer', 'Vial', 'فيال', '1.5 mg', '1', 'مضاد حيوي', NULL, '6221180000855', NULL, 1502, '2022-12-09', 0, 'Indicated for the treatment of following infections caused by susceptible bacteria:[label]



1) Respiratory tract infections caused by _S. pneumoniae_, _H. influenzae_, _S. aureus_ (penicillinase and non-penicillinase producing strains), _S. pyogenes_ (Group A beta-hemolytic streptococci), _P. aeruginosa_, _Klebsiella pneumoniae_, _E. coli_, _Proteus mirabilis_, and Enterobacter species.



2) Peritonitis and other intra-abdominal infections caused by _E. coli_, _P. aeruginosa_, and anaerobic gram-negative bacilli (including _Bacteroides fragilis_).



3) Bacterial septicemia caused by _S. pneumoniae_, _S. agalactiae_, _S. aureus_, _Pseudomonas aeruginosa_, _E. coli_, _Klebsiella_ spp., _Klebsiella pneumoniae_, Proteus species (indole-positive and indole-negative), _Clostridium_ spp. and anaerobic gram-positive cocci.



4) Infections of the skin and skin structures caused by S. aureus (penicillinase and non-penicillinase producing strains), S. pyogenes, and P. aeruginosa.



5) Pelvic Inflammatory Disease, Endometritis, and Other Infections of the Female Genital Tract caused by N. gonorrhoeae, S. epidermidis, S. agalactiae, E. coli, Clostridium spp., Bacteroides species (including Bacteroides fragilis), and anaerobic gram-positive cocci.



6) Urinary tract infections caused by Escherichia coli and Pseudomonas aeruginosa.



7) Enterococcal Infections. Although cefoperazone has been shown to be clinically effective in the treatment of infections caused by enterococci in cases of peritonitis and other intra-abdominal infections, infections of the skin and skin structures, pelvic inflammatory disease, endometritis and other infections of the female genital tract, and urinary tract infections, the majority of clinical isolates of enterococci tested are not susceptible to cefoperazone but fall just at or in the intermediate zone of susceptibility, and are moderately resistant to cefoperazone. However, _in vitro_ susceptibility testing may not correlate directly with _in vivo_ results. Despite this, cefoperazone therapy has resulted in clinical cures of enterococcal infections, chiefly in polymicrobial infections. Cefoperazone should be used in enterococcal infections with care and at doses that achieve satisfactory serum levels of cefoperazone.', 'Like all beta-lactam antibiotics, cefoperazone binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins.', 'Cefoperazone is a third generation cephalosporin antibiotic. Cefoperazone exerts its bactericidal effect by inhibiting the bacterial cell wall synthesis', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (10992, 'Sulphazine cream 30 gm', 'سلفازين كريم 30 جم', '5', NULL, 'Burns', 'Sulphadiazine', 'Pfizer', 'Cream', 'كريم', '30 gm', '1', 'للحروق', NULL, NULL, NULL, 3675, '2022-06-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11006, 'Super antioxidant ( vita-vigor ) 30 tab', 'سوبر انتي اوكسيدانت 30 قرص', '35', NULL, 'Antioxidant', 'Beta carotene-copper-manganese', 'Alexandria for chemicals', 'Tab', 'أقراص', NULL, '3', 'مضاد للاكسدة --تحسين حالات الكبد المصاب بفيروس سي', NULL, NULL, NULL, 2622, '2023-02-05', 0, 'Beta-carotene is FDA approved to be used as a nutrient supplement and to be even added in infant formula as a source of vitamin A.[L2191] It is also approved to be used as a color additive for food products,[L2192] drugs (with the label of "only as a color additive")[L2193] and cosmetics.[L2194]



It is used commonly for the reduction of photosensitivity in patients with erythropoietic protoporphyria and other photosensitivity diseases.[A32485]', 'Beta-carotene is an antioxidant that presents significant efficacy against the reactive oxygen species singlet oxygen.[T159] Beta-carotene acts as a scavenger of lipophilic radicals within the membranes of every cell compartments. It also presents an oxidative modification of LDL.[T160] The presence of long chains of conjugated double bonds is responsible for its antioxidative properties by allowing beta-carotene to chelate oxygen-free radicals and dissipate their energy.[T162] The chelation of free radicals inhibits the peroxidation of lipids.[T163]



The effect of beta-carotene in the immune response is thought to be related to the direct effect on the thymus which increases the production of immune cells.[L2202]', 'Oral administration of beta-carotene increases the serum concentration of beta-carotene by 60% but it does not change the concentration found in the heart, liver or kidneys.[T159] In vitro studies in hepatocytes have shown that beta-carotene ameliorates oxidative stress, enhances antioxidant activity and decreases apoptosis.[T161]



Other than the antioxidant activities, some other actions have been correlated to beta-carotene. It is thought to have detoxifying properties, as well as to help increase resistance to inflammation and infection and increase immune response and enhance RNA production.[L2202]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11008, 'Vaxato 2.5mg 30 tabs', 'فاكساتو 2.5مجم 30 قرص', '97', NULL, 'Antiplatelet.direct factor xa inhibitor', 'Rivaroxaban', 'Liptis', 'Tab', 'أقراص', '2.5mg', '3', NULL, NULL, NULL, NULL, 1153, '2022-08-16', 0, 'Rivaroxaban is indicated for the prevention of venous thromboembolic events (VTE) in patients who have undergone total hips replacements and total knee replacement surgery; prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE); to reduce risk of recurrent DVT and/or PE. Rivaroxaban is also indicated, in combination with aspirin, for reducing the risk of major cardiovascular events in patients with chronic coronary artery disease or peripheral artery disease. Its use is also not recommended in those with severe renal impairment (<30mL/min).[L12819]



Rivaroxaban is also indicated for the treatment and prevention of VTE in pediatric patients (from birth to 18 years of age) and for thromboprophylaxis in pediatric patients ≥2 years old with congenital heart disease following the Fontan procedure.[L12819]

', 'Rivaroxaban competitively inhibits free and clot bound factor Xa. Factor Xa is needed to activate prothrombin (factor II) to thrombin (factor IIa). Thrombin is a serine protease that is required to activate fibrinogen to fibrin, which is the loose meshwork that completes the clotting process. Since one molecule of factor Xa can generate more than 1000 molecules of thrombin, selective inhibitors of factor Xa are profoundly useful in terminating the amplification of thrombin generation. The action of rivaroxaban is irreversible.

 

', 'Rivaroxaban is an anticoagulant which binds directly to factor Xa. Thereafter, it effectively blocks the amplification of the coagulation cascade, preventing the formation of thrombus. Rivaroxaban is a unqiue anticoagulant for two reasons. First of all, it is does not involve antithrombin III (ATIII) to exert its anticoagulant effects. Secondly, it is an oral agent whereas the widely used unfractionated heparin and low molecular weight heparins are for parenteral use only. Although the activated partial thromboplastin time (aPTT) and HepTest (a test developed to assay low molecular weight heparins) are prolonged in a dose-dependant manner, neither test is recommended for the assessment of the pharmacodynamic effects of rivaroxaban. Anti-Xa activity and inhibition of anti-Xa activity monitoring is also not recommended despite being influenced by rivaroxaban.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11009, 'Super artichoke 30 capsules', 'سوبر ارتيشوك 30 كبسولة', '20', NULL, 'Liver support supplement', 'Artichoke extract', 'Western pharmaceutical industries', 'Capsule', 'كبسولة', NULL, '3', 'مدعم للكبد', 'improve liver functions', '6224007308264', NULL, 999, NULL, 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11011, 'Super cal zinc 20 tabs.', 'سوبر كال زنك 20 قرص', '30', NULL, 'Calcium supplement', 'Magnesium oxide+calcium carbonate+zinc sulphate', 'Mepaco', 'Tab', 'أقراص', NULL, '2', '1- مكمل غذائى لدعم صحة العظام والجهاز المناعى والوقاية من الكساح وهشاشة العظام', NULL, '6223002212613', NULL, 8693, '2022-12-09', 0, 'Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.', 'Magnesium is the second most plentiful cation of the intracellular fluids. It is essential for the activity of many enzyme systems and plays an important role with regard to neurochemical transmission and muscular excitability. Magnesium sulfate reduces striated muscle contractions and blocks peripheral neuromuscular transmission by reducing acetylcholine release at the myoneural junction. Additionally, Magnesium inhibits Ca<sup>2+</sup> influx through dihydropyridine-sensitive, voltage-dependent channels. This accounts for much of its relaxant action on vascular smooth muscle.', 'Magnesium sulfate is a small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. Magnesium sulfate is gaining popularity as an initial treatment in the management of various dysrhythmias, particularly torsades de pointes, and dyrhythmias secondary to TCA overdose or digitalis toxicity.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11012, 'Super citrimax 20 capsules', 'سوبر سيتريماكس 20 كبسولة', '29', NULL, NULL, 'Chromium+niacin+hydroxycitric acid', 'Swanson', 'Capsule', 'كبسولة', NULL, '2', NULL, NULL, NULL, NULL, 1660, '2023-05-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11028, 'Super omega 20 caps.', 'سوبر اوميجا 20 كبسولة', '45', NULL, 'Omega-3', 'Omega-3 fish oil', 'Safe pharma > novell pharma', 'Cap', 'كبسولة', NULL, '2', 'يحسن المهارات العقلية والادراكية -- يقلل من اعراض مرض فرط الحركة -- يعمل علي حماية الاوعية الدموية', NULL, '6224009652914', NULL, 1860, '2022-12-26', 0, 'Provided as daily supplements. Aa preparation of omega-3-acid ethyl esters is licensed in UK for prevention of recurrent events after myocardial infarction in addition to treatment of hypertriglyceridaemia. ', 'Omega-3 fatty acids mediate anti-inflammatory effects and increased levels of EPA or DHA has shown to decrease the levels of PGE2 and 4 series-LT. 

Eicosapentaenoic acids compete with constitutive levels of arachidonic acid in cell membranes for the same desaturation enzymes and produce 3-series prostaglandins and thromboxanes, and 5-series leukotrienes which have low pro-inflammatory potential. The alteration in leukotriene biosynthesis due to higher concentration of omega-3 fatty acids compared to arachidonic acid underlies the anti-inflammatory effects. 

EPA and DHA also give rise to resolvins and related lipid signalling molecules such as protectins via cyclooxygenase and lipoxygenase pathways, which have anti-inflammatory effects. They inhibit transendothelial migration of neutrophils and inhibit TNF and IL-1β production. Omega-3 fatty acids also decrease adhesion molecule expression on leukocytes and on endothelial cells and decrease intercellular adhesive interactions.

Omega-3 (or n-3) polyunsaturated fatty acids (PUFAs) and their metabolites are natural ligands for peroxisome proliferator-activated receptor (PPAR) gamma that regulates inflammatory gene expression and NFκB activation. PPAR alpha activation is also associated with induction of COX-2 expression. 

The role of EPA and DHA in reducing triglyceride levels include inhibition of acyl-CoA:1,2-diacylglycerol acyltransferase, increased mitochondrial and peroxisomal-beta-oxidation in the liver, decreased lipogenesis in the liver, and increased plasma lipoprotein lipase activity. They also may reduce triglyceride synthesis because they are poor substrates for the enzymes responsible for TG synthesis, and EPA and DHA inhibit esterification of other fatty acids. ', 'Omega-3 fatty acids are triglycerides that get broken down into smaller fatty acid units. They act to reduce plasma triglyceride levels however increase the cholesterol levels and are thought to possess potent antiarrythmic effects. Polyunsaturated fatty acids including eicosapentaenoic and docosahexaenoic acid mediate important cellular function such as inhibition of platelet function, prolongation of bleeding time, anti-inflammatory effects and reduction of plasma fibrinogen. Polyunsaturated fatty acids are components of the phospholipids that form the structures of the cell membranes and also serve as energy source. They form eicosanoids which are important signalling molecules with wide-ranging functions in the body''s cardiovascular, pulmonary, immune and endocrine systems. DHA tends to exist in high concentrations in the retina, brain (via uptake by Mfsd2a as a transporter), and sperm.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11032, 'Carishema 60 gm massage gel', 'كاريشيما مساج جل 60 جم', '40', NULL, 'Massage gel', 'Camphor oil + eucalyptus oil + menthol crystal + phenoxy ethanol + vitamin e', 'P pharm', 'Gel', 'جل', '60 gm', '1', NULL, NULL, NULL, NULL, 933, '2022-08-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11034, 'Roval 20 pieces', 'روفال 20 قطعة', '94', NULL, 'Iron supplement', 'Lactoferrin + iron + vitamin b complex + vitamin c + folic acid', 'Esspero pharma', 'Piece', 'قطعة', NULL, '1', NULL, NULL, NULL, NULL, 1400, '2022-08-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11056, 'Supranil 25mg 20 caps.', 'سوبرانيل 25مجم 20 كبسولة', '21', '21', 'Psychiatric.antidepressants', 'Clomipramine', 'Alfacure pharmaceuticals', 'Cap', 'كبسولة', '25mg', '2', 'علاج للاكتئاب', 'about clomipramine tricyclic antidepressant (tertiary amine) antiobsessional. mechanism of action clomipramine acts by inhibiting the re-uptake of noradrenaline and serotonin (5 ht) in the cns nerve terminals.this will result in an increased concentration', '6224000875176', NULL, 2521, '2024-11-13', 0, 'May be used to treat obsessive-compulsive disorder and disorders with an obsessive-compulsive component (e.g. depression, schizophrenia, Tourette’s disorder).

Unlabeled indications include: depression, panic disorder, chronic pain (e.g. central pain, idiopathic pain disorder, tension headache, diabetic peripheral neuropathy, neuropathic pain), cataplexy and associated narcolepsy (limited evidence), autistic disorder (limited evidence), trichotillomania (limited evidence), onchophagia (limited evidence), stuttering (limited evidence), premature ejaculation, and premenstrual syndrome. ', 'Clomipramine is a strong, but not completely selective serotonin reuptake inhibitor (SRI), as the active main metabolite desmethyclomipramine acts preferably as an inhibitor of noradrenaline reuptake. &alpha;<sub>1</sub>-receptor blockage and &beta;-down-regulation have been noted and most likely play a role in the short term effects of clomipramine. A blockade of sodium-channels and NDMA-receptors might, as with other tricyclics, account for its effect in chronic pain, in particular the neuropathic type.', 'Clomipramine, a tricyclic antidepressant, is the 3-chloro derivative of Imipramine. It was thought that tricyclic antidepressants work exclusively by inhibiting the re-uptake of the neurotransmitters norepinephrine and serotonin by nerve cells. However, this response occurs immediately, yet mood does not lift for around two weeks. It is now thought that changes occur in receptor sensitivity in the cerebral cortex and hippocampus. The hippocampus is part of the limbic system, a part of the brain involved in emotions. Presynaptic receptors are affected: &alpha;<sub>1</sub> and &beta;<sub>1</sub> receptors are sensitized, &alpha;<sub>2</sub> receptors are desensitized (leading to increased noradrenaline production). Tricyclics are also known as effective analgesics for different types of pain, especially neuropathic or neuralgic pain.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11057, 'Rovament massage spray 100 ml', 'روفامنت مساج سبراي 100 مل', '85', '75', 'Massage', NULL, 'Rovamed pharma', 'Spray', 'بخاخ', '100 ml', '1', NULL, NULL, NULL, NULL, 669, '2025-01-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11059, 'Supranil 50mg 20 caps.', 'سوبرانيل 50مجم 20 كبسولة', '24', NULL, 'Psychiatric.antidepressants', 'Clomipramine', 'Alfacure pharmaceuticals', 'Cap', 'كبسولة', '50mg', '2', NULL, 'about clomipramine tricyclic antidepressant (tertiary amine) antiobsessional. mechanism of action clomipramine acts by inhibiting the re-uptake of noradrenaline and serotonin (5 ht) in the cns nerve terminals.this will result in an increased concentration', NULL, NULL, 2171, '2023-05-16', 0, 'May be used to treat obsessive-compulsive disorder and disorders with an obsessive-compulsive component (e.g. depression, schizophrenia, Tourette’s disorder).

Unlabeled indications include: depression, panic disorder, chronic pain (e.g. central pain, idiopathic pain disorder, tension headache, diabetic peripheral neuropathy, neuropathic pain), cataplexy and associated narcolepsy (limited evidence), autistic disorder (limited evidence), trichotillomania (limited evidence), onchophagia (limited evidence), stuttering (limited evidence), premature ejaculation, and premenstrual syndrome. ', 'Clomipramine is a strong, but not completely selective serotonin reuptake inhibitor (SRI), as the active main metabolite desmethyclomipramine acts preferably as an inhibitor of noradrenaline reuptake. &alpha;<sub>1</sub>-receptor blockage and &beta;-down-regulation have been noted and most likely play a role in the short term effects of clomipramine. A blockade of sodium-channels and NDMA-receptors might, as with other tricyclics, account for its effect in chronic pain, in particular the neuropathic type.', 'Clomipramine, a tricyclic antidepressant, is the 3-chloro derivative of Imipramine. It was thought that tricyclic antidepressants work exclusively by inhibiting the re-uptake of the neurotransmitters norepinephrine and serotonin by nerve cells. However, this response occurs immediately, yet mood does not lift for around two weeks. It is now thought that changes occur in receptor sensitivity in the cerebral cortex and hippocampus. The hippocampus is part of the limbic system, a part of the brain involved in emotions. Presynaptic receptors are affected: &alpha;<sub>1</sub> and &beta;<sub>1</sub> receptors are sensitized, &alpha;<sub>2</sub> receptors are desensitized (leading to increased noradrenaline production). Tricyclics are also known as effective analgesics for different types of pain, especially neuropathic or neuralgic pain.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11061, 'Supravit 28 caps.', 'سوبرافيت 28 كبسولة', '18', NULL, 'Multivitamins', 'Minerals+vitamins', 'Glaxo smithkline', 'Cap', 'كبسولة', NULL, '2', 'فيتامينات.', NULL, '6221045001652', NULL, 16251, '2023-02-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11062, 'Suprax 100mg/5 ml susp. 60ml', 'سوبراكس 100مجم/5مل معلق 60 مل', '131', '98', 'Antibiotic.cephalosporin.third-generation', 'Cefixime', 'Kahira > hikma pharma', 'Susp', 'معلق', '100mg', '1', NULL, NULL, '6224007321232', NULL, 14757, '2024-06-27', 0, 'Cefixime is indicated for the treatment of uncomplicated urinary tract infections caused by _Escherichia coli_ and _Proteus mirabilis_, otitis media caused by _Haemophilus influenzae_, _Moraxella catarrhalis_, and _Streptococcus pyogenes_, pharyngitis and tonsillitis caused by _Streptococcus pyogenes_,  acute exacerbations of chronic bronchitis caused by _Streptococcus pneumoniae_ and _Haemophilus influenzae_, and uncomplicated gonorrhea (cervical/urethral) caused by _Neisseria gonorrhoeae_ (penicillinase-and non-penicillinase-producing isolates).[L49293]', 'The bacterial cell wall, which is located at the periphery of Gram-positive bacteria and within the periplasm of Gram-negative bacteria, comprises a glycopeptide polymer synthesized through cross-linking of glycans to peptide stems on alternating saccharides, which is known commonly as peptidoglycan.[A232920] Cell wall formation, recycling, and remodelling require numerous enzymes, including a family of enzymes with similar active site character despite distinct and sometimes overlapping roles as carboxypeptidases, endopeptidases, transpeptidases, and transglycosylases, known as "penicillin-binding proteins" (PBPs). The number of PBPs differs between bacteria, in which some are considered essential and others redundant. In general, inhibition of one or more essential PBPs results in impaired cell wall homeostasis, loss of cell integrity, and is ultimately bactericidal.[A232920, A232925, A232930]



Cefixime is a cephalosporin and cephalosporins work by using their beta-lactam rings to inhibit bacterial cell wall synthesis by binding to the penicillin-binding proteins transpeptidases on bacteria.[A262995,A262945,A262950] The inhibition of synthesis of the bacteria cell wall will cause lysis, particularly in fast growing organisms such as bacteria.[A262945] Specifically, cephalosporins inhibit penicillin-sensitive enzymes responsible for the final 3D structure of the bacterial cell wall which in turn inhibit bacterial cell wall peptidoglycan synthesis.[T894, T322] ', 'Cefixime, a broad-spectrum antibiotic, is an orally-active third-generation semisynthetic cephalosporin.[A262894,L49293] Like other cephalosporins, the antibacterial action of cefixime results from inhibition of cell wall synthesis.[L49293] Also like other cephalosporins, cefixime is stable when in the presence of certain beta-lactamase enzymes, which means certain organisms resistant to penicillins and some cephalosporins due to the presence of beta-lactamases could be susceptible to cefixime.[L49293]



Use of cefixime can result in hypersensitivity reactions including anaphylactic/anaphylactoid reactions and _Clostridium difficile_-associated diarrhea (CDAD); it may also be associated with a fall in prothrombin activity.[L49293] Cefixime doses should be adjusted for patients that have renal impairment and patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD), while patients on dialysis should be monitored while taking cefixime.[L49293]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11064, 'Suprax 200mg 8 cap', 'سوبراكس 200مجم 8 كبسولات', '138', '95', 'Antibiotic.cephalosporin.third-generation', 'Cefixime', 'Kahira > hikma pharma', 'Cap', 'كبسولة', '200mg', '1', 'مضاد حيوي', NULL, '6224007321249', NULL, 3005, '2024-06-26', 0, 'Cefixime is indicated for the treatment of uncomplicated urinary tract infections caused by _Escherichia coli_ and _Proteus mirabilis_, otitis media caused by _Haemophilus influenzae_, _Moraxella catarrhalis_, and _Streptococcus pyogenes_, pharyngitis and tonsillitis caused by _Streptococcus pyogenes_,  acute exacerbations of chronic bronchitis caused by _Streptococcus pneumoniae_ and _Haemophilus influenzae_, and uncomplicated gonorrhea (cervical/urethral) caused by _Neisseria gonorrhoeae_ (penicillinase-and non-penicillinase-producing isolates).[L49293]', 'The bacterial cell wall, which is located at the periphery of Gram-positive bacteria and within the periplasm of Gram-negative bacteria, comprises a glycopeptide polymer synthesized through cross-linking of glycans to peptide stems on alternating saccharides, which is known commonly as peptidoglycan.[A232920] Cell wall formation, recycling, and remodelling require numerous enzymes, including a family of enzymes with similar active site character despite distinct and sometimes overlapping roles as carboxypeptidases, endopeptidases, transpeptidases, and transglycosylases, known as "penicillin-binding proteins" (PBPs). The number of PBPs differs between bacteria, in which some are considered essential and others redundant. In general, inhibition of one or more essential PBPs results in impaired cell wall homeostasis, loss of cell integrity, and is ultimately bactericidal.[A232920, A232925, A232930]



Cefixime is a cephalosporin and cephalosporins work by using their beta-lactam rings to inhibit bacterial cell wall synthesis by binding to the penicillin-binding proteins transpeptidases on bacteria.[A262995,A262945,A262950] The inhibition of synthesis of the bacteria cell wall will cause lysis, particularly in fast growing organisms such as bacteria.[A262945] Specifically, cephalosporins inhibit penicillin-sensitive enzymes responsible for the final 3D structure of the bacterial cell wall which in turn inhibit bacterial cell wall peptidoglycan synthesis.[T894, T322] ', 'Cefixime, a broad-spectrum antibiotic, is an orally-active third-generation semisynthetic cephalosporin.[A262894,L49293] Like other cephalosporins, the antibacterial action of cefixime results from inhibition of cell wall synthesis.[L49293] Also like other cephalosporins, cefixime is stable when in the presence of certain beta-lactamase enzymes, which means certain organisms resistant to penicillins and some cephalosporins due to the presence of beta-lactamases could be susceptible to cefixime.[L49293]



Use of cefixime can result in hypersensitivity reactions including anaphylactic/anaphylactoid reactions and _Clostridium difficile_-associated diarrhea (CDAD); it may also be associated with a fall in prothrombin activity.[L49293] Cefixime doses should be adjusted for patients that have renal impairment and patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD), while patients on dialysis should be monitored while taking cefixime.[L49293]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11065, 'Suprax 400 mg 5 caps.', 'سوبراكس 400مجم 5 كبسولات', '159', '110', 'Antibiotic.cephalosporin third generation', 'Cefixime', 'Kahira hikma pharma', 'Cap', 'كبسولة', '400 mg', '1', 'مضاد حيوي', NULL, '6224007321256', NULL, 14494, '2024-06-24', 0, 'Cefixime is indicated for the treatment of uncomplicated urinary tract infections caused by _Escherichia coli_ and _Proteus mirabilis_, otitis media caused by _Haemophilus influenzae_, _Moraxella catarrhalis_, and _Streptococcus pyogenes_, pharyngitis and tonsillitis caused by _Streptococcus pyogenes_,  acute exacerbations of chronic bronchitis caused by _Streptococcus pneumoniae_ and _Haemophilus influenzae_, and uncomplicated gonorrhea (cervical/urethral) caused by _Neisseria gonorrhoeae_ (penicillinase-and non-penicillinase-producing isolates).[L49293]', 'The bacterial cell wall, which is located at the periphery of Gram-positive bacteria and within the periplasm of Gram-negative bacteria, comprises a glycopeptide polymer synthesized through cross-linking of glycans to peptide stems on alternating saccharides, which is known commonly as peptidoglycan.[A232920] Cell wall formation, recycling, and remodelling require numerous enzymes, including a family of enzymes with similar active site character despite distinct and sometimes overlapping roles as carboxypeptidases, endopeptidases, transpeptidases, and transglycosylases, known as "penicillin-binding proteins" (PBPs). The number of PBPs differs between bacteria, in which some are considered essential and others redundant. In general, inhibition of one or more essential PBPs results in impaired cell wall homeostasis, loss of cell integrity, and is ultimately bactericidal.[A232920, A232925, A232930]



Cefixime is a cephalosporin and cephalosporins work by using their beta-lactam rings to inhibit bacterial cell wall synthesis by binding to the penicillin-binding proteins transpeptidases on bacteria.[A262995,A262945,A262950] The inhibition of synthesis of the bacteria cell wall will cause lysis, particularly in fast growing organisms such as bacteria.[A262945] Specifically, cephalosporins inhibit penicillin-sensitive enzymes responsible for the final 3D structure of the bacterial cell wall which in turn inhibit bacterial cell wall peptidoglycan synthesis.[T894, T322] ', 'Cefixime, a broad-spectrum antibiotic, is an orally-active third-generation semisynthetic cephalosporin.[A262894,L49293] Like other cephalosporins, the antibacterial action of cefixime results from inhibition of cell wall synthesis.[L49293] Also like other cephalosporins, cefixime is stable when in the presence of certain beta-lactamase enzymes, which means certain organisms resistant to penicillins and some cephalosporins due to the presence of beta-lactamases could be susceptible to cefixime.[L49293]



Use of cefixime can result in hypersensitivity reactions including anaphylactic/anaphylactoid reactions and _Clostridium difficile_-associated diarrhea (CDAD); it may also be associated with a fall in prothrombin activity.[L49293] Cefixime doses should be adjusted for patients that have renal impairment and patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD), while patients on dialysis should be monitored while taking cefixime.[L49293]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11067, 'Supristol 12 tab', 'سوبريستول 12 قرص', '7', NULL, 'Antibiotic', 'Sulfamoxol-trimethoprim', 'Knoll/alex', 'Tab', 'أقراص', NULL, '1', 'مضاد حيوي لاتلهابات الجهاز البولي -- علاج التهابات الجهاز التناسلي', NULL, '6223000176825', NULL, 1051, '2022-12-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11072, 'Sustanon 100mg amp', 'سوستانون 100مجم امبول', '3', NULL, 'Androgen', 'Testosterone', 'Organon', 'Amp', 'أمبول', '100mg', '1', NULL, NULL, NULL, NULL, 972, '2023-05-19', 0, 'Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.[L8983,L8935,L8938,L8986,L8989,L8992,L8995]', 'The androgen receptor exists in the cytoplasm bound to the heat shock proteins HSP90, HSP70, and other chaperones.[A187114] After binding to an androgen, the androgen receptor dissociates from HSP90 and undergoes a conformational change to slow the rate of dissociation from the androgen receptor.[A187114] The androgen-receptor complex is transported into the nucleus where it binds to DNA and recruits other transcriptional regulators to form a pre-initiation complex and eventually induce expression of specific genes.[A187114]



Testosterone and its active metabolite dihydrotestosterone (DHT) antagonize the androgen receptor to develop masculine sex organs including the prostate, seminal vesicles, penis, and scrotum.[A187111,L8983,L8935,L8938,L8986,L8989,L8992,L8995]



Antagonism of the androgen receptor is also responsible for the development of secondary sexual characteristics including facial and body hair, enlargement of the larynx, thickening of the vocal cords, and changes in muscle and fat distribution.[A187111,L8983,L8935,L8938,L8986,L8989,L8992,L8995]', 'Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics.[A187114,L8983,L8935,L8938,L8986,L8989,L8992,L8995] The duration of action of testosterone is variable from patient to patient with a half life of 10-100 minutes.[L8983,L8935,L8938,L8986,L8989,L8992,L8995] The therapeutic index is wide considering the normal testosterone levels in an adult man range from 300-1000ng/dL.[L8983,L8938,L8986,L8989,L8992,L8995] Counsel patients regarding the risk of secondary exposure of testosterone topical products to children.[L8983,L8938,L8986,L8989,L8992]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11073, 'Sustanon 250mg amp', 'سوستانون 250مجم امبول', '6', NULL, 'Androgen', 'Testosterone', 'Organon', 'Amp', 'أمبول', '250mg', '1', 'يمد الجسم بالتستستيرون لتعزيز نمو الاعضاء التناسلية للذكور -- تعزيز ظهور علامات الذكورة', NULL, '6221077121519', NULL, 3375, '2023-05-19', 0, 'Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.[L8983,L8935,L8938,L8986,L8989,L8992,L8995]', 'The androgen receptor exists in the cytoplasm bound to the heat shock proteins HSP90, HSP70, and other chaperones.[A187114] After binding to an androgen, the androgen receptor dissociates from HSP90 and undergoes a conformational change to slow the rate of dissociation from the androgen receptor.[A187114] The androgen-receptor complex is transported into the nucleus where it binds to DNA and recruits other transcriptional regulators to form a pre-initiation complex and eventually induce expression of specific genes.[A187114]



Testosterone and its active metabolite dihydrotestosterone (DHT) antagonize the androgen receptor to develop masculine sex organs including the prostate, seminal vesicles, penis, and scrotum.[A187111,L8983,L8935,L8938,L8986,L8989,L8992,L8995]



Antagonism of the androgen receptor is also responsible for the development of secondary sexual characteristics including facial and body hair, enlargement of the larynx, thickening of the vocal cords, and changes in muscle and fat distribution.[A187111,L8983,L8935,L8938,L8986,L8989,L8992,L8995]', 'Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics.[A187114,L8983,L8935,L8938,L8986,L8989,L8992,L8995] The duration of action of testosterone is variable from patient to patient with a half life of 10-100 minutes.[L8983,L8935,L8938,L8986,L8989,L8992,L8995] The therapeutic index is wide considering the normal testosterone levels in an adult man range from 300-1000ng/dL.[L8983,L8938,L8986,L8989,L8992,L8995] Counsel patients regarding the risk of secondary exposure of testosterone topical products to children.[L8983,L8938,L8986,L8989,L8992]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11074, 'Sutaprim d.s. 10 tabs.', 'سوتابريم دي اس 10 اقراص', '9', NULL, 'Antibiotic', 'Sulphamethoxazole+trimethoprim', 'Sedico', 'Tab', 'أقراص', NULL, '1', NULL, 'indication for the treatment bacterial infections causing bronchitis prostatitis and urinary tract infections. mechanism of action sulfonamides inhibit the enzymatic conversion of pteridine and p-aminobenzoic acid (paba) to dihydropteroic acid by competin', '6221042077018', NULL, 944, '2022-12-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11076, 'Sutrim 400/80mg 20*10 tab.', 'ستريم 400/80مجم 20*10 اقراص', '340', '230', 'Antibiotic', 'Sulphamethoxazole+trimethoprim', 'Memphis', 'Tab', 'أقراص', '80mg', '20', NULL, 'indication for the treatment bacterial infections causing bronchitis prostatitis and urinary tract infections. mechanism of action sulfonamides inhibit the enzymatic conversion of pteridine and p-aminobenzoic acid (paba) to dihydropteroic acid by competin', '6221050030647', NULL, 5152, '2025-10-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11077, 'Sutrim 200/40mg susp. 100ml', 'ستريم 200/40مجم معلق 100 مل', '19', '8.5', 'Antibiotic', 'Sulphamethoxazole+trimethoprim', 'Memphis', 'Susp', 'معلق', '40mg', '1', 'مضاد حيوي', 'indication for the treatment bacterial infections causing bronchitis prostatitis and urinary tract infections. mechanism of action sulfonamides inhibit the enzymatic conversion of pteridine and p-aminobenzoic acid (paba) to dihydropteroic acid by competin', '6221050090016', NULL, 1229, '2024-01-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11078, 'Sutrim forte 800/160mg 10 tab.', 'ستريم فورت 10 اقراص', '17', '9', 'Antibiotic', 'Sulphamethoxazole+trimethoprim', 'Memphis', 'Tab', 'أقراص', '160mg', '1', NULL, 'indication for the treatment bacterial infections causing bronchitis prostatitis and urinary tract infections. mechanism of action sulfonamides inhibit the enzymatic conversion of pteridine and p-aminobenzoic acid (paba) to dihydropteroic acid by competin', NULL, NULL, 1611, '2025-10-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11088, 'Sweetal 100 tab sugar', 'سويتال 100 قرص سكر', '80', '60', 'Sweetener', 'Sorbitol+sucralose', 'Biopharm egypt > hygint pharmaceuticals-egypt', 'Tab', 'أقراص', NULL, '1', 'سكر صناعي لمرضى السكر', NULL, '6223004400155', NULL, 1266, '2025-06-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11089, 'Sweetal 1g*100 sachets', 'سويتال 1 جم 100 كيس', '110', '100', 'Sweetener', 'Sorbitol+sucralose', 'Biopharm egypt > hygint pharmaceuticals-egypt', 'Sachet', 'أكياس', NULL, '1', 'سكر محلي صناعي لمرضى السكر', NULL, '6225000177857', NULL, 935, '2024-01-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11090, 'Sweetal 1g*25 sachets', 'سويتال 1 جم 25 كيس', '35', '30', 'Sweetener', 'Sorbitol+sucralose', 'Biopharm egypt > hygint pharmaceuticals-egypt', 'Sachet', 'أكياس', NULL, '1', 'سكر صناعي', NULL, '6225000177840', NULL, 930, '2024-01-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11094, 'Sycocetam 100mg/ml oral soln. 120 ml', 'سيكوسيتام 100مجم/مل شراب 120 مل', '91', '69.5', 'Anti-epileptic.pyrrolidine', 'Levetiracetam', 'Marcyrl co.', 'Sol', 'محلول', '100mg', '1', NULL, 'about levetiracetam it is s-enantiomer of etiracetam. anticonvulsant medication used to treat epilepsy. mechanism of action of levetiracetam the exact mechanism for levetiracetam is unknown. however the drug binds to a synaptic vesicle protein sv2a which', '6223003571658', NULL, 1763, '2024-11-25', 0, 'Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606]



Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]', 'The exact mechanism through which levetiracetam exerts its anti-epileptic effects is unclear, but is thought to be unique amongst other anti-epileptic medications. Current knowledge suggests that levetiracetam’s binding to synaptic vesicle protein 2A (SV2A) is a key driver of its action. SV2A is a membrane-bound protein that is found on synaptic vesicles and is ubiquitous throughout the CNS[A12546] - it appears to play a role in vesicle exocytosis[L8606,L8615] and in the modulation of synaptic transmission by increasing the available amount of secretory vesicles available for neurotransmission.[A12552] Stimulation of pre-synaptic SV2A by levetiracetam may inhibit neurotransmitter release,[A12551] but this action does not appear to affect normal neurotransmission. This has led to the suggestion that levetiracetam exclusively modulates the function of SV2A only under pathophysiological conditions.[A12546] Levetiracetam and related analogues showed a correlation between affinity for SV2A and anti-epileptic potency, further suggesting that action at this site contributes to the anti-epileptic activity of the drug.[L8606,L8615]



Levetiracetam has also been shown to indirectly affect GABAergic neurotransmission (despite having no direct effect on GABAergic or glutamatergic receptors) and modulate ionic currents.[A12552] Similarly, levetiracetam has been shown in vitro to inhibit N-type calcium channels.[A16562] How, or even if, these actions are implicated in its anti-epileptic action have yet to be elucidated.', 'Levetiracetam appears to prevent seizure activity via the selective inhibition of hypersynchronized epileptiform burst firing without affecting normal neuronal transmission, though the exact mechanism through which this occurs is unclear.[L8606,L8615] The therapeutic index of levetiracetam is wide,[L8615,A185918] making it relatively unique amongst other anti-epileptic medications.



Anti-epileptic drugs, including levetiracetam, may increase the risk of suicidal ideation or behaviour - patients taking levetiracetam should be monitored for the emergence or worsening of depressive symptoms, suicidal ideation, and behavioural abnormalities.[L8606,L8600,L8615]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11095, 'Sycocetam 1000 mg 20 f.c. tabs.', 'سيكوسيتام 1000مجم 20 قرص', '174', '130', 'Anti-epileptic.pyrrolidine', 'Levetiracetam', 'Marcyrl co.', 'Tab', 'أقراص', '1000 mg', '2', NULL, NULL, '6223003571658', NULL, 2033, '2024-10-22', 0, 'Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606]



Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]', 'The exact mechanism through which levetiracetam exerts its anti-epileptic effects is unclear, but is thought to be unique amongst other anti-epileptic medications. Current knowledge suggests that levetiracetam’s binding to synaptic vesicle protein 2A (SV2A) is a key driver of its action. SV2A is a membrane-bound protein that is found on synaptic vesicles and is ubiquitous throughout the CNS[A12546] - it appears to play a role in vesicle exocytosis[L8606,L8615] and in the modulation of synaptic transmission by increasing the available amount of secretory vesicles available for neurotransmission.[A12552] Stimulation of pre-synaptic SV2A by levetiracetam may inhibit neurotransmitter release,[A12551] but this action does not appear to affect normal neurotransmission. This has led to the suggestion that levetiracetam exclusively modulates the function of SV2A only under pathophysiological conditions.[A12546] Levetiracetam and related analogues showed a correlation between affinity for SV2A and anti-epileptic potency, further suggesting that action at this site contributes to the anti-epileptic activity of the drug.[L8606,L8615]



Levetiracetam has also been shown to indirectly affect GABAergic neurotransmission (despite having no direct effect on GABAergic or glutamatergic receptors) and modulate ionic currents.[A12552] Similarly, levetiracetam has been shown in vitro to inhibit N-type calcium channels.[A16562] How, or even if, these actions are implicated in its anti-epileptic action have yet to be elucidated.', 'Levetiracetam appears to prevent seizure activity via the selective inhibition of hypersynchronized epileptiform burst firing without affecting normal neuronal transmission, though the exact mechanism through which this occurs is unclear.[L8606,L8615] The therapeutic index of levetiracetam is wide,[L8615,A185918] making it relatively unique amongst other anti-epileptic medications.



Anti-epileptic drugs, including levetiracetam, may increase the risk of suicidal ideation or behaviour - patients taking levetiracetam should be monitored for the emergence or worsening of depressive symptoms, suicidal ideation, and behavioural abnormalities.[L8606,L8600,L8615]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11096, 'Sunseiz 750 mg 30 f.c.tabs.', 'صن سيز 750مجم 30 قرص', '186', '138', 'Anti-epileptic.pyrrolidine', 'Levetiracetam', 'Sun pharma egypt limited', 'Tab', 'أقراص', '750 mg', '3', NULL, NULL, NULL, NULL, 755, '2025-10-22', 0, 'Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606]



Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]', 'The exact mechanism through which levetiracetam exerts its anti-epileptic effects is unclear, but is thought to be unique amongst other anti-epileptic medications. Current knowledge suggests that levetiracetam’s binding to synaptic vesicle protein 2A (SV2A) is a key driver of its action. SV2A is a membrane-bound protein that is found on synaptic vesicles and is ubiquitous throughout the CNS[A12546] - it appears to play a role in vesicle exocytosis[L8606,L8615] and in the modulation of synaptic transmission by increasing the available amount of secretory vesicles available for neurotransmission.[A12552] Stimulation of pre-synaptic SV2A by levetiracetam may inhibit neurotransmitter release,[A12551] but this action does not appear to affect normal neurotransmission. This has led to the suggestion that levetiracetam exclusively modulates the function of SV2A only under pathophysiological conditions.[A12546] Levetiracetam and related analogues showed a correlation between affinity for SV2A and anti-epileptic potency, further suggesting that action at this site contributes to the anti-epileptic activity of the drug.[L8606,L8615]



Levetiracetam has also been shown to indirectly affect GABAergic neurotransmission (despite having no direct effect on GABAergic or glutamatergic receptors) and modulate ionic currents.[A12552] Similarly, levetiracetam has been shown in vitro to inhibit N-type calcium channels.[A16562] How, or even if, these actions are implicated in its anti-epileptic action have yet to be elucidated.', 'Levetiracetam appears to prevent seizure activity via the selective inhibition of hypersynchronized epileptiform burst firing without affecting normal neuronal transmission, though the exact mechanism through which this occurs is unclear.[L8606,L8615] The therapeutic index of levetiracetam is wide,[L8615,A185918] making it relatively unique amongst other anti-epileptic medications.



Anti-epileptic drugs, including levetiracetam, may increase the risk of suicidal ideation or behaviour - patients taking levetiracetam should be monitored for the emergence or worsening of depressive symptoms, suicidal ideation, and behavioural abnormalities.[L8606,L8600,L8615]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11097, 'Sylvester 1 - 20 caps', 'سلفستر 1 للتخسيس وانقاص الوزن 20 كبسولة', '150', '70', 'Weight loss', 'Gymnema sylvestre+chromium picocolinate', 'Debeiky', 'Cap', 'كبسولة', NULL, '2', 'للتخسيس وانقاص الوزن وبرامج الحمية الغذائية', NULL, NULL, NULL, 25008, '2024-04-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11100, 'Symbicort 160/4.5mcg/dose turbuhaler 120 doses', 'سيمبيكورت 160/4.5مكجم/جرعة تربوهيلر 120 جرعة', '432', '332', 'Bronchodilator.glucocorticoid steroid and long-acting b2 agonist', 'Budesonide+formoterol', 'Astra zeneca > healthy family', 'Unknown', 'غير محدد', '4.5mcg', '1', 'موسع للشعب ومضاد للحساسية', 'uses: this product contains 2 medications budesonide and formoterol. it is an inhaler used as a long-term (maintenance) treatment to prevent or decrease wheezing and trouble breathing caused by asthma or ongoing lung disease (such as copd). it works in th', '6223003270766', NULL, 4185, '2024-09-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11105, 'Synacthen depot 1mg/ml amp. (n/a)', 'سيناكتين ديبو 1مجم/مل أمبولة', '30', NULL, NULL, 'Tetracosactide', 'Nycomed > novartis', 'Amp', 'أمبول', '1mg', '1', 'مضاد للحساسية -- تقليل الالام والالتهابات -- تقليل الحكة والاحمرار والتورم', NULL, NULL, NULL, 2831, '2022-11-29', 0, 'For use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency.', 'Cosyntropin combines with a specific receptor in the adrenal cell plasma membrane and, in patients with normal adrenocortical function, stimulates the initial reaction involved in the synthesis of adrenal steroids (including cortisol, cortisone, weak androgenic substances, and a limited quantity of aldosterone) from cholesterol by increasing the quantity of the substrate within the mitochondria. Cosyntropin does not significantly increase plasma cortisol concentration in patients with primary or secondary adrenocortical insufficiency. ', 'Cosyntropin exhibits the full corticosteroidogenic activity of natural ACTH. Various studies have shown that the biologic activity of ACTH resides in the N- terminal portion of the molecule and that the 1-20 amino acid residue is the minimal sequence retaining full activity. Partial or complete loss of activity is noted with progressive shortening of the chain beyond 20 amino acid residue. For example, the decrement from 20 to 19 results in a 70% loss of potency. The pharmacologic profile of Cosyntropin is similar to that of purified natural ACTH. It has been established that 0.25 mg of Cosyntropin will stimulate the adrenal cortex maximally and to the same extent as 25 units of natural ACTH. Cosyntropin has less immunogenic activity than ACTH because the amino acid sequence having most of the antigenic activity of ACTH, i.e., amino acids 25-39, is not present in cosyntropin. The extra-adrenal effects which natural ACTH and Cosyntropin have in common include increased melanotropic activity, increased growth hormone secretion and an adipokinetic effect. These are considered to be without physiological or clinical significance.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11108, 'Synchrogit 10mg 20 tab.', 'سينكروجيت 10مجم 20 قرص', '15', '8', 'Antiemetic', 'Domperidone', 'Rameda', 'Tab', 'أقراص', '10mg', '2', NULL, 'about domperidone antidopaminergic motility stimulant piperidine derivative antiemetic anti-vertigo. mechanism of action of domperidone domperidone is a potent dopamine receptor antagonist. it acts centrally and blocks the dopamine receptor in the chemore', '6223003970284', NULL, 810, '2024-12-12', 0, 'For management of dyspepsia, heartburn, epigastric pain, nausea, and vomiting.', 'Domperidone acts as a gastrointestinal emptying (delayed) adjunct and peristaltic stimulant. The gastroprokinetic properties of domperidone are related to its peripheral dopamine receptor blocking properties. Domperidone facilitates gastric emptying and decreases small bowel transit time by increasing esophageal and gastric peristalsis and by lowering esophageal sphincter pressure. Antiemetic: The antiemetic properties of domperidone are related to its dopamine receptor blocking activity at both the chemoreceptor trigger zone and at the gastric level. It has strong affinities for the D2 and D3 dopamine receptors, which are found in the chemoreceptor trigger zone, located just outside the blood brain barrier, which - among others - regulates nausea and vomiting', 'Domperidone is a specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11112, 'Saja-vit iron syrup 120 ml', 'ساجا فيت بالحديد شراب 120 مل', '45', '35', 'Anemia', 'Iron', 'Saja', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 997, '2025-04-19', 0, 'For treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Also used to replenish body iron stores in Non-Dialysis Dependent-Chronic Kidney Disease (NDD-CKD) patients receiving or not receiving erythropoietin and in Hemodialysis Dependent (HDD-CKD) and Peritoneal Dialysis Dependent (PDD-CKD) - Chronic Kidney Disease patients receiving an erythropoietin.', 'After iron dextran is injected, the circulating iron dextran is removed from the plasma by cells of the reticuloendothelial system, which split the complex into its components of iron and dextran. The iron is immediately bound to the available protein moieties to form hemosiderin or ferritin, the physiological forms of iron, or to a lesser extent to transferrin. This iron which is subject to physiological control replenishes hemoglobin and depleted iron stores.', 'Iron dextran is a dark brown, slightly viscous sterile liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. It is for treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Iron is essential to the formation of hemoglobin and to the function and formation of other heme and nonheme compounds. Untreated depletion of iron stores leads to iron-deficient erythropoiesis and, in turn, to iron deficiency anemia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11114, 'Synobar soap 100 gm', 'سينوبار صابون 100جم', '60', '50', 'Soap', 'Tea tree oil+irgasan+lavendula oily extract+wheat germ oil+salicylic acid+thyme oil+clove oil+pine o', 'Macro group pharmaceuticals', 'Soap', 'صابون', '100 gm', '1', NULL, 'for acne black heads and dark spots', '6224000437183', NULL, 1373, '2025-03-04', 0, 'Indicated for topical use to help protect against infection in minor cuts, scrapes, and burns. No FDA-approved therapeutic indications.', 'The components of tea tree oil, particularly terpinen-4-ol and α-terpineol, mediate antimicrobial actions by disrupting the structural and functional integrity of bacterial membrane. Hydrocarbons are capable of partitioning into the cell and cytoplasmic membrane of microorganisms and disrupt their vital functions, which may result in leakage of ions such as potassium, and the inhibition of respiration [A32439]. Eventually, cell lysis may occur due to weakening of the cell wall, and loss of turgor pressure and subsequent rupture of the cytoplasmic membrane [A32441]. The loss of 260-nm-absorbing material may be indicative of a damaged cytoplasmic membrane and loss of nucleic acids [A32441]. In _E. coli_, perturbed potassium homeostasis, glucose-dependent respiration, cell morphology, and ability to exclude propidium iodide was observed. 



Tea tree oil also mediates its antifungal actions in a similar way, where it alters the permeability of Candida albicans and inhibits its respiration in a dose-dependent manner [A32439]. Plasma and mitochondrial membranes of fungal species are also thought to be negatively affected by inhibition of glucose-induced medium acidification by tea tree oil, which involves inhibition of membrane ATPase responsible for the expulsion of protons [A32439]. Tea tree oil also inhibits the formation of germ tubes, or mycelial conversion, in _C. albicans_, thereby disrupting cell morphogenesis [A32439]. Water-soluble fraction of TTO, terpinen-4-ol, and α-terpineol, can inhibit the lipopolysaccharide-induced production of the inflammatory mediators such as TNF-α, IL-1β and IL-10 by human peripheral monocytes by approximately 50% and that of prostaglandin E2 by about 30% after 40 h [A32439]. These components of tea tree oil may also suppress superoxide production by agonist-stimulated monocytes and decrease the production of reactive oxygen species by both stimulated neutrophils and monocytes [A32439].', 'Tea tree oil exhibits antibacterial, antifungal, antiviral, and antiprotozoal activities [A32439]. It mostly mediates bactericidal actions at concentrations of 1.0% or less in most bacteria such as _Staphylococcus aureus_ and _Escherichia coli_, and causes bacteriostatic effects at lower concentrations [A32439]. Organisms such as commensal skin staphylococci and micrococci, _Enterococcus faecalis_, and Pseudomonas aeruginosa_emphasized text_ were susceptible to tea tree oil concentrations of 2% [A32439]. It is proposed that water-soluble components of tea tree oil are capable in inducing anti-inflammatory actions; terpinen-4-ol attenuates the vasodilation and plasma extravasation associated with histamine-induced inflammation in humans [A32438].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11118, 'Syntocinon 5 i.u./ml i.m/i.v 5 amp.', 'سينتوسينون 5 وحدات دولية/مل 5 امبولات', '52', '30', 'Smooth muscle constrictor', 'Oxytocin', 'Novartis > mylan', 'Amp', 'أمبول', NULL, '5', NULL, NULL, '6221042404050', NULL, 2273, '2024-11-25', 0, 'Administration of exogenous oxytocin is indicated in the antepartum period to initiate or improve uterine contractions for vaginal delivery in situations where there is fetal or maternal concern.[L31433] For example, It may be used to induce labor in cases of Rh sensitization, maternal diabetes, preeclampsia at or near term, and when delivery is indicated due to prematurely ruptured membranes.[A229018,L31433] Importantly, oxytocin is not approved or indicated for elective induction of labor. Oxytocin may be used to reinforce labor in select cases of uterine inertia and as adjunctive therapy in the management of incomplete or inevitable abortion. In the postpartum period, oxytocin may be used to induced contractions in the 3rd stage of labor and to control postpartum bleeding or hemorrhage.[L31433]', 'Oxytocin plays a vital role in labour and delivery.[A228928] The hormone is produced in the hypothalamus and is secreted from the paraventricular nucleus to the posterior pituitary where it is stored.[A228928,A228958] It is then released in pulses during childbirth to induce uterine contractions.[A228928]



The concentration of oxytocin receptors on the myometrium increases significantly during pregnancy and reaches a peak in early labor.[L31433] Activation of oxytocin receptors on the myometrium triggers a downstream cascade that leads to increased intracellular calcium in uterine myofibrils which strengthens and increases the frequency of uterine contractions.[L31433,A228958,A228718]



In humans, most hormones are regulated by negative feedback; however, oxytocin is one of the few that is regulated by positive feedback.[A228958] The head of the fetus pushing on the cervix signals the release of oxytocin from the posterior pituitary of the mother.[A228958] Oxytocin then travels to the uterus where it stimulates uterine contractions.[A228958] The elicited uterine contractions will then stimulate the release of increasing amounts of oxytocin.[A228958] This positive feedback loop will continue until parturition.[A228958]



Since exogenously administered and endogenously secreted oxytocin result in the same effects on the female reproductive system, synthetic oxytocin may be used in specific instances during the antepartum and postpartum period to induce or improve uterine contractions.[A228958,L31433]', 'Oxytocin is a nonapeptide, pleiotropic hormone that exerts important physiological effects.[A228718, A228723] It is most well known to stimulate parturition and lactation, but also has important physiological influences on metabolic and cardiovascular functions, sexual and maternal behaviour, pair bonding, social cognition, and fear conditioning.[A228718,A228998,A229013] 



It is worth noting that oxytocin receptors are not limited to the reproductive system but can be found in many peripheral tissues and in central nervous system structures including the brain stem and amygdala.[A228998,A229003,A229008,A229013]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11119, 'Navitae plus 15ml eye drops', 'نافيتي بلس قطرة عين 15 مل', '355', '335', 'Lubricant antioxidant ophthalmic solution', 'Sodium hyaluronate+carboxy methyl beta glucan+vitamin a+vitamin e', 'Rx healthcare', 'Drops', 'نقط', '15ml', '1', NULL, NULL, NULL, NULL, 2138, '2025-11-06', 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11122, 'Systane eye drops 30 x 0.7 ml sdu (n/a)', 'سيستان قطرة عين 30 وحدة * 0.7 مل', '57', NULL, 'Eye lubricant', 'Polyethylene glycol 400+propylene glycol', 'Alcon', 'Drops', 'نقط', '0.7 ml', '1', 'مرطب للعين', 'eye lubricant', '408574890223', NULL, 1994, '2024-12-12', 0, 'Polyethylene glycol is indicated for use as an over-the-counter osmotic laxative to relieve occasional constipation.[L11812] When used in combination with sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride and potassium chloride, it is used for cleansing of the colon in preparation for colonoscopy in adults.[L6421]', 'Osmotic laxatives contain substances that are poorly absorbable and draw water into the lumen of the bowel.[L11854] Polyethylene glycol functions is an osmotic laxative that causes increased water retention in the lumen of the colon by binding to water molecules, thereby producing loose stools.[A177092,L6421]', 'The osmotic effect of PEG produces a copious watery diarrhea. The onset of action of PEG 3350 is about 1 to 2 hours after oral ingestion.[L6421] The colonic transit of polyethylene glycol occurs in a dose-dependent manner.[A190975] When used for bowel preparation before colonscopy, electrolytes are typically added in the oral solution to prevent dehydration and electrolyte disturbances. As an over-the-counter laxative, the OTC product does not contain any salts that can be absorbed.[A177092] In a study involving healthy subjects, PEG 3350 had negligible effects on colonic fluid absorption or with the ability of the colonic mucosa to generate and sustain steep electrochemical gradients.[A190978]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11123, 'Systane hydration eye drops 10 ml', 'سيستان هيدريشن ترطيب قطرة عين 10 مل', '390', '350', 'Eye lubricant', 'Sodium hyalouronate+polyethylene glycol 400+propylene glycol', 'Alcon', 'Drops', 'نقط', '10 ml', '1', 'مرطب للعين', 'uses for the temporary relief of burning and irritation due to dryness of the eye. may also be used for rewetting of all silicone hydrogel and soft (hydrophilic) contact lenses for minor irritation discomfort and blurring.', '8427324893682', NULL, 10145, '2025-01-21', 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11126, 'T.b.zide 50 mg 100 tab', 'تي بي زايد 50 مجم 100 قرص', '16', NULL, 'Antitubercular', 'Isoniazid', 'El nasr', 'Tab', 'أقراص', '50 mg', '1', 'مضاد حيوي يستخدم للعلاج والوقاية من مرض السل', NULL, NULL, NULL, 1979, '2022-08-21', 0, 'Isoniazid is used for the treatment of all forms of tuberculosis in which organisms are susceptible. It is also used in combination with rifampin and pyrazinamide.[L45369]', 'Isoniazid is a prodrug and must be activated by bacterial catalase. Specficially, activation is associated with reduction of the mycobacterial ferric KatG catalase-peroxidase by hydrazine and reaction with oxygen to form an oxyferrous enzyme complex. Once activated, isoniazid inhibits the synthesis of mycoloic acids, an essential component of the bacterial cell wall. At therapeutic levels isoniazid is bacteriocidal against actively growing intracellular and extracellular <i>Mycobacterium tuberculosis</i> organisms. Specifically isoniazid inhibits InhA, the enoyl reductase from <i>Mycobacterium tuberculosis</i>, by forming a covalent adduct with the NAD cofactor. It is the INH-NAD adduct that acts as a slow, tight-binding competitive inhibitor of InhA.', 'Isoniazid is a bactericidal agent active against organisms of the genus Mycobacterium, specifically <i>M. tuberculosis</i>, <i>M. bovis</i> and <i>M. kansasii</i>. It is a highly specific agent, ineffective against other microorganisms. Isoniazid is bactericidal when mycobacteria grow rapidly and bacteriostatic when they grow slowly.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11127, 'T.b.zide forte 200mg 50 tab.', 'تي بي زايد فورت 200 مجم 50 قرص', '16', NULL, 'Antitubercular', 'Isoniazid', 'El nasr', 'Tab', 'أقراص', '200mg', '5', NULL, NULL, NULL, NULL, 653, '2022-08-21', 0, 'Isoniazid is used for the treatment of all forms of tuberculosis in which organisms are susceptible. It is also used in combination with rifampin and pyrazinamide.[L45369]', 'Isoniazid is a prodrug and must be activated by bacterial catalase. Specficially, activation is associated with reduction of the mycobacterial ferric KatG catalase-peroxidase by hydrazine and reaction with oxygen to form an oxyferrous enzyme complex. Once activated, isoniazid inhibits the synthesis of mycoloic acids, an essential component of the bacterial cell wall. At therapeutic levels isoniazid is bacteriocidal against actively growing intracellular and extracellular <i>Mycobacterium tuberculosis</i> organisms. Specifically isoniazid inhibits InhA, the enoyl reductase from <i>Mycobacterium tuberculosis</i>, by forming a covalent adduct with the NAD cofactor. It is the INH-NAD adduct that acts as a slow, tight-binding competitive inhibitor of InhA.', 'Isoniazid is a bactericidal agent active against organisms of the genus Mycobacterium, specifically <i>M. tuberculosis</i>, <i>M. bovis</i> and <i>M. kansasii</i>. It is a highly specific agent, ineffective against other microorganisms. Isoniazid is bactericidal when mycobacteria grow rapidly and bacteriostatic when they grow slowly.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11132, 'Tabocine 100mg 10 caps.', 'تابوسين 100 مجم 10 كبسولات', '46', '31.5', 'Antibiotic.tetracycline', 'Doxycycline', 'Tabuk pharmaceutical manufacturing company', 'Tab', 'أقراص', '100mg', '1', 'مضاد حيوي', 'about doxycycline tetracycline derivative antibiotic. mechanism of action of doxycycline doxycycline is a broad spectrum antibiotic which acts against both gram positive and gram negative organisms. it exerts its bacteriostatic action by accumulating insi', '6285147004577', NULL, 3459, '2025-08-04', 0, 'Doxycycline is indicated for the treatment of various infections by gram-positive and gram-negative bacteria, aerobes and anaerobes, as well other types of bacteria, including:



- Early Lyme disease (as evidenced by erythema migraines) due to _Borrelia burgdorferi_ in adults and pediatric patients 8 years of age and older weighing 45 kg and above [L42875]

- Rickettsial infections,[L42870] such as Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers [L42880]

- Sexually transmitted infections [L42870]

- Respiratory tract infections [L42870] caused by _Mycoplasma pneumoniae_ and _Haemophilus influenzae_ [L42880]

- Specific bacterial infections [L42870] after indicative bacteriologic testing. These include infections caused by _Escherichia coli_, _Enterobacter aerogenes_, _Shigella_ species, _Acinetobacter_ species, and _Klebsiella_ species [L42880]

- Ophthalmic infections,[L42870] such as inclusion conjunctivitis caused by _Chlamydia trachomatis_ [L42880]

- Anthrax, including inhalational anthrax (post-exposure) [L42870]

- Alternative treatment for selected infections when [penicillin] is contraindicated [L42870]

- Adjunctive therapy in acute intestinal amebiasis and severe acne [L42870, L42880]

- Lymphogranuloma venereum caused by _Chlamydia trachomatis_ [L42880]

- Psittacosis (ornithosis) caused by _Chlamydophila psittaci_ [L42880]

- Trachoma caused by _Chlamydia trachomatis_, although the infectious agent is not always eliminated, as judged by immunofluorescence [L42880]

- Uncomplicated urethral, endocervical, or rectal infections in adults caused by _Chlamydia trachomatis_ [L42880]

- Nongonococcal urethritis caused by _Ureaplasma urealyticum_ [L42880]

- Relapsing fever due to _Borrelia recurrentis_ [L42880]

- Prophylaxis of malaria due to _Plasmodium falciparum_ in short-term travelers (<4 months) to areas with chloroquine and/or pyrimethamine-sulfadoxine resistant strains [L42870, L42880]



It is also used to treat infections caused by the following gram-negative microorganisms:



- Chancroid caused by _Haemophilus ducreyi_ [L42880]

- Plague due to _Yersinia pestis_ [L42880]

- Tularemia due to _Francisella tularensis_ [L42880]

- Cholera caused by _Vibrio cholerae_ [L42880]

- Campylobacter fetus infections caused by _Campylobacter fetus_ [L42880]

- Brucellosis due to _Brucella_ species (in conjunction with [streptomycin]) [L42880]

- Bartonellosis due to _Bartonella bacilliformis_ [L42880]

- Granuloma inguinale caused by _Klebsiella granulomatis_ [L42880]', 'Protein synthesis is essential for survival and functioning of cells, including bacteria.[A251725] Doxycycline inhibits bacterial protein synthesis by allosterically binding to the 30S prokaryotic ribosomal subunit.[A251730, L42870] The drug blocks the association charged aminoacyl-tRNA (aa-tRNA) with the ribosomal A site, which is the acceptor site on the mRNA-ribosome complex. Doxycycline ultimately impedes the elongation phase of protein synthesis and halts the production of essential proteins for bacterial survival and functioning.[A251725, A251730]



Doxycycline mediates anti-inflammatory actions by preventing calcium-dependent microtubular assembly and lymphocytic proliferation, thereby inhibiting leukocyte movement during inflammation.[A251730] It also inhibits nitric oxide synthase, which is an enzyme that produces nitric oxide, an inflammatory signaling molecule.[A251730]', 'Doxycycline and other tetracyclines are mainly bacteriostatic and are thought to exert antimicrobial effects by the inhibition of protein synthesis. They suppress the growth of bacteria or keep them in the stationary phase of growth.[A174025] Tetracyclines have antimicrobial spectrum of activity against a variety of gram-positive and gram-negative microorganisms.[L42870] Cross-resistance of these microorganisms to tetracyclines is a common occurrence.[L42870] 



As it is a highly lipophilic drug, doxycycline crosses multiple membranes of target molecules.[A251730] Doxycycline shows favorable intra-cellular penetration, with bacteriostatic activity against a wide range of bacteria.[A174028] Doxycycline also exhibits antiparasitic properties [A372, A373, A174025] and anti-inflammatory actions.[A174031, A251730] Its anti-inflammatory effects were investigated in various inflammatory skin conditions, such as bullous dermatoses [A251730] and rosacea.[A174031, A251730]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11142, 'Tala oil drops 10 ml', 'تالا نقط زيت 10 مل', '14', '12', 'Hair Removal', 'Ant egg oil', 'Company', 'Drops', 'نقط', '10 ml', '1', 'يستخدم لتاخير نمو الشعر', NULL, '6225000130401', NULL, 1784, '2023-11-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11143, 'Talopram 40mg 10 f.c. tab.', 'تالوبرام 40مجم 10 اقراص', '36', NULL, 'Psychiatric.antidepressants', 'Citalopram', 'Adwia', 'Tab', 'أقراص', '40mg', '1', 'مضاد للإكتئاب -- الأمراض النفسية العصبية', 'about citalopram selective serotonin reuptake inhibitor (ssris) antidepressant. mechanism of action of citalopram citalopram blocks the re-uptake of neurotransmitter serotonin from the synapse to the presynaptic nerve terminal in the cns. this potentiates', '6223002977116', NULL, 1502, '2022-12-09', 0, 'Citalopram is approved by the FDA for treating adults with major depressive disorder.[L47941] It has also been used off-label to treat various diseases, including but not limited to sexual dysfunction, ethanol abuse, psychiatric conditions such as obsessive-compulsive disorder (OCD), social anxiety disorder, panic disorder, and diabetic neuropathy.[L5224,A321,A322,A261296] ', 'The mechanism of action of citalopram is unclear but is presumed to be related to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT), potentially through the inhibition of the serotonin transporter (solute carrier family 6 member 4, _SLC6A4_).[L47941,A37688] 



Citalopram binds with significantly less affinity to histamine, acetylcholine, and norepinephrine receptors than tricyclic antidepressant drugs. Particularly, citalopram has no or very low affinity for 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, dopamine D<sub>1</sub> and D<sub>2</sub>, α<sub>1</sub>-, α<sub>2</sub>-, and β-adrenergic, histamine H<sub>1</sub>, gamma aminobutyric acid (GABA), muscarinic cholinergic, and benzodiazepine receptors.[L47941]', 'Citalopram belongs to a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). It has been found to relieve or manage symptoms of depression, anxiety, eating disorders and obsessive-compulsive disorder among other mood disorders. The antidepressant, anti-anxiety, and other actions of citalopram are linked to its inhibition of CNS central uptake of serotonin.[L47941] Serotonergic abnormalities have been reported in patients with mood disorders. Behavioral and neuropsychological effects of serotonin include the regulation of mood, perception, reward, anger, aggression, appetite, memory, sexuality, and attention, as examples. The onset of action for depression is approximately 1 to 4 weeks. The complete response may take 8-12 weeks after initiation of citalopram.[L5224]



 <i>In vitro</i> studies demonstrate that citalopram is a strong and selective inhibitor of neuronal serotonin reuptake and has weak effects on norepinephrine and dopamine central reuptake. The chronic administration of citalopram has been shown to downregulate central norepinephrine receptors, similar to other drugs effective in the treatment of major depressive disorder. Citalopram does not inhibit monoamine oxidase.[A325]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11147, 'Taminil-n 12mg/ml susp. 30 ml', 'تامينيل ان 12مجم/مل شراب معلق 30 مل', '124', '95', 'Antiviral.release phase', 'Oseltamivir', 'El nile.', 'Susp', 'معلق', '12mg', '1', 'علاج الانفلونزا الفيروسية', 'about oseltamivir antiviral neuraminidase inhibitor mechanism of action of oseltamivir oseltamivir is an ethyl ester prodrug requiring ester hydrolysis for conversion to active form oseltamivir carboxylate. oseltamivir is a neuraminidase inhibitor serving', '6221077041312', NULL, 4858, '2023-09-16', 0, 'According to FDA prescribing information, oseltamivir is indicated for the treatment of acute, uncomplicated illness due to influenza A and B infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours [F3094]. In particular, this agent is indicated in adults and children including full-term neonates who present with symptoms typical of influenza when influenza virus is circulating in the community. Efficacy has been demonstrated when treatment is initiated within two days of the first onset of symptoms.[F3097]



Oseltamivir is also indicated for the prophylaxis of influenza in patients one year and older [F3094]. Specifically, post-exposure prevention in individuals one year of age or older following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community qualifies for such prophylactic therapy. Oseltamivir would only be indicated for post-exposure prevention of influenza in infants less than 1 year of age during a pandemic influenza outbreak. [F3097]', 'Oseltamivir phosphate is a pro-drug of the active metabolite (oseltamivir carboxylate) which is a potent and selective inhibitor of influenza virus neuraminidase enzymes, which are glycoproteins found on the virion surface. Viral neuraminidase enzyme activity is important for viral entry into uninfected cells, for the release of recently formed virus particles from infected cells, and for the further spread of the infectious virus in the body.[F3097, L5161, F3115] Oseltamivir activity reduces viral shedding and infectivity.



Oseltamivir is effective agaisnt viral neuraminidases of influenza A (including pandemic H1N1) and influenza B.[F3097, L5161, F3115] ', 'There have been postmarketing reports of delirium and abnormal behavior leading to injury, and in some cases resulting in fatal outcomes, in patients with influenza who were receiving oseltamivir. Because these events were reported voluntarily during clinical practice, estimates of frequency cannot be made but they appear to be uncommon based on oseltamivir. These events were reported primarily among pediatric patients and often had an abrupt onset and rapid resolution. The contribution of oseltamivir to these events has not been established. Influenza can be associated with a variety of neurologic and behavioral symptoms that can include events such as hallucinations, delirium, and abnormal behavior, in some cases resulting in fatal outcomes. These events may occur in the setting of encephalitis or encephalopathy but can occur without obvious severe disease.[F3097, A180586, A180589]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11150, 'Tamol 100mg/ml oral drops 10 ml', 'تامول 100مجم/مل نقط فم 10 مل', '9', NULL, 'Analgesics.narcotic opioid', 'Tramadol', 'Marcyrl co.', 'Drops', 'نقط', '100mg', '1', 'مسكن للألام المتوسطة او الشديدة', '(indications): this medication is an opioid analgesic prescribed for moderate to severe pain in adults.it works by changing the way the body senses pain. (contraindications): acute alcoholism head injuries severe kidney impairment breastfeeding hypersensi', NULL, NULL, 1323, '2022-11-30', 0, 'Tramadol is approved for the management of moderate to severe pain in adults.[L9257,F4679]



Tramadol is also used off-label in the treatment of premature ejaculation.[A173986]', 'Tramadol is a centrally acting μ-opioid receptor agonist and SNRI (serotonin/norepinephrine reuptake-inhibitor) that is structurally related to [codeine] and [morphine]. Tramadol binds weakly to κ- and δ-opioid receptors and to the μ-opioid receptor with 6000-fold less affinity than morphine.[A182300]



Tramadol exists as a racemic mixture consisting of two pharmacologically active enantiomers that both contribute to its analgesic property through different mechanisms: (+)-tramadol and its primary metabolite (+)-O-desmethyl-tramadol (M1) are agonists of the μ opioid receptor while (+)-tramadol inhibits serotonin reuptake and (-)-tramadol inhibits norepinephrine reuptake. These pathways are complementary and synergistic, improving tramadol''s ability to modulate the perception of and response to pain.[A4269] 



In animal models, M1 is up to 6 times more potent than tramadol in producing analgesia and 200 times more potent in μ-opioid binding.[L9257] 



Tramadol has also been shown to affect a number of pain modulators including alpha2-adrenoreceptors, neurokinin 1 receptors, the voltage-gated sodium channel type II alpha subunit[A183728], transient receptor potential cation channel subfamily V member 1 (TRPV1 - also known as the capsaicin receptor)[A183734], muscarinic receptors (M1 and M3), N-methyl-D-aspartate receptor (also known as the NMDA receptor or glutamate receptor)[A17158], Adenosine A1 receptors[A183761], and nicotinic acetylcholine receptor.[A17159] 



In addition to the above neuronal targets, tramadol has a number of effects on inflammatory and immune mediators involved in the pain response. This includes inhibitory effects on cytokines, prostaglandin E2 (PGE2), nuclear factor-κB, and glial cells as well as a change in the polarization state of M1 macrophages.[A182300]', 'Tramadol modulates the descending pain pathways within the central nervous system through the binding of parent and M1 metabolite to μ-opioid receptors and the weak inhibition of the reuptake of norepinephrine and serotonin.[A173983,A173980] 



Apart from analgesia, tramadol may produce a constellation of symptoms (including dizziness, somnolence, nausea, constipation, sweating and pruritus) similar to that of other opioids. 



**Central Nervous System**



In contrast to [morphine], tramadol has not been shown to cause histamine release. At therapeutic doses, tramadol has no effect on heart rate, left-ventricular function or cardiac index. Orthostatic hypotension has been observed.[L9257]



Tramadol produces respiratory depression by direct action on brain stem respiratory centres. The respiratory depression involves both a reduction in the responsiveness of the brain stem centres to increases in CO2 tension and to electrical stimulation. 



Tramadol depresses the cough reflex by a direct effect on the cough centre in the medulla. Antitussive effects may occur with doses lower than those usually required for analgesia.



Tramadol causes miosis, even in total darkness. Pinpoint pupils are a sign of opioid overdose but

are not pathognomonic (e.g., pontine lesions of hemorrhagic or ischemic origin may produce

similar findings). Marked mydriasis rather than miosis may be seen with hypoxia in the setting of

oxycodone overdose.[F4679]



Seizures have been reported in patients receiving tramadol within the recommended dosage range. Spontaneous post-marketing reports indicate that seizure risk is increased with doses of tramadol above the recommended range. Risk of convulsions may also increase in patients with epilepsy, those with a history of seizures

or in patients with a recognized risk for seizure (such as head trauma, metabolic disorders,

alcohol and drug withdrawal, CNS infections), or with concomitant use of other drugs known to reduce the seizure threshold.[F4679]



Tramadol can cause a rare but potentially life-threatening condition resulting from concomitant administration of serotonergic drugs (e.g., anti-depressants, migraine medications). Treatment with the serotoninergic drug should be discontinued if such events (characterized by clusters of symptoms such as hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of vital signs, mental status changes including confusion, irritability, extreme agitation progressing to delirium and coma) occur and supportive symptomatic treatment should be initiated. Tramadol should not be used in combination with MAO inhibitors or serotonin-precursors (such as L-tryptophan, oxitriptan) and should be used with caution in combination with other serotonergic drugs (triptans, certain tricyclic antidepressants, lithium, St. John’s Wort) due to the risk of serotonin syndrome.[F4679]



**Gastrointestinal Tract and Other Smooth Muscle**



Tramadol causes a reduction in motility associated with an increase in smooth muscle tone in the antrum of the stomach and duodenum. Digestion of food in the small intestine is delayed and propulsive contractions are decreased. Propulsive peristaltic waves in the colon are decreased, while tone may be increased to the point of spasm resulting in constipation. Other opioid-induced effects may include a reduction in gastric, biliary and pancreatic secretions, spasm of the sphincter of Oddi, and transient elevations in serum amylase.[F4679]



**Endocrine System**



Opioids may influence the hypothalamic-pituitary-adrenal or -gonadal axes. Some changes that can be seen include an increase in serum prolactin and decreases in plasma cortisol and testosterone. Clinical signs and symptoms may be manifest from these hormonal changes.[F4679]



Hyponatremia has been reported very rarely with the use of tramadol, usually in patients with predisposing risk factors, such as elderly patients and/or patients using concomitant medications that may cause hyponatremia (e.g., antidepressants, benzodiazepines, diuretics). In some reports, hyponatremia appeared to be the result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH) and resolved with discontinuation of tramadol and appropriate treatment (e.g., fluid restriction). During tramadol treatment, monitoring for signs and symptoms of hyponatremia is recommended for patients with predisposing risk factors.[F4679]



**Cardiovascular**



Tramadol administration may result in severe hypotension in patients whose ability to maintain adequate blood pressure is compromised by reduced blood volume, or concurrent administration of drugs such as phenothiazines and other tranquillizers, sedative/hypnotics, tricyclic antidepressants or general anesthetics. These patients should be monitored for signs of hypotension after initiating or titrating the dose of tramadol.[F4679]



**QTc-Interval Prolongation**



The maximum placebo-adjusted mean change from baseline in the QTcF interval was 5.5 ms in the 400 mg/day treatment arm and 6.5 ms in the 600 mg/day mg treatment arm, both occurring at the 8h time point. Both treatment groups were within the 10 ms threshold for QT prolongation. Post-marketing experience with the use of tramadol containing products included rare reports of QT prolongation reported with an overdose. Particular care should be exercised when administering tramadol to patients who are suspected to be at an increased risk of experiencing torsade de pointes during treatment with a QTc-prolonging drug.[F4679]



**Abuse and Misuse**



Like all opioids, tramadol has the potential for abuse and misuse, which can lead to overdose and death. Therefore, tramadol should be prescribed and handled with caution.[F4679]



**Dependence/Tolerance**



Physical dependence and tolerance reflect the neuroadaptation of the opioid receptors to chronic exposure to an opioid and are separate and distinct from abuse and addiction. Tolerance, as well as physical dependence, may develop upon repeated administration of opioids, and are not by themselves evidence of an addictive disorder or abuse. Patients on prolonged therapy should be tapered gradually from the drug if it is no longer required for pain control. Withdrawal symptoms may occur following abrupt discontinuation of therapy or upon administration of an opioid antagonist. Some of the symptoms that may be associated with abrupt withdrawal of an opioid analgesic include body aches, diarrhea, gooseflesh, loss of appetite, nausea, nervousness or restlessness, anxiety, runny nose, sneezing, tremors or shivering, stomach cramps, tachycardia, trouble with sleeping, unusual increase in sweating, palpitations, unexplained fever, weakness and yawning.[F4679]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11152, 'Revano soft 50 gm cream', 'ريفانو سوفت كريم 50 جم', '55', NULL, 'Moisturizing and emollient cream', 'Panthenol+sun flower oil+alo vera extract+avocado oil+shea butter', 'Revano pharm', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, NULL, NULL, 924, '2024-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11153, 'Tamoxifen 10mg 30 tablets', 'تاموكسيفين 10مجم 30 قرص', '66', '25.5', 'Estrogen antagonist', 'Tamoxifen', 'Technopharm', 'Tablet', 'أقراص', '10mg', '3', 'علاج بعض امراض النساء ولتنشيط التبويض لتأخر الحمل', NULL, '6224008302407', NULL, 4175, '2025-04-11', 0, 'Tamoxifen is indicated to treat estrogen receptor positive metastatic breast cancer in adults, as an adjuvant in the treatment of early stage estrogen receptor positive breast cancer in adults, to reduce the risk of invasive breast cancer after surgery and radiation in adult women with ductal carcinoma in situ.[L7802]', 'Tamoxifen competitively inhibits estrogen binding to its receptor, which is critical for it''s activity in breast cancer cells.[A1025] Tamoxifen leads to a decrease in tumor growth factor α and insulin-like growth factor 1, and an increase in sex hormone binding globulin.[A1025] The increase in sex hormon binding globulin limits the amount of freely available estradiol.[A1025] These changes reduce levels of factors that stimulate tumor growth.[A1025]



Tamoxifen has also been shown to induce apoptosis in estrogen receptor positive cells.[A182195] This action is thought to be the result of inhibition of protein kinase C, which prevents DNA synthesis.[A182195] Alternate theories for the apoptotic effect of tamoxifen comes from the approximately 3 fold increase in intracellular and mitochondrial calcium ion levels after administration or the induction of tumor growth factor β.[A182195]', 'Tamoxifen is a selective estrogen receptor modulator that inhibits growth and promotes apoptosis in estrogen receptor positive tumors.[A1025,A182195] It has a long duration of action as the active metabolite N-desmethyltamoxifen has a half life of approximately 2 weeks.[L7799,L7802] It has a narrow therapeutic index as higher doses can lead to breathing difficulty or convulsions.[L7799,L7802] Tamoxifen administration is also associated with an increased incidence of uterine malignancies.[L7799,L7802]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11155, 'Tamoxifen 20mg 20 tab.', 'تاموكسيفين 20مجم 20 قرص', '68', '28', 'Estrogen antagonist', 'Tamoxifen', 'Amriya', 'Tab', 'أقراص', '20mg', '2', NULL, NULL, '6221075010181', NULL, 6165, '2025-04-11', 0, 'Tamoxifen is indicated to treat estrogen receptor positive metastatic breast cancer in adults, as an adjuvant in the treatment of early stage estrogen receptor positive breast cancer in adults, to reduce the risk of invasive breast cancer after surgery and radiation in adult women with ductal carcinoma in situ.[L7802]', 'Tamoxifen competitively inhibits estrogen binding to its receptor, which is critical for it''s activity in breast cancer cells.[A1025] Tamoxifen leads to a decrease in tumor growth factor α and insulin-like growth factor 1, and an increase in sex hormone binding globulin.[A1025] The increase in sex hormon binding globulin limits the amount of freely available estradiol.[A1025] These changes reduce levels of factors that stimulate tumor growth.[A1025]



Tamoxifen has also been shown to induce apoptosis in estrogen receptor positive cells.[A182195] This action is thought to be the result of inhibition of protein kinase C, which prevents DNA synthesis.[A182195] Alternate theories for the apoptotic effect of tamoxifen comes from the approximately 3 fold increase in intracellular and mitochondrial calcium ion levels after administration or the induction of tumor growth factor β.[A182195]', 'Tamoxifen is a selective estrogen receptor modulator that inhibits growth and promotes apoptosis in estrogen receptor positive tumors.[A1025,A182195] It has a long duration of action as the active metabolite N-desmethyltamoxifen has a half life of approximately 2 weeks.[L7799,L7802] It has a narrow therapeutic index as higher doses can lead to breathing difficulty or convulsions.[L7799,L7802] Tamoxifen administration is also associated with an increased incidence of uterine malignancies.[L7799,L7802]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11156, 'Mannitol 10% (otsuka) i.v. inf. 500 ml (rubber cap)', 'مانيتول 10% اوتوسوكا محلول وريدي 500 مل بغطاء مطاطي', '13', NULL, 'Osmotic diuretic', 'Mannitol', 'Otsuka', 'Cap', 'كبسولة', '10%', '1', NULL, NULL, NULL, NULL, 870, '2022-08-02', 0, 'Used for the promotion of diuresis before irreversible renal failure becomes established, the reduction of intracranial pressure, the treatment of cerebral edema, and the promotion of urinary excretion of toxic substances.



Mannitol is also indicated as add-on maintenance therapy for improving pulmonary function in cystic fibrosis patients aged 18 and over who have passed the BRONCHITOL tolerance test (BTT). It is recommended that patients take an orally inhaled short-acting bronchodilator 5-15 minutes prior to every inhaled mannitol dose.[L20024]', 'Mannitol is an osmotic diuretic that is metabolically inert in humans and occurs naturally, as a sugar or sugar alcohol, in fruits and vegetables. Mannitol elevates blood plasma osmolality, resulting in enhanced flow of water from tissues, including the brain and cerebrospinal fluid, into interstitial fluid and plasma. As a result, cerebral edema, elevated intracranial pressure, and cerebrospinal fluid volume and pressure may be reduced. As a diurectic mannitol induces diuresis because it is not reabsorbed in the renal tubule, thereby increasing the osmolality of the glomerular filtrate, facilitating excretion of water, and inhibiting the renal tubular reabsorption of sodium, chloride, and other solutes. Mannitol promotes the urinary excretion of toxic materials and protects against nephrotoxicity by preventing the concentration of toxic substances in the tubular fluid. As an Antiglaucoma agent mannitol levates blood plasma osmolarity, resulting in enhanced flow of water from the eye into plasma and a consequent reduction in intraocular pressure. As a renal function diagnostic aid mannitol is freely filtered by the glomeruli with less than 10% tubular reabsorption. Therefore, its urinary excretion rate may serve as a measurement of glomerular filtration rate (GFR).



The exact mechanism of action of inhaled mannitol in the symptomatic maintenance treatment of cystic fibrosis remains unclear.[A223199, L20024] It is hypothesized that mannitol produces an osmotic gradient across the airway epithelium that draws fluid into the extracellular space and alters the properties of the airway surface mucus layer, allowing easier mucociliary clearance.[A223199]', 'Chemically, mannitol is an alcohol and a sugar, or a polyol; it is similar to xylitol or sorbitol. However, mannitol has a tendency to lose a hydrogen ion in aqueous solutions, which causes the solution to become acidic. For this reason, it is not uncommon to add a substance to adjust its pH, such as sodium bicarbonate. Mannitol is commonly used to increase urine production (diuretic). It is also used to treat or prevent medical conditions that are caused by an increase in body fluids/water (e.g., cerebral edema, glaucoma, kidney failure). Mannitol is frequently given along with other diuretics (e.g., furosemide, chlorothiazide) and/or IV fluid replacement.



Inhaled mannitol has the possibility to cause bronchospasm and hemoptysis; the occurrence of either should lead to discontinuation of inhaled mannitol.[L20024]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11157, 'Multigrinto syrup 120 ml', 'مالتي جرينتو شراب 120 مل', '75', '60', 'Multivitamins', 'Vitamin b1+b2+b3+b5+b6+b12+folic acid+lysine+iodine+zinc+vit c+iron+calcium', 'Grinta pharma', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 2044, '2025-08-04', 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11158, 'Kamillodent mouth spray', 'كاميلودنت سبراي للفم', '75', NULL, NULL, NULL, 'Company', 'Spray', 'بخاخ', NULL, '1', NULL, NULL, NULL, NULL, 1385, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11160, 'Tamsul 0.4mg 30 capsules', 'تامسول 0.4مجم 30 كبسولة', '105', NULL, 'Urination difficulty. alpha blocker.bph', 'Tamsulosin', 'Amoun', 'Capsule', 'كبسولة', '0.4mg', '3', 'احتقان البروستاتا . صعوبة وتنقيط البول', NULL, '6221025021632', NULL, 3563, '2022-12-09', 0, 'Tamsulosin is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia.[Label]



Tamsulosin is also used off label for the treatment of ureteral stones, prostatitis, and female voiding dysfunction.[A178339,L6259]', 'Tamsulosin is a blocker of alpha-1A and alpha-1D adrenoceptors.[Label,A1078] About 70% of the alpha-1 adrenoceptors in the prostate are of the alpha-1A subtype.[Label] By blocking these adrenoceptors, smooth muscle in the prostate is relaxed and urinary flow is improved.[Label] The blocking of alpha-1D adrenoceptors relaxes the detrusor muscles of the bladder which prevents storage symptoms.[A1078] The specificity of tamsulosin focuses the effects to the target area while minimizing effects in other areas.[Label]', 'Tamsulosin is an alpha adrenoceptor blocker with specificity for the alpha-1A and alpha-1D subtypes, which are more common in the prostate and submaxillary tissue.[A1078] The final subtype, alpha-1B, are most common in the aorta and spleen.[A1078] Tamsulosin binds to alpha-1A receptors 3.9-38 times more selectively than alpha-1B and 3-20 times more selectively than alpha-1D.[A1078] This selectivity allows for a significant effect on urinary flow with a reduced incidence of adverse reactions like orthostatic hypotension.[A1078]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11161, 'Tamsulin 0.4mg 28 caps', 'تامسولين 0.4مجم 28 كبسولة', '124', '93', 'Urination difficulty. alpha blocker.bph', 'Tamsulosin', 'Amoun', 'Cap', 'كبسولة', '0.4mg', '2', 'لعلاج تضخم البروستاتا', NULL, '6223003570514', NULL, 19058, '2024-06-29', 0, 'Tamsulosin is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia.[Label]



Tamsulosin is also used off label for the treatment of ureteral stones, prostatitis, and female voiding dysfunction.[A178339,L6259]', 'Tamsulosin is a blocker of alpha-1A and alpha-1D adrenoceptors.[Label,A1078] About 70% of the alpha-1 adrenoceptors in the prostate are of the alpha-1A subtype.[Label] By blocking these adrenoceptors, smooth muscle in the prostate is relaxed and urinary flow is improved.[Label] The blocking of alpha-1D adrenoceptors relaxes the detrusor muscles of the bladder which prevents storage symptoms.[A1078] The specificity of tamsulosin focuses the effects to the target area while minimizing effects in other areas.[Label]', 'Tamsulosin is an alpha adrenoceptor blocker with specificity for the alpha-1A and alpha-1D subtypes, which are more common in the prostate and submaxillary tissue.[A1078] The final subtype, alpha-1B, are most common in the aorta and spleen.[A1078] Tamsulosin binds to alpha-1A receptors 3.9-38 times more selectively than alpha-1B and 3-20 times more selectively than alpha-1D.[A1078] This selectivity allows for a significant effect on urinary flow with a reduced incidence of adverse reactions like orthostatic hypotension.[A1078]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11162, 'Tamsulosin 0.4mg 20 tab', 'تامسولوسين 0.4مجم 20 قرص', '42', NULL, 'Urination difficulty alpha blocker', 'Tamsulosin', 'Glaxo smithkline >sandoz', 'Tab', 'أقراص', '0.4mg', '2', 'حالات صعوبة التبول -- حالات التهاب البروستاتا الشديد', NULL, '6223002642274', NULL, 6342, '2023-02-15', 0, 'Tamsulosin is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia.[Label]



Tamsulosin is also used off label for the treatment of ureteral stones, prostatitis, and female voiding dysfunction.[A178339,L6259]', 'Tamsulosin is a blocker of alpha-1A and alpha-1D adrenoceptors.[Label,A1078] About 70% of the alpha-1 adrenoceptors in the prostate are of the alpha-1A subtype.[Label] By blocking these adrenoceptors, smooth muscle in the prostate is relaxed and urinary flow is improved.[Label] The blocking of alpha-1D adrenoceptors relaxes the detrusor muscles of the bladder which prevents storage symptoms.[A1078] The specificity of tamsulosin focuses the effects to the target area while minimizing effects in other areas.[Label]', 'Tamsulosin is an alpha adrenoceptor blocker with specificity for the alpha-1A and alpha-1D subtypes, which are more common in the prostate and submaxillary tissue.[A1078] The final subtype, alpha-1B, are most common in the aorta and spleen.[A1078] Tamsulosin binds to alpha-1A receptors 3.9-38 times more selectively than alpha-1B and 3-20 times more selectively than alpha-1D.[A1078] This selectivity allows for a significant effect on urinary flow with a reduced incidence of adverse reactions like orthostatic hypotension.[A1078]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11163, 'Tanakan 40mg 20 f.c tab.', 'تاناكان 40 مجم 20 قرص', '19', NULL, 'Anti-ischemic', 'Ginkgo biloba', 'Amriya > ipsen', 'Tab', 'أقراص', '40mg', '2', 'مقوي للاعصاب -- علاج الخرف لكبار السن -- منشط للدورة الدموية التي تصل الي الاطراف', NULL, '6221075010679', NULL, 2678, '2022-12-09', 0, '_Ginkgo biloba_ does not currently have any approved therapeutic indications, and there is insufficient evidence to support its unapproved use.[A232379] It is available in over-the-counter herbal products mostly for oral use, to improve memory and cognitive problems. ', 'Two key active ingredients in _ginkgo biloba_ are terpene lactones (notably ginkgolides and diterpenes) and ginkgo flavone glycosides (notably ginkgetin, bilobetin, and sciadopitysin), which are present at varying concentrations. _Ginkgo biloba_ extract EGb 761 is the standardized extract of _ginkgo biloba_ used in studies, which contains 6% terpenoids and 24% flavonoid glycosides. Animal studies have shown that _ginkgo biloba_ works on several neurotransmitter pathways and brain structures. Flavones were shown to inhibit lipid peroxidation; inhibit the uptake of serotonin, dopamine, and norepinephrine; and inhibit platelet aggregation.[A232404] Terpene lactones may also act as potent antagonists of the platelet-activating factor and may possess anti-ischemic and fibrinolytic effects.[A232379] They were also shown to downregulate adrenal peripheral benzodiazepine receptors and increase adrenocorticotropic hormone levels.[A232404] _Ginkgo biloba_ also reversibly inhibits monoamine oxidase A; and modestly inhibits anticholinesterase activity,[A232379, A232389] leading to enhanced cholinergic transmission in the brain.[A232394] 



Several studies suggest that _ginkgo biloba_ exerts neuroprotective effects by reducing free radical production in the prefrontal cortex, which may explain its improvement on short-term memory. _Ginkgo biloba_ extract acts as a free radical scavenger, protecting neurons from oxidative damage and apoptosis related to aging, cerebral ischemia, and neurodegenerative disorders.[A232379] _Ginkgo biloba_ also inhibits amyloid-β neurotoxicity and protects against hypoxic challenges and increased oxidative stress.[A232389] One study showed that bilobalide, a terpene lactone, delays the onset of hypoxic glycolysis.[A232404] _Ginkgo biloba_ has the potential to regulate metabolism, stabilize the membrane, and promote vasodilation. In the arterial endothelium, EGb stimulated the release of endogenous relaxing factors, such as endothelium-derived relaxing factor and prostacyclin. In the inflammatory environment that causes tissue damage, EGb promoted nitric oxide production, leading to enhanced peripheral and cerebral blood flow.[A232379] ', '_Ginkgo biloba_ is a herbal ingredient with demonstrated antioxidant, vasoactive, antiapoptotic, anti-inflammatory, antiplatelet, and fibrinolytic properties.[A232389, A232399] _Ginkgo biloba_ has been investigated for use in a variety of medical conditions, but the most extensively studied area is in the context of cognitive impairment and neurodegenerative disorders. _Ginkgo biloba_ was examined as a potential nootropic agent or cognitive enhancer but research findings supporting the therapeutic efficacy of _ginkgo biloba_ extract (EGb) in dementia remain controversial. Some clinical studies of dementia that were up to one year long showed that EGb improves the cognitive performance and social functioning of patients. However, other studies did not support its clinical benefit for patients with cognitive impairment and dementia. Numerous meta-analysis studies showed insufficient evidence of the effectiveness of EGb in reducing both all-cause dementia incidence and Alzheimer''s disease-associated dementia incidence in elderly patients with normal cognition or with mild cognitive impairment. Additionally, there is no up-to-date evidence that demonstrates the benefit of the long-term use of standardized EGb in reducing the risk of progression to Alzheimer''s disease. A 2012 meta-analysis did not support the use of EGb in enhancing cognitive function in healthy adults.[A232379]



In the context of cardiovascular diseases, a limited number of studies showed that EGb improved mortality or neurological recovery in the post-stroke period, reduced cognitive and neurological impairment after acute ischemic stroke, and improved blood flow in the coronary artery in patients with coronary artery disease. However, a systemic review found no statistical or clinically significant benefit of EGb for patients with peripheral arterial disease or hypertension. Overall, there is a lack of strong evidence in the use of EGb for the treatment or prevention of cardiovascular diseases.[A232379]



In a small trial, the use of EGb as an adjunctive treatment with citalopram improved depressive symptoms and cognitive function in patients with depression.[A232379] _Ginkgo biloba_ was also investigated as a potential treatment for antidepressant-induced sexual dysfunction.[A2434] Another study showed EGb improving the symptoms of tardive dyskinesia. There is insufficient evidence to prove the effectiveness of EGb in these psychiatric disorders. Limited studies have investigated the role of _ginkgo biloba_ in the treatment of vertigo, tinnitus, vitiligo, macular degeneration, and glaucoma, as well as the prevention of acute mountain sickness. As results are either preliminary or controversial, more quality research is warranted.[A232379]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11168, 'Famichew 30 chew tab', 'فاميتشو 30 قرص مضغ', '31', NULL, 'Antacid', 'Famotidine+calcium carbonate+magnesium hydroxide', 'October pharma', 'Tab', 'أقراص', NULL, '3', 'مضاد للحموضة', NULL, '6221088000070', NULL, 1455, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11169, 'Tantum 5% cream forte 20 gm', 'تانتم فورت كريم 20 جم', '15', '7.5', 'Nsaid.analgesic.antibacterial', 'Benzydamine', 'Eipico > angliny', 'Cream', 'كريم', '5%', '1', NULL, 'about benzydamine hydrochloride nonsteroidal anti-inflammatory agent analgesic and local anaesthetic. mechanism of action : it exerts it`s local analgesic anti-inflammatory actions by acting as a prostaglandin synthesis inhibitor. it inhibits cycloxygenas', '6221032241009', NULL, 974, '2024-11-08', 0, 'Available predominantly as a liquid mouthwash, oromucosal spray, or topical cream, benzydamine is most frequently employed as a locally acting analgesic and anti-inflammatory treatment for the relief of painful inflammatory conditions. 



When formulated as a mouthwash or spray, benzydamine may be used to treat traumatic conditions like pharyngitis following tonsillectomy or the use of a naso-gastric tube, inflammatory conditions like pharyngitis, aphthous ulcers and oral ulceration due to radiation therapy, dentistry operations and procedures, or more general conditions like sore throat, sore tongue, sore gums, mouth ulcers, or discomfort caused by dentures. [L1121] 



When used as a topical cream, benzydamine may be employed to relieve symptoms associated with painful inflammatory conditions of the muscolo-skeletal system including acute inflammatory disorders such as myalgia and bursitis or traumatic conditions like sprains, strains, bruises, sore muscles, stiff joints, or even the after-effects of fractures. [ L1123]', 'Despite being categorized as a non-steroidal anti-inflammatory drug (NSAID), benzydamine demonstrates various mechanisms of action that differ from those of traditional aspirin-like NSAIDs. In particular, benzydamine predominantly acts by inhibiting the synthesis of pro inflammatory cytokines like tumour necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) without largely affecting other pro inflammatory cytokines (ie. such as IL-6 and IL-8) or anti-inflammatory cytokines (ie. like IL-10 or IL-1 receptor antagonist). [A31528, L1120]



Moreover, benzydamine is largely a weak inhibitor of prostaglandin synthesis as it has been shown to effectively inhibit cyclooxygenase (COX) and lipoxygenase enzyme activity only at concentrations of 1mM or greater. Considering most contemporary usages of benzydamine are topical applications that are generally not well absorbed through the skin and/or non-specialized mucosae, benzydamine does not often achieve the kind of absorption or blood concentrations necessary to cause any extraneous distant systemic effects or COX inhibition, allowing it to localize its action. [A31528, L1120]



Additionally, it is also hypothesized that benzydamine is capable of inhibiting the oxidative burst of neutrophils and membrane stabilization. These actions are exhibited by the substance’s ability to inhibit the release of granules from neutrophils and to stabilize lysosomes. [A31528, L1120]



Furthermore, benzydamine is capable of a local anaesthetic effect that may be related to its capability for inhibiting the release of inflammatory mediators like substance P and calcitonin gene related peptide from sensory nerve endings. Since substance P is capable of causing the release of histamine from mast cells, benzydamine’s prevention of substance P release further contributes to an anti-inflammatory effect. [A31528, L1120]



Benzydamine also demonstrates a non-specific antibacterial activity against various bacterial strains that are resistant to broad-spectrum antibiotics such as ampicillin, chloramphenicol, and tetracycline at concentrations of about 3 mmol/L. Combinatorial use of benzydamine and other antibiotics like tetracycline and chloramphenicol are also synergistic against antibiotic resistant strains of *Staphylococcus aureus* and *Pseudomonas aeruginosa*. [A31528]', 'Benzydamine is a non-steroidal anti-inflammatory drug (NSAID) designed to elicit local anesthetic and analgesic effects mainly for the mouth and throat. It specifically acts on the local mechanisms of inflammation such as pain, oedema, or granuloma. Typically applied topically, the drug demonstrates anti-inflammatory activity reducing oedema as well as exudate and granuloma formation. Moreover, benzydamine exhibits analgesic properties and local anaesthetic activity if pain is caused by an inflammatory condition. Benzydamine can be absorbed into the oral mucosa and intact skin. Once absorbed in the local area of pain or inflammation, benzydamine binds selectively to local inflamed tissues, usually allowing it to act with few adverse systemic effects. On average a period of 2 to 4 hours is necessary for the substance to reach peak plasma concentration. [L1120]

 

Benzydamine can be synthesized with the reaction of the N-benzyl derivative from methyl anthranilate with nitrous acid to give N-nitoso derivative. This is next reduced by sodium thiosulfate to give transient hydrazine. This hydrazine can then undergo spontaneous internal hydrazide formation. Treating this resultant enolate with 3-chloro-1-dimethylamkino propane ultimately yields benzydamine.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11170, 'Tantum 5% top. gel 20gm', 'تانتم جيل 20 جرام', '22', '15', 'Nsaid.analgesic.antibacterial', 'Benzydamine', 'Eipico > angliny', 'Gel', 'جل', '5%', '1', 'مسكن ومضاد للبكتريا.', NULL, '6221032241047', NULL, 2651, '2025-10-27', 0, 'Available predominantly as a liquid mouthwash, oromucosal spray, or topical cream, benzydamine is most frequently employed as a locally acting analgesic and anti-inflammatory treatment for the relief of painful inflammatory conditions. 



When formulated as a mouthwash or spray, benzydamine may be used to treat traumatic conditions like pharyngitis following tonsillectomy or the use of a naso-gastric tube, inflammatory conditions like pharyngitis, aphthous ulcers and oral ulceration due to radiation therapy, dentistry operations and procedures, or more general conditions like sore throat, sore tongue, sore gums, mouth ulcers, or discomfort caused by dentures. [L1121] 



When used as a topical cream, benzydamine may be employed to relieve symptoms associated with painful inflammatory conditions of the muscolo-skeletal system including acute inflammatory disorders such as myalgia and bursitis or traumatic conditions like sprains, strains, bruises, sore muscles, stiff joints, or even the after-effects of fractures. [ L1123]', 'Despite being categorized as a non-steroidal anti-inflammatory drug (NSAID), benzydamine demonstrates various mechanisms of action that differ from those of traditional aspirin-like NSAIDs. In particular, benzydamine predominantly acts by inhibiting the synthesis of pro inflammatory cytokines like tumour necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) without largely affecting other pro inflammatory cytokines (ie. such as IL-6 and IL-8) or anti-inflammatory cytokines (ie. like IL-10 or IL-1 receptor antagonist). [A31528, L1120]



Moreover, benzydamine is largely a weak inhibitor of prostaglandin synthesis as it has been shown to effectively inhibit cyclooxygenase (COX) and lipoxygenase enzyme activity only at concentrations of 1mM or greater. Considering most contemporary usages of benzydamine are topical applications that are generally not well absorbed through the skin and/or non-specialized mucosae, benzydamine does not often achieve the kind of absorption or blood concentrations necessary to cause any extraneous distant systemic effects or COX inhibition, allowing it to localize its action. [A31528, L1120]



Additionally, it is also hypothesized that benzydamine is capable of inhibiting the oxidative burst of neutrophils and membrane stabilization. These actions are exhibited by the substance’s ability to inhibit the release of granules from neutrophils and to stabilize lysosomes. [A31528, L1120]



Furthermore, benzydamine is capable of a local anaesthetic effect that may be related to its capability for inhibiting the release of inflammatory mediators like substance P and calcitonin gene related peptide from sensory nerve endings. Since substance P is capable of causing the release of histamine from mast cells, benzydamine’s prevention of substance P release further contributes to an anti-inflammatory effect. [A31528, L1120]



Benzydamine also demonstrates a non-specific antibacterial activity against various bacterial strains that are resistant to broad-spectrum antibiotics such as ampicillin, chloramphenicol, and tetracycline at concentrations of about 3 mmol/L. Combinatorial use of benzydamine and other antibiotics like tetracycline and chloramphenicol are also synergistic against antibiotic resistant strains of *Staphylococcus aureus* and *Pseudomonas aeruginosa*. [A31528]', 'Benzydamine is a non-steroidal anti-inflammatory drug (NSAID) designed to elicit local anesthetic and analgesic effects mainly for the mouth and throat. It specifically acts on the local mechanisms of inflammation such as pain, oedema, or granuloma. Typically applied topically, the drug demonstrates anti-inflammatory activity reducing oedema as well as exudate and granuloma formation. Moreover, benzydamine exhibits analgesic properties and local anaesthetic activity if pain is caused by an inflammatory condition. Benzydamine can be absorbed into the oral mucosa and intact skin. Once absorbed in the local area of pain or inflammation, benzydamine binds selectively to local inflamed tissues, usually allowing it to act with few adverse systemic effects. On average a period of 2 to 4 hours is necessary for the substance to reach peak plasma concentration. [L1120]

 

Benzydamine can be synthesized with the reaction of the N-benzyl derivative from methyl anthranilate with nitrous acid to give N-nitoso derivative. This is next reduced by sodium thiosulfate to give transient hydrazine. This hydrazine can then undergo spontaneous internal hydrazide formation. Treating this resultant enolate with 3-chloro-1-dimethylamkino propane ultimately yields benzydamine.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11171, 'Tantum rosa 0.5g powder for vaginal solution', 'تانتم وردي بودرة 10 جم 5 اكياس', '19', '13', 'Vaginal wash', 'Benzydamine', 'Eipico > angliny', 'Solution', 'محلول', NULL, '1', NULL, NULL, '6221032160546', NULL, 2067, '2024-11-08', 0, 'Available predominantly as a liquid mouthwash, oromucosal spray, or topical cream, benzydamine is most frequently employed as a locally acting analgesic and anti-inflammatory treatment for the relief of painful inflammatory conditions. 



When formulated as a mouthwash or spray, benzydamine may be used to treat traumatic conditions like pharyngitis following tonsillectomy or the use of a naso-gastric tube, inflammatory conditions like pharyngitis, aphthous ulcers and oral ulceration due to radiation therapy, dentistry operations and procedures, or more general conditions like sore throat, sore tongue, sore gums, mouth ulcers, or discomfort caused by dentures. [L1121] 



When used as a topical cream, benzydamine may be employed to relieve symptoms associated with painful inflammatory conditions of the muscolo-skeletal system including acute inflammatory disorders such as myalgia and bursitis or traumatic conditions like sprains, strains, bruises, sore muscles, stiff joints, or even the after-effects of fractures. [ L1123]', 'Despite being categorized as a non-steroidal anti-inflammatory drug (NSAID), benzydamine demonstrates various mechanisms of action that differ from those of traditional aspirin-like NSAIDs. In particular, benzydamine predominantly acts by inhibiting the synthesis of pro inflammatory cytokines like tumour necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) without largely affecting other pro inflammatory cytokines (ie. such as IL-6 and IL-8) or anti-inflammatory cytokines (ie. like IL-10 or IL-1 receptor antagonist). [A31528, L1120]



Moreover, benzydamine is largely a weak inhibitor of prostaglandin synthesis as it has been shown to effectively inhibit cyclooxygenase (COX) and lipoxygenase enzyme activity only at concentrations of 1mM or greater. Considering most contemporary usages of benzydamine are topical applications that are generally not well absorbed through the skin and/or non-specialized mucosae, benzydamine does not often achieve the kind of absorption or blood concentrations necessary to cause any extraneous distant systemic effects or COX inhibition, allowing it to localize its action. [A31528, L1120]



Additionally, it is also hypothesized that benzydamine is capable of inhibiting the oxidative burst of neutrophils and membrane stabilization. These actions are exhibited by the substance’s ability to inhibit the release of granules from neutrophils and to stabilize lysosomes. [A31528, L1120]



Furthermore, benzydamine is capable of a local anaesthetic effect that may be related to its capability for inhibiting the release of inflammatory mediators like substance P and calcitonin gene related peptide from sensory nerve endings. Since substance P is capable of causing the release of histamine from mast cells, benzydamine’s prevention of substance P release further contributes to an anti-inflammatory effect. [A31528, L1120]



Benzydamine also demonstrates a non-specific antibacterial activity against various bacterial strains that are resistant to broad-spectrum antibiotics such as ampicillin, chloramphenicol, and tetracycline at concentrations of about 3 mmol/L. Combinatorial use of benzydamine and other antibiotics like tetracycline and chloramphenicol are also synergistic against antibiotic resistant strains of *Staphylococcus aureus* and *Pseudomonas aeruginosa*. [A31528]', 'Benzydamine is a non-steroidal anti-inflammatory drug (NSAID) designed to elicit local anesthetic and analgesic effects mainly for the mouth and throat. It specifically acts on the local mechanisms of inflammation such as pain, oedema, or granuloma. Typically applied topically, the drug demonstrates anti-inflammatory activity reducing oedema as well as exudate and granuloma formation. Moreover, benzydamine exhibits analgesic properties and local anaesthetic activity if pain is caused by an inflammatory condition. Benzydamine can be absorbed into the oral mucosa and intact skin. Once absorbed in the local area of pain or inflammation, benzydamine binds selectively to local inflamed tissues, usually allowing it to act with few adverse systemic effects. On average a period of 2 to 4 hours is necessary for the substance to reach peak plasma concentration. [L1120]

 

Benzydamine can be synthesized with the reaction of the N-benzyl derivative from methyl anthranilate with nitrous acid to give N-nitoso derivative. This is next reduced by sodium thiosulfate to give transient hydrazine. This hydrazine can then undergo spontaneous internal hydrazide formation. Treating this resultant enolate with 3-chloro-1-dimethylamkino propane ultimately yields benzydamine.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11172, 'Tantum verde 0.15% mouth wash 125 ml', 'تانتم اخضر مضمضة للفم 125 مل', '31', '21.5', 'Analgesic.antibacterial', 'Benzydamine', 'Eipico', 'Mouth wash', 'غسول للفم', '0.15%', '1', 'مضمضة مطهرة للفم', 'about benzydamine hydrochloride nonsteroidal anti-inflammatory agent analgesic and local anaesthetic. mechanism of action : it exerts it`s local analgesic anti-inflammatory actions by acting as a prostaglandin synthesis inhibitor. it inhibits cycloxygenas', '6221032222275', NULL, 24061, '2024-07-27', 0, 'Available predominantly as a liquid mouthwash, oromucosal spray, or topical cream, benzydamine is most frequently employed as a locally acting analgesic and anti-inflammatory treatment for the relief of painful inflammatory conditions. 



When formulated as a mouthwash or spray, benzydamine may be used to treat traumatic conditions like pharyngitis following tonsillectomy or the use of a naso-gastric tube, inflammatory conditions like pharyngitis, aphthous ulcers and oral ulceration due to radiation therapy, dentistry operations and procedures, or more general conditions like sore throat, sore tongue, sore gums, mouth ulcers, or discomfort caused by dentures. [L1121] 



When used as a topical cream, benzydamine may be employed to relieve symptoms associated with painful inflammatory conditions of the muscolo-skeletal system including acute inflammatory disorders such as myalgia and bursitis or traumatic conditions like sprains, strains, bruises, sore muscles, stiff joints, or even the after-effects of fractures. [ L1123]', 'Despite being categorized as a non-steroidal anti-inflammatory drug (NSAID), benzydamine demonstrates various mechanisms of action that differ from those of traditional aspirin-like NSAIDs. In particular, benzydamine predominantly acts by inhibiting the synthesis of pro inflammatory cytokines like tumour necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) without largely affecting other pro inflammatory cytokines (ie. such as IL-6 and IL-8) or anti-inflammatory cytokines (ie. like IL-10 or IL-1 receptor antagonist). [A31528, L1120]



Moreover, benzydamine is largely a weak inhibitor of prostaglandin synthesis as it has been shown to effectively inhibit cyclooxygenase (COX) and lipoxygenase enzyme activity only at concentrations of 1mM or greater. Considering most contemporary usages of benzydamine are topical applications that are generally not well absorbed through the skin and/or non-specialized mucosae, benzydamine does not often achieve the kind of absorption or blood concentrations necessary to cause any extraneous distant systemic effects or COX inhibition, allowing it to localize its action. [A31528, L1120]



Additionally, it is also hypothesized that benzydamine is capable of inhibiting the oxidative burst of neutrophils and membrane stabilization. These actions are exhibited by the substance’s ability to inhibit the release of granules from neutrophils and to stabilize lysosomes. [A31528, L1120]



Furthermore, benzydamine is capable of a local anaesthetic effect that may be related to its capability for inhibiting the release of inflammatory mediators like substance P and calcitonin gene related peptide from sensory nerve endings. Since substance P is capable of causing the release of histamine from mast cells, benzydamine’s prevention of substance P release further contributes to an anti-inflammatory effect. [A31528, L1120]



Benzydamine also demonstrates a non-specific antibacterial activity against various bacterial strains that are resistant to broad-spectrum antibiotics such as ampicillin, chloramphenicol, and tetracycline at concentrations of about 3 mmol/L. Combinatorial use of benzydamine and other antibiotics like tetracycline and chloramphenicol are also synergistic against antibiotic resistant strains of *Staphylococcus aureus* and *Pseudomonas aeruginosa*. [A31528]', 'Benzydamine is a non-steroidal anti-inflammatory drug (NSAID) designed to elicit local anesthetic and analgesic effects mainly for the mouth and throat. It specifically acts on the local mechanisms of inflammation such as pain, oedema, or granuloma. Typically applied topically, the drug demonstrates anti-inflammatory activity reducing oedema as well as exudate and granuloma formation. Moreover, benzydamine exhibits analgesic properties and local anaesthetic activity if pain is caused by an inflammatory condition. Benzydamine can be absorbed into the oral mucosa and intact skin. Once absorbed in the local area of pain or inflammation, benzydamine binds selectively to local inflamed tissues, usually allowing it to act with few adverse systemic effects. On average a period of 2 to 4 hours is necessary for the substance to reach peak plasma concentration. [L1120]

 

Benzydamine can be synthesized with the reaction of the N-benzyl derivative from methyl anthranilate with nitrous acid to give N-nitoso derivative. This is next reduced by sodium thiosulfate to give transient hydrazine. This hydrazine can then undergo spontaneous internal hydrazide formation. Treating this resultant enolate with 3-chloro-1-dimethylamkino propane ultimately yields benzydamine.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11173, 'Tantum verde-p 3mg 20 lozenge', 'تانتم اخضر باستيلية 20 قرص استحلاب', '40', '9', 'Nsaid.analgesic.antibacterial', 'Benzydamine', 'Eipico > angliny', 'Unknown', 'غير محدد', '3mg', '2', NULL, 'about benzydamine hydrochloride nonsteroidal anti-inflammatory agent analgesic and local anaesthetic. mechanism of action : it exerts it`s local analgesic anti-inflammatory actions by acting as a prostaglandin synthesis inhibitor. it inhibits cycloxygenas', '6221032115089', NULL, 2452, '2024-11-09', 0, 'Available predominantly as a liquid mouthwash, oromucosal spray, or topical cream, benzydamine is most frequently employed as a locally acting analgesic and anti-inflammatory treatment for the relief of painful inflammatory conditions. 



When formulated as a mouthwash or spray, benzydamine may be used to treat traumatic conditions like pharyngitis following tonsillectomy or the use of a naso-gastric tube, inflammatory conditions like pharyngitis, aphthous ulcers and oral ulceration due to radiation therapy, dentistry operations and procedures, or more general conditions like sore throat, sore tongue, sore gums, mouth ulcers, or discomfort caused by dentures. [L1121] 



When used as a topical cream, benzydamine may be employed to relieve symptoms associated with painful inflammatory conditions of the muscolo-skeletal system including acute inflammatory disorders such as myalgia and bursitis or traumatic conditions like sprains, strains, bruises, sore muscles, stiff joints, or even the after-effects of fractures. [ L1123]', 'Despite being categorized as a non-steroidal anti-inflammatory drug (NSAID), benzydamine demonstrates various mechanisms of action that differ from those of traditional aspirin-like NSAIDs. In particular, benzydamine predominantly acts by inhibiting the synthesis of pro inflammatory cytokines like tumour necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) without largely affecting other pro inflammatory cytokines (ie. such as IL-6 and IL-8) or anti-inflammatory cytokines (ie. like IL-10 or IL-1 receptor antagonist). [A31528, L1120]



Moreover, benzydamine is largely a weak inhibitor of prostaglandin synthesis as it has been shown to effectively inhibit cyclooxygenase (COX) and lipoxygenase enzyme activity only at concentrations of 1mM or greater. Considering most contemporary usages of benzydamine are topical applications that are generally not well absorbed through the skin and/or non-specialized mucosae, benzydamine does not often achieve the kind of absorption or blood concentrations necessary to cause any extraneous distant systemic effects or COX inhibition, allowing it to localize its action. [A31528, L1120]



Additionally, it is also hypothesized that benzydamine is capable of inhibiting the oxidative burst of neutrophils and membrane stabilization. These actions are exhibited by the substance’s ability to inhibit the release of granules from neutrophils and to stabilize lysosomes. [A31528, L1120]



Furthermore, benzydamine is capable of a local anaesthetic effect that may be related to its capability for inhibiting the release of inflammatory mediators like substance P and calcitonin gene related peptide from sensory nerve endings. Since substance P is capable of causing the release of histamine from mast cells, benzydamine’s prevention of substance P release further contributes to an anti-inflammatory effect. [A31528, L1120]



Benzydamine also demonstrates a non-specific antibacterial activity against various bacterial strains that are resistant to broad-spectrum antibiotics such as ampicillin, chloramphenicol, and tetracycline at concentrations of about 3 mmol/L. Combinatorial use of benzydamine and other antibiotics like tetracycline and chloramphenicol are also synergistic against antibiotic resistant strains of *Staphylococcus aureus* and *Pseudomonas aeruginosa*. [A31528]', 'Benzydamine is a non-steroidal anti-inflammatory drug (NSAID) designed to elicit local anesthetic and analgesic effects mainly for the mouth and throat. It specifically acts on the local mechanisms of inflammation such as pain, oedema, or granuloma. Typically applied topically, the drug demonstrates anti-inflammatory activity reducing oedema as well as exudate and granuloma formation. Moreover, benzydamine exhibits analgesic properties and local anaesthetic activity if pain is caused by an inflammatory condition. Benzydamine can be absorbed into the oral mucosa and intact skin. Once absorbed in the local area of pain or inflammation, benzydamine binds selectively to local inflamed tissues, usually allowing it to act with few adverse systemic effects. On average a period of 2 to 4 hours is necessary for the substance to reach peak plasma concentration. [L1120]

 

Benzydamine can be synthesized with the reaction of the N-benzyl derivative from methyl anthranilate with nitrous acid to give N-nitoso derivative. This is next reduced by sodium thiosulfate to give transient hydrazine. This hydrazine can then undergo spontaneous internal hydrazide formation. Treating this resultant enolate with 3-chloro-1-dimethylamkino propane ultimately yields benzydamine.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11177, 'Tareg 160mg 28 f.c. tab.', 'تارج 160مجم 28 قرص', '320', '244', 'Antihypertensive.angiotensin blocker', 'Valsartan', 'Novartis', 'Tab', 'أقراص', '160mg', '4', NULL, 'about valsartan angiotensin ii receptor antagonist antihypertensive. mechanism of action of valsartansit is a competitive antagonist of angiotensin-2 at at-1 receptor. it decreases peripheral resistance and lowers bp in hypertensive individuals. it blocks', '622300264024', NULL, 3621, '2024-08-05', 0, 'Valsartan is indicated for the treatment of hypertension to reduce the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It is also indicated for the treatment of heart failure (NYHA class II-IV) and for left ventricular dysfunction or failure after myocardial infarction when the use of an angiotensin-converting enzyme inhibitor (ACEI) is not appropriate.[F4703, L11305]



It is also used in combination with [sacubitril].[L36445]', 'Valsartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which selectively bind to angiotensin receptor 1 (AT1) and prevent angiotensin II from binding and exerting its hypertensive effects. These include vasoconstriction, stimulation and synthesis of aldosterone and ADH, cardiac stimulation, and renal reabsorption of sodium among others. Overall, valsartan''s physiologic effects lead to reduced blood pressure, lower aldosterone levels, reduced cardiac activity, and increased excretion of sodium. 



Valsartan also affects the renin-angiotensin aldosterone system (RAAS), which plays an important role in hemostasis and regulation of kidney, vascular, and cardiac functions. Pharmacological blockade of RAAS via  AT1 receptor blockade inhibits negative regulatory feedback within RAAS which is a contributing factor to the pathogenesis and progression of cardiovascular disease, heart failure, and renal disease. In particular, heart failure is associated with chronic activation of RAAS, leading to inappropriate fluid retention, vasoconstriction, and ultimately a further decline in left ventricular function. ARBs have been shown to have a protective effect on the heart by improving cardiac function, reducing afterload, increasing cardiac output and prevent ventricular hypertrophy.[A174154]



The angiotensin-converting enzyme inhibitor (ACEI) class of medications (which includes drugs such as [ramipril], [lisinopril], and [perindopril]) inhibits the conversion of angiotensin I to angiotensin II by inhibiting the ACE enzyme but does not prevent the formation of all angiotensin II. ARB activity is unique in that it blocks all angiotensin II activity, regardless of where or how it was synthesized. 



Valsartan is commonly used for the management of hypertension, heart failure, and type 2 diabetes-associated nephropathy, particularly in patients who are unable to tolerate ACE inhibitors. ARBs such as valsartan have been shown in a number of large-scale clinical outcomes trials to improve cardiovascular outcomes including reducing risk of myocardial infarction, stroke, the progression of heart failure, and hospitalization.[A174124,A178153,A173869,A185324,A185327,A185333,A185342,A185345] Valsartan also slows the progression of diabetic nephropathy due to its renoprotective effects.[A174157,A174160,A174163] Improvements in chronic kidney disease with valsartan include both clinically and statistically significant decreases in urinary albumin and protein excretion in patients diagnosed with type 2 diabetes and in nondiabetic patients diagnosed with chronic kidney disease.[A174124,A173869]



Valsartan also binds to the AT2 receptor, however AT2 is not known to be associated with cardiovascular homeostasis like AT1. Valsartan has about 20,000-fold higher affinity for the AT1 receptor than for the AT2 receptor. The increased plasma levels of angiotensin II following AT1 receptor blockade with valsartan may stimulate the unblocked AT2 receptor.[L11305]', 'Valsartan inhibits the pressor effects of angiotensin II with oral doses of 80 mg inhibiting the pressor effect by about 80% at peak with approximately 30% inhibition persisting for 24 hours. Removal of the negative feedback of angiotensin II causes a 2- to 3-fold rise in plasma renin and consequent rise in angiotensin II plasma concentration in hypertensive patients. Minimal decreases in plasma aldosterone were observed after administration of valsartan.



In multiple-dose studies in hypertensive patients, valsartan had no notable effects on total cholesterol, fasting triglycerides, fasting serum glucose, or uric acid.[L11305]



**Hypotension** 



Excessive hypotension was rarely seen (0.1%) in patients with uncomplicated hypertension treated with valsartan alone. In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients receiving high doses of diuretics, symptomatic hypotension may occur. This condition should be corrected prior to administration of valsartan, or the treatment should start under close medical supervision. 



Caution should be observed when initiating therapy in patients with heart failure. Patients with heart failure given valsartan commonly have some reduction in blood pressure, but discontinuation of therapy because of continuing symptomatic hypotension usually is not necessary when dosing instructions are followed. In controlled trials in heart failure patients, the incidence of hypotension in valsartan-treated patients was 5.5% compared to 1.8% in placebo-treated patients. 



If excessive hypotension occurs, the patient should be placed in the supine position and, if necessary, given an intravenous infusion of normal saline. A transient hypotensive response is not a contraindication to further treatment, which usually can be continued without difficulty once the blood pressure has stabilized.[L11305]





**Impaired Renal Function**



Changes in renal function including acute renal failure can be caused by drugs that inhibit the renin-angiotensin system and by diuretics. Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing acute renal failure on valsartan. Monitor renal function periodically in these patients. Consider withholding or discontinuing therapy in patients who develop a clinically significant decrease in renal function on valsartan.[L11305]





**Hyperkalemia**



Some patients with heart failure have developed increases in potassium. These effects are usually minor and transient, and they are more likely to occur in patients with pre-existing renal impairment. Dosage reduction and/or discontinuation of valsartan may be required.[L11305]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11178, 'Tareg 320mg 10 f.c. tab.', 'تارج 320مجم 10 اقراص', '140', '107', 'Antihypertensive.angiotensin blocker', 'Valsartan', 'Novartis', 'Tab', 'أقراص', '320mg', '1', NULL, 'about valsartan angiotensin ii receptor antagonist antihypertensive. mechanism of action of valsartan it is a competitive antagonist of angiotensin-2 at at-1 receptor. it decreases peripheral resistance and lowers bp in hypertensive individuals. it blocks', '6223002641970', NULL, 1458, '2024-08-05', 0, 'Valsartan is indicated for the treatment of hypertension to reduce the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It is also indicated for the treatment of heart failure (NYHA class II-IV) and for left ventricular dysfunction or failure after myocardial infarction when the use of an angiotensin-converting enzyme inhibitor (ACEI) is not appropriate.[F4703, L11305]



It is also used in combination with [sacubitril].[L36445]', 'Valsartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which selectively bind to angiotensin receptor 1 (AT1) and prevent angiotensin II from binding and exerting its hypertensive effects. These include vasoconstriction, stimulation and synthesis of aldosterone and ADH, cardiac stimulation, and renal reabsorption of sodium among others. Overall, valsartan''s physiologic effects lead to reduced blood pressure, lower aldosterone levels, reduced cardiac activity, and increased excretion of sodium. 



Valsartan also affects the renin-angiotensin aldosterone system (RAAS), which plays an important role in hemostasis and regulation of kidney, vascular, and cardiac functions. Pharmacological blockade of RAAS via  AT1 receptor blockade inhibits negative regulatory feedback within RAAS which is a contributing factor to the pathogenesis and progression of cardiovascular disease, heart failure, and renal disease. In particular, heart failure is associated with chronic activation of RAAS, leading to inappropriate fluid retention, vasoconstriction, and ultimately a further decline in left ventricular function. ARBs have been shown to have a protective effect on the heart by improving cardiac function, reducing afterload, increasing cardiac output and prevent ventricular hypertrophy.[A174154]



The angiotensin-converting enzyme inhibitor (ACEI) class of medications (which includes drugs such as [ramipril], [lisinopril], and [perindopril]) inhibits the conversion of angiotensin I to angiotensin II by inhibiting the ACE enzyme but does not prevent the formation of all angiotensin II. ARB activity is unique in that it blocks all angiotensin II activity, regardless of where or how it was synthesized. 



Valsartan is commonly used for the management of hypertension, heart failure, and type 2 diabetes-associated nephropathy, particularly in patients who are unable to tolerate ACE inhibitors. ARBs such as valsartan have been shown in a number of large-scale clinical outcomes trials to improve cardiovascular outcomes including reducing risk of myocardial infarction, stroke, the progression of heart failure, and hospitalization.[A174124,A178153,A173869,A185324,A185327,A185333,A185342,A185345] Valsartan also slows the progression of diabetic nephropathy due to its renoprotective effects.[A174157,A174160,A174163] Improvements in chronic kidney disease with valsartan include both clinically and statistically significant decreases in urinary albumin and protein excretion in patients diagnosed with type 2 diabetes and in nondiabetic patients diagnosed with chronic kidney disease.[A174124,A173869]



Valsartan also binds to the AT2 receptor, however AT2 is not known to be associated with cardiovascular homeostasis like AT1. Valsartan has about 20,000-fold higher affinity for the AT1 receptor than for the AT2 receptor. The increased plasma levels of angiotensin II following AT1 receptor blockade with valsartan may stimulate the unblocked AT2 receptor.[L11305]', 'Valsartan inhibits the pressor effects of angiotensin II with oral doses of 80 mg inhibiting the pressor effect by about 80% at peak with approximately 30% inhibition persisting for 24 hours. Removal of the negative feedback of angiotensin II causes a 2- to 3-fold rise in plasma renin and consequent rise in angiotensin II plasma concentration in hypertensive patients. Minimal decreases in plasma aldosterone were observed after administration of valsartan.



In multiple-dose studies in hypertensive patients, valsartan had no notable effects on total cholesterol, fasting triglycerides, fasting serum glucose, or uric acid.[L11305]



**Hypotension** 



Excessive hypotension was rarely seen (0.1%) in patients with uncomplicated hypertension treated with valsartan alone. In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients receiving high doses of diuretics, symptomatic hypotension may occur. This condition should be corrected prior to administration of valsartan, or the treatment should start under close medical supervision. 



Caution should be observed when initiating therapy in patients with heart failure. Patients with heart failure given valsartan commonly have some reduction in blood pressure, but discontinuation of therapy because of continuing symptomatic hypotension usually is not necessary when dosing instructions are followed. In controlled trials in heart failure patients, the incidence of hypotension in valsartan-treated patients was 5.5% compared to 1.8% in placebo-treated patients. 



If excessive hypotension occurs, the patient should be placed in the supine position and, if necessary, given an intravenous infusion of normal saline. A transient hypotensive response is not a contraindication to further treatment, which usually can be continued without difficulty once the blood pressure has stabilized.[L11305]





**Impaired Renal Function**



Changes in renal function including acute renal failure can be caused by drugs that inhibit the renin-angiotensin system and by diuretics. Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing acute renal failure on valsartan. Monitor renal function periodically in these patients. Consider withholding or discontinuing therapy in patients who develop a clinically significant decrease in renal function on valsartan.[L11305]





**Hyperkalemia**



Some patients with heart failure have developed increases in potassium. These effects are usually minor and transient, and they are more likely to occur in patients with pre-existing renal impairment. Dosage reduction and/or discontinuation of valsartan may be required.[L11305]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11179, 'Tareg 40mg 15 f.c.tab.', 'تارج 40مجم 15 قرص', '150', '117', 'Antihypertensive.angiotensin blocker', 'Valsartan', 'Novartis', 'Tab', 'أقراص', '40mg', '3', NULL, NULL, '6223002641826', NULL, 4881, '2024-08-04', 0, 'Valsartan is indicated for the treatment of hypertension to reduce the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It is also indicated for the treatment of heart failure (NYHA class II-IV) and for left ventricular dysfunction or failure after myocardial infarction when the use of an angiotensin-converting enzyme inhibitor (ACEI) is not appropriate.[F4703, L11305]



It is also used in combination with [sacubitril].[L36445]', 'Valsartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which selectively bind to angiotensin receptor 1 (AT1) and prevent angiotensin II from binding and exerting its hypertensive effects. These include vasoconstriction, stimulation and synthesis of aldosterone and ADH, cardiac stimulation, and renal reabsorption of sodium among others. Overall, valsartan''s physiologic effects lead to reduced blood pressure, lower aldosterone levels, reduced cardiac activity, and increased excretion of sodium. 



Valsartan also affects the renin-angiotensin aldosterone system (RAAS), which plays an important role in hemostasis and regulation of kidney, vascular, and cardiac functions. Pharmacological blockade of RAAS via  AT1 receptor blockade inhibits negative regulatory feedback within RAAS which is a contributing factor to the pathogenesis and progression of cardiovascular disease, heart failure, and renal disease. In particular, heart failure is associated with chronic activation of RAAS, leading to inappropriate fluid retention, vasoconstriction, and ultimately a further decline in left ventricular function. ARBs have been shown to have a protective effect on the heart by improving cardiac function, reducing afterload, increasing cardiac output and prevent ventricular hypertrophy.[A174154]



The angiotensin-converting enzyme inhibitor (ACEI) class of medications (which includes drugs such as [ramipril], [lisinopril], and [perindopril]) inhibits the conversion of angiotensin I to angiotensin II by inhibiting the ACE enzyme but does not prevent the formation of all angiotensin II. ARB activity is unique in that it blocks all angiotensin II activity, regardless of where or how it was synthesized. 



Valsartan is commonly used for the management of hypertension, heart failure, and type 2 diabetes-associated nephropathy, particularly in patients who are unable to tolerate ACE inhibitors. ARBs such as valsartan have been shown in a number of large-scale clinical outcomes trials to improve cardiovascular outcomes including reducing risk of myocardial infarction, stroke, the progression of heart failure, and hospitalization.[A174124,A178153,A173869,A185324,A185327,A185333,A185342,A185345] Valsartan also slows the progression of diabetic nephropathy due to its renoprotective effects.[A174157,A174160,A174163] Improvements in chronic kidney disease with valsartan include both clinically and statistically significant decreases in urinary albumin and protein excretion in patients diagnosed with type 2 diabetes and in nondiabetic patients diagnosed with chronic kidney disease.[A174124,A173869]



Valsartan also binds to the AT2 receptor, however AT2 is not known to be associated with cardiovascular homeostasis like AT1. Valsartan has about 20,000-fold higher affinity for the AT1 receptor than for the AT2 receptor. The increased plasma levels of angiotensin II following AT1 receptor blockade with valsartan may stimulate the unblocked AT2 receptor.[L11305]', 'Valsartan inhibits the pressor effects of angiotensin II with oral doses of 80 mg inhibiting the pressor effect by about 80% at peak with approximately 30% inhibition persisting for 24 hours. Removal of the negative feedback of angiotensin II causes a 2- to 3-fold rise in plasma renin and consequent rise in angiotensin II plasma concentration in hypertensive patients. Minimal decreases in plasma aldosterone were observed after administration of valsartan.



In multiple-dose studies in hypertensive patients, valsartan had no notable effects on total cholesterol, fasting triglycerides, fasting serum glucose, or uric acid.[L11305]



**Hypotension** 



Excessive hypotension was rarely seen (0.1%) in patients with uncomplicated hypertension treated with valsartan alone. In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients receiving high doses of diuretics, symptomatic hypotension may occur. This condition should be corrected prior to administration of valsartan, or the treatment should start under close medical supervision. 



Caution should be observed when initiating therapy in patients with heart failure. Patients with heart failure given valsartan commonly have some reduction in blood pressure, but discontinuation of therapy because of continuing symptomatic hypotension usually is not necessary when dosing instructions are followed. In controlled trials in heart failure patients, the incidence of hypotension in valsartan-treated patients was 5.5% compared to 1.8% in placebo-treated patients. 



If excessive hypotension occurs, the patient should be placed in the supine position and, if necessary, given an intravenous infusion of normal saline. A transient hypotensive response is not a contraindication to further treatment, which usually can be continued without difficulty once the blood pressure has stabilized.[L11305]





**Impaired Renal Function**



Changes in renal function including acute renal failure can be caused by drugs that inhibit the renin-angiotensin system and by diuretics. Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing acute renal failure on valsartan. Monitor renal function periodically in these patients. Consider withholding or discontinuing therapy in patients who develop a clinically significant decrease in renal function on valsartan.[L11305]





**Hyperkalemia**



Some patients with heart failure have developed increases in potassium. These effects are usually minor and transient, and they are more likely to occur in patients with pre-existing renal impairment. Dosage reduction and/or discontinuation of valsartan may be required.[L11305]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11182, 'Tareg 80mg 14 f.c. tab.', 'تارج 80مجم 14 قرص', '148', '113', 'Antihypertensive.angiotensin blocker', 'Valsartan', 'Novartis', 'Tab', 'أقراص', '80mg', '2', 'علاج ارتفاع ضغط الدم', NULL, '6223002641123', NULL, 6552, '2024-08-04', 0, 'Valsartan is indicated for the treatment of hypertension to reduce the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It is also indicated for the treatment of heart failure (NYHA class II-IV) and for left ventricular dysfunction or failure after myocardial infarction when the use of an angiotensin-converting enzyme inhibitor (ACEI) is not appropriate.[F4703, L11305]



It is also used in combination with [sacubitril].[L36445]', 'Valsartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which selectively bind to angiotensin receptor 1 (AT1) and prevent angiotensin II from binding and exerting its hypertensive effects. These include vasoconstriction, stimulation and synthesis of aldosterone and ADH, cardiac stimulation, and renal reabsorption of sodium among others. Overall, valsartan''s physiologic effects lead to reduced blood pressure, lower aldosterone levels, reduced cardiac activity, and increased excretion of sodium. 



Valsartan also affects the renin-angiotensin aldosterone system (RAAS), which plays an important role in hemostasis and regulation of kidney, vascular, and cardiac functions. Pharmacological blockade of RAAS via  AT1 receptor blockade inhibits negative regulatory feedback within RAAS which is a contributing factor to the pathogenesis and progression of cardiovascular disease, heart failure, and renal disease. In particular, heart failure is associated with chronic activation of RAAS, leading to inappropriate fluid retention, vasoconstriction, and ultimately a further decline in left ventricular function. ARBs have been shown to have a protective effect on the heart by improving cardiac function, reducing afterload, increasing cardiac output and prevent ventricular hypertrophy.[A174154]



The angiotensin-converting enzyme inhibitor (ACEI) class of medications (which includes drugs such as [ramipril], [lisinopril], and [perindopril]) inhibits the conversion of angiotensin I to angiotensin II by inhibiting the ACE enzyme but does not prevent the formation of all angiotensin II. ARB activity is unique in that it blocks all angiotensin II activity, regardless of where or how it was synthesized. 



Valsartan is commonly used for the management of hypertension, heart failure, and type 2 diabetes-associated nephropathy, particularly in patients who are unable to tolerate ACE inhibitors. ARBs such as valsartan have been shown in a number of large-scale clinical outcomes trials to improve cardiovascular outcomes including reducing risk of myocardial infarction, stroke, the progression of heart failure, and hospitalization.[A174124,A178153,A173869,A185324,A185327,A185333,A185342,A185345] Valsartan also slows the progression of diabetic nephropathy due to its renoprotective effects.[A174157,A174160,A174163] Improvements in chronic kidney disease with valsartan include both clinically and statistically significant decreases in urinary albumin and protein excretion in patients diagnosed with type 2 diabetes and in nondiabetic patients diagnosed with chronic kidney disease.[A174124,A173869]



Valsartan also binds to the AT2 receptor, however AT2 is not known to be associated with cardiovascular homeostasis like AT1. Valsartan has about 20,000-fold higher affinity for the AT1 receptor than for the AT2 receptor. The increased plasma levels of angiotensin II following AT1 receptor blockade with valsartan may stimulate the unblocked AT2 receptor.[L11305]', 'Valsartan inhibits the pressor effects of angiotensin II with oral doses of 80 mg inhibiting the pressor effect by about 80% at peak with approximately 30% inhibition persisting for 24 hours. Removal of the negative feedback of angiotensin II causes a 2- to 3-fold rise in plasma renin and consequent rise in angiotensin II plasma concentration in hypertensive patients. Minimal decreases in plasma aldosterone were observed after administration of valsartan.



In multiple-dose studies in hypertensive patients, valsartan had no notable effects on total cholesterol, fasting triglycerides, fasting serum glucose, or uric acid.[L11305]



**Hypotension** 



Excessive hypotension was rarely seen (0.1%) in patients with uncomplicated hypertension treated with valsartan alone. In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients receiving high doses of diuretics, symptomatic hypotension may occur. This condition should be corrected prior to administration of valsartan, or the treatment should start under close medical supervision. 



Caution should be observed when initiating therapy in patients with heart failure. Patients with heart failure given valsartan commonly have some reduction in blood pressure, but discontinuation of therapy because of continuing symptomatic hypotension usually is not necessary when dosing instructions are followed. In controlled trials in heart failure patients, the incidence of hypotension in valsartan-treated patients was 5.5% compared to 1.8% in placebo-treated patients. 



If excessive hypotension occurs, the patient should be placed in the supine position and, if necessary, given an intravenous infusion of normal saline. A transient hypotensive response is not a contraindication to further treatment, which usually can be continued without difficulty once the blood pressure has stabilized.[L11305]





**Impaired Renal Function**



Changes in renal function including acute renal failure can be caused by drugs that inhibit the renin-angiotensin system and by diuretics. Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing acute renal failure on valsartan. Monitor renal function periodically in these patients. Consider withholding or discontinuing therapy in patients who develop a clinically significant decrease in renal function on valsartan.[L11305]





**Hyperkalemia**



Some patients with heart failure have developed increases in potassium. These effects are usually minor and transient, and they are more likely to occur in patients with pre-existing renal impairment. Dosage reduction and/or discontinuation of valsartan may be required.[L11305]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11185, 'Targofloxin 750 mg 5 f.c.tab.', 'تارجوفلوكساسين 750مجم 5 قرص', '94', '49.5', 'Antibiotic.quinolone', 'Levofloxacin', 'Global napi pharmaceuticals', 'Tab', 'أقراص', '750 mg', '1', 'مضاد حيوي', NULL, '6223002140299', NULL, 15943, '2024-08-07', 0, 'In oral and intravenous formulations, levofloxacin is indicated in adults for the treatment of various infections caused by susceptible bacteria, including infections of the upper respiratory tract, lower respiratory tract, skin, skin structures, urinary tract, and prostate.[L11638,L11692] The oral formulation is also indicated in both adults and children 6 months of age and older for the post-exposure management of inhalational anthrax caused by _Bacillus anthracis_ and for the treatment and/or prophylaxis of plague caused by _Yersinia pestis_.[L11638]



In its ophthalmic formulation, levofloxacin is indicated for the treatment of bacterial conjunctivitis caused by susceptible organisms.[L11641] An inhalational solution available in Canada is indicated for the management of cystic fibrosis patients aged 18 years or older with chronic pulmonary _Pseudomonas aeruginosa_ infections.[L11689]', 'Levofloxacin, like other fluoroquinolone antibiotics, exerts its antimicrobial activity via the inhibition of two key bacterial enzymes: DNA gyrase and topoisomerase IV.[L11638] Both targets are type II topoisomerases, but have unique functions within the bacterial cell. DNA gyrase is an enzyme found only in bacteria that introduces negative supercoils into DNA during replication - this helps to relieve torsional strain caused by the introduction of positive supercoils during replication, and these negative supercoils are essential for chromosome condensation and the promotion of transcription initiation.[A31453] It is comprised of four subunits (two A subunits and two B subunits) of which the A subunits appear to be the target of fluoroquinolone antibiotics.[A190663] Bacterial topoisomerase IV, in addition to contributing to the relaxation of positive supercoils, is essential at the terminal stages of DNA replication and functions to “unlink” newly replicated chromosomes to allow for the completion of cell division.[A31453]



Inhibition of these enzymes by levofloxacin likely occurs via complexation with the topoisomerase enzymes.[A31453] The end result is a blockade of DNA replication, thus inhibiting cell division and resulting in cell death.', 'Levofloxacin is bactericidal and exerts its antimicrobial effects via inhibition of bacterial DNA replication.[L11638] It has a relatively long duration of action in comparison with other antibiotics that allows for once or twice daily dosing. Levofloxacin is associated with QTc-interval prolongation and should be used with caution in patients with other risk factors for prolongation (e.g. hypokalemia, concomitant medications).[L11638]



Levofloxacin has demonstrated _in vitro_ activity against a number of aerobic gram-positive and gram-negative bacteria and may carry some activity against certain species of anaerobic bacteria[L11638] and other pathogens such as _Chlamydia_ and _Legionella_.[A190663] Resistance to levofloxacin may develop, and is generally due to mutations in DNA gyrase or topoisomerase IV, or via alterations to drug efflux.[L11638,A31453] Cross-resistance may occur between levofloxacin and other fluoroquinolones, but is unlikely to develop between levofloxacin and other antibiotic classes (e.g. macrolides) due to significant differences in chemical structure and mechanism of action.[L11638]



As antimicrobial susceptibility patterns are geographically distinct, local antibiograms should be consulted to ensure adequate coverage of relevant pathogens prior to use.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11186, 'Targocid 200 mg vial for i.v/i.m inj.', 'تارجوسيد 200مجم فيال', '408', '285', 'Antibiotic with glycopeptide', 'Teicoplanin', 'Gruppo lepetit > sanofi', 'Inj', 'حقن', '200 mg', '1', NULL, 'about teicoplanin glycopeptide antibiotic antibiotic similar to vancomycin. mechanism of action of teicoplanin teicoplanin binds to the terminal dipeptide (amino d alanyl d alanine residue) sequence of peptidoglycan and inhibits the association and cross', '3582910016021', NULL, 1932, '2024-12-15', 0, 'For the treatment of bacterial infections caused by susceptible microorganisms.', 'Teicoplanin inhibits peptidoglycan polymerization, resulting in inhibition of bacterial cell wall synthesis and cell death.', 'It is a glycopeptide antiobiotic extracted from <i>Actinoplanes teichomyceticus</i>, with a similar spectrum of activity to vancomycin. Its mechanism of action is to inhibit bacterial cell wall synthesis. Oral teicoplanin has been demonstrated to be effective in the treatment of pseudomembranous colitis and Clostridium difficile-associated diarrhoea, with comparable efficacy to vancomycin.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11187, 'Targocid 400mg vial for i.v/i.m inj.', 'تارجوسيد 400مجم فيال', '528', '369', 'Antibiotic with glycopeptide', 'Teicoplanin', 'Gruppo lepetit > sanofi', 'Inj', 'حقن', '400mg', '1', NULL, 'about teicoplanin glycopeptide antibiotic antibiotic similar to vancomycin. mechanism of action of teicoplanin teicoplanin binds to the terminal dipeptide (amino d alanyl d alanine residue) sequence of peptidoglycan and inhibits the association and cross', '3582910029014', NULL, 2588, '2024-11-02', 0, 'For the treatment of bacterial infections caused by susceptible microorganisms.', 'Teicoplanin inhibits peptidoglycan polymerization, resulting in inhibition of bacterial cell wall synthesis and cell death.', 'It is a glycopeptide antiobiotic extracted from <i>Actinoplanes teichomyceticus</i>, with a similar spectrum of activity to vancomycin. Its mechanism of action is to inhibit bacterial cell wall synthesis. Oral teicoplanin has been demonstrated to be effective in the treatment of pseudomembranous colitis and Clostridium difficile-associated diarrhoea, with comparable efficacy to vancomycin.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11188, 'Tariflox 3mg/ml eye dps. 10 ml', 'تاريفلوكس 3مجم/مل قطرة للعين 10 مل', '20', '8', 'Antibiotic.quinolone', 'Ofloxacin', 'Borg', 'Unknown', 'غير محدد', '3mg', '1', NULL, NULL, '6223002570447', NULL, 833, '2025-01-16', 0, 'For the treatment of infections (respiratory tract, kidney, skin, soft tissue, UTI), urethral and cervical gonorrhoea.', 'Ofloxacin acts on DNA gyrase and toposiomerase IV, enzymes which, like human topoisomerase, prevents the excessive supercoiling of DNA during replication or transcription. By inhibiting their function, the drug thereby inhibits normal cell division.', 'Ofloxacin is a quinolone/fluoroquinolone antibiotic. Ofloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Ofloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11189, 'Tariflox 200 mg 10 tab.', 'تاريفلوكس 200مجم 10 اقراص', '26', '16.8', 'Antibiotic.quinolone', 'Ofloxacin', 'Borg', 'Tab', 'أقراص', '200 mg', '1', NULL, NULL, '6223002570430', NULL, 1174, '2024-09-27', 0, 'For the treatment of infections (respiratory tract, kidney, skin, soft tissue, UTI), urethral and cervical gonorrhoea.', 'Ofloxacin acts on DNA gyrase and toposiomerase IV, enzymes which, like human topoisomerase, prevents the excessive supercoiling of DNA during replication or transcription. By inhibiting their function, the drug thereby inhibits normal cell division.', 'Ofloxacin is a quinolone/fluoroquinolone antibiotic. Ofloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Ofloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11190, 'Tariflox 400 mg 10 tabs.', 'تاريفلوكس 400 مجم 10 اقراص', '45', '28.8', 'Antibiotic.quinolone', 'Ofloxacin', 'Borg', 'Tab', 'أقراص', '400 mg', '2', 'مضاد حيوي', 'about ofloxacin a second generation fluoroquinolone(quinolones) antibiotic. mechanism of action of ofloxacin ofloxacin is a bactericidal drug. it act by inhibiting the enzyme dna gyrase (topoisomerase 2) and topoisomerase 4.dna gyrase helps in the formati', '6223002570041', NULL, 1993, '2024-09-27', 0, 'For the treatment of infections (respiratory tract, kidney, skin, soft tissue, UTI), urethral and cervical gonorrhoea.', 'Ofloxacin acts on DNA gyrase and toposiomerase IV, enzymes which, like human topoisomerase, prevents the excessive supercoiling of DNA during replication or transcription. By inhibiting their function, the drug thereby inhibits normal cell division.', 'Ofloxacin is a quinolone/fluoroquinolone antibiotic. Ofloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Ofloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11191, 'Tarivan 200mg 10 tab.', 'تاريفان 200مجم 10 اقراص', '44', '30', 'Antibiotic.quinolone', 'Ofloxacin', 'Alexandria', 'Tab', 'أقراص', '200mg', '1', NULL, 'about ofloxacin a second generation fluoroquinolone(quinolones) antibiotic. mechanism of action of ofloxacin ofloxacin is a bactericidal drug. it act by inhibiting the enzyme dna gyrase (topoisomerase 2) and topoisomerase 4.dna gyrase helps in the formati', '6223000172285', NULL, 1312, '2024-04-05', 0, 'For the treatment of infections (respiratory tract, kidney, skin, soft tissue, UTI), urethral and cervical gonorrhoea.', 'Ofloxacin acts on DNA gyrase and toposiomerase IV, enzymes which, like human topoisomerase, prevents the excessive supercoiling of DNA during replication or transcription. By inhibiting their function, the drug thereby inhibits normal cell division.', 'Ofloxacin is a quinolone/fluoroquinolone antibiotic. Ofloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Ofloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11196, 'Tarolimus 0.03% topical oint. 15 gm', 'تاروليمس مرهم 03% 15 جم', '129', '129', 'Immunosuppressants.psoriasis', 'Tacrolimus', 'Andalous pharma', 'Oint', 'مرهم', '0.03%', '1', 'علاج حالات الصدفية.', 'this form of tacrolimus is used on the skin to treat a skin condition called eczema (atopic dermatitis) in patients who have not responded well to (or should not use) other eczema medications. eczema is an allergic-type condition that causes red irritated', '6224000396701', NULL, 11983, '2025-12-15', 0, 'Immediate-release formulations of tacrolimus are indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney, heart, or lung transplants, in combination with other immunosuppressants.[L8162] Extended-release formulations of tacrolimus are indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving kidney transplants, in combination with other immunosuppressants,[L20034,L41005] and may be used in patients converted from immediate-release formulations.[L41005]



Topical tacrolimus ointment is indicated as second-line therapy for short-term and non-continuous treatment of moderate-to-severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical treatments or for whom alternative treatments are not advisable.[L3935] Both available strengths are indicated in adult patients, while only the lower strength (0.03%) formulation is indicated in pediatric patients between 2 and 15 years of age.[L3935]', 'The mechanism of action of tacrolimus in atopic dermatitis is not known. While the following have been observed, the clinical significance of these observations in atopic dermatitis is not known. It has been demonstrated that tacrolimus inhibits T-lymphocyte activation by first binding to an intracellular protein, FKBP-12. A complex of tacrolimus-FKBP-12, calcium, calmodulin, and calcineurin is then formed and the phosphatase activity of calcineurin is inhibited. This prevents the dephosphorylation and translocation of nuclear factor of activated T-cells (NF-AT), a nuclear component thought to initiate gene transcription for the formation of lymphokines. Tacrolimus also inhibits the transcription for genes which encode IL-3, IL-4, IL-5, GM-CSF, and TNF-, all of which are involved in the early stages of T-cell activation. Additionally, tacrolimus has been shown to inhibit the release of pre-formed mediators from skin mast cells and basophils, and to downregulate the expression of FceRI on Langerhans cells.', 'Tacrolimus acts by reducing peptidyl-prolyl isomerase activity by binding to the immunophilin FKBP-12 (FK506 binding protein) creating a new complex. This inhibits both T-lymphocyte signal transduction and IL-2 transcription. Tacrolimus has similar activity to cyclosporine but rates of rejection are lower with tacrolimus. Tacrolimus has also been shown to be effective in the topical treatment of eczema, particularly atopic eczema. It suppresses inflammation in a similar way to steroids, but is not as powerful. An important dermatological advantage of tacrolimus is that it can be used directly on the face; topical steroids cannot be used on the face, as they thin the skin dramatically there. On other parts of the body, topical steroid are generally a better treatment.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11201, 'Tavacin 500mg 5 f.c. tab', 'تافاسين 500مجم 5 اقراص', '90', '63.5', 'Antibiotic.quinolone', 'Levofloxacin', 'Hikma pharma', 'Tab', 'أقراص', '500mg', '1', 'مضاد حيوي', NULL, '6221000001178', NULL, 10387, '2024-07-04', 0, 'In oral and intravenous formulations, levofloxacin is indicated in adults for the treatment of various infections caused by susceptible bacteria, including infections of the upper respiratory tract, lower respiratory tract, skin, skin structures, urinary tract, and prostate.[L11638,L11692] The oral formulation is also indicated in both adults and children 6 months of age and older for the post-exposure management of inhalational anthrax caused by _Bacillus anthracis_ and for the treatment and/or prophylaxis of plague caused by _Yersinia pestis_.[L11638]



In its ophthalmic formulation, levofloxacin is indicated for the treatment of bacterial conjunctivitis caused by susceptible organisms.[L11641] An inhalational solution available in Canada is indicated for the management of cystic fibrosis patients aged 18 years or older with chronic pulmonary _Pseudomonas aeruginosa_ infections.[L11689]', 'Levofloxacin, like other fluoroquinolone antibiotics, exerts its antimicrobial activity via the inhibition of two key bacterial enzymes: DNA gyrase and topoisomerase IV.[L11638] Both targets are type II topoisomerases, but have unique functions within the bacterial cell. DNA gyrase is an enzyme found only in bacteria that introduces negative supercoils into DNA during replication - this helps to relieve torsional strain caused by the introduction of positive supercoils during replication, and these negative supercoils are essential for chromosome condensation and the promotion of transcription initiation.[A31453] It is comprised of four subunits (two A subunits and two B subunits) of which the A subunits appear to be the target of fluoroquinolone antibiotics.[A190663] Bacterial topoisomerase IV, in addition to contributing to the relaxation of positive supercoils, is essential at the terminal stages of DNA replication and functions to “unlink” newly replicated chromosomes to allow for the completion of cell division.[A31453]



Inhibition of these enzymes by levofloxacin likely occurs via complexation with the topoisomerase enzymes.[A31453] The end result is a blockade of DNA replication, thus inhibiting cell division and resulting in cell death.', 'Levofloxacin is bactericidal and exerts its antimicrobial effects via inhibition of bacterial DNA replication.[L11638] It has a relatively long duration of action in comparison with other antibiotics that allows for once or twice daily dosing. Levofloxacin is associated with QTc-interval prolongation and should be used with caution in patients with other risk factors for prolongation (e.g. hypokalemia, concomitant medications).[L11638]



Levofloxacin has demonstrated _in vitro_ activity against a number of aerobic gram-positive and gram-negative bacteria and may carry some activity against certain species of anaerobic bacteria[L11638] and other pathogens such as _Chlamydia_ and _Legionella_.[A190663] Resistance to levofloxacin may develop, and is generally due to mutations in DNA gyrase or topoisomerase IV, or via alterations to drug efflux.[L11638,A31453] Cross-resistance may occur between levofloxacin and other fluoroquinolones, but is unlikely to develop between levofloxacin and other antibiotic classes (e.g. macrolides) due to significant differences in chemical structure and mechanism of action.[L11638]



As antimicrobial susceptibility patterns are geographically distinct, local antibiograms should be consulted to ensure adequate coverage of relevant pathogens prior to use.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11202, 'Tavacin 750mg 5 tab', 'تافاسين 750مجم 5 اقراص', '96', '65.5', 'Antibiotic quinolone', 'Levofloxacin', 'Hikma phrarma', 'Tab', 'أقراص', '750mg', '1', 'مضاد حيوي', NULL, '6221000001185', NULL, 7227, '2024-07-23', 0, 'In oral and intravenous formulations, levofloxacin is indicated in adults for the treatment of various infections caused by susceptible bacteria, including infections of the upper respiratory tract, lower respiratory tract, skin, skin structures, urinary tract, and prostate.[L11638,L11692] The oral formulation is also indicated in both adults and children 6 months of age and older for the post-exposure management of inhalational anthrax caused by _Bacillus anthracis_ and for the treatment and/or prophylaxis of plague caused by _Yersinia pestis_.[L11638]



In its ophthalmic formulation, levofloxacin is indicated for the treatment of bacterial conjunctivitis caused by susceptible organisms.[L11641] An inhalational solution available in Canada is indicated for the management of cystic fibrosis patients aged 18 years or older with chronic pulmonary _Pseudomonas aeruginosa_ infections.[L11689]', 'Levofloxacin, like other fluoroquinolone antibiotics, exerts its antimicrobial activity via the inhibition of two key bacterial enzymes: DNA gyrase and topoisomerase IV.[L11638] Both targets are type II topoisomerases, but have unique functions within the bacterial cell. DNA gyrase is an enzyme found only in bacteria that introduces negative supercoils into DNA during replication - this helps to relieve torsional strain caused by the introduction of positive supercoils during replication, and these negative supercoils are essential for chromosome condensation and the promotion of transcription initiation.[A31453] It is comprised of four subunits (two A subunits and two B subunits) of which the A subunits appear to be the target of fluoroquinolone antibiotics.[A190663] Bacterial topoisomerase IV, in addition to contributing to the relaxation of positive supercoils, is essential at the terminal stages of DNA replication and functions to “unlink” newly replicated chromosomes to allow for the completion of cell division.[A31453]



Inhibition of these enzymes by levofloxacin likely occurs via complexation with the topoisomerase enzymes.[A31453] The end result is a blockade of DNA replication, thus inhibiting cell division and resulting in cell death.', 'Levofloxacin is bactericidal and exerts its antimicrobial effects via inhibition of bacterial DNA replication.[L11638] It has a relatively long duration of action in comparison with other antibiotics that allows for once or twice daily dosing. Levofloxacin is associated with QTc-interval prolongation and should be used with caution in patients with other risk factors for prolongation (e.g. hypokalemia, concomitant medications).[L11638]



Levofloxacin has demonstrated _in vitro_ activity against a number of aerobic gram-positive and gram-negative bacteria and may carry some activity against certain species of anaerobic bacteria[L11638] and other pathogens such as _Chlamydia_ and _Legionella_.[A190663] Resistance to levofloxacin may develop, and is generally due to mutations in DNA gyrase or topoisomerase IV, or via alterations to drug efflux.[L11638,A31453] Cross-resistance may occur between levofloxacin and other fluoroquinolones, but is unlikely to develop between levofloxacin and other antibiotic classes (e.g. macrolides) due to significant differences in chemical structure and mechanism of action.[L11638]



As antimicrobial susceptibility patterns are geographically distinct, local antibiograms should be consulted to ensure adequate coverage of relevant pathogens prior to use.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11203, 'Tavanic 250mg 5 tab', 'تافانيك 250مجم 5 اقراص', '50', NULL, 'Antibiotic.quinolone', 'Levofloxacin', 'Sanofi', 'Tab', 'أقراص', '250mg', '1', NULL, NULL, NULL, NULL, 1418, '2022-08-22', 0, 'In oral and intravenous formulations, levofloxacin is indicated in adults for the treatment of various infections caused by susceptible bacteria, including infections of the upper respiratory tract, lower respiratory tract, skin, skin structures, urinary tract, and prostate.[L11638,L11692] The oral formulation is also indicated in both adults and children 6 months of age and older for the post-exposure management of inhalational anthrax caused by _Bacillus anthracis_ and for the treatment and/or prophylaxis of plague caused by _Yersinia pestis_.[L11638]



In its ophthalmic formulation, levofloxacin is indicated for the treatment of bacterial conjunctivitis caused by susceptible organisms.[L11641] An inhalational solution available in Canada is indicated for the management of cystic fibrosis patients aged 18 years or older with chronic pulmonary _Pseudomonas aeruginosa_ infections.[L11689]', 'Levofloxacin, like other fluoroquinolone antibiotics, exerts its antimicrobial activity via the inhibition of two key bacterial enzymes: DNA gyrase and topoisomerase IV.[L11638] Both targets are type II topoisomerases, but have unique functions within the bacterial cell. DNA gyrase is an enzyme found only in bacteria that introduces negative supercoils into DNA during replication - this helps to relieve torsional strain caused by the introduction of positive supercoils during replication, and these negative supercoils are essential for chromosome condensation and the promotion of transcription initiation.[A31453] It is comprised of four subunits (two A subunits and two B subunits) of which the A subunits appear to be the target of fluoroquinolone antibiotics.[A190663] Bacterial topoisomerase IV, in addition to contributing to the relaxation of positive supercoils, is essential at the terminal stages of DNA replication and functions to “unlink” newly replicated chromosomes to allow for the completion of cell division.[A31453]



Inhibition of these enzymes by levofloxacin likely occurs via complexation with the topoisomerase enzymes.[A31453] The end result is a blockade of DNA replication, thus inhibiting cell division and resulting in cell death.', 'Levofloxacin is bactericidal and exerts its antimicrobial effects via inhibition of bacterial DNA replication.[L11638] It has a relatively long duration of action in comparison with other antibiotics that allows for once or twice daily dosing. Levofloxacin is associated with QTc-interval prolongation and should be used with caution in patients with other risk factors for prolongation (e.g. hypokalemia, concomitant medications).[L11638]



Levofloxacin has demonstrated _in vitro_ activity against a number of aerobic gram-positive and gram-negative bacteria and may carry some activity against certain species of anaerobic bacteria[L11638] and other pathogens such as _Chlamydia_ and _Legionella_.[A190663] Resistance to levofloxacin may develop, and is generally due to mutations in DNA gyrase or topoisomerase IV, or via alterations to drug efflux.[L11638,A31453] Cross-resistance may occur between levofloxacin and other fluoroquinolones, but is unlikely to develop between levofloxacin and other antibiotic classes (e.g. macrolides) due to significant differences in chemical structure and mechanism of action.[L11638]



As antimicrobial susceptibility patterns are geographically distinct, local antibiograms should be consulted to ensure adequate coverage of relevant pathogens prior to use.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11204, 'Tavanic 500mg 5 tab', 'تافانيك 500مجم 5 اقراص', '192', '134', 'Antibiotic quinolone', 'Levofloxacin', 'Sanofi', 'Tab', 'أقراص', '500mg', '1', 'مضاد حيوي في علاج حالات مثل الالتهاب الرئوي والتهاب الشعب والتهاب الجلد والتهاب المسالك البولية', NULL, '6223003991340', NULL, 21748, '2024-10-22', 0, 'In oral and intravenous formulations, levofloxacin is indicated in adults for the treatment of various infections caused by susceptible bacteria, including infections of the upper respiratory tract, lower respiratory tract, skin, skin structures, urinary tract, and prostate.[L11638,L11692] The oral formulation is also indicated in both adults and children 6 months of age and older for the post-exposure management of inhalational anthrax caused by _Bacillus anthracis_ and for the treatment and/or prophylaxis of plague caused by _Yersinia pestis_.[L11638]



In its ophthalmic formulation, levofloxacin is indicated for the treatment of bacterial conjunctivitis caused by susceptible organisms.[L11641] An inhalational solution available in Canada is indicated for the management of cystic fibrosis patients aged 18 years or older with chronic pulmonary _Pseudomonas aeruginosa_ infections.[L11689]', 'Levofloxacin, like other fluoroquinolone antibiotics, exerts its antimicrobial activity via the inhibition of two key bacterial enzymes: DNA gyrase and topoisomerase IV.[L11638] Both targets are type II topoisomerases, but have unique functions within the bacterial cell. DNA gyrase is an enzyme found only in bacteria that introduces negative supercoils into DNA during replication - this helps to relieve torsional strain caused by the introduction of positive supercoils during replication, and these negative supercoils are essential for chromosome condensation and the promotion of transcription initiation.[A31453] It is comprised of four subunits (two A subunits and two B subunits) of which the A subunits appear to be the target of fluoroquinolone antibiotics.[A190663] Bacterial topoisomerase IV, in addition to contributing to the relaxation of positive supercoils, is essential at the terminal stages of DNA replication and functions to “unlink” newly replicated chromosomes to allow for the completion of cell division.[A31453]



Inhibition of these enzymes by levofloxacin likely occurs via complexation with the topoisomerase enzymes.[A31453] The end result is a blockade of DNA replication, thus inhibiting cell division and resulting in cell death.', 'Levofloxacin is bactericidal and exerts its antimicrobial effects via inhibition of bacterial DNA replication.[L11638] It has a relatively long duration of action in comparison with other antibiotics that allows for once or twice daily dosing. Levofloxacin is associated with QTc-interval prolongation and should be used with caution in patients with other risk factors for prolongation (e.g. hypokalemia, concomitant medications).[L11638]



Levofloxacin has demonstrated _in vitro_ activity against a number of aerobic gram-positive and gram-negative bacteria and may carry some activity against certain species of anaerobic bacteria[L11638] and other pathogens such as _Chlamydia_ and _Legionella_.[A190663] Resistance to levofloxacin may develop, and is generally due to mutations in DNA gyrase or topoisomerase IV, or via alterations to drug efflux.[L11638,A31453] Cross-resistance may occur between levofloxacin and other fluoroquinolones, but is unlikely to develop between levofloxacin and other antibiotic classes (e.g. macrolides) due to significant differences in chemical structure and mechanism of action.[L11638]



As antimicrobial susceptibility patterns are geographically distinct, local antibiograms should be consulted to ensure adequate coverage of relevant pathogens prior to use.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11205, 'Tavanic 500mg/100ml vial for i.v. inf.', 'تافانيك 500مجم/100مل وريدي', '305', '211', 'Antibiotic.quinolone', 'Levofloxacin', 'Sanofi', 'Vial', 'فيال', '500mg', '1', NULL, 'about levofloxacin third generation fluoroquinolone (or quinolone) a broad spectrum antiinfective. mechanism of action of levofloxacin levofloxacin is a broad spectrum antibacterial agent. it act by inhibiting the enzyme dna gyrase (topoisomerase 2) and t', '3664798008159', NULL, 3004, '2024-09-30', 0, 'In oral and intravenous formulations, levofloxacin is indicated in adults for the treatment of various infections caused by susceptible bacteria, including infections of the upper respiratory tract, lower respiratory tract, skin, skin structures, urinary tract, and prostate.[L11638,L11692] The oral formulation is also indicated in both adults and children 6 months of age and older for the post-exposure management of inhalational anthrax caused by _Bacillus anthracis_ and for the treatment and/or prophylaxis of plague caused by _Yersinia pestis_.[L11638]



In its ophthalmic formulation, levofloxacin is indicated for the treatment of bacterial conjunctivitis caused by susceptible organisms.[L11641] An inhalational solution available in Canada is indicated for the management of cystic fibrosis patients aged 18 years or older with chronic pulmonary _Pseudomonas aeruginosa_ infections.[L11689]', 'Levofloxacin, like other fluoroquinolone antibiotics, exerts its antimicrobial activity via the inhibition of two key bacterial enzymes: DNA gyrase and topoisomerase IV.[L11638] Both targets are type II topoisomerases, but have unique functions within the bacterial cell. DNA gyrase is an enzyme found only in bacteria that introduces negative supercoils into DNA during replication - this helps to relieve torsional strain caused by the introduction of positive supercoils during replication, and these negative supercoils are essential for chromosome condensation and the promotion of transcription initiation.[A31453] It is comprised of four subunits (two A subunits and two B subunits) of which the A subunits appear to be the target of fluoroquinolone antibiotics.[A190663] Bacterial topoisomerase IV, in addition to contributing to the relaxation of positive supercoils, is essential at the terminal stages of DNA replication and functions to “unlink” newly replicated chromosomes to allow for the completion of cell division.[A31453]



Inhibition of these enzymes by levofloxacin likely occurs via complexation with the topoisomerase enzymes.[A31453] The end result is a blockade of DNA replication, thus inhibiting cell division and resulting in cell death.', 'Levofloxacin is bactericidal and exerts its antimicrobial effects via inhibition of bacterial DNA replication.[L11638] It has a relatively long duration of action in comparison with other antibiotics that allows for once or twice daily dosing. Levofloxacin is associated with QTc-interval prolongation and should be used with caution in patients with other risk factors for prolongation (e.g. hypokalemia, concomitant medications).[L11638]



Levofloxacin has demonstrated _in vitro_ activity against a number of aerobic gram-positive and gram-negative bacteria and may carry some activity against certain species of anaerobic bacteria[L11638] and other pathogens such as _Chlamydia_ and _Legionella_.[A190663] Resistance to levofloxacin may develop, and is generally due to mutations in DNA gyrase or topoisomerase IV, or via alterations to drug efflux.[L11638,A31453] Cross-resistance may occur between levofloxacin and other fluoroquinolones, but is unlikely to develop between levofloxacin and other antibiotic classes (e.g. macrolides) due to significant differences in chemical structure and mechanism of action.[L11638]



As antimicrobial susceptibility patterns are geographically distinct, local antibiograms should be consulted to ensure adequate coverage of relevant pathogens prior to use.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11206, 'Tavegyl 1mg/10ml syrup 100ml', 'تافيجيل 1مجم/10مل شراب 100مل', '9', NULL, 'Antihistamine.antiallergy', 'Clemastine', 'Novartis > glaxo smithkline', 'Syrup', 'شراب', '1mg', '1', NULL, 'description an ethanolamine-derivative first generation histamine h1 antagonist used in hay fever rhinitis allergic skin conditions and pruritus. indication for the relief of symptoms associated with allergic rhinitis such as sneezing rhinorrhea pruritus', '6223002640218', NULL, 939, '2023-05-01', 0, 'For the relief of symptoms associated with allergic rhinitis such as sneezing, rhinorrhea, pruritus and acrimation. Also for the management of mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Used as self-medication for temporary relief of symptoms associated with the common cold.', 'Clemastine is a selective histamine H1 antagonist and binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.', 'Clemastine is an antihistamine that also induces anticholinergic and sedative effects. Antihistamines competitively antagonize various physiological effects of histamine including increased capillary permeability and dilatation, the formation of edema, the "flare" and "itch" response, and gastrointestinal and respiratory smooth muscle constriction. Within the vascular tree, H1- receptor antagonists inhibit both the vasoconstrictor and vasodilator effects of histamine. Depending on the dose, H1- receptor antagonists can produce CNS stimulation or depression. Most antihistamines exhibit central and/or peripheral anticholinergic activity. Antihistamines act by competitively blocking H1- receptor sites. Antihistamines do not pharmacologically antagonize or chemically inactivate histamine, nor do they prevent the release of histamine.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11208, 'Tavegyl 2mg/2ml 3 amp. i.m. i.v. inj.', 'تافيجيل 2مجم/2مل 3 امبولات', '11', NULL, 'Antihistamine.antiallergy', 'Clemastine', 'Novartis > glaxo smithkline', 'Inj', 'حقن', '2mg', '3', NULL, 'description an ethanolamine-derivative first generation histamine h1 antagonist used in hay fever rhinitis allergic skin conditions and pruritus. indication for the relief of symptoms associated with allergic rhinitis such as sneezing rhinorrhea pruritus', '6223002640751', NULL, 977, '2023-05-01', 0, 'For the relief of symptoms associated with allergic rhinitis such as sneezing, rhinorrhea, pruritus and acrimation. Also for the management of mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Used as self-medication for temporary relief of symptoms associated with the common cold.', 'Clemastine is a selective histamine H1 antagonist and binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.', 'Clemastine is an antihistamine that also induces anticholinergic and sedative effects. Antihistamines competitively antagonize various physiological effects of histamine including increased capillary permeability and dilatation, the formation of edema, the "flare" and "itch" response, and gastrointestinal and respiratory smooth muscle constriction. Within the vascular tree, H1- receptor antagonists inhibit both the vasoconstrictor and vasodilator effects of histamine. Depending on the dose, H1- receptor antagonists can produce CNS stimulation or depression. Most antihistamines exhibit central and/or peripheral anticholinergic activity. Antihistamines act by competitively blocking H1- receptor sites. Antihistamines do not pharmacologically antagonize or chemically inactivate histamine, nor do they prevent the release of histamine.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11209, 'Tavoniflox 500mg 7 f.c. tabs', 'تافونيفلوكس 500مجم 7 اقراص', '52', '35', 'Antibiotic.quinolone', 'Levofloxacin', 'Borg', 'Tab', 'أقراص', '500mg', '1', 'مضاد حيوي', NULL, '6223002570614', NULL, 2797, '2024-09-03', 0, 'In oral and intravenous formulations, levofloxacin is indicated in adults for the treatment of various infections caused by susceptible bacteria, including infections of the upper respiratory tract, lower respiratory tract, skin, skin structures, urinary tract, and prostate.[L11638,L11692] The oral formulation is also indicated in both adults and children 6 months of age and older for the post-exposure management of inhalational anthrax caused by _Bacillus anthracis_ and for the treatment and/or prophylaxis of plague caused by _Yersinia pestis_.[L11638]



In its ophthalmic formulation, levofloxacin is indicated for the treatment of bacterial conjunctivitis caused by susceptible organisms.[L11641] An inhalational solution available in Canada is indicated for the management of cystic fibrosis patients aged 18 years or older with chronic pulmonary _Pseudomonas aeruginosa_ infections.[L11689]', 'Levofloxacin, like other fluoroquinolone antibiotics, exerts its antimicrobial activity via the inhibition of two key bacterial enzymes: DNA gyrase and topoisomerase IV.[L11638] Both targets are type II topoisomerases, but have unique functions within the bacterial cell. DNA gyrase is an enzyme found only in bacteria that introduces negative supercoils into DNA during replication - this helps to relieve torsional strain caused by the introduction of positive supercoils during replication, and these negative supercoils are essential for chromosome condensation and the promotion of transcription initiation.[A31453] It is comprised of four subunits (two A subunits and two B subunits) of which the A subunits appear to be the target of fluoroquinolone antibiotics.[A190663] Bacterial topoisomerase IV, in addition to contributing to the relaxation of positive supercoils, is essential at the terminal stages of DNA replication and functions to “unlink” newly replicated chromosomes to allow for the completion of cell division.[A31453]



Inhibition of these enzymes by levofloxacin likely occurs via complexation with the topoisomerase enzymes.[A31453] The end result is a blockade of DNA replication, thus inhibiting cell division and resulting in cell death.', 'Levofloxacin is bactericidal and exerts its antimicrobial effects via inhibition of bacterial DNA replication.[L11638] It has a relatively long duration of action in comparison with other antibiotics that allows for once or twice daily dosing. Levofloxacin is associated with QTc-interval prolongation and should be used with caution in patients with other risk factors for prolongation (e.g. hypokalemia, concomitant medications).[L11638]



Levofloxacin has demonstrated _in vitro_ activity against a number of aerobic gram-positive and gram-negative bacteria and may carry some activity against certain species of anaerobic bacteria[L11638] and other pathogens such as _Chlamydia_ and _Legionella_.[A190663] Resistance to levofloxacin may develop, and is generally due to mutations in DNA gyrase or topoisomerase IV, or via alterations to drug efflux.[L11638,A31453] Cross-resistance may occur between levofloxacin and other fluoroquinolones, but is unlikely to develop between levofloxacin and other antibiotic classes (e.g. macrolides) due to significant differences in chemical structure and mechanism of action.[L11638]



As antimicrobial susceptibility patterns are geographically distinct, local antibiograms should be consulted to ensure adequate coverage of relevant pathogens prior to use.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11210, 'Tavoniflox 750mg 7 f.c. tabs', 'تافونيفلوكس 750مجم 7 اقراص', '66', '45', 'Antibiotic.quinolone', 'Levofloxacin', 'Borg', 'Tab', 'أقراص', '750mg', '1', 'مضاد حيوي', NULL, '6223002570621', NULL, 2838, '2024-09-03', 0, 'In oral and intravenous formulations, levofloxacin is indicated in adults for the treatment of various infections caused by susceptible bacteria, including infections of the upper respiratory tract, lower respiratory tract, skin, skin structures, urinary tract, and prostate.[L11638,L11692] The oral formulation is also indicated in both adults and children 6 months of age and older for the post-exposure management of inhalational anthrax caused by _Bacillus anthracis_ and for the treatment and/or prophylaxis of plague caused by _Yersinia pestis_.[L11638]



In its ophthalmic formulation, levofloxacin is indicated for the treatment of bacterial conjunctivitis caused by susceptible organisms.[L11641] An inhalational solution available in Canada is indicated for the management of cystic fibrosis patients aged 18 years or older with chronic pulmonary _Pseudomonas aeruginosa_ infections.[L11689]', 'Levofloxacin, like other fluoroquinolone antibiotics, exerts its antimicrobial activity via the inhibition of two key bacterial enzymes: DNA gyrase and topoisomerase IV.[L11638] Both targets are type II topoisomerases, but have unique functions within the bacterial cell. DNA gyrase is an enzyme found only in bacteria that introduces negative supercoils into DNA during replication - this helps to relieve torsional strain caused by the introduction of positive supercoils during replication, and these negative supercoils are essential for chromosome condensation and the promotion of transcription initiation.[A31453] It is comprised of four subunits (two A subunits and two B subunits) of which the A subunits appear to be the target of fluoroquinolone antibiotics.[A190663] Bacterial topoisomerase IV, in addition to contributing to the relaxation of positive supercoils, is essential at the terminal stages of DNA replication and functions to “unlink” newly replicated chromosomes to allow for the completion of cell division.[A31453]



Inhibition of these enzymes by levofloxacin likely occurs via complexation with the topoisomerase enzymes.[A31453] The end result is a blockade of DNA replication, thus inhibiting cell division and resulting in cell death.', 'Levofloxacin is bactericidal and exerts its antimicrobial effects via inhibition of bacterial DNA replication.[L11638] It has a relatively long duration of action in comparison with other antibiotics that allows for once or twice daily dosing. Levofloxacin is associated with QTc-interval prolongation and should be used with caution in patients with other risk factors for prolongation (e.g. hypokalemia, concomitant medications).[L11638]



Levofloxacin has demonstrated _in vitro_ activity against a number of aerobic gram-positive and gram-negative bacteria and may carry some activity against certain species of anaerobic bacteria[L11638] and other pathogens such as _Chlamydia_ and _Legionella_.[A190663] Resistance to levofloxacin may develop, and is generally due to mutations in DNA gyrase or topoisomerase IV, or via alterations to drug efflux.[L11638,A31453] Cross-resistance may occur between levofloxacin and other fluoroquinolones, but is unlikely to develop between levofloxacin and other antibiotic classes (e.g. macrolides) due to significant differences in chemical structure and mechanism of action.[L11638]



As antimicrobial susceptibility patterns are geographically distinct, local antibiograms should be consulted to ensure adequate coverage of relevant pathogens prior to use.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11211, 'Taximodel 1 gm i.m./i.v.vial', 'تاكسيموديل 1جم فيال', '35', '26', 'Antibiotic.cephalosporin.third-generation', 'Cefotaxime', 'Rameda > pioneer pharmaceutical industries', 'Vial', 'فيال', '1 gm', '1', 'مضاد حيوي', 'about cefotaxime third generation cephalosporin parenteral antibiotic. mechanism of action of cefotaxime cefotaxime is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & aerobic gram negative organisms by inhi', '6223004000553', NULL, 1054, '2024-04-06', 0, 'Used to treat gonorrhoea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery.', 'The bactericidal activity of cefotaxime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cefotaxime shows high affinity for penicillin-binding proteins in the cell wall including PBP Ib and PBP III.', 'Cefotaxime is a third generation intravenous cephalosporin antibiotic. It has broad spectrum activity against Gram positive and Gram negative bacteria. It does not have activity against <i>Pseudomonas aeruginosa</i>. Cefotaxime works by inhibiting bacterial cell wall biosynthesis. A positive feature of cefotaxime is that it display a resistance to penicillinases and is useful to treat infections that are resistant to penicillin derivatives.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11212, 'Taxol 30mg/5ml vial', 'تاكسول 300مجم/5مل فيال', '450', NULL, 'Antineoplastic', 'Paclitaxel', 'Bristol-myers squibb', 'Vial', 'فيال', '30mg', '1', 'علاج السرطان يستخدم لعلاج سرطان الثدي والمبيض', 'about paclitaxel taxane derivative microtubule inhibitor(mitotic inhibitor) antineoplastic. mechanism of action of paclitaxel drug binds specifically to the beta- tubuline and then enhances the polymerization of tubuline to stable microtubules. it also in', NULL, NULL, 4638, '2023-01-16', 0, 'Used in the treatment of Kaposi''s sarcoma and cancer of the lung, ovarian, and breast. Abraxane® is specfically indicated for the treatment of metastatic breast cancer and locally advanced or metastatic non-small cell lung cancer.', 'Paclitaxel interferes with the normal function of microtubule growth. Whereas drugs like colchicine cause the depolymerization of microtubules in vivo, paclitaxel arrests their function by having the opposite effect; it hyper-stabilizes their structure. This destroys the cell''s ability to use its cytoskeleton in a flexible manner. Specifically, paclitaxel binds to the &beta; subunit of tubulin. Tubulin is the "building block" of mictotubules, and the binding of paclitaxel locks these building blocks in place. The resulting microtubule/paclitaxel complex does not have the ability to disassemble. This adversely affects cell function because the shortening and lengthening of microtubules (termed dynamic instability) is necessary for their function as a transportation highway for the cell. Chromosomes, for example, rely upon this property of microtubules during mitosis. Further research has indicated that paclitaxel induces programmed cell death (apoptosis) in cancer cells by binding to an apoptosis stopping protein called Bcl-2 (B-cell leukemia 2) and thus arresting its function.', 'Paclitaxel is a taxoid antineoplastic agent indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast cancer. Paclitaxel is a novel antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilizes microtubules by preventing depolymerization. This stability results in the inhibition of the normal dynamic reorganization of the microtubule network that is essential for vital interphase and mitotic cellular functions. In addition, paclitaxel induces abnormal arrays or "bundles" of microtubules throughout the cell cycle and multiple asters of microtubules during mitosis.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11214, 'Taxotere 20mg/ml i.v. infusion', 'تاكسوتير 20مجم/2مل فيال وريد', '1,225', '800', 'Antineoplastic', 'Docetaxel', 'Sanofi', 'Unknown', 'غير محدد', '20mg', '1', NULL, 'about docetaxel antimicrotubular natural source (plant) derivative taxane derivative antineoplastic. mechanism of action of docetaxel this paclitaxel congener binds to beta tubuline and enhances the polymerization of tubuline to stable microtubules. it al', '5013011003316', NULL, 1288, '2024-11-25', 0, 'Docetaxel is indicated as a single agent for the treatment of locally advanced or metastatic breast cancer after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC. It is also indicated as a single agent for locally advanced or metastatic non-small cell lung cancer (NSCLC) after platinum therapy failure; and with cisplatin for unresectable, locally advanced or metastatic untreated NSCLC. For the treatment of metastatic castration-resistant prostate cancer, docetaxel is indicated with prednisone. Docetaxel is also indicated with cisplatin and fluorouracil for untreated, advanced gastric adenocarcinoma, including the gastroesophageal junction, and with cisplatin and fluorouracil for induction treatment of locally advanced squamous cell carcinoma of the head and neck (SCCHN).[L46466]', 'Docetaxel interferes with the normal function of microtubule growth. Whereas drugs like [colchicine] cause the depolymerization of microtubules in vivo, docetaxel arrests their function by having the opposite effect; it hyper-stabilizes their structure. This destroys the cell''s ability to use its cytoskeleton in a flexible manner. Specifically, docetaxel binds to the &beta;-subunit of tubulin. Tubulin is the "building block" of microtubules, and the binding of docetaxel locks these building blocks in place. The resulting microtubule/docetaxel complex does not have the ability to disassemble. This adversely affects cell function because the shortening and lengthening of microtubules (termed dynamic instability) is necessary for their function as a transportation highway for the cell. Chromosomes, for example, rely upon this property of microtubules during mitosis. Further research has indicated that docetaxel induces programmed cell death (apoptosis) in cancer cells by binding to an apoptosis-stopping protein called Bcl-2 (B-cell leukemia 2), thus arresting its function.[A259666,A259671,L46466]', 'Docetaxel is a taxoid antineoplastic agent. It promotes the assembly of microtubules from tubulin dimers and stabilizes microtubules by preventing depolymerization. This stability results in the inhibition of the normal dynamic reorganization of the microtubule network which is essential for vital interphase and mitotic cellular functions. In addition, docetaxel induces abnormal arrays or "bundles" of microtubules throughout the cell cycle and multiple asters of microtubules during mitosis.[A259666,A259671]



The use of docetaxel may lead to treatment-related deaths in breast cancer and non-small cell lung cancer patients, hepatic impairment, hematologic effects, enterocolitis and neutropenic colitis, hypersensitivity reactions, fluid retention, second primary malignancies, cutaneous reactions, neurologic reactions, eye disorders, asthenia, embryo-fetal toxicity, and tumor lysis syndrome.[L46466]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11215, 'Taxotere 80mg/4ml i.v. inf', 'تاكسوتير 80مجم/4مل فيال وريد', '4,365', NULL, 'Antineoplastic', 'Docetaxel', 'Sanofi', 'Unknown', 'غير محدد', '80mg', '1', NULL, 'about docetaxel antimicrotubular natural source (plant) derivative taxane derivative antineoplastic. mechanism of action of docetaxel this paclitaxel congener binds to beta tubuline and enhances the polymerization of tubuline to stable microtubules. it al', '5013011003323', NULL, 2116, '2022-12-09', 0, 'Docetaxel is indicated as a single agent for the treatment of locally advanced or metastatic breast cancer after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC. It is also indicated as a single agent for locally advanced or metastatic non-small cell lung cancer (NSCLC) after platinum therapy failure; and with cisplatin for unresectable, locally advanced or metastatic untreated NSCLC. For the treatment of metastatic castration-resistant prostate cancer, docetaxel is indicated with prednisone. Docetaxel is also indicated with cisplatin and fluorouracil for untreated, advanced gastric adenocarcinoma, including the gastroesophageal junction, and with cisplatin and fluorouracil for induction treatment of locally advanced squamous cell carcinoma of the head and neck (SCCHN).[L46466]', 'Docetaxel interferes with the normal function of microtubule growth. Whereas drugs like [colchicine] cause the depolymerization of microtubules in vivo, docetaxel arrests their function by having the opposite effect; it hyper-stabilizes their structure. This destroys the cell''s ability to use its cytoskeleton in a flexible manner. Specifically, docetaxel binds to the &beta;-subunit of tubulin. Tubulin is the "building block" of microtubules, and the binding of docetaxel locks these building blocks in place. The resulting microtubule/docetaxel complex does not have the ability to disassemble. This adversely affects cell function because the shortening and lengthening of microtubules (termed dynamic instability) is necessary for their function as a transportation highway for the cell. Chromosomes, for example, rely upon this property of microtubules during mitosis. Further research has indicated that docetaxel induces programmed cell death (apoptosis) in cancer cells by binding to an apoptosis-stopping protein called Bcl-2 (B-cell leukemia 2), thus arresting its function.[A259666,A259671,L46466]', 'Docetaxel is a taxoid antineoplastic agent. It promotes the assembly of microtubules from tubulin dimers and stabilizes microtubules by preventing depolymerization. This stability results in the inhibition of the normal dynamic reorganization of the microtubule network which is essential for vital interphase and mitotic cellular functions. In addition, docetaxel induces abnormal arrays or "bundles" of microtubules throughout the cell cycle and multiple asters of microtubules during mitosis.[A259666,A259671]



The use of docetaxel may lead to treatment-related deaths in breast cancer and non-small cell lung cancer patients, hepatic impairment, hematologic effects, enterocolitis and neutropenic colitis, hypersensitivity reactions, fluid retention, second primary malignancies, cutaneous reactions, neurologic reactions, eye disorders, asthenia, embryo-fetal toxicity, and tumor lysis syndrome.[L46466]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11218, 'Tazocin 4.5 gm pd. for i.v. vial', 'تازوسين 4.5 جم فيال', '225', '180', 'Antiboitic', 'Piperacillin+tazobactam', 'Pfizer', 'Vial', 'فيال', '4.5 gm', '1', 'مضاد حيوي', NULL, '6251613000213', NULL, 4180, '2024-11-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11222, 'Tears guard 0.3% eye drops 15 ml', 'تيرز جارد قطرة عين 15 مل', '39', '30', 'Eye lubricant', 'Hydroxypropyl methylcellulose', 'Orchidia pharmaceutical industries', 'Drops', 'نقط', '0.3%', '1', 'علاج جفاف العين', 'mechanism of action hydroxypropyl cellulose is a derivative of cellulose that is soluble in both water and organic solvents. it is particularly good at trapping water and producing a film that serves as a barrier to water loss. hydroxypropyl cellulose pos', '6223005440082', NULL, 11499, '2025-05-20', 0, 'Used to relieve dryness and irritation caused by reduced tear flow that occurs in certain eye diseases (keratoconjunctivitis sicca), recurrent corneal erosions, decreased corneal sensitivity, exposure and neuroparalytic keratitis, and as a lubricant for artificial eyes.', 'Hydroxypropyl cellulose is a derivative of cellulose that is soluble in both water and organic solvents. It is particularly good at trapping water and producing a film that serves as a barrier to water loss. Hydroxypropyl cellulose possesses good surface activity but does not gel as it forms open helical coils. In general Hydroxypropyl cellulose is a water-soluble thickener, emulsifier and film-former often used in tablet coating.', 'Hydroxypropyl cellulose (cellulose, 2-hydroxypropyl ether) is a derivative of cellulose with both water solubility and organic solubility. Hydroxypropyl cellulose acts to stabilize and thicken the precorneal tear film and prolong the tear film breakup time which is usually accelerated in patients with dry eye states. Hydroxypropyl cellulose also acts to lubricate and protect the eye. Hydroxypropyl cellulose usually reduces the signs and symptoms resulting from moderate to severe dry eye syndromes, such as conjunctival hyperemia, corneal and conjunctival staining with rose bengal, exudation, itching, burning, foreign body sensation, smarting, photophobia, dryness and blurred or cloudy vision. Progressive visual deterioration which occurs in some patients may be retarded, halted, or sometimes reversed.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11224, 'Tebonina forte 40mg 20 f.c. tab', 'تيبونينا فورت 40 مجم 20 قرص', '90', '50', 'Anti-ischemic', 'Ginkgo biloba', 'Eipico > dr. willmar schwabe gmbh & co. kg', 'Tab', 'أقراص', '40mg', '2', '- حالات الدوار والدوخة', NULL, '6221032115119', NULL, 22891, '2023-09-20', 0, '_Ginkgo biloba_ does not currently have any approved therapeutic indications, and there is insufficient evidence to support its unapproved use.[A232379] It is available in over-the-counter herbal products mostly for oral use, to improve memory and cognitive problems. ', 'Two key active ingredients in _ginkgo biloba_ are terpene lactones (notably ginkgolides and diterpenes) and ginkgo flavone glycosides (notably ginkgetin, bilobetin, and sciadopitysin), which are present at varying concentrations. _Ginkgo biloba_ extract EGb 761 is the standardized extract of _ginkgo biloba_ used in studies, which contains 6% terpenoids and 24% flavonoid glycosides. Animal studies have shown that _ginkgo biloba_ works on several neurotransmitter pathways and brain structures. Flavones were shown to inhibit lipid peroxidation; inhibit the uptake of serotonin, dopamine, and norepinephrine; and inhibit platelet aggregation.[A232404] Terpene lactones may also act as potent antagonists of the platelet-activating factor and may possess anti-ischemic and fibrinolytic effects.[A232379] They were also shown to downregulate adrenal peripheral benzodiazepine receptors and increase adrenocorticotropic hormone levels.[A232404] _Ginkgo biloba_ also reversibly inhibits monoamine oxidase A; and modestly inhibits anticholinesterase activity,[A232379, A232389] leading to enhanced cholinergic transmission in the brain.[A232394] 



Several studies suggest that _ginkgo biloba_ exerts neuroprotective effects by reducing free radical production in the prefrontal cortex, which may explain its improvement on short-term memory. _Ginkgo biloba_ extract acts as a free radical scavenger, protecting neurons from oxidative damage and apoptosis related to aging, cerebral ischemia, and neurodegenerative disorders.[A232379] _Ginkgo biloba_ also inhibits amyloid-β neurotoxicity and protects against hypoxic challenges and increased oxidative stress.[A232389] One study showed that bilobalide, a terpene lactone, delays the onset of hypoxic glycolysis.[A232404] _Ginkgo biloba_ has the potential to regulate metabolism, stabilize the membrane, and promote vasodilation. In the arterial endothelium, EGb stimulated the release of endogenous relaxing factors, such as endothelium-derived relaxing factor and prostacyclin. In the inflammatory environment that causes tissue damage, EGb promoted nitric oxide production, leading to enhanced peripheral and cerebral blood flow.[A232379] ', '_Ginkgo biloba_ is a herbal ingredient with demonstrated antioxidant, vasoactive, antiapoptotic, anti-inflammatory, antiplatelet, and fibrinolytic properties.[A232389, A232399] _Ginkgo biloba_ has been investigated for use in a variety of medical conditions, but the most extensively studied area is in the context of cognitive impairment and neurodegenerative disorders. _Ginkgo biloba_ was examined as a potential nootropic agent or cognitive enhancer but research findings supporting the therapeutic efficacy of _ginkgo biloba_ extract (EGb) in dementia remain controversial. Some clinical studies of dementia that were up to one year long showed that EGb improves the cognitive performance and social functioning of patients. However, other studies did not support its clinical benefit for patients with cognitive impairment and dementia. Numerous meta-analysis studies showed insufficient evidence of the effectiveness of EGb in reducing both all-cause dementia incidence and Alzheimer''s disease-associated dementia incidence in elderly patients with normal cognition or with mild cognitive impairment. Additionally, there is no up-to-date evidence that demonstrates the benefit of the long-term use of standardized EGb in reducing the risk of progression to Alzheimer''s disease. A 2012 meta-analysis did not support the use of EGb in enhancing cognitive function in healthy adults.[A232379]



In the context of cardiovascular diseases, a limited number of studies showed that EGb improved mortality or neurological recovery in the post-stroke period, reduced cognitive and neurological impairment after acute ischemic stroke, and improved blood flow in the coronary artery in patients with coronary artery disease. However, a systemic review found no statistical or clinically significant benefit of EGb for patients with peripheral arterial disease or hypertension. Overall, there is a lack of strong evidence in the use of EGb for the treatment or prevention of cardiovascular diseases.[A232379]



In a small trial, the use of EGb as an adjunctive treatment with citalopram improved depressive symptoms and cognitive function in patients with depression.[A232379] _Ginkgo biloba_ was also investigated as a potential treatment for antidepressant-induced sexual dysfunction.[A2434] Another study showed EGb improving the symptoms of tardive dyskinesia. There is insufficient evidence to prove the effectiveness of EGb in these psychiatric disorders. Limited studies have investigated the role of _ginkgo biloba_ in the treatment of vertigo, tinnitus, vitiligo, macular degeneration, and glaucoma, as well as the prevention of acute mountain sickness. As results are either preliminary or controversial, more quality research is warranted.[A232379]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11225, 'Tecavir 0.5mg 30 f.c. tab.', 'تيكافير 0.5مجم 30 قرص', '1,680', '1170', 'Antiviral.nucleoside', 'Entecavir', 'Eva pharma', 'Tab', 'أقراص', '0.5mg', '3', 'مضاد للفيروسات', 'about entecavir nucleoside analog reverse transcriptase inhibitor oral antiviral drug used in the treatment of hepatitis b infection. mechanism of action of entecavir by competing with the natural substrate deoxyguanosine triphosphate entecavir functional', '6223002459810', NULL, 3742, '2024-11-16', 0, 'For the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.', 'By competing with the natural substrate deoxyguanosine triphosphate, entecavir functionally inhibits all three activities of the HBV polymerase (reverse transcriptase, rt): (1) base priming, (2) reverse transcription of the negative strand from the pregenomic messenger RNA, and (3) synthesis of the positive strand of HBV DNA. Upon activation by kinases, the drug can be incorporated into the DNA which has the ultimate effect of inhibiting the HBV polymerase activity.', 'Entecavir is a guanosine nucleoside analogue with selective activity against hepatitis B virus (HBV). It is designed to selectively inhibit the Hepatitis B virus, blocking all three steps in the replication process. Entecavir is more efficient than an older Hepatitis B drug, lamivudine.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11226, 'Tecavir 1mg 30 f.c. tab.', 'تيكافير 1مجم 30 قرص', '2,517', '1755', 'Antiviral.nucleoside', 'Entecavir', 'Eva pharma', 'Tab', 'أقراص', '1mg', '3', NULL, NULL, '6223005910226', NULL, 2815, '2024-11-17', 0, 'For the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.', 'By competing with the natural substrate deoxyguanosine triphosphate, entecavir functionally inhibits all three activities of the HBV polymerase (reverse transcriptase, rt): (1) base priming, (2) reverse transcription of the negative strand from the pregenomic messenger RNA, and (3) synthesis of the positive strand of HBV DNA. Upon activation by kinases, the drug can be incorporated into the DNA which has the ultimate effect of inhibiting the HBV polymerase activity.', 'Entecavir is a guanosine nucleoside analogue with selective activity against hepatitis B virus (HBV). It is designed to selectively inhibit the Hepatitis B virus, blocking all three steps in the replication process. Entecavir is more efficient than an older Hepatitis B drug, lamivudine.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11228, 'Tegral 200mg 50 scored tabs.', 'تيجرال 200مجم 50 قرص', '105', '32.5', 'Anti-epileptic.carboxamides', 'Carbamazepine', 'Cid', 'Tab', 'أقراص', '200mg', '5', 'يستخدم لعلاج حالات الصرع', 'about carbamazepine tricyclic anticonvulsant iminostilbene derivative anticonvulsant in trigeminal neuralgia. mechanism of action of carbamazepine carbamazepine prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by incr', '6221043012179', NULL, 2857, '2024-12-18', 0, 'Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.[L1335] In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures.[A180301,L1335] Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.[L1335] Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome.[A180415,A180421]', 'Carbamazepine''s mechanism of action is not fully elucidated and is widely debated.[A180310,L9713] One major hypothesis is that carbamazepine inhibits sodium channel firing, treating seizure activity. Animal research studies have demonstrated that carbamazepine exerts its effects by lowering polysynaptic nerve response and inhibiting post-tetanic potentiation. In both cats and rats, carbamazepine was shown to decrease pain caused by infraorbital nerve stimulation. A decrease in the action potential in the nucleus ventralis of the thalamus in the brain and inhibition of the lingual mandibular reflex were observed in other studies after carbamazepine use. Carbamazepine causes the above effects by binding to voltage-dependent sodium channels and preventing action potentials, which normally lead to stimulatory effects on nerves.[A180403,T634] In bipolar disorder, carbamazepine is thought to increase dopamine turnover and increase GABA transmission, treating manic and depressive symptoms.[L7216]



A common issue that has arisen is resistance to this drug in up to 30% of epileptic patients, which may occur to altered metabolism in patients with variant genotypes.[A180436] A potential therapeutic target to combat carbamazepine resistance has recently been identified as the EPHX1 gene promoter, potentially conferring resistance to carbamazepine through methylation.[A180439]', '**General effects**



Carbamazepine treats seizures and the symptoms of trigeminal neuralgia by inhibiting sodium channels.  In bipolar 1 disorder, carbamazepine has been found to decrease mania symptoms in a clinically significant manner according to the Young Mania Rating Scale (YMRS).[L1335] Carbamazepine has a narrow therapeutic index.[A180301]



**A note on genetic variation and carbamazepine use**



In studies of Han Chinese ancestry patients, a pronounced association between the HLA-B*1502 genotype and Steven Johnson syndrome and/or toxic epidermal necrolysis (SJS/TEN) resulting from carbamazepine use was observed.[A180397]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11232, 'Tegretol 2% syrup 100ml', 'تجريتول 2% شراب 100 مل', '10', NULL, 'Anti-epileptic.carboxamides', 'Carbamazepine', 'Novartis', 'Syrup', 'شراب', '2%', '1', 'علاج الصرع -- تقليل التشنجات الناتجة عن الصرع', NULL, '6223002640577', NULL, 1757, '2022-12-09', 0, 'Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.[L1335] In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures.[A180301,L1335] Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.[L1335] Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome.[A180415,A180421]', 'Carbamazepine''s mechanism of action is not fully elucidated and is widely debated.[A180310,L9713] One major hypothesis is that carbamazepine inhibits sodium channel firing, treating seizure activity. Animal research studies have demonstrated that carbamazepine exerts its effects by lowering polysynaptic nerve response and inhibiting post-tetanic potentiation. In both cats and rats, carbamazepine was shown to decrease pain caused by infraorbital nerve stimulation. A decrease in the action potential in the nucleus ventralis of the thalamus in the brain and inhibition of the lingual mandibular reflex were observed in other studies after carbamazepine use. Carbamazepine causes the above effects by binding to voltage-dependent sodium channels and preventing action potentials, which normally lead to stimulatory effects on nerves.[A180403,T634] In bipolar disorder, carbamazepine is thought to increase dopamine turnover and increase GABA transmission, treating manic and depressive symptoms.[L7216]



A common issue that has arisen is resistance to this drug in up to 30% of epileptic patients, which may occur to altered metabolism in patients with variant genotypes.[A180436] A potential therapeutic target to combat carbamazepine resistance has recently been identified as the EPHX1 gene promoter, potentially conferring resistance to carbamazepine through methylation.[A180439]', '**General effects**



Carbamazepine treats seizures and the symptoms of trigeminal neuralgia by inhibiting sodium channels.  In bipolar 1 disorder, carbamazepine has been found to decrease mania symptoms in a clinically significant manner according to the Young Mania Rating Scale (YMRS).[L1335] Carbamazepine has a narrow therapeutic index.[A180301]



**A note on genetic variation and carbamazepine use**



In studies of Han Chinese ancestry patients, a pronounced association between the HLA-B*1502 genotype and Steven Johnson syndrome and/or toxic epidermal necrolysis (SJS/TEN) resulting from carbamazepine use was observed.[A180397]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11234, 'Tegretol 200mg 30 tab.', 'تجريتول 200مجم 30 قرص', '89', '55.5', 'Anti-epileptic.carboxamides', 'Carbamazepine', 'Novartis', 'Tab', 'أقراص', '200mg', '3', 'علاج الصرع -- علاج التشنجات التي تنتج من الصرع', 'about carbamazepine tricyclic anticonvulsant iminostilbene derivative anticonvulsant in trigeminal neuralgia. mechanism of action of carbamazepine carbamazepine prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by incr', '6223002641710', NULL, 16380, '2024-09-30', 0, 'Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.[L1335] In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures.[A180301,L1335] Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.[L1335] Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome.[A180415,A180421]', 'Carbamazepine''s mechanism of action is not fully elucidated and is widely debated.[A180310,L9713] One major hypothesis is that carbamazepine inhibits sodium channel firing, treating seizure activity. Animal research studies have demonstrated that carbamazepine exerts its effects by lowering polysynaptic nerve response and inhibiting post-tetanic potentiation. In both cats and rats, carbamazepine was shown to decrease pain caused by infraorbital nerve stimulation. A decrease in the action potential in the nucleus ventralis of the thalamus in the brain and inhibition of the lingual mandibular reflex were observed in other studies after carbamazepine use. Carbamazepine causes the above effects by binding to voltage-dependent sodium channels and preventing action potentials, which normally lead to stimulatory effects on nerves.[A180403,T634] In bipolar disorder, carbamazepine is thought to increase dopamine turnover and increase GABA transmission, treating manic and depressive symptoms.[L7216]



A common issue that has arisen is resistance to this drug in up to 30% of epileptic patients, which may occur to altered metabolism in patients with variant genotypes.[A180436] A potential therapeutic target to combat carbamazepine resistance has recently been identified as the EPHX1 gene promoter, potentially conferring resistance to carbamazepine through methylation.[A180439]', '**General effects**



Carbamazepine treats seizures and the symptoms of trigeminal neuralgia by inhibiting sodium channels.  In bipolar 1 disorder, carbamazepine has been found to decrease mania symptoms in a clinically significant manner according to the Young Mania Rating Scale (YMRS).[L1335] Carbamazepine has a narrow therapeutic index.[A180301]



**A note on genetic variation and carbamazepine use**



In studies of Han Chinese ancestry patients, a pronounced association between the HLA-B*1502 genotype and Steven Johnson syndrome and/or toxic epidermal necrolysis (SJS/TEN) resulting from carbamazepine use was observed.[A180397]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11236, 'Tegretol cr 400mg 20 f.c. divitabs', 'تجريتول سي ار 400مجم 20 قرص', '106', '68', 'Anti-epileptic.carboxamides', 'Carbamazepine', 'Novartis', 'Tab', 'أقراص', '400mg', '2', 'علاج الصرع -- تقليل التشنجات الناتجة عن الصرع', NULL, '6223002641987', NULL, 7047, '2024-10-16', 0, 'Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.[L1335] In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures.[A180301,L1335] Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.[L1335] Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome.[A180415,A180421]', 'Carbamazepine''s mechanism of action is not fully elucidated and is widely debated.[A180310,L9713] One major hypothesis is that carbamazepine inhibits sodium channel firing, treating seizure activity. Animal research studies have demonstrated that carbamazepine exerts its effects by lowering polysynaptic nerve response and inhibiting post-tetanic potentiation. In both cats and rats, carbamazepine was shown to decrease pain caused by infraorbital nerve stimulation. A decrease in the action potential in the nucleus ventralis of the thalamus in the brain and inhibition of the lingual mandibular reflex were observed in other studies after carbamazepine use. Carbamazepine causes the above effects by binding to voltage-dependent sodium channels and preventing action potentials, which normally lead to stimulatory effects on nerves.[A180403,T634] In bipolar disorder, carbamazepine is thought to increase dopamine turnover and increase GABA transmission, treating manic and depressive symptoms.[L7216]



A common issue that has arisen is resistance to this drug in up to 30% of epileptic patients, which may occur to altered metabolism in patients with variant genotypes.[A180436] A potential therapeutic target to combat carbamazepine resistance has recently been identified as the EPHX1 gene promoter, potentially conferring resistance to carbamazepine through methylation.[A180439]', '**General effects**



Carbamazepine treats seizures and the symptoms of trigeminal neuralgia by inhibiting sodium channels.  In bipolar 1 disorder, carbamazepine has been found to decrease mania symptoms in a clinically significant manner according to the Young Mania Rating Scale (YMRS).[L1335] Carbamazepine has a narrow therapeutic index.[A180301]



**A note on genetic variation and carbamazepine use**



In studies of Han Chinese ancestry patients, a pronounced association between the HLA-B*1502 genotype and Steven Johnson syndrome and/or toxic epidermal necrolysis (SJS/TEN) resulting from carbamazepine use was observed.[A180397]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11237, 'Tegretol cr 200mg 20 f.c. divitab.', 'تجريتول سي ار 200مجم 20 قرص', '61', '38', 'Anti-epileptic.carboxamides', 'Carbamazepine', 'Novartis', 'Tab', 'أقراص', '200mg', '2', NULL, 'about carbamazepine tricyclic anticonvulsant iminostilbene derivative anticonvulsant in trigeminal neuralgia. mechanism of action of carbamazepine carbamazepine prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by incr', '6223002640416', NULL, 4929, '2024-09-06', 0, 'Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.[L1335] In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures.[A180301,L1335] Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.[L1335] Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome.[A180415,A180421]', 'Carbamazepine''s mechanism of action is not fully elucidated and is widely debated.[A180310,L9713] One major hypothesis is that carbamazepine inhibits sodium channel firing, treating seizure activity. Animal research studies have demonstrated that carbamazepine exerts its effects by lowering polysynaptic nerve response and inhibiting post-tetanic potentiation. In both cats and rats, carbamazepine was shown to decrease pain caused by infraorbital nerve stimulation. A decrease in the action potential in the nucleus ventralis of the thalamus in the brain and inhibition of the lingual mandibular reflex were observed in other studies after carbamazepine use. Carbamazepine causes the above effects by binding to voltage-dependent sodium channels and preventing action potentials, which normally lead to stimulatory effects on nerves.[A180403,T634] In bipolar disorder, carbamazepine is thought to increase dopamine turnover and increase GABA transmission, treating manic and depressive symptoms.[L7216]



A common issue that has arisen is resistance to this drug in up to 30% of epileptic patients, which may occur to altered metabolism in patients with variant genotypes.[A180436] A potential therapeutic target to combat carbamazepine resistance has recently been identified as the EPHX1 gene promoter, potentially conferring resistance to carbamazepine through methylation.[A180439]', '**General effects**



Carbamazepine treats seizures and the symptoms of trigeminal neuralgia by inhibiting sodium channels.  In bipolar 1 disorder, carbamazepine has been found to decrease mania symptoms in a clinically significant manner according to the Young Mania Rating Scale (YMRS).[L1335] Carbamazepine has a narrow therapeutic index.[A180301]



**A note on genetic variation and carbamazepine use**



In studies of Han Chinese ancestry patients, a pronounced association between the HLA-B*1502 genotype and Steven Johnson syndrome and/or toxic epidermal necrolysis (SJS/TEN) resulting from carbamazepine use was observed.[A180397]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11241, 'Teklo 30 tabs.', 'تكلو 30 قرص', '81', '60', 'Antihypertensive', 'Amiloride+atenolol+chlorothalidone', 'Alfacure pharmaceuticals', 'Tab', 'أقراص', NULL, '3', 'لعلاج ارتفاع ضغط الدم', 'pregnancy related information contraindicated; atenolol amiloride and hydrochlorothiazide are contraindicated in pregnancy. so the combination generic is contraindicated in pregnancy. breast feeding related information breast feeding: contraindicated; sin', '6224000875442', NULL, 2934, '2024-10-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11244, 'Telebrix-35 (50ml) vial(hospital only)', 'تليبريكس-35 50 مل فيال', '240', '140', NULL, 'Meglumine ioxitalamate+sodium ioxitalamate', 'Amoun > lab. guerbet - france', 'Vial', 'فيال', '50ml', '1', NULL, NULL, '6221025011947', NULL, 1438, '2023-11-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11245, 'Telebrix-35 (100ml) vial(hospital only)', 'تليبريكس-35 100 مل فيال', '238', NULL, NULL, 'Meglumine ioxitalamate+sodium ioxitalamate', 'Amoun > lab. guerbet - france', 'Vial', 'فيال', '100ml', '1', NULL, NULL, NULL, NULL, 921, '2023-04-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11246, 'Telfast 30mg/5ml susp. 100 ml', 'تلفاست 30مجم/5مل 100 مل معلق', '50', '32', 'Antihistamine.antiallergy', 'Fexofenadine', 'Sanofi', 'Susp', 'معلق', '30mg', '1', 'علاج قوي لأعراض الحساسية.', 'about fexofenadine second generation h1 antagonist antihistamine. mechanism of action of fexofenadine fexofenadine blocks one type of peripheral receptor for histamine (the h1 receptor) and thus prevents activation of h1 receptor-containing cells by hista', '6223003991715', NULL, 13816, '2024-08-01', 0, 'In the United States, fexofenadine is indicated for the symptomatic treatment of allergic rhinitis in patients ≥2 years old and chronic idiopathic urticaria in patients ≥6 months old.[L4269] In Canada, fexofenadine carries the same indications but is approved only for patients ≥12 years old.[L10779] Fexofenadine is also available in combination with [pseudoephedrine] for the symptomatic treatment of season allergic rhinitis in patients ≥12 years old.[L10800]', 'The H<sub>1</sub> histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to an allergen results in degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H<sub>1</sub> receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes.[A1495]



Fexofenadine is considered an “inverse agonist” of the H<sub>1</sub> receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects.[A1495] It has a potent and selective affinity for H<sub>1</sub> receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity.[L10779] Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.[L10779]', 'Fexofenadine relieves allergy symptoms by antagonizing the actions of histamine, an endogenous compound predominantly responsible for allergic symptomatology.[L4269] The relatively long duration of action of fexofenadine (approximately 24 hours)[A1495] allows for once or twice daily dosing, and its rapid absorption allows for an onset of action within 1-3 hours. Fexofenadine should not be taken with fruit juice, as this may impair its absorption.[L4269]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11247, 'Telfast 120mg 20 f.c. tab', 'تلفاست 120مجم 20 قرص', '116', '99', 'Antihistamine.antiallergy', 'Fexofenadine', 'Sanofi', 'Tab', 'أقراص', '120mg', '2', 'علاج قوي لأعراض الحساسية.', NULL, '6223003991364', NULL, 13859, '2025-05-07', 0, 'In the United States, fexofenadine is indicated for the symptomatic treatment of allergic rhinitis in patients ≥2 years old and chronic idiopathic urticaria in patients ≥6 months old.[L4269] In Canada, fexofenadine carries the same indications but is approved only for patients ≥12 years old.[L10779] Fexofenadine is also available in combination with [pseudoephedrine] for the symptomatic treatment of season allergic rhinitis in patients ≥12 years old.[L10800]', 'The H<sub>1</sub> histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to an allergen results in degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H<sub>1</sub> receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes.[A1495]



Fexofenadine is considered an “inverse agonist” of the H<sub>1</sub> receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects.[A1495] It has a potent and selective affinity for H<sub>1</sub> receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity.[L10779] Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.[L10779]', 'Fexofenadine relieves allergy symptoms by antagonizing the actions of histamine, an endogenous compound predominantly responsible for allergic symptomatology.[L4269] The relatively long duration of action of fexofenadine (approximately 24 hours)[A1495] allows for once or twice daily dosing, and its rapid absorption allows for an onset of action within 1-3 hours. Fexofenadine should not be taken with fruit juice, as this may impair its absorption.[L4269]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11248, 'Telfast 180mg 20 f.c. tabs', 'تلفاست 180مجم 20 قرص', '160', '144', 'Antihistamine.antiallergy', 'Fexofenadine', 'Sanofi', 'Tab', 'أقراص', '180mg', '2', 'علاج قوي لأعراض الحساسية.', NULL, '6223003991388', NULL, 23772, '2025-05-07', 0, 'In the United States, fexofenadine is indicated for the symptomatic treatment of allergic rhinitis in patients ≥2 years old and chronic idiopathic urticaria in patients ≥6 months old.[L4269] In Canada, fexofenadine carries the same indications but is approved only for patients ≥12 years old.[L10779] Fexofenadine is also available in combination with [pseudoephedrine] for the symptomatic treatment of season allergic rhinitis in patients ≥12 years old.[L10800]', 'The H<sub>1</sub> histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to an allergen results in degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H<sub>1</sub> receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes.[A1495]



Fexofenadine is considered an “inverse agonist” of the H<sub>1</sub> receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects.[A1495] It has a potent and selective affinity for H<sub>1</sub> receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity.[L10779] Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.[L10779]', 'Fexofenadine relieves allergy symptoms by antagonizing the actions of histamine, an endogenous compound predominantly responsible for allergic symptomatology.[L4269] The relatively long duration of action of fexofenadine (approximately 24 hours)[A1495] allows for once or twice daily dosing, and its rapid absorption allows for an onset of action within 1-3 hours. Fexofenadine should not be taken with fruit juice, as this may impair its absorption.[L4269]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11249, 'Telzim 240mg s.r. 10 caps.', 'تيلزيم 240مجم 10 كبسولات', '13', NULL, 'Antihypertensive.nonselective calcium channel blocker', 'Diltiazem', 'Sigma', 'Cap', 'كبسولة', '240mg', '1', NULL, 'about diltiazem a benzothiazepine derivative calcium channel blocker anti hypertensive anti-anginal class iv antiarrhythmic. mechanism of action of diltiazem diltiazem is a benzothiazepine; ca channel blocker. it exerts it`s antianginal antihypertensive a', '6221051020975', NULL, 737, '2022-12-16', 0, '**Oral**



Indicated for the management of hypertension, to lower blood pressure, alone or in combination with other antihypertensive agents.[L10556]



Indicated for use to improve exercise tolerance in patients with chronic stable angina.[L10556]



Indicated for the management of variant angina (Prinzmetal''s angina).[L6298]



**Intravenous**



Indicated for the short-term management of atrial fibrillation or atrial flutter for temporary control of rapid ventricular rate.[L6292]



Indicated for the rapid conversion of paroxysmal supraventricular tachycardias (PSVT) to sinus rhythm. This includes AV nodal reentrant tachycardias and reciprocating tachycardias associated with an extranodal accessory pathway such as the WPW syndrome or short PR syndrome.[L6292]



**Off-label**



Indicated for off-label uses in anal fissures (as topical formulation), migraine prophylaxis, cramps in lower leg related to rest, pulmonary hypertension,[L6289] idiopathic dilated cardiomyopathy, and proteinuria associated with diabetic nephropathy.[L6298]', 'Excitation of cardiac muscle involves the activation of a slow calcium inward current that is induced by L-type slow calcium channels, which are voltage-sensitive, ion-selective channels[A178444] associated with a high activation threshold and slow inactivation profile.[T28] L-type calcium channels are the main current responsible for the late phase of the pacemaker potential.[A178492] Acting as the main Ca2+ source for contraction in smooth and cardiac muscle, activation of L-type calcium channels allows the influx of calcium ions into the muscles upon depolarization and excitation of the channel.[A178444] It is proposed that this cation influx may also trigger the release of additional calcium ions from intracellular storage sites.[A178444] Diltiazem is a slow calcium channel blocker that binds to the extracellular site of the alpha-1C subunit of the channel, which is thought to be the S5-6 linker region of the transmembrane domain IV and/or S6 segment of domain III.[A178492]  Diltiazem can get access to this binding site from either the intracellular or extracellular side, but it requires a voltage-induced conformational changes in the membrane.[A178492] Diltiazem inhibits the influx of extracellular calcium across the myocardial and vascular smooth muscle cell membranes.[L10556] In isolated human atrial and ventricular myocardium, diltiazem suppressed tension over the range of membrane potentials associated with calcium channel activity but had little effect on the tension-voltage relations at more positive potentials.[A178453] This effect is thought to be mediated by the voltage-dependent block of the L-type calcium channels and inhibition of calcium ion release from the ER stores, without altering the sodium-calcium coupled transport or calcium sensitivity of myofilaments.[A178453] Through inhibition of inward calcium current, diltiazem exerts a direct ionotropic and energy sparing effect on the myocardium.[A178444] Diltiazem fslows atrioventricular nodal conduction, which is due to its ability to impede slow channel function.[A178444]



Reduced intracellular calcium concentrations equate to increased smooth muscle relaxation resulting in arterial vasodilation and therefore, decreased blood pressure.[L6289] The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.[L6289,L10556] Through its actions on reducing calcium levels in cardiac and vascular smooth muscles, diltiazem causes a reduction in the contractile processes of the myocardial smooth muscle cells and vasodilation of the coronary and systemic arteries, including epicardial and subendocardial. This subsequently leads to increased oxygen delivery to the myocardial tissue, improved cardiac output due to increased stroke volume, decreased total peripheral resistance, decreased systemic blood pressure and heart rate, and decreased afterload.[L6289,L10556] Diltiazem lowers myocardial oxygen demand through a reduction in heart rate, blood pressure, and cardiac contractility; this leads to a therapeutic effect in improving exercise tolerance in chronic stable angina.[A178432,L6289] ', 'Diltiazem is an antihypertensive and vasodilating agent that works by relaxing the vascular muscle and reducing blood pressure. This is related to the long-term therapeutic effects, as lowering the blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.[L10556] Diltiazem inhibits the influx of extracellular calcium ions across the myocardial and vascular smooth muscle cell membranes during depolarization. Diltiazem is classified as a negative inotrope (decreased force) and negative chronotrope (decreased rate).[L6289] It is also considered a rate-control drug as it reduces heart rate.[A178432,T28] Diltiazem is exerts hemodynamic actions by reducing blood pressure, systemic vascular resistance, the rate-pressure product, and coronary vascular resistance while increasing coronary blood flow.[L6292] Diltiazem decreases sinoatrial and atrioventricular conduction in isolated tissues and has a negative inotropic effect in isolated preparations.[L10556] In supraventricular tachycardia, diltiazem prolongs AV nodal refractories.[L6292]



As the magnitude of blood pressure reduction is related to the degree of hypertension, the antihypertensive effect of diltiazem is most pronounced in individuals with hypertension. In a randomized, double-blind, parallel-group, dose-response study involving patients with essential hypertension, there was a reduction in the diastolic blood pressure by 1.9, 5.4, 6.1, and 8.6 mmHg in the patients receiving diltiazem at doses of 120, 240, 360, and 540 mg, respectively. In patients receiving placebo, there was a reduction in the diastolic blood pressure by 2.6 mmHg.In a randomized, double-blind study involving patients with chronic stable angina, variable doses of diltiazem administered at night all caused an increased exercise tolerance in the after 21 hours, compared to placebo.[L10556] In the NORDIL study of patients with hypertension, the therapeutic effectiveness of diltiazem in reducing cardiovascular morbidity and mortality was assessed.[A178432] When using the combined primary endpoint as fatal and non-fatal stroke, myocardial infarction, and other cardiovascular death, fatal and non-fatal stroke was shown to be reduced by 25% in the diltiazem group. Although the clinical significance to this effect remains unclear, it is suggested that diltiazem may exert a protective role against cerebral stroke in hypertensive patients.[A178432] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11252, 'Temporal 250mg/5ml susp. 60 ml', 'تمبورال 250مجم/5مل معلق 60 مل', '20', '11.5', 'Antipyretic', 'Paracetamol(acetaminophen)', 'Mup', 'Susp', 'معلق', '250mg', '1', 'مسكن -- خافض للحرارة', 'about paracetamol acetanilide derivative non narcotic analgesic antipyretic. mechanism of action of paracetamol paracetamol has analgesic and antipyretic action. it is more active on cyclo-oxygenase enzyme in brain. peripherally it is a poor inhibitor of', '6221508070218', NULL, 5175, '2024-08-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11255, 'Tendratine 2.5mg/5ml syrup 100ml', 'تندراتين 2.5مجم/5مل شراب 100مل', '9', NULL, 'Antihistamine.antiallergy', 'Desloratadine', 'Eva pharma', 'Syrup', 'شراب', '2.5mg', '1', NULL, 'about desloratadine second generation long-acting tricyclic h1 antagonist antihistamine. mechanism of action of desloratadine this second generation antihistamine has a selective peripheral h1-antagonist action.desloratadine competes with free histamine f', '6223002451838', NULL, 781, '2022-12-09', 0, 'For the relief of symptoms of seasonal allergic rhinitis, perennial (non-seasonal) allergic rhinitis. Desloratidine is also used for the sympomatic treatment of pruritus and urticaria (hives) associated with chronic idiopathic urticaria.', 'Like other H1-blockers, Desloratadine competes with free histamine for binding at H<sub>1</sub>-receptors in the GI tract, uterus, large blood vessels, and bronchial smooth muscle. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms (eg. nasal congestion, watery eyes) brought on by histamine.', 'Desloratadine is a long-acting second-generation H<sub>1</sub>-receptor antagonist which has a selective and peripheral H1-antagonist action. Histamine is a chemical that causes many of the signs that are part of allergic reactions, such as the swelling of tissues. Histamine is released from histamine-storing cells (mast cells) and attaches to other cells that have receptors for histamine. The attachment of the histamine to the receptors causes the cell to be "activated," releasing other chemicals which produce the effects that we associate with allergies. Desloratadine blocks one type of receptor for histamine (the H1 receptor) and thus prevents activation of cells by histamine. Unlike most other antihistamines, Desloratadine does not enter the brain from the blood and, therefore, does not cause drowsiness.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11256, 'Tenedone 100/25mg 30 f.c. tab.', 'تينيدون 25/100مجم 30 قرص', '57', '31.5', 'Beta blocker and thiazide diuretics', 'Atenolol+chlorthalidone', 'Sigma', 'Tab', 'أقراص', '25mg', '3', 'علاج ارتفاع ضغط الدم', 'indications for atenolol + chlorthalidone beta blocker and thiazide diuretics are given in combination to treat hypertension. atenolol reduces the work load on the heart and chlorthalidone reduce the hypertension by increasing the flow of urine. 1. hypert', '6221051012895', NULL, 2461, '2025-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11259, 'Tenedone 50/25mg 30 f.c. tab.', 'تينيدون 50/25مجم 30 قرص', '45', '22.5', 'Beta blocker and thiazide diuretics', 'Atenolol+chlorthalidone', 'Sigma', 'Tab', 'أقراص', '25mg', '3', NULL, 'indications for atenolol + chlorthalidone beta blocker and thiazide diuretics are given in combination to treat hypertension. atenolol reduces the work load on the heart and chlorthalidone reduce the hypertension by increasing the flow of urine. 1. hypert', '6221051012871', NULL, 1918, '2024-12-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11264, 'Nervalta 30 mg 28 del. rel. caps.(n/a yet)', 'نيرفالتا 30 مجم 28 كبسولة', '118', NULL, 'Psychiatric.antidepressants', 'Duloxetine', 'Pharco', 'Cap', 'كبسولة', '30 mg', '2', NULL, 'about duloxetine a serotonin-norepinephrine reuptake inhibitor thiophene derivative antidepressant. mechanism of action of duloxetine duloxetine preferentially inhibits the re-uptake of noradrenaline and serotonin (5 ht) in the cns nerve terminals .this w', NULL, NULL, 1232, '2022-08-16', 0, '**Indicated** for:



1) Management of Major Depressive Disorder.[label]



2) Management of Generalized Anxiety Disorder.[label]



3) Management of diabetic peripheral neuropathy.[label]



4) Management of fibromyalgia.[label]



5) Management of chronic musculoskeletal pain.[label]



6) Management of osteoarthritis of the knee in adults.[L6364]



7) Management of chronic lower back pain in adults.[L6364]



8) Management of stress urinary incontinence in adult women.[L6367]



**Off-label** uses include:



1) Management of chemotherapy-induced peripheral neuropathy.[A178603]



2) Management of stress urinary incontinence in adult men after prostatectomy until recovery is complete.[L6370]', 'Duloxetine is a potent inhibitor of neuronal serotonin and norepinephrine reuptake and a less potent inhibitor of dopamine reuptake.[A178714] Duloxetine has no significant affinity for dopaminergic, adrenergic, cholinergic, histaminergic, opioid, glutamate, and GABA receptors.



Action on the external urinary sphincter is mediated via duloxetine''s CNS effects. Increased serotonin and norepinephrine concentrations in Onuf''s nucleus leads to increased activation of 5-HT<sub>2</sub>, 5-HT<sub>3</sub>, and α<sub>1</sub> adrenergic receptors.[A178663,A178666] 5-HT<sub>2</sub> and α<sub>1</sub> are both G<sub>q</sub> coupled and their activation increases the activity of the inositol trisphosphate/phospholipase C (IP<sub>3</sub>/PLC) pathway.[T116] This pathway leads to release of intracellular calcium stores, increasing intracellular calcium concentrations, and facilitating neuronal excitability. 5-HT<sub>3</sub> functions as a ligand-gated sodium channel which allows sodium to flow into the neuron when activated. Increased flow of sodium into the neuron contributes to depolarization and activation of voltage gated channels involved in action potential generation. The combined action of these three receptors contributes to increased excitability of the pudendal motor nerve in response to glutamate.



Also related to duloxetine''s action at the spinal cord is its modulation of pain. Increasing the concentration of serotonin and norepinephrine in the dorsal horn of the spinal cord increases descending inhibition of pain through activation of 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, 5-HT<sub>1D</sub>, 5-HT<sub>2</sub>, 5-HT<sub>3</sub>, α<sub>1</sub>-adrenergic, and α<sub>2</sub>-adrenergic receptors.[A178705] 5-HT<sub>2</sub>, 5-HT<sub>3</sub>, and α<sub>1</sub>-adrenergic mediate neuronal activation as described above. The activated neuron in this case is the GABAergic inhibitory interneuron which synapses onto the nociceptive projection neuron to inhibit the transmission of painful stimuli to the brain. The 5-HT<sub>1</sub> and α<sub>2</sub> receptors are G<sub>i</sub>/G<sub>o</sub> coupled and their activation leads to increased potassium current through inward rectifier channels and decreased adenylyl cyclase/protein kinase A signaling which contributes to neuronal inhibition.[A178705,T116] These inhibitory receptors are present on the projection neuron itself as well as the dorsal root ganglion which precedes it and serves to directly suppress the transmission of painful stimuli.



The mechanisms involved in duloxetine''s benefits in depression and anxiety have not been fully elucidated. Dysfunctional serotonin and norepinephrine signaling are thought to be involved and increases in the availability of these neurotransmitters at the synaptic cleft thought to mediate a therapeutic effect.[A178666] It is postulated that the involvement of serotonin and norepinephrine in area responsible for emotional modulation such as the limbic system contributes to the effects in mood disorders specifically but this has yet to be confirmed.



Duloxetine''s hypertensive effect is related to its intended pharmacological effect. Increased availability of norepinephrine leads to activation of adrenergic receptors on the vascular endothelium. Since the action of α<sub>1</sub> receptors predominates, vasoconstriction results as the G<sub>q</sub> coupled receptor mediates calcium release from the sarcoplasmic reticulum to facilitate smooth muscle contraction.[T116]', 'Duloxetine, through increasing serotonin and norepinephrine concentrations in Onuf''s nucleus, enhances glutamatergic activation of the pudendal motor nerve which innervates the external urethral sphinter.[A178663,A178666] This enhanced signaling allows for stronger contraction. Increased contraction of this sphincter increases the pressure needed to produce an incontinence episode in stress urinary incontinence. Duloxetine has been shown to improve Patient Global Impression of Improvement and Incontinence Quality of Life scores.[A178669] It has also been shown to reduce the median incontinence episode frequency at doses of 40 and 80 mg.



Action at the dorsal horn of the spinal cord allows duloxetine to strengthen the the serotonergic and adrenergic pathways involved in descending inhibition of pain.[A178666,A178705] This results in an increased threshold of activation necessary to transmit painful stimuli to the brain and effective relief of pain, particularly in neuropathic pain. Pain relief has been noted in a variety of painful conditions including diabetic peripheral neuropathy, fibromyalgia, and osteoarthritis using a range of pain assessment surveys.[A178711]



While duloxetine has been shown to be effective in both animal models of mood disorders and in clinical trials for the treatment of these disorders in humans, the broad scope of its pharmacodynamic effects on mood regulation in the brain has yet to be explained.[A178714]



Increased blood pressure is a common side effect with duloxetine due to vasoconstriction mediated by the intended increase in norepinephrine signaling.[label,T116]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11265, 'Valenodrex 30 tabs', 'فالندوركس 30 قرص', '81', NULL, 'Calcium', 'Calcium+mg+vit.d3+b+cu+zn', 'Lifeline', 'Tab', 'أقراص', NULL, '3', 'مكمل غذائى لدعم نمو وصحة العظام والوقاية من الكساح وهشاشة العظام', NULL, '745604424837', NULL, 1050, '2022-08-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11268, 'Tenormin 100mg 28 f.c.tab.', 'تينورمين 100مجم 28 قرص', '60', '43', 'Antihypertensive.beta blocker.selective b1', 'Atenolol', 'Astra zeneca', 'Tab', 'أقراص', '100mg', '2', 'علاج لمرض ارتفاع ضغط الدم', 'description : a cardioselective beta-adrenergic blocker possessing properties and potency similar to propranolol but without a negative inotropic effect. dose: adult: po- angina pectoris; htn- 50-100 mg once daily. migraine prophylaxis 50-100 mg/day. indi', '6223003270117', NULL, 2163, '2025-10-23', 0, '**Indicated** for:[label]



1) Management of hypertension alone and in combination with other antihypertensives.



2) Management of angina pectoris associated with coronary atherosclerosis.



3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg.



**Off-label** uses include:



1) Secondary prevention of myocardial infarction.[A178156]



2) Management of heart failure.[A178153]



3) Management of atrial fibrillation.[A178141]



4) Management of supraventricular tachycardia.[A178162]



5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy.[A178168]



6) Management of symptomatic thyrotoxicosis in combination with [methimazole].[A178147]



7) Prophylaxis of migraine headaches.[A178171]



8) Management of alcohol withdrawal.[A178174,A178177]', 'Atenolol is a cardioselective beta-blocker, called such because it selectively binds to the β1-adrenergic receptor as an antagonist up to a reported 26 fold more than β2 receptors.[A178372] Selective activity at the β1 receptor produces cardioselectivity due to the higher population of this receptor in cardiac tissue. Some binding to β2 and possibly β3 receptors can still occur at therapeutic dosages but the effects mediated by antagonizing these are significantly reduced from those of non-selective agents. β1 and β2 receptors are G<sub>s</sub> coupled therefore antagonism of their activation reduces activity of adenylyl cyclase and its downstream signalling via cyclic adenosime monophosphate and protein kinase A (PKA). 



In cardiomyocytes PKA is thought to mediate activation of L-type calcium channels and ryanodine receptors through their phosphorylation.[A178396] L-type calcium channels can then provide an initial rise in intracellular calcium and trigger the ryanodine receptors to release calcium stored in the sarcoplasmic reticulum (SR) and increased contractility. PKA also plays a role in the cessation of contraction by phosphorylating phospholamban which in turn increases the affinity of SR Ca<sup>2+</sup> ATPase to increase reuptake of calcium into the SR. It also phophorylates troponin I to reduce affinity of the protein for calcium. Both of these events lead to a reduction in contraction which, when coupled with the initial increase in contraction, allows for faster cycling and consequently higher heart rate with increased contractility. L-type calcium channels are also a major contributor to cardiac depolarization and their activation can increase frequency of action potentials and possibly the incidence of ectopic potentials.[A178405] 



Similar inihibitory events occur in the bronchial smooth muscle to mediate relaxation including phosphorylation of myosin light-chain kinase, reducing its affinity for calcium.[A178408] PKA also inhibits the excitatory G<sub>q</sub> coupled pathway by phosphorylating the inositol trisphosphate receptor and phospholipase C resulting in inhibition of intracellular calcium release. Antagonism of this activity by beta-blocker agents like atenolol can thus cause increased bronchoconstriction.

', 'Atenolol is a cardio-selective beta-blocker and as such exerts most of its effects on the heart.[label] It acts as an antagonist to sympathetic innervation and prevents increases in heart rate, electrical conductivity, and contractility in the heart due to increased release of norepinephrine from the peripheral nervous system.[label,T116,A178258] Together the decreases in contractility and rate produce a reduction in cardiac output resulting in a compensatory increase in peripheral vascular resistance in the short-term. This response later declines to baseline with long-term use of atenolol. More importantly, this reduction in the work demanded of the myocardium also reduces oxygen demand which provides therapeutic benefit by reducing the mismatch of oxygen supply and demand in settings where coronary blood flow is limited, such as in coronary atherosclerosis. Reducing oxygen demand, particularly due to exercise, can reduce the frequency of angina pectoris symptoms and potentially improve survival of the remaining myocardium after myocardial infarction. The decrease in rate of sinoatrial node potentials, electrical conduction, slowing of potentials traveling through the atrioventricular node, and reduced frequency of ectopic potentials due to blockade of adrenergic beta receptors has led to benefit in arrhythmic conditions such as atrial fibrillation by controlling the rate of action potential generation and allowing for more effective coordinated contractions. Since a degree of sympathetic activity is necessary to maintain cardiac function, the reduced contractility induced by atenolol may precipitate or worsen heart failure, especially during volume overload.[label]



The effects of atenolol on blood pressure have been established, although it is less effective than alternative beta-blockers, but the mechanism has not yet been characterized.[label,T116] As a β1 selective drug, it does not act via the vasodilation produced by non-selective agents.[T116] Despite this there is a sustained reduction in peripheral vascular resistance, and consequently blood pressure, alongside a decrease in cardiac output. It is thought that atenolol''s antihypertensive activity may be related to action on the central nervous system (CNS) or it''s inhibition of the renin-aldosterone-angiotensin system rather than direct effects on the vasculature.[label]



Atenolol produces CNS effects similar to other beta-blockers, but does so to a lesser extent due to reduces ability to cross the blood-brain barrier.[T116] It has the potential to produce fatigue, depression, and sleep disturbances such as nightmares or insomnia.[label,T116] The exact mechanisms behind these have not been characterized but their occurrence must be considered as they represent clinically relevant adverse effects.



Atenolol exerts some effects on the respiratory system although to a much lesser extent than non-selective beta-blockers.[label] Interaction with β2 receptors in the airways can produce bronchoconstriction by blocking the relaxation of bronchial smooth muscle mediated by the sympathetic nervous system.[T116] The same action can interfere with β-agonist therapies used in asthma and chronic obstructive pulmonary disease.[label,A178258,T116]



Unlike some other beta-blocker drugs, atenolol does not have intrinsic sympathomimetic or membrane stabilizing activity nor does it produce changes in glycemic control.[label]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11269, 'Primrose-e 30 capsule', 'بريمروز-اي 30 كبسولة', '185', '185', 'Evening primrose oil', 'Evening primrose oil+vitamin e', 'Pharma zad', 'Capsule', 'كبسولة', NULL, '3', NULL, NULL, NULL, NULL, 2252, '2024-10-18', 0, 'Evening primrose oil is used as part of over-the-counter dietary supplements.[L1113]



It is also used for the treatment of systemic inflammatory diseases and for women''s health conditions such as cyclical mastalgia. These indications do not have sufficient evidence of their effectiveness. It was used for the treatment of atopic dermatitis in the United Kingdom but it is currently withdrawn due to lack of evidence of effectiveness.[A33131]', 'Evening primrose oil presents a content of 74% [DB00132] and 9% [DB13854] from which the later seems to be the key active ingredient of this oil. These major essential fatty acids are required for the normal structure of cell membranes and they are not synthesized endogenously.[T218] The therapeutic activity of evening primrose oil is attributed to the direct action of its essential fatty acids on immune cells as well as to an indirect effect on the synthesis of eicosanoids. The actions of highly unsaturated fatty acids in tissues and eicosanoids are thought to be implicated in inflammatory and immunologic pathogeneses.[A33131]



The essential fatty acids found in evening primrose oil are involved in the biosynthesis of prostaglandin. For this activity, the main involved component is the [DB13854]. The presence of this essential fatty acid allows the synthesis of anti-inflammatory substances such as 15-hydroxy-eicosatrienoic acid and prostaglandin E1.[T218] ', 'The effectivity of evening primrose oil is debatable as the evidence is very limited.[F111] Evening primrose oil improves the essential fatty acid content in plasma, erythrocyte, and platelet lipids. It has also been registered to increase alpha-tocopherol levels in non-diabetic and type I diabetic patients. Evening primrose oil affects the fatty acid composition of serum lipids and adipose tissue as well as it helps maintain normal cellular structures and it serves as a prostaglandin precursor. Administration of evening primrose oil is part of long-term therapy and thus, immediate results are never expected.[T218]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11270, 'Tenormin 50mg 28 f.c.tab.', 'تينورمين 50مجم 28 قرص', '42', '29', 'Antihypertensive.beta blocker.selective b1', 'Atenolol', 'Astra zeneca', 'Tab', 'أقراص', '50mg', '2', NULL, 'description : a cardioselective beta-adrenergic blocker possessing properties and potency similar to propranolol but without a negative inotropic effect. dose: adult: po- angina pectoris; htn- 50-100 mg once daily. migraine prophylaxis 50-100 mg/day. indi', '6223003270100', NULL, 1947, '2025-11-13', 0, '**Indicated** for:[label]



1) Management of hypertension alone and in combination with other antihypertensives.



2) Management of angina pectoris associated with coronary atherosclerosis.



3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg.



**Off-label** uses include:



1) Secondary prevention of myocardial infarction.[A178156]



2) Management of heart failure.[A178153]



3) Management of atrial fibrillation.[A178141]



4) Management of supraventricular tachycardia.[A178162]



5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy.[A178168]



6) Management of symptomatic thyrotoxicosis in combination with [methimazole].[A178147]



7) Prophylaxis of migraine headaches.[A178171]



8) Management of alcohol withdrawal.[A178174,A178177]', 'Atenolol is a cardioselective beta-blocker, called such because it selectively binds to the β1-adrenergic receptor as an antagonist up to a reported 26 fold more than β2 receptors.[A178372] Selective activity at the β1 receptor produces cardioselectivity due to the higher population of this receptor in cardiac tissue. Some binding to β2 and possibly β3 receptors can still occur at therapeutic dosages but the effects mediated by antagonizing these are significantly reduced from those of non-selective agents. β1 and β2 receptors are G<sub>s</sub> coupled therefore antagonism of their activation reduces activity of adenylyl cyclase and its downstream signalling via cyclic adenosime monophosphate and protein kinase A (PKA). 



In cardiomyocytes PKA is thought to mediate activation of L-type calcium channels and ryanodine receptors through their phosphorylation.[A178396] L-type calcium channels can then provide an initial rise in intracellular calcium and trigger the ryanodine receptors to release calcium stored in the sarcoplasmic reticulum (SR) and increased contractility. PKA also plays a role in the cessation of contraction by phosphorylating phospholamban which in turn increases the affinity of SR Ca<sup>2+</sup> ATPase to increase reuptake of calcium into the SR. It also phophorylates troponin I to reduce affinity of the protein for calcium. Both of these events lead to a reduction in contraction which, when coupled with the initial increase in contraction, allows for faster cycling and consequently higher heart rate with increased contractility. L-type calcium channels are also a major contributor to cardiac depolarization and their activation can increase frequency of action potentials and possibly the incidence of ectopic potentials.[A178405] 



Similar inihibitory events occur in the bronchial smooth muscle to mediate relaxation including phosphorylation of myosin light-chain kinase, reducing its affinity for calcium.[A178408] PKA also inhibits the excitatory G<sub>q</sub> coupled pathway by phosphorylating the inositol trisphosphate receptor and phospholipase C resulting in inhibition of intracellular calcium release. Antagonism of this activity by beta-blocker agents like atenolol can thus cause increased bronchoconstriction.

', 'Atenolol is a cardio-selective beta-blocker and as such exerts most of its effects on the heart.[label] It acts as an antagonist to sympathetic innervation and prevents increases in heart rate, electrical conductivity, and contractility in the heart due to increased release of norepinephrine from the peripheral nervous system.[label,T116,A178258] Together the decreases in contractility and rate produce a reduction in cardiac output resulting in a compensatory increase in peripheral vascular resistance in the short-term. This response later declines to baseline with long-term use of atenolol. More importantly, this reduction in the work demanded of the myocardium also reduces oxygen demand which provides therapeutic benefit by reducing the mismatch of oxygen supply and demand in settings where coronary blood flow is limited, such as in coronary atherosclerosis. Reducing oxygen demand, particularly due to exercise, can reduce the frequency of angina pectoris symptoms and potentially improve survival of the remaining myocardium after myocardial infarction. The decrease in rate of sinoatrial node potentials, electrical conduction, slowing of potentials traveling through the atrioventricular node, and reduced frequency of ectopic potentials due to blockade of adrenergic beta receptors has led to benefit in arrhythmic conditions such as atrial fibrillation by controlling the rate of action potential generation and allowing for more effective coordinated contractions. Since a degree of sympathetic activity is necessary to maintain cardiac function, the reduced contractility induced by atenolol may precipitate or worsen heart failure, especially during volume overload.[label]



The effects of atenolol on blood pressure have been established, although it is less effective than alternative beta-blockers, but the mechanism has not yet been characterized.[label,T116] As a β1 selective drug, it does not act via the vasodilation produced by non-selective agents.[T116] Despite this there is a sustained reduction in peripheral vascular resistance, and consequently blood pressure, alongside a decrease in cardiac output. It is thought that atenolol''s antihypertensive activity may be related to action on the central nervous system (CNS) or it''s inhibition of the renin-aldosterone-angiotensin system rather than direct effects on the vasculature.[label]



Atenolol produces CNS effects similar to other beta-blockers, but does so to a lesser extent due to reduces ability to cross the blood-brain barrier.[T116] It has the potential to produce fatigue, depression, and sleep disturbances such as nightmares or insomnia.[label,T116] The exact mechanisms behind these have not been characterized but their occurrence must be considered as they represent clinically relevant adverse effects.



Atenolol exerts some effects on the respiratory system although to a much lesser extent than non-selective beta-blockers.[label] Interaction with β2 receptors in the airways can produce bronchoconstriction by blocking the relaxation of bronchial smooth muscle mediated by the sympathetic nervous system.[T116] The same action can interfere with β-agonist therapies used in asthma and chronic obstructive pulmonary disease.[label,A178258,T116]



Unlike some other beta-blocker drugs, atenolol does not have intrinsic sympathomimetic or membrane stabilizing activity nor does it produce changes in glycemic control.[label]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11273, 'Tenoxicam 20mg 20 caps', 'تينوكسيكام 20مجم 20 كبسولة', '60', '39', 'Nsaid.oxicam', 'Tenoxicam', 'El-obour', 'Cap', 'كبسولة', '20mg', '2', 'مسكن الام', NULL, '6223004600074', NULL, 2152, '2024-12-06', 0, 'For the treatment of rheumatoid arthritis, osteoarthritis, backache, and pain.', 'The antiinflammatory effects of tenoxicam may result from the inhibition of the enzyme cycooxygenase and the subsequent peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, their inhibition accounts for the peripheral analgesic effects of tenoxicam. Antipyresis may occur by central action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat loss.', 'Tenoxicam, an antiinflammatory agent with analgesic and antipyretic properties, is used to treat osteoarthritis and control acute pain.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11276, 'Depzabid 0.5% eye drops 5 ml', 'ديبزابيد 0.5% قطرة عين 5 مل', '17', '12', 'Antibiotic.quinolone', 'Moxifloxacin', 'Marcyrl co.', 'Drops', 'نقط', '0.5%', '1', NULL, NULL, '6223003579586', NULL, 875, '2024-01-06', 0, 'For the treatment of sinus and lung infections such as sinusitis, pneumonia, and secondary infections in chronic bronchitis. Also for the treatment of bacterial conjunctivitis (pinkeye).', 'The bactericidal action of moxifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. DNA gyrase is an essential enzyme that is involved in the replication, transcription and repair of bacterial DNA. Topoisomerase IV is an enzyme known to play a key role in the partitioning of the chromosomal DNA during bacterial cell division.', 'Moxifloxacin is a quinolone/fluoroquinolone antibiotic. Moxifloxacin can be used to treat infections caused by the following bacteria: Aerobic Gram-positive microorganisms: _Corynebacterium_ species, _Micrococcus luteus_, _Staphylococcus aureus_, _Staphylococcus epidermidis_, _Staphylococcus haemolyticus_, _Staphylococcus hominis_, _Staphylococcus warneri_, _Streptococcus pneumoniae_, and _Streptococcus viridans_ group. Aerobic Gram-negative microorganisms: _Acinetobacter lwoffii_, _Haemophilus influenzae_, and _Haemophilus parainfluenzae_. Other microorganisms: _Chlamydia trachomatis_. Moxifloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Moxifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11285, 'Shield omega 3 - 60 pieces', 'شيلد اوميجا 3 - 60 قطعة', '199', '180', NULL, 'Vitamin and minerals', 'Pharma zad', 'Piece', 'قطعة', NULL, '1', NULL, NULL, '6224002280046', NULL, 3218, '2024-08-10', 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11287, 'Terbin 1% cream 15 gm', 'تيربن كريم 15 جرام', '17', '11', 'Antifungals.allylamines', 'Terbinafine', 'Global napi pharmaceuticals', 'Cream', 'كريم', '1%', '1', 'مضاد للفطريات، يستخدم موضعيًا لعلاج العدوى الفطرية التي تصيب الجلد', 'about terbinafine a synthetic allylamine derivative antifungal. mechanism of action of terbinafine terbinafine is a fungicidal drug. it interfere the conversion of squalene to ergosterol by inhibiting the enzyme squalene epoxidase.this results in accumula', '6223002148387', NULL, 3102, '2023-11-12', 0, 'Terbinafine hydrochloride is indicated to treat fungal skin and nail infections caused by _Trichophyton_ species, _Microsporum canis_, _Epidermophyton floccosum_,[L9068] and _Tinea_ species.[L9065] Terbinafine hydrochloride also treats yeast infections of the skin caused by _Candida_ species and _Malassezia furfur_.[L9068]', 'Terbinafine inhibits the enzyme squalene monooxygenase (also called squalene epoxidase), preventing the conversion of squalene to 2,3-oxydosqualene, a step in the synthesis of ergosterol.[A1279,A1281,L9068] This inhibition leads to decreased ergosterol, which would normally be incorporated into the cell wall, and accumulation of squalene.[A1281,L9068]



Generation of a large number of squalene containing vesicles in the cytoplasm may leach other lipids away from, and further weaken, the cell wall.[A1281]', 'Terbinafine is an allylamine antifungal that inhibits squalene epoxidase (also known as squalene monooxygenase) to prevent the formation of ergosterol and cause an accumulation of squalene, weakening the cell wall of fungal cells.[A1279,A1281,L9068] Terbinafine distributes into tissues and has a long terminal elimination half life, so the duration of action is long.[A1279] Overdose with terbinafine is rare, even above the therapeutic dose, so the therapeutic index is wide.[L9065,L9068] Patients taking oral terbinafine should have liver function tests performed prior to treatment to reduce the risk of liver injury.[L9065]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11289, 'Terbinafine 1% foam spray 120 ml', 'تيربينافين 1% فوم سبراي 120 مل', '87', '48.6', 'Antifungal', 'Terbinafine', 'Egyptian co. for adv. pharma. (ecap)', 'Spray', 'بخاخ', '1%', '1', NULL, NULL, '6224000588045', NULL, 2478, '2024-08-10', 0, 'Terbinafine hydrochloride is indicated to treat fungal skin and nail infections caused by _Trichophyton_ species, _Microsporum canis_, _Epidermophyton floccosum_,[L9068] and _Tinea_ species.[L9065] Terbinafine hydrochloride also treats yeast infections of the skin caused by _Candida_ species and _Malassezia furfur_.[L9068]', 'Terbinafine inhibits the enzyme squalene monooxygenase (also called squalene epoxidase), preventing the conversion of squalene to 2,3-oxydosqualene, a step in the synthesis of ergosterol.[A1279,A1281,L9068] This inhibition leads to decreased ergosterol, which would normally be incorporated into the cell wall, and accumulation of squalene.[A1281,L9068]



Generation of a large number of squalene containing vesicles in the cytoplasm may leach other lipids away from, and further weaken, the cell wall.[A1281]', 'Terbinafine is an allylamine antifungal that inhibits squalene epoxidase (also known as squalene monooxygenase) to prevent the formation of ergosterol and cause an accumulation of squalene, weakening the cell wall of fungal cells.[A1279,A1281,L9068] Terbinafine distributes into tissues and has a long terminal elimination half life, so the duration of action is long.[A1279] Overdose with terbinafine is rare, even above the therapeutic dose, so the therapeutic index is wide.[L9065,L9068] Patients taking oral terbinafine should have liver function tests performed prior to treatment to reduce the risk of liver injury.[L9065]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11290, 'Ferzy 20 sachets', 'فيرزي 20 كيس', '120', '100', 'Iron supplement', 'Iron + lactoferrin + zinc + folic acid', 'Lanova pharma', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, NULL, NULL, 1324, '2025-09-21', 0, 'For treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Also used to replenish body iron stores in Non-Dialysis Dependent-Chronic Kidney Disease (NDD-CKD) patients receiving or not receiving erythropoietin and in Hemodialysis Dependent (HDD-CKD) and Peritoneal Dialysis Dependent (PDD-CKD) - Chronic Kidney Disease patients receiving an erythropoietin.', 'After iron dextran is injected, the circulating iron dextran is removed from the plasma by cells of the reticuloendothelial system, which split the complex into its components of iron and dextran. The iron is immediately bound to the available protein moieties to form hemosiderin or ferritin, the physiological forms of iron, or to a lesser extent to transferrin. This iron which is subject to physiological control replenishes hemoglobin and depleted iron stores.', 'Iron dextran is a dark brown, slightly viscous sterile liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. It is for treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Iron is essential to the formation of hemoglobin and to the function and formation of other heme and nonheme compounds. Untreated depletion of iron stores leads to iron-deficient erythropoiesis and, in turn, to iron deficiency anemia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11291, 'Didder cream 75 gm', 'ديدر كريم 75 جرام', '130', '120', 'Moisturizing and healing cream', 'Honey+propolis+royal jelly+beaswax+glycerol+vit e', 'Safe life', 'Cream', 'كريم', '75 gm', '1', 'كريم مرطب وملطف للبشرة بعد جلسة الليزر', NULL, NULL, NULL, 4291, '2025-10-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11296, 'Terhexine syrup 120ml', 'تيرهكسين شراب 120 مل', '20', '12', 'Cough drugs', 'Bromhexine+guaifenesin+menthol+terbutaline', 'European egyptian pharm. ind.', 'Syrup', 'شراب', '120ml', '1', 'علاج الكحة', 'indications expectorants are drugs which have been proposed to be useful in loosening and liquefying mucous in soothing irritated bronchial mucosa and in making coughs more productive. azmaril is recommended for clinical relief of cough associated with br', '6221076050179', NULL, 2201, '2024-01-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11299, 'Zero sand antidandruff shampoo', 'زيرو ساند شامبو مضاد للقشرة', '55', NULL, 'Antidandruff shampoo', 'Proctone olamine+zinc pyrithrone+salicylic acid', 'Stay green', 'Amp', 'أمبول', NULL, '1', 'مضاد حيوي -- كورتيزون', NULL, NULL, NULL, 1310, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11300, 'Edica 415mg 30tabs', 'اديكا 415مجم 30 قرص', '110', NULL, 'Calcium+multivitamins', 'Calcium+magnesium+vitamin d', 'Vilatriq', 'Tab', 'أقراص', '415mg', '1', NULL, NULL, NULL, NULL, 1524, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11301, 'Care dipine plus 30 f.c. tabs', 'كير ديبين بلس 30 قرص', '165', '122.25', 'Anti-hypertensive.combined ace with calcium channel blocker', 'Lercanidipine+enalapril', 'Misr > pharmacare', 'Tab', 'أقراص', NULL, '3', NULL, NULL, '6224007326831', NULL, 1673, '2025-06-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11302, 'Ancavaz 5/10 mg 20 tabs.', 'انكافاز 5/10مجم 20 قرص', '69', NULL, 'Anti-hypertensive.combined ace with calcium channel blocker', 'Amlodipine + perindopril', 'Zeta pharm', 'Tab', 'أقراص', '10 mg', '2', NULL, 'indication for the treatment of mild to moderate essential hypertension mild to moderate congestive heart failure and to reduce the cardiovascular risk of individuals with hypertension or post-myocardial infarction and stable coronary disease. about amlod', NULL, NULL, 887, '2022-08-02', 0, 'Amlodipine may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of the following conditions [FDA label]:



• Hypertension 



• Coronary artery disease



• Chronic stable angina



• Vasospastic angina (Prinzmetal’s or Variant angina) 



• Angiographically documented coronary artery disease in patients without heart failure or an ejection fraction < 40%', '**Mechanism of action on blood pressure**



Amlodipine is considered a peripheral arterial vasodilator that exerts its action directly on vascular smooth muscle to lead to a reduction in peripheral vascular resistance, causing a decrease in blood pressure. Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the influx of calcium ions into both vascular smooth muscle and cardiac muscle. Experimental studies imply that amlodipine binds to both _dihydropyridine_ and _nondihydropyridine_ binding sites, located on cell membranes. The contraction of cardiac muscle and vascular smooth muscle are dependent on the movement of extracellular calcium ions into these cells by specific ion channels. Amlodipine blocks calcium ion influx across cell membranes with selectivity. A stronger effect of amlodipine is exerted on vascular smooth muscle cells than on cardiac muscle cells [FDA label]. Direct actions of amlodipine on vascular smooth muscle result in reduced blood pressure [F3757]. 



**Mechanism of action in angina**



The exact mechanism by which amlodipine relieves the symptoms of angina have not been fully elucidated to this date, however, the mechanism of action is likely twofold:



Amlodipine has a dilating effect on peripheral arterioles, reducing the total peripheral resistance (afterload) against which the cardiac muscle functions. Since the heart rate remains stable during amlodipine administration, the reduced work of the heart reduces both myocardial energy use and oxygen requirements [F3757].



Dilatation of the main coronary arteries and coronary arterioles, both in healthy and ischemic areas, is another possible mechanism of amlodipine reduction of blood pressure. The dilatation causes an increase in myocardial oxygen delivery in patients experiencing coronary artery spasm (Prinzmetal''s or variant angina) and reduces coronary vasoconstriction caused by smoking [F3757].', '**General pharmacodynamic effects**



Amlodipine has a strong affinity for cell membranes, modulating calcium influx by inhibiting selected membrane calcium channels. This drug''s unique binding properties allow for its long-acting action and less frequent dosing regimen [A573], [FDA label].  



**Hemodynamic effects**



After the administration of therapeutic doses of amlodipine to patients diagnosed with hypertension, amlodipine causes vasodilation, which results in a reduction of supine and standing blood pressure. During these blood pressure reductions, there are no clinically significant changes in heart rate or plasma catecholamine levels with long-term use. Acute intravenous administration of amlodipine reduces arterial blood pressure and increases heart rate in patients with chronic stable angina, however, chronic oral administration of amlodipine in clinical studies did not cause clinically significant alterations in heart rate or blood pressures in patients diagnosed with angina and normal blood pressure. With long-term, once daily oral administration, antihypertensive effectiveness is maintained for at least 24 hours [FDA label]. 



**Electrophysiologic effects**



Amlodipine does not change sinoatrial (SA) nodal function or atrioventricular (AV) conduction in animals or humans. In patients who were diagnosed with chronic stable angina, the intravenous administration of 10 mg of amlodipine did not cause clinically significant alterations A-H and H-V conduction and sinus node recovery time after cardiac pacing. Patients administered amlodipine with concomitant beta-blockers produced similar results. In clinical trials in which amlodipine was given in combination with beta-blockers to patients diagnosed with hypertension or angina, no adverse effects on electrocardiographic parameters were noted. In clinical studies comprised of angina patients alone, amlodipine did not change electrocardiographic intervals or produce high degrees of AV block [FDA label]. 



**Effects on angina**



Amlodipine relieves the symptoms of chest pain associated with angina. In patients diagnosed with angina, daily administration of a single amlodipine dose increases total exercise time, the time to angina onset, and the time to 1 mm ST-segment depression on ECG studies, decreases anginal attack frequency, and decreases the requirement for nitroglycerin tablets [F3757]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11303, 'Terramycin eye oint. 5 gm', 'تيراميسين مرهم عين 5 جم انبوبة', '28', '19.5', 'Antibiotic tetracycline', 'Oxytetracycline+polymyxin', 'Pfizer', 'Oint', 'مرهم', '5 gm', '1', '1- التهابات العين السطحية والتهاب الجفن.', 'about oxytetracycline tetracycline derivative a broad spectrum antibiotic. mechanism of action of oxytetracycline oxytetracycline is a broad spectrum antibiotic which has action against both gram positive organisms & gram negative organisms. it exerts its', NULL, NULL, 38057, '2024-11-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11305, 'Looby 16 lozenges', 'لوبي 60 قرص استحلاب', '30', NULL, 'Sore throat', 'Menthol+vitamin c', 'Merge pharma', 'Lozenges', 'استحلاب', NULL, '1', NULL, NULL, NULL, NULL, 898, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11306, 'Gerolix 10 sachets 10 gm', 'جيروليكس 10 اكياس', '69', NULL, NULL, 'Protein with iron and vitamin b complex and vitamin c', 'Med care for procare', 'Sachet', 'أكياس', '10 gm', '1', NULL, NULL, NULL, NULL, 1316, '2022-07-21', 0, 'Protein C concentrate is indicated for pediatric and adult patients with severe congenital protein C deficiency for the prevention and treatment of venous thrombosis and purpura fulminans.[L12831] It is also found as a component of some prothrombin complex concentrate (i.e. [Factor IX Complex (Human)]) formulations, such as Kcentra.[L12834]



Along with other blood coagulation factors, it is used to reverse acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with a need for an urgent surgery/invasive procedure.[L50517]', 'Protein C is an endogenously occurring plasma protein that plays a key role within the coagulation cascade. Also known as blood coagulation factor XIV, Protein C is a zymogen, or enzyme precursor, of a vitamin K-dependent anticoagulant glycoprotein (serine protease) that is synthesized in the liver. It is converted by the thrombin/thrombomodulin-complex on the endothelial cell surface to Activated Protein C (APC). Once in its activated form, APC functions as a serine protease with potent anticoagulant effects, especially in the presence of its cofactor protein S. APC exerts its effect by inactivating essential components of the coagulation cascade (specifically factors V and VIII), which leads to a decrease in thrombin formation, and therefore a reduction in clot formation. ', 'In clinical studies, the intravenous administration of Protein C Concentrate demonstrated a temporary increase, within approximately half an hour of administration, in plasma levels of APC. Replacement of protein C in protein C-deficient patients is expected to control or, if given prophylactically, to prevent thrombotic complications.[L12831]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11307, 'Bone care 2 mcg/ml 5 i.v. amps.', 'بون كير 2مكجم/مل 5 امبولات وريد', '150', '101.5', 'Vitamin d', 'Alfacalcidol', 'Multicare', 'Amp', 'أمبول', '2 mcg', '5', NULL, NULL, NULL, NULL, 1268, '2024-12-30', 0, 'Alfacalcidol is indicated in adult patients with chronic renal failure for the management of hypocalcemia, secondary hyperparathyroidism, or osteodystrophy.[L33284]



Alfacalcidol is indicated in the management of nutritional and malabsorptive rickets and osteomalacia, vitamin D-dependent rickets and osteomalacia, and hypophosphataemic vitamin D resistant rickets and osteomalacia.[L33364,L33369]', 'In conditions like chronic renal failure, renal bone disease, hypoparathyroidism, and vitamin D dependent rickets, the kidneys'' capacity for 1α-hydroxylation is impaired, leading to reduced production of endogenous 1,25-dihydroxyvitamin D and aberrated mineral metabolism. As an active and potent analog of vitamin D, alfacalcidol works to restore the functions and activities of endogenous 1,25-dihydroxyvitamin D.[L33369]', 'Alfacalcidol works to increase serum levels of calcium by stimulating intestinal calcium absorption, reabsorption of calcium from bone, and possibly the renal reabsorption of calcium. It also modestly promotes intestinal phosphorus absorption.[L33284] In patients with renal failure, alfacalcidol increased intestinal calcium and phosphorus absorption in a dose-related manner. This increase in calcium and phosphorus levels occurs within three days following drug administration: this effect was reversed within three days of drug discontinuation. In patients with chronic renal failure, serum calcium levels were elevated while parathyroid hormone and alkaline phosphatase levels returned to normal levels within five days following alfacalcidol administration.[L33369] Since alfacalcidol suppresses parathyroid hormone, a reduction in parathyroid hormone levels is achieved more rapidly in patients on intermittent intravenous therapy, with significant reductions occurring within three months of therapy. In patients receiving daily oral therapy of alfacalcidol, the time it takes alfacalcidol to normalize plasma calcium levels may be up to several months, possibly reflecting calcium being utilized for bone mineralization.[L33284] In patients with nutritional osteomalacia, alfacalcidol increased calcium absorption with six hours of oral administration and the effects peaked at 24 hours.[L33369]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11308, 'Zyrovazet 5/10mg 30 tablets', 'زيروفازيت 5/10مجم 30 قرص', '132', '97.5', 'Antihyperlipidemic.statins', 'Rosuvastatin+ezetimibe', 'Marcyrl > xeedia pharma', 'Tablet', 'أقراص', '10mg', '3', NULL, NULL, NULL, NULL, 1892, '2024-06-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11309, 'Fertitonex 30 caps', 'فرتيتونكس 30 كبسولة', '300', '225', 'Antioxidant', 'L-carnitine+l-arginine+vitamin b6+vitamin b12+vitamin d3+vitamin e+vitamin c+selenium+zinc+folic acid+co q10 enzyme', 'Copad egypt > integra pharm', 'Cap', 'كبسولة', NULL, '3', '1- زيادة ودعم الخصوبة والتكاثر للرجال.', 'supports male and female infertility & antioxidants', '6224009369430', NULL, 131656, '2024-04-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11313, 'Testone e 3 i.m. oily amp.', 'تستون-هـ 3 امبولات', '14', NULL, 'Androgen', 'Testosterone+vitamin e', 'Misr', 'Amp', 'أمبول', NULL, '3', 'هرمون الأندروجين -- مضاد أكسدة', NULL, '6221035016246', NULL, 2402, '2022-05-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11318, 'Tetanus antitoxin 1500 i u 10 ampoules', 'تيتانوس مصل انتي توكسين 1500 وحدة دولية 10 امبولات', '1,100', '950', 'Anti tetanus serum', 'Tetenus vaccine', 'Sinochem ningbo imp.-china > international trading office', 'Ampoule', 'أمبول', NULL, '10', 'مصل طبي ضد الفيروسات والأمراض التي قد تنتقل بالجروح', NULL, '6224011116244', NULL, 4285, '2025-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11319, 'Ivo stark 30 tabs', 'ايفو ستارك 30 قرص', '99', NULL, 'Multivitamin.bones', 'Calcium+cholecalciferol (vitamin d3)+magnesium+zinc+boron+manganese+copper+selenium', 'Ivory care pharma', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 1254, '2022-10-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11320, 'Melanthenol ss 30gm cream', 'ميلانثينول اس اس كريم 30 جم', '75', NULL, 'Moisturizer', 'D-panthenol+glycerin+vitamin e+allantoin', 'Melano pharma', 'Cream', 'كريم', '30gm', '1', NULL, NULL, NULL, NULL, 917, '2022-10-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11321, 'Cute agar 15 ml oral drops', 'كيوت اجار نقط فم 15 مل', '69', NULL, 'Agar drop', 'Agar -agar', 'Life pharma international', 'Drops', 'نقط', '15 ml', '1', NULL, NULL, NULL, NULL, 740, '2022-10-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11322, 'Taysecal 30 tablets', 'تايسيكال 30 قرص', '69', NULL, 'Calcium deficiency and bones support', 'Calcium+magnesium+zinc+vitamin d3', 'Altayseer', 'Tablet', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 729, '2022-10-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11323, 'Landymo syrup 120 ml', 'لانديمو شراب 120 مل', '50', NULL, 'Iron supplement multivitamin', 'Liposoml iron+vit c+zinc+vit e+vit b-complex+folic acid', 'Auc pharma', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 1237, '2022-10-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11325, 'Alejon deodorant roll on 50 ml', 'اليجون مزيل عرق رول 50 مل', '180', NULL, 'Skin care', NULL, 'Alejon co.', 'Unknown', 'غير محدد', '50 ml', '1', NULL, NULL, NULL, NULL, 699, '2022-10-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11326, 'Tetanus antitoxin (a.t.s) 1500 i.u. 1amp.(n/a)', 'تيتانوس مصل انتي توكسين 1500 وحدة دولية 1 امبول', '3', NULL, 'Anti tetanus serum', 'Tetenus vaccine', 'Sinochem ningbo imp.-china > international trading office', 'Amp', 'أمبول', NULL, '1', NULL, NULL, NULL, NULL, 2148, '2022-10-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11330, 'Tetracid 250 mg 16 cap.', 'تتراسيد 250 مجم 16 كبسولة', '22', NULL, 'Antibiotic.tetracycline', 'Tetracycline', 'Cid', 'Cap', 'كبسولة', '250 mg', '2', 'مضاد حيوي', 'about tetracycline a broad-spectrum polyketide antibiotic tetracycline derivative. mechanism of action of tetracycline tetracycline is a broad spectrum antibiotic which has more specific action against gram positive organisms than gram negative organisms.', '6221043012216', NULL, 3951, '2023-07-30', 0, 'Used to treat bacterial infections such as Rocky Mountain spotted fever, typhus fever, tick fevers, Q fever, rickettsialpox and Brill-Zinsser disease. May be used to treat infections caused by Chlamydiae spp., B. burgdorferi (Lyme disease), and upper respiratory infections caused by typical (S. pneumoniae, H. influenzae, and M. catarrhalis) and atypical organisms (C. pneumoniae, M. pneumoniae, L. pneumophila). May also be used to treat acne. Tetracycline may be an alternative drug for people who are allergic to penicillin.', 'Tetracycline passively diffuses through porin channels in the bacterial membrane and reversibly binds to the 30S ribosomal subunit, preventing binding of tRNA to the mRNA-ribosome complex, and thus interfering with protein synthesis.', 'Tetracycline is a short-acting antibiotic that  inhibits bacterial growth by inhibiting translation. It binds to the 30S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome. It also binds to some extent to the 50S ribosomal subunit. This binding is reversible in nature. Additionally tetracycline may alter the cytoplasmic membrane of bacteria causing leakage of intracellular contents, such as nucleotides, from the cell. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11332, 'Gastropexy 10 mg 28 tabs.', 'جاستروبيكسي 10 مجم 28 قرص', '118', NULL, 'Peptic ulcer.potassium-competitive acid blocker', 'Vonoprazan', 'Apex pharma', 'Tab', 'أقراص', '10 mg', '4', NULL, NULL, NULL, NULL, 878, '2022-08-17', 0, 'Vonoprazan is indicated for the following conditions: 



- for healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults.[L51224]

- to maintain healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults.[L51224]

- for the relief of heartburn associated with non-erosive gastroesophageal reflux disease in adults.[L51224]

- in combination with [amoxicillin] and [clarithromycin] for the treatment of Helicobacter pylori (_H. pylori_) infection in adults.[L41695, L51224]

- in combination with amoxicillin for the treatment of H. pylori infection in adults.[L51224]', 'Vonoprazan is a potassium-competitive acid blocker (PCAB) that inhibits the H<sup>+</sup>, K<sup>+</sup>-ATPase enzyme system in a potassium-competitive manner. Through this mechanism, vonoprazan suppresses basal and stimulated gastric acid secretion at the secretory surface of gastric parietal cells.[L41695] 



Although both classes of drugs inhibit the H<sup>+</sup>, K<sup>+</sup>-ATPase, the mechanism of action of PCABs differs from that of proton-pump inhibitors (PPIs). PPIs form a covalent disulphide bond with a cysteine residue on the H<sup>+</sup>, K<sup>+</sup>-ATPase, which leads to the inactivation of the enzyme, while PCABs interfere with the binding of K<sup>+</sup> to the H<sup>+</sup>, K<sup>+</sup>-ATPase.[A253702]', 'The use of vonoprazan leads to an increase in intragastric pH. The inhibitory effect of vonoprazan on acid secretion increases with repeated daily dosing. Although the antisecretory effect of vonoprazan decreases after drug discontinuation, intragastric pH remains elevated for 24 to 48 hours. Vonoprazan does not have a clinically significant effect on QT prolongation.[L41695] 



Compared to other potassium-competitive acid blockers (PCABs), vonoprazan has a higher point-positive charge (pKa of 9.06). This allows vonoprazan to accumulate at higher concentrations in the canalicular space of the gastric parietal cells, where it binds H<sup>+</sup>, K<sup>+</sup>-ATPase in a  K<sup>+</sup>-competitive and reversible manner. Compared to other PCABs, such as SCH28080, or proton-pump inhibitors, such as lansoprazole, vonoprazan has a more potent H<sup>+</sup>, K<sup>+</sup>-ATPase inhibitory activity.[A253702]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11335, 'Prominexil 120 ml lotion', 'برومينكسيل لوشن 120 مل', '230', '180', 'Anti hair loss', 'Aminixeil+procapil+fiberhance bm solution+caffeine 5%+keratin+collagen+rosemary+saw palmetto+panthenol+argan / jojoba /olive oile', 'United scientific office ( uso pharma )', 'Lotion', 'لوشن', '120 ml', '1', NULL, NULL, NULL, NULL, 1014, '2025-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11336, 'Tetracycline 250 mg 240 caps. (adco)', 'تتراسيكلين 250 مجم 240 كبسولة ادكو', '462', '330', 'Antibiotic.tetracycline', 'Tetracycline', 'Arab drug company.', 'Cap', 'كبسولة', '250 mg', '20', 'مضاد حيوي.', NULL, NULL, NULL, 3523, '2025-02-01', 0, 'Used to treat bacterial infections such as Rocky Mountain spotted fever, typhus fever, tick fevers, Q fever, rickettsialpox and Brill-Zinsser disease. May be used to treat infections caused by Chlamydiae spp., B. burgdorferi (Lyme disease), and upper respiratory infections caused by typical (S. pneumoniae, H. influenzae, and M. catarrhalis) and atypical organisms (C. pneumoniae, M. pneumoniae, L. pneumophila). May also be used to treat acne. Tetracycline may be an alternative drug for people who are allergic to penicillin.', 'Tetracycline passively diffuses through porin channels in the bacterial membrane and reversibly binds to the 30S ribosomal subunit, preventing binding of tRNA to the mRNA-ribosome complex, and thus interfering with protein synthesis.', 'Tetracycline is a short-acting antibiotic that  inhibits bacterial growth by inhibiting translation. It binds to the 30S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome. It also binds to some extent to the 50S ribosomal subunit. This binding is reversible in nature. Additionally tetracycline may alter the cytoplasmic membrane of bacteria causing leakage of intracellular contents, such as nucleotides, from the cell. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11337, 'Linex massage spray 120 ml', 'لينكس بخاخ مساج 120 مل', '120', NULL, 'Massage', 'Camphor+menthol+aloe vera extract+clove extract+peppermint extract', 'Pixel', 'Spray', 'بخاخ', '120 ml', '1', NULL, NULL, NULL, NULL, 996, '2025-02-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11338, 'Tetracycline 250 mg 12 caps. (adco)', 'تتراسيكلين 250 مجم 12 كبسولة ادكو', '17', NULL, 'Antibiotic.tetracycline', 'Tetracycline', 'Arab drug company.', 'Cap', 'كبسولة', '250 mg', '2', NULL, NULL, NULL, NULL, 1021, '2022-08-17', 0, 'Used to treat bacterial infections such as Rocky Mountain spotted fever, typhus fever, tick fevers, Q fever, rickettsialpox and Brill-Zinsser disease. May be used to treat infections caused by Chlamydiae spp., B. burgdorferi (Lyme disease), and upper respiratory infections caused by typical (S. pneumoniae, H. influenzae, and M. catarrhalis) and atypical organisms (C. pneumoniae, M. pneumoniae, L. pneumophila). May also be used to treat acne. Tetracycline may be an alternative drug for people who are allergic to penicillin.', 'Tetracycline passively diffuses through porin channels in the bacterial membrane and reversibly binds to the 30S ribosomal subunit, preventing binding of tRNA to the mRNA-ribosome complex, and thus interfering with protein synthesis.', 'Tetracycline is a short-acting antibiotic that  inhibits bacterial growth by inhibiting translation. It binds to the 30S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome. It also binds to some extent to the 50S ribosomal subunit. This binding is reversible in nature. Additionally tetracycline may alter the cytoplasmic membrane of bacteria causing leakage of intracellular contents, such as nucleotides, from the cell. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11339, 'Tetracycline 250mg 12caps.', 'تيتراسيكلين 250مجم 12 كبسولة', '17', '8.25', 'Antibiotic.tetracycline', 'Tetracycline', 'Hi-pharm > pyramids for trading pharmaceuticals-egypt', 'Cap', 'كبسولة', '250mg', '2', NULL, NULL, NULL, NULL, 1035, '2025-08-04', 0, 'Used to treat bacterial infections such as Rocky Mountain spotted fever, typhus fever, tick fevers, Q fever, rickettsialpox and Brill-Zinsser disease. May be used to treat infections caused by Chlamydiae spp., B. burgdorferi (Lyme disease), and upper respiratory infections caused by typical (S. pneumoniae, H. influenzae, and M. catarrhalis) and atypical organisms (C. pneumoniae, M. pneumoniae, L. pneumophila). May also be used to treat acne. Tetracycline may be an alternative drug for people who are allergic to penicillin.', 'Tetracycline passively diffuses through porin channels in the bacterial membrane and reversibly binds to the 30S ribosomal subunit, preventing binding of tRNA to the mRNA-ribosome complex, and thus interfering with protein synthesis.', 'Tetracycline is a short-acting antibiotic that  inhibits bacterial growth by inhibiting translation. It binds to the 30S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome. It also binds to some extent to the 50S ribosomal subunit. This binding is reversible in nature. Additionally tetracycline may alter the cytoplasmic membrane of bacteria causing leakage of intracellular contents, such as nucleotides, from the cell. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11340, 'Tetracycline hydrochloride 250mg 16caps. usp24', 'تتراسيكلين 250مجم 16 كبسولة', '11', NULL, 'Antibiotic.tetracycline', 'Tetracycline', 'El nasr', 'Cap', 'كبسولة', '250mg', '2', NULL, NULL, NULL, NULL, 990, '2022-08-17', 0, 'Used to treat bacterial infections such as Rocky Mountain spotted fever, typhus fever, tick fevers, Q fever, rickettsialpox and Brill-Zinsser disease. May be used to treat infections caused by Chlamydiae spp., B. burgdorferi (Lyme disease), and upper respiratory infections caused by typical (S. pneumoniae, H. influenzae, and M. catarrhalis) and atypical organisms (C. pneumoniae, M. pneumoniae, L. pneumophila). May also be used to treat acne. Tetracycline may be an alternative drug for people who are allergic to penicillin.', 'Tetracycline passively diffuses through porin channels in the bacterial membrane and reversibly binds to the 30S ribosomal subunit, preventing binding of tRNA to the mRNA-ribosome complex, and thus interfering with protein synthesis.', 'Tetracycline is a short-acting antibiotic that  inhibits bacterial growth by inhibiting translation. It binds to the 30S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome. It also binds to some extent to the 50S ribosomal subunit. This binding is reversible in nature. Additionally tetracycline may alter the cytoplasmic membrane of bacteria causing leakage of intracellular contents, such as nucleotides, from the cell. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11342, 'Tendozyme 20 f.c.tabs.', 'تيندوزايم 20 قرص', '150', '120', 'Anti-inflammatory.anti-edematous', 'Trypsin+bromelain+rutin+serrapeptase+papain', 'Advocure', 'Tab', 'أقراص', NULL, '2', NULL, NULL, '6224009460137', NULL, 1572, '2025-05-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11343, 'Melanoxidil 5% hair spray 60 ml', 'ميلانوكسيديل 5% سبراي للشعر 60 مل', '121', '82', 'Antihypertensives.hair regrowth.vasodilator agents', 'Minoxidil', 'Melano pharma', 'Spray', 'بخاخ', '5%', '1', NULL, NULL, '6224009517398', NULL, 1503, '2024-12-13', 0, 'For the treatment of severe hypertension and in the topical treatment (regrowth) of androgenic alopecia in males and females and stabilisation of hair loss in patients with androgenic alopecia.', 'Minoxidil is thought to promote the survival of human dermal papillary cells (DPCs) or hair cells by activating both extracellular signal-regulated kinase (ERK) and Akt and by preventing cell death by increasing the ratio of BCl<sup>-</sup>2/Bax. Minoxidil may stimulate the growth of human hairs by prolonging anagen through these proliferative and anti-apoptotic effects on DPCs. Minoxidil, when used as a vasodilator, acts by opening adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells. This vasodilation may also improve the viability of hair cells or hair follicles.', 'Minoxidil is an orally effective direct acting peripheral vasodilator that reduces elevated systolic and diastolic blood pressure by decreasing peripheral vascular resistance. Minoxidil is also used topically to treat androgenetic alopecia. Microcirculatory blood flow in animals is enhanced or maintained in all systemic vascular beds. In man, forearm and renal vascular resistance decline; forearm blood flow increases while renal blood flow and glomerular filtration rate are preserved. The predominant site of minoxidil action is arterial. Venodilation does not occur with minoxidil; thus, postural hypotension is unusual with its administration. The antihypertensive activity of minoxidil is due to its sulphate metabolite, minoxidil sulfate.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11344, 'Texacort 0.1% top. lipocream 20 gm', 'تكساكورت 0.1% كريم 20 جم', '22', '12.5', 'Glucocorticoid', 'Hydrocortisone butyrate', 'Marcyrl co.', 'Cream', 'كريم', '0.1%', '1', 'كورتيزون', 'about hydrocortisone systemic synthetic glucocorticoid anti-inflammatory mechanism of action of hydrocortisone the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and causes a structural change in steroid', '6223003579821', NULL, 3719, '2024-10-16', 0, 'Otic solutions are indicated for infections of the external auditory canal caused by susceptible organisms and with inflammation.[L10529,L10532] Hydrocortisone tablets are indicated for certain endocrine, rheumatic, collagen, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, gastrointestinal, and other conditions.[L10535] A hydrocortisone enema is indicated for ulcerative colitis,[L10538] a topical ointment with antibiotics is indicated for corticosteroid responsive dermatoses with infections,[L7772] and a topical cream with [acyclovir] is indicated to treat cold sores.[L7321] Oral granules of hydrocortisone are used as a replacement therapy for Adrenocortical Insufficiency (AI) in children under 17 years of age.[L16533]', 'The short-term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation.[A187463] Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days.[A187463]



Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10.[A187463]



Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.[A187463] High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.[A187463]', 'Hydrocortisone binds to the glucocorticoid receptor leading to downstream effects such as inhibition of phospholipase A2, NF-kappa B, other inflammatory transcription factors, and the promotion of anti-inflammatory genes.[A187463] Hydrocortisone has a wide therapeutic index[A188405] and a moderate duration of action.[A188354,A188381] Patients should stop taking the medication if irritation or sensitization occurs.[L10529,L10532,L10535,L10538,L7772,L7321]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11347, 'Omisec 20mg 14caps.', 'اوميسيك 20 مجم 14 كبسوله', '42', NULL, 'Peptic ulcer.proton pump inhibitor', 'Omeprazole', 'Modern pharma', 'Cap', 'كبسولة', '20mg', '2', NULL, NULL, '6221045000488', NULL, 726, '2022-12-30', 0, 'Omeprazole, according to the FDA label [FDA label] is a proton pump inhibitor (PPI) used for the following purposes:



• Treatment of active duodenal ulcer in adults 



• Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer

recurrence in adults 



• Treatment of active benign gastric ulcer in adults 



• Reduction of risk of upper gastrointestinal (GI) bleeding in critically ill adult patients.



• Treatment of symptomatic gastroesophageal reflux disease (GERD) in

patients 1 year of age and older 



• Treatment of erosive esophagitis (EE) due to acid-mediated GERD in

patients 1 month of age and older 



• Maintenance of healing of EE due to acid-mediated GERD in patients 1

year of age and older 



• Pathologic hypersecretory conditions in adults', 'Hydrochloric acid (HCl) secretion into the gastric lumen is a process regulated mainly by the H(+)/K(+)-ATPase of the proton pump [A175180], expressed in high quantities by the parietal cells of the stomach. ATPase is an enzyme on the parietal cell membrane that facilitates hydrogen and potassium exchange through the cell, which normally results in the extrusion of potassium and formation of HCl (gastric acid) [A174295].



Omeprazole is a member of a class of antisecretory compounds, the substituted _benzimidazoles_, that stop gastric acid secretion by selective inhibition of the _H+/K+ ATPase_ enzyme system. Proton-pump inhibitors such as omeprazole bind covalently to cysteine residues via disulfide bridges on the alpha subunit of the _H+/K+ ATPase_ pump, inhibiting gastric acid secretion for up to 36 hours [A175192].  This antisecretory effect is dose-related and leads to the inhibition of both basal and stimulated acid secretion, regardless of the stimulus [FDA label].  



**Mechanism of H. pylori eradication**



Peptic ulcer disease (PUD) is frequently associated with _Helicobacter pylori_ bacterial infection (NSAIDs) [A175195]. The treatment of H. pylori infection may include the addition of omeprazole or other proton pump inhibitors as part of the treatment regimen [FDA label], [A175198]. 

_H. pylori_ replicates most effectively at a neutral pH [A175213]. Acid inhibition in H. pylori eradication therapy, including proton-pump inhibitors such as omeprazole, raises gastric pH, discouraging the growth of H.pylori [A175198]. It is generally believed that proton pump inhibitors inhibit the _urease_ enzyme, which increases the pathogenesis of H. pylori in gastric-acid related conditions [A175216].   ', '**Effects on gastric acid secretion**



This drug decreases gastric acid secretion [FDA label]. After oral administration, the onset of the antisecretory effect of omeprazole is usually achieved within one hour, with the maximum effect occurring by 2 hours after administration. The inhibitory effect of omeprazole on acid secretion increases with repeated once-daily dosing, reaching a plateau after four days [FDA label].



**Effects on serum gastrin**



In studies of 200 or more patients, serum gastrin levels increased during the first 1-2 weeks of daily administration of therapeutic doses of omeprazole. This occurred in a parallel fashion with the inhibition of acid secretion. No further increase in serum gastrin occurred with continued omeprazole administration. Increased gastrin causes enterochromaffin-like cell hyperplasia and increased serum Chromogranin A (CgA) levels. The increased CgA levels may lead to false positive results in diagnostic studies for neuroendocrine tumors [FDA label].



**Enterochromaffin-like (ECL) cell effects**



Human gastric biopsy samples have been obtained from more than 3000 pediatric and adult patients treated with omeprazole in long-term clinical studies. The incidence of enterochromaffin-like cell hyperplasia in these studies increased with time; however, no case of ECL cell carcinoids, dysplasia, or neoplasia have been identified in these patients. These studies, however, are of insufficient in power and duration to draw conclusions on the possible influence of long-term administration of omeprazole in the development of any premalignant or malignant conditions [FDA label]. 



**Other effects**



Systemic effects of omeprazole in the central nervous system, cardiovascular and respiratory systems have not been found to date. Omeprazole, given in oral doses of 30 or 40 mg for 2-4 weeks, showed no effect on thyroid function, carbohydrate metabolism, or circulating levels of parathyroid hormone, cortisol, estradiol, testosterone, prolactin, cholecystokinin or secretin [FDA label]. 





', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11348, 'Theo 200mg s.r. 20 caps.', 'ثيو 200مجم اس ار 20 كبسولة', '9', NULL, 'Bronchodilator.phosphodiesterase inhibitors', 'Theophylline', 'Glaxo smithkline', 'Cap', 'كبسولة', '200mg', '2', 'موسع للشعب الهوائية -- تحسين التنفس -- علاج الربو -- علاج الازمات التنفسية', NULL, '6221045000501', NULL, 931, '2022-12-30', 0, 'For the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis.', 'Theophylline relaxes the smooth muscle of the bronchial airways and pulmonary blood vessels and reduces airway responsiveness to histamine, methacholine, adenosine, and allergen. Theophylline competitively inhibits type III and type IV phosphodiesterase (PDE), the enzyme responsible for breaking down cyclic AMP in smooth muscle cells, possibly resulting in bronchodilation. Theophylline also binds to the adenosine A2B receptor and blocks adenosine mediated bronchoconstriction. In inflammatory states, theophylline activates histone deacetylase to prevent transcription of inflammatory genes that require the acetylation of histones for transcription to begin.', 'Theophylline, an xanthine derivative chemically similar to caffeine and theobromine, is used to treat asthma and bronchospasm. Theophylline has two distinct actions in the airways of patients with reversible (asthmatic) obstruction; smooth muscle relaxation (i.e., bronchodilation) and suppression of the response of the airways to stimuli (i.e., non-bronchodilator prophylactic effects).', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11349, 'Theo 300mg s.r. 10 caps.', 'ثيو 300مجم اس ار 10 كبسولات', '5', NULL, 'Bronchodilator.phosphodiesterase inhibitors', 'Theophylline', 'Glaxo smithkline', 'Cap', 'كبسولة', '300mg', '1', NULL, NULL, '6221045000518', NULL, 1099, '2022-12-30', 0, 'For the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis.', 'Theophylline relaxes the smooth muscle of the bronchial airways and pulmonary blood vessels and reduces airway responsiveness to histamine, methacholine, adenosine, and allergen. Theophylline competitively inhibits type III and type IV phosphodiesterase (PDE), the enzyme responsible for breaking down cyclic AMP in smooth muscle cells, possibly resulting in bronchodilation. Theophylline also binds to the adenosine A2B receptor and blocks adenosine mediated bronchoconstriction. In inflammatory states, theophylline activates histone deacetylase to prevent transcription of inflammatory genes that require the acetylation of histones for transcription to begin.', 'Theophylline, an xanthine derivative chemically similar to caffeine and theobromine, is used to treat asthma and bronchospasm. Theophylline has two distinct actions in the airways of patients with reversible (asthmatic) obstruction; smooth muscle relaxation (i.e., bronchodilation) and suppression of the response of the airways to stimuli (i.e., non-bronchodilator prophylactic effects).', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11352, 'Sunseiz 250 mg 30 f.c.tabs.', 'صن سيز 250 مجم 30 قرص', '144', '105', 'Anti-epileptic.pyrrolidine', 'Levetiracetam', 'Sun pharma egypt limited', 'Tab', 'أقراص', '250 mg', '3', NULL, NULL, NULL, NULL, 832, '2025-12-12', 0, 'Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606]



Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]', 'The exact mechanism through which levetiracetam exerts its anti-epileptic effects is unclear, but is thought to be unique amongst other anti-epileptic medications. Current knowledge suggests that levetiracetam’s binding to synaptic vesicle protein 2A (SV2A) is a key driver of its action. SV2A is a membrane-bound protein that is found on synaptic vesicles and is ubiquitous throughout the CNS[A12546] - it appears to play a role in vesicle exocytosis[L8606,L8615] and in the modulation of synaptic transmission by increasing the available amount of secretory vesicles available for neurotransmission.[A12552] Stimulation of pre-synaptic SV2A by levetiracetam may inhibit neurotransmitter release,[A12551] but this action does not appear to affect normal neurotransmission. This has led to the suggestion that levetiracetam exclusively modulates the function of SV2A only under pathophysiological conditions.[A12546] Levetiracetam and related analogues showed a correlation between affinity for SV2A and anti-epileptic potency, further suggesting that action at this site contributes to the anti-epileptic activity of the drug.[L8606,L8615]



Levetiracetam has also been shown to indirectly affect GABAergic neurotransmission (despite having no direct effect on GABAergic or glutamatergic receptors) and modulate ionic currents.[A12552] Similarly, levetiracetam has been shown in vitro to inhibit N-type calcium channels.[A16562] How, or even if, these actions are implicated in its anti-epileptic action have yet to be elucidated.', 'Levetiracetam appears to prevent seizure activity via the selective inhibition of hypersynchronized epileptiform burst firing without affecting normal neuronal transmission, though the exact mechanism through which this occurs is unclear.[L8606,L8615] The therapeutic index of levetiracetam is wide,[L8615,A185918] making it relatively unique amongst other anti-epileptic medications.



Anti-epileptic drugs, including levetiracetam, may increase the risk of suicidal ideation or behaviour - patients taking levetiracetam should be monitored for the emergence or worsening of depressive symptoms, suicidal ideation, and behavioural abnormalities.[L8606,L8600,L8615]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11354, 'Theophylline 200mg s.r. 20 tab.', 'ثيوفيللين 200مجم اس ار 20 قرص', '7', NULL, 'Bronchodilator.phosphodiesterase inhibitors', 'Theophylline', 'Amriya', 'Tab', 'أقراص', '200mg', '2', 'موسع للشعب الهوائية -- علاج الازمات التنفسية --علاج امراض الضيق التنفسي -- علاج الالتهاب الرئوي', 'about theophylline bronchodilator a methylxanthine derivative anti asthma in copd. mechanism of action of theophylline it inhibit phosphodiesterase enzyme which degrades cyclic nucleotides intracellularly and it results the cyclic amp accumulation in the', '6221075010433', NULL, 3265, '2023-01-11', 0, 'For the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis.', 'Theophylline relaxes the smooth muscle of the bronchial airways and pulmonary blood vessels and reduces airway responsiveness to histamine, methacholine, adenosine, and allergen. Theophylline competitively inhibits type III and type IV phosphodiesterase (PDE), the enzyme responsible for breaking down cyclic AMP in smooth muscle cells, possibly resulting in bronchodilation. Theophylline also binds to the adenosine A2B receptor and blocks adenosine mediated bronchoconstriction. In inflammatory states, theophylline activates histone deacetylase to prevent transcription of inflammatory genes that require the acetylation of histones for transcription to begin.', 'Theophylline, an xanthine derivative chemically similar to caffeine and theobromine, is used to treat asthma and bronchospasm. Theophylline has two distinct actions in the airways of patients with reversible (asthmatic) obstruction; smooth muscle relaxation (i.e., bronchodilation) and suppression of the response of the airways to stimuli (i.e., non-bronchodilator prophylactic effects).', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11356, 'Treato-ulc 20/1100mg 14 caps.', 'تريتو الس 20/1100مجم 14 كبسولة', '75', '50.5', 'Peptic ulcer.proton pump inhibitor', 'Omeprazole+sodium bicarbonate', 'Global napi pharmaceuticals > global advanced pharmaceutical (gap)', 'Cap', 'كبسولة', '1100mg', '1', NULL, 'about omeprazole proton pump inhibitor substituted benzimidazole anti-secretory antiulcer. mechanism of action of omeprazole omeprazole is a proton pump inhibitor and it is a prodrug. after administration it diffuses in to the parietal cell of the stomach', '6223005941008', NULL, 1714, '2025-06-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11357, 'Theragran- m 28 tab.', 'ثيراجران- ام 28 قرص', '24', NULL, 'Vitamins', 'Vitamins', 'Smithkline beecham', 'Tab', 'أقراص', NULL, '2', NULL, 'about vitamins vitamins are substances that are found in foods we eat. the term vitamin is derived from the words vital and amine because vitamins are required for life and were originally thought to be amines. all vitamins are not amines. vitamins are di', '6224001007965', NULL, 1411, '2022-12-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11358, 'Theragran hematenic 30 tab.', 'ثيراجران هيماتينيك 30 قرص', '29', NULL, 'Multivitamins', 'Multivitamins+iron', 'Smithkline beecham', 'Tab', 'أقراص', NULL, '3', '1- مقويات مع فيتامينات للضعف العام.', NULL, '6224001007408', NULL, 8459, '2023-03-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11359, 'Theragran syrup 90 ml', 'ثيراجران شراب 90 مل', '8', NULL, 'Multivitamins', 'Multivitamins+iron', 'Smithkline beecham', 'Syrup', 'شراب', '90 ml', '1', 'مصدر للفيتامينات -- علاج الانيميا -- مصدر للحديد -- مصدر للطاقة', NULL, NULL, NULL, 1538, '2022-08-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11360, 'Theragran stress 28 tab.', 'ثيراجران سترس 28 قرص', '24', NULL, 'Vitamins', 'Vitamins', 'Smithkline beecham', 'Tab', 'أقراص', NULL, '2', 'مصدر للفيتامينات -- مصدر للطاقة -- علاج الانيميا -- مقوي للاعصاب', 'about vitamins vitamins are substances that are found in foods we eat. the term vitamin is derived from the words vital and amine because vitamins are required for life and were originally thought to be amines. all vitamins are not amines. vitamins are di', NULL, NULL, 2631, '2022-08-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11368, 'Saja-cod syrup 120 ml', 'ساجا كود شراب 120 مل', '190', '70', NULL, NULL, 'Saja', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 1067, '2025-09-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11370, 'Thiolkan 300mg 10 tab.', 'ثيولكان 300مجم 10 اقراص', '10', NULL, 'Antioxidant', 'Thioctic acid(alpha lipoic acid)', 'Hikma pharma', 'Tab', 'أقراص', '300mg', '1', 'مضاد للاكسدة -- مصدر للطاقة -- حماية الجسم من الامراض -- يحسن التركيز والانتباه', 'uses alpha-lipoic acid (ala) has been used as an antioxidant for the treatment of diabetes and hiv. it also has been used for cancer liver ailments and various other conditions. dosing oral dosage of alpha-lipoic acid given in numerous clinical studies ra', NULL, NULL, 1580, '2022-07-28', 0, 'Investigated for use/treatment in diabetes mellitus type 2, neuropathy (diabetic), and vascular diseases.', NULL, NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11373, 'Thiophenicol 250mg 16 f.c. tab.', 'ثيوفينيكول 250مجم 16 قرص', '8', NULL, 'Antibiotic', 'Thiamphenicol', 'Sanofi', 'Tab', 'أقراص', '250mg', '2', NULL, 'thiamphenicol (also known as thiophenicol and dextrosulphenidol) is an antibiotic & immunosuppressive agent. it is the methyl-sulfonyl analogue of chloramphenicol and has a similar spectrum of activity but is 2.5 to 5 times as potent. like chloramphenicol', '6223003991395', NULL, 1241, '2023-04-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11374, 'Thiophenicol 750mg vial', 'ثيوفينيكول 750مجم فيال', '7', NULL, 'Antibiotic', 'Thiamphenicol', 'El nile. > sanofi aventis', 'Vial', 'فيال', '750mg', '1', NULL, 'thiamphenicol (also known as thiophenicol and dextrosulphenidol) is an antibiotic & immunosuppressive agent. it is the methyl-sulfonyl analogue of chloramphenicol and has a similar spectrum of activity but is 2.5 to 5 times as potent. like chloramphenicol', '6221077160112', NULL, 1109, '2023-04-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11375, 'Thiotacid 600 original 30 tab.', 'ثيوتاسيد 600 اوريجينال 30 قرص', '245', '230', 'Antioxidant', 'Thioctic acid(alpha lipoic acid)', 'Eva pharma', 'Tab', 'أقراص', NULL, '3', NULL, NULL, '6223007357302', NULL, 4995, '2025-06-04', 0, 'Investigated for use/treatment in diabetes mellitus type 2, neuropathy (diabetic), and vascular diseases.', NULL, NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11376, 'Lungotropium 250mcg/1ml 20 unit dose vial nebulizer soln', 'لانجوتروبيوم 250مكجم/مل 20 وحدة فيال مفردة للاستنشاق', '152', '90', 'Anti-muscarinic.asthma', 'Ipratropium bromide', 'Eva pharma', 'Vial', 'فيال', '250mcg', '20', NULL, NULL, '6223007356916', NULL, 1260, '2024-10-07', 0, 'Inhaled ipratropium is indicated in combination with inhaled beta-agonist systemic corticosteroids for the management of severe exacerbations of asthma flares requiring treatment.[A176939]



Asthma exacerbations are characterized by a progressive increase in one or more of asthma symptoms accompanied by a decrease in expiratory flow.[L5900]



As a single agent, ipratropium was indicated for the symptomatic relief of rhinorrhea associated with the common cold or seasonal allergic rhinitis for patients 5 years or older. It does not alleviate nasal congestion nor sneezing.[FDA label]



Rhinorrhea refers to recurrent or chronic watery nasal discharge. This condition is debilitating and its pathogenesis and etiology is complex and not very well understood presenting very substantial cost burden.[L5903]



Additionally, ipratropium is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema.[FDA label]



The chronic obstructive pulmonary disease includes a large number of conditions characterized by breathlessness. As this includes several conditions, the etiology, symptoms, and treatments are diverse.[L5906]



Ipratropium has also been studied to be used for the treatment of sialorrhea.[A176942]



Sialorrhea is a common symptom that accompanies different neurologic conditions and it is characterized by drooling or excessive salivation.[A176963]', 'Ipratropium acts as an antagonist of the muscarinic acetylcholine receptor.[A176939] This effect produces the inhibition of the parasympathetic nervous system in the airways and hence, inhibit their function. The function of the parasympathetic system in the airway is to generate bronchial secretions and constriction and hence, the inhibition of this action can lead to bronchodilation and fewer secretions.[A176945]



At the cellular level, the diameter of the airways is controlled by the release of acetylcholine into the muscle cells causing them to contract and producing a narrow airway. Thus administration of ipratropium stops the activity of acetylcholine in the smooth muscle preventing the contraction and producing relaxed airways.[T457]', 'Ipratropium is a short-acting agent that inhibits the parasympathetic nervous system at the level of the airway which then produces bronchodilatation. The effect of this agent starts after 1-2 hours and it is known to last only from 4 to 6 hours.[A176945] As part of the effect, ipratropium relaxes the bronchial airways which reverse the narrowing that accounts for wheezy breathing, chest tightness, cough and abnormal gas exchange.[T457]



In clinical trials where ipratropium was used in the initial management of status asthmaticus, it was demonstrated a clear benefit in pulmonary function in children and adults. However, the continuous use of ipratropium after an acute asthmatic attack is not proven to be significantly advantageous[A176939] nor the prophylactic administration of this agent.[T542]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11377, 'Thiotacid compound 300mg 30 caps', 'ثيوتاسيد 300مجم مركب 30 كبسولة', '168', '109.5', 'Antioxidant', 'Thioctic acid(alpha lipoic acid)+vitamin b1+vitamin b12', 'Eva pharma', 'Cap', 'كبسولة', '300mg', '3', 'مضاد للاكسدة -- تحسين التركيز والانتباه و الذاكرة -- علاج التهاب الاعصاب', NULL, '6223002453658', NULL, 6465, '2024-06-05', 0, 'Investigated for use/treatment in diabetes mellitus type 2, neuropathy (diabetic), and vascular diseases.', NULL, NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11379, 'Thiotacid 600 original 20 f.c. tabs', 'ثيوتاسيد 600 اوريجينال 20 قرص', '108', '108', 'Antioxidant', 'Thioctic acid(alpha lipoic acid)', 'Eva pharma', 'Tab', 'أقراص', NULL, '2', 'مضاد للأكسدة', NULL, '6223007351928', NULL, 6005, '2024-09-27', 0, 'Investigated for use/treatment in diabetes mellitus type 2, neuropathy (diabetic), and vascular diseases.', NULL, NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11380, 'Canolife 10 h.g cap', 'كانولايف 10 كبسولات جيلاتينية صلبة', '180', NULL, NULL, 'Lactoferrin 100 mg+vitamin c 40 mg', 'Pharma zad > cantreat company', 'Cap', 'كبسولة', NULL, '1', NULL, NULL, NULL, NULL, 4041, '2024-05-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11381, 'Thiotacid compound 600mg 20 tab.', 'ثيوتاسيد مركب 600مجم 20 قرص', '166', '109', 'Antioxidant', 'Thioctic acid(alpha lipoic acid)+vitamin b1+vitamin b12', 'Eva pharma', 'Tab', 'أقراص', '600mg', '2', 'مضاد للاكسدة -- تحسين التركيز والانتباه و الذاكرة -- علاج التهاب الاعصاب', NULL, '6223007356718', NULL, 21762, '2024-06-10', 0, 'Investigated for use/treatment in diabetes mellitus type 2, neuropathy (diabetic), and vascular diseases.', NULL, NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11382, 'Thiotex 300mg 30 caps.', 'ثيوتكس 300مجم 30 كبسولة', '90', NULL, 'Antioxidant', 'Thioctic acid(alpha lipoic acid)', 'Marcyrl co.', 'Cap', 'كبسولة', '300mg', '3', 'مضاد لللكسدة -- مقوي للاعصاب -- زيادة التركيز والانتباه والذاكرة', 'uses alpha-lipoic acid (ala) has been used as an antioxidant for the treatment of diabetes and hiv. it also has been used for cancer liver ailments and various other conditions. dosing oral dosage of alpha-lipoic acid given in numerous clinical studies ra', '6223003579951', NULL, 5985, '2023-05-14', 0, 'Investigated for use/treatment in diabetes mellitus type 2, neuropathy (diabetic), and vascular diseases.', NULL, NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11383, 'Thiotex forte 600mg 20 caps', 'ثيوتكس فورت 600مجم 20 كبسولة', '255', '110', 'Antioxidant', 'Thioctic acid(alpha lipoic acid)', 'Marcyrl co.', 'Cap', 'كبسولة', '600mg', '2', 'مضاد اكسدة', NULL, '6223003573850', NULL, 1890, '2025-05-20', 0, 'Investigated for use/treatment in diabetes mellitus type 2, neuropathy (diabetic), and vascular diseases.', NULL, NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11384, 'Covopax 50ml mouth spray', 'كوفوباكس سبراي للفم 50 مل', '55', NULL, 'Antiseptic', 'Clove oil+chlorohexidine+menthol+sodium benzoat', 'Hi - q pharma', 'Spray', 'بخاخ', '50ml', '1', NULL, NULL, NULL, NULL, 1036, '2024-06-09', 0, 'Clove oil is primarily indicated in conditions like colic, flatulence, and toothache [L2849].', 'The chief constituent present in clove oil is the phenol "_eugenol_" which is present in amounts up to 85%. Clove oil acts as a germicide [L2849] to Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa [A24841]. 



Clove oil is thought to inhibit prostaglandin synthesis, thereby reducing painful symptoms [A33145].



Eugenol, the main constituent of clove oil is purported to have anticancer action. In one study, eugenol-treated HL-60 cells showed features of apoptosis including DNA fragmentation and formation of DNA ladders in agarose gel electrophoresis. It was observed that eugenol transduced the apoptotic signal via reactive oxygen species (ROS) generation, inducing mitochondrial permeability transition (MPT), decreasing anti-apoptotic protein _bcl-2_ level, inducing _cytochrome c_ release to the cytosol, and subsequent apoptotic cell death. When taken together, the study showed that ROS plays a critical role in eugenol-induced apoptosis in _HL-60_, and this is the first report on the mechanism of the anticancer effect of eugenol [A33146].', 'Clove (Eugenia caryophyllata Thunb. [Myrtaceae]) essential oil (CEO) has been demonstrated to possess antimicrobial, antifungal, antiviral, antioxidant, anti-inflammatory, anti-histamine, and anticancer properties. However, few studies have focused on its topical use [A33133], [L2850].



Clove essential oil, used as an antiseptic in oral infections, inhibits gram-negative and gram-positive bacteria as well as yeast [A24841].



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11385, 'Thiozin 50mg 20 f.c tab', 'ثيوزين 50مجم 20 قرص', '13', NULL, 'Anti psychotic', 'Thioridazine', 'Delta pharma', 'Tab', 'أقراص', '50mg', '2', 'علاج الامراض النفسية -- مضاد للاكتئاب -- يؤخذ تحت اشراف طبي', NULL, NULL, NULL, 1108, '2023-01-12', 0, 'For the treatment of schizophrenia and generalized anxiety disorder.', 'Thioridazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; blocks alpha-adrenergic effect, depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.', 'Thioridazine is a trifluoro-methyl phenothiazine derivative intended for the management of schizophrenia and other psychotic disorders. Thioridazine has not been shown effective in the management of behaviorial complications in patients with mental retardation.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11387, 'Three zed topical lotion 120ml', 'ثري زد لوشن 120 مل', '55', '45', 'Soothing topical', 'Zinc oxide+menthol extract+glycerin+c.m.c', 'Top.z pharma co.', 'Lotion', 'لوشن', '120ml', '1', 'لوشن مرطب غنى بالفتامينات ومضادات الاكسدة يعمل على ترطيب وتغذية البشرة', 'soothing and anti-pruritic.', '6225000029125', NULL, 2901, '2025-06-03', 0, 'Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].  



', '**Zinc has three primary biological roles**: _catalytic_, _structural_, and _regulatory_. The catalytic and structural role of zinc is well established, and there are various noteworthy reviews on these functions. For example, zinc is a structural constituent in numerous proteins, inclusive of growth factors, cytokines, receptors, enzymes, and transcription factors for different cellular signaling pathways. It is implicated in numerous cellular processes as a cofactor for approximately 3000 human proteins including enzymes, nuclear factors, and hormones [L2096].



Zinc promotes resistance to epithelial apoptosis through cell protection (cytoprotection) against reactive oxygen species and bacterial toxins, likely through the antioxidant activity of the cysteine-rich metallothioneins [A32419].



In HL-60 cells (promyelocytic leukemia cell line), zinc enhances the up-regulation of A20 mRNA, which, via TRAF pathway, decreases NF-kappaB activation, leading to decreased gene expression and generation of tumor necrosis factor-alpha (TNF-alpha), IL-1beta, and IL-8 [A32418].



There are several mechanisms of action of zinc on acute diarrhea. Various mechanisms are specific to the gastrointestinal system: zinc restores mucosal barrier integrity and enterocyte brush-border enzyme activity, it promotes the production of antibodies and circulating lymphocytes against intestinal pathogens, and has a direct effect on ion channels, acting as a potassium channel blocker of adenosine 3-5-cyclic monophosphate-mediated chlorine secretion. Cochrane researchers examined the evidence available up to 30 September 2016 [L2106].



Zinc deficiency in humans decreases the activity of serum _thymulin_ (a hormone of the thymus), which is necessary for the maturation of T-helper cells. T-helper 1 (Th(1)) cytokines are decreased but T-helper 2 (Th(2)) cytokines are not affected by zinc deficiency in humans [A32417].



The change of _Th(1)_ to _Th(2)_ function leads to cell-mediated immune dysfunction. Because IL-2 production (Th(1) cytokine) is decreased, this causes decreased activity of natural-killer-cell (NK cell) and T cytolytic cells, normally involved in killing viruses, bacteria, and malignant cells [A32424]. 



In humans, zinc deficiency may lead to the generation of new CD4+ T cells, produced in the thymus. In cell culture studies (HUT-78, a Th(0) human malignant lymphoblastoid cell line), as a result of zinc deficiency, nuclear factor-kappaB (NF-kappaB) activation, phosphorylation of IkappaB, and binding of NF-kappaB to DNA are decreased and this results in decreased Th(1) cytokine production [A32417].



In another study, zinc supplementation in human subjects suppressed the gene expression and production of pro-inflammatory cytokines and decreased oxidative stress markers [A32424]. In HL-60 cells (a human pro-myelocytic leukemia cell line), zinc deficiency increased the levels of TNF-alpha, IL-1beta, and IL-8 cytokines and mRNA. In such cells, zinc was found to induce A20, a zinc finger protein that inhibited NF-kappaB activation by the tumor necrosis factor receptor-associated factor pathway. This process decreased gene expression of pro-inflammatory cytokines and oxidative stress markers [A32417].



The exact mechanism of zinc in acne treatment is poorly understood. However, zinc is considered to act directly on microbial inflammatory equilibrium and facilitate antibiotic absorption when used in combination with other agents. Topical zinc alone as well as in combination with other agents may be efficacious because of its anti-inflammatory activity and ability to reduce P. acnes bacteria by the inhibition of P. acnes lipases and free fatty acid levels [L2102].', 'Zinc is involved in various aspects of cellular metabolism. It has been estimated that approximately 10% of human proteins may bind zinc, in addition to hundreds of proteins that transport and traffic zinc. It is required for the catalytic activity of more than 200 enzymes, and it plays a role in immune function wound healing, protein synthesis, DNA synthesis, and cell division. Zinc is an essential element for a proper sense of taste and smell and supports normal growth and development during pregnancy, childhood, and adolescence. It is thought to have antioxidant properties, which may be protective against accelerated aging and helps to speed up the healing process after an injury; however, studies differ as to its effectiveness. Zinc ions are effective antimicrobial agents even if administered in low concentrations [L2211].



Studies on oral zinc for specific conditions shows the following evidence in various conditions [L2095]:



**Colds:** Evidence suggests that if zinc lozenges or syrup are taken within 24 hours after cold symptoms start, the supplement may shorten the length of colds. The use intranasal zinc has been associated with the loss of the sense of smell, in some cases long-term or permanently [L2095].



**Wound healing:** Patients with skin ulcers and decreased levels of zinc may benefit from oral zinc supplements [L2095]. 



**Diahrrea**: Oral zinc supplements can reduce the symptoms of diarrhea in children with low levels of zinc, especially in cases of malnutrition [L2095].

', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11389, 'Thrombexx dna 1120 i.u/100gm topical gel 40 gm', 'ثرومبكس دي ان ايه جل 40 جرام', '77', '77', 'Anticoagulant.direct thrombin inhibitor', 'Recombinant hirudin', 'Mina pharm', 'Gel', 'جل', '100gm', '1', 'جيل يعمل علي التئام الجروح -- يقلل من الانتفاخات و التورمات بالجلد نتيجة الكدمات', NULL, '6222003702147', NULL, 7789, '2024-11-12', 0, 'Investigated for use/treatment in alpha 1 antitrypsin deficiency, atopic dermatitis, and chronic obstructive pulmonary disease (COPD).', 'rAAT belongs to a family of structurally-related proteins classified as serine protease inhibitors or SERPINS, which are known to inhibit several proteases including trypsin, cathepsin G, thrombin, tissue kallikrein, as well as neutrophil elastase.', 'Alpha 1-antitrypsin is a glycoprotein primarily produced by hepatocytes, and to a lesser extent, immune system cells. Recombinant alpha 1-antitrypsin (rAAT) is produced from yeast, which unlike commercially available forms of plasma-derived AAT, eliminates the risk associated with blood-borne infectious agents and allows for a increased manufacturing.  rAAT belongs to a family of structurally-related proteins classified as serine protease inhibitors or SERPINS, which are known to inhibit several proteases including trypsin, cathepsin G, thrombin, tissue kallikrein, as well as neutrophil elastase. The proteinase/antiproteinase balance is believed to be important for maintaining healthy skin. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11390, 'Thrombo 75mg 30 f.c.tab', 'ثرومبو 75مجم 30 قرص', '123', NULL, 'Antiplatelet.adp receptor blocker', 'Clopidogrel', 'Eipico', 'Tab', 'أقراص', '75mg', '3', NULL, NULL, '6221032241191', NULL, 2002, '2022-12-13', 0, 'Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and in recent MI, stroke, or established peripheral arterial disease,[L7213]', 'Clopidogrel is activated via a 2 steps reaction to an active thiol-containing metabolite.[A180508] This active form is a platelet inhibitor that irreversibly binds to P2Y<sub>12</sub> ADP receptors on platelets.[L7213] This binding prevents ADP binding to P2Y<sub>12</sub> receptors, activation of the glycoprotein GPIIb/IIIa complex, and platelet aggregation.[L7213]', 'Clopidogrel is a prodrug of a platelet inhibitor used to reduce the risk of myocardial infarction and stroke.[A180508,L7213] It has a long duration of action as it is taken once daily and a large therapeutic window as it is given in doses of 75-300mg daily.[L7213]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11391, 'Gelsolina transparent soap with glycerin 100 gm', 'جيلسولينا صابونة بالجلسرين 100 جم', '64', NULL, NULL, NULL, 'Company', 'Gel', 'جل', '100 gm', '1', NULL, NULL, '6225000235717', NULL, 730, '2022-08-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11393, 'Thrombostat solution for i.v.infusion', 'ثرومبوستات محلول للحقن', '900', NULL, 'Antiplatelet', 'Tirofiban', 'Memphis > genesis pharmaceuticals', 'Solution', 'محلول', NULL, '1', NULL, NULL, NULL, NULL, 826, '2022-08-03', 0, 'For treatment, in combination with heparin, of acute coronary syndrome, including patients who are to be managed medically and those undergoing PTCA or atherectomy.', 'Tirofiban is a reversible antagonist of fibrinogen binding to the GP IIb/IIIa receptor, the major platelet surface receptor involved in platelet aggregation. Platelet aggregation inhibition is reversible following cessation of the infusion of tirofiban.', 'Tirofiban prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery. It is a non-peptide antagonist of the platelet glycoprotein (GP) IIb/IIIa receptor, and inhibits platelet aggregation. When administered intravenously, tirofiban inhibits ex vivo platelet aggregation in a dose- and concentration-dependent manner. When given according to the recommended regimen, >90% inhibition is attained by the end of the 30-minute infusion. Tirofiban has been recently shown in patients with unstable angina to reduce ischemic events at 48 hours following infusion when compared to standard heparin therapy.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11394, 'Thymotal syrup 100 ml', 'ثيموتال شراب 100 مل', '18', NULL, 'Cough drugs', 'Thyme fluid extract', 'Atos pharma', 'Syrup', 'شراب', '100 ml', '1', NULL, NULL, '6223000471609', NULL, 1159, '2022-12-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11395, 'Thymotal oral drops 30 ml', 'ثايموتال نقط للفم 30مل', '16', NULL, 'Cough drugs', 'Thyme fluid extract', 'Atos pharma', 'Drops', 'نقط', '30 ml', '1', NULL, NULL, '6223000471586', NULL, 842, '2022-12-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11398, 'Thyrocil 50mg 30 tab.', 'ثيروسيل 50مجم 30 قرص', '72', '54', 'Antithyroid', 'Propylthiouracil', 'Amoun', 'Tab', 'أقراص', '50mg', '3', 'علاج زيادة إفراز هرمون الغدة الدرقية', NULL, '6221025010209', NULL, 2026, '2024-12-14', 0, 'Used to manage hyperthyroidism which is due to an overactive thyroid gland (Grave''s disease).', 'Propylthiouracil binds to thyroid peroxidase and thereby inhibits the conversion of iodide to iodine. Thyroid peroxidase normally converts iodide to iodine (via hydrogen peroxide as a cofactor) and also catalyzes the incorporation of the resulting iodide molecule onto both the 3 and/or 5 positions of the phenol rings of tyrosines found in thyroglobulin. Thyroglobulin is degraded to produce thyroxine (T4) and tri-iodothyronine (T3), which are the main hormones produced by the thyroid gland. Therefore propylthiouracil effectively inhibits the production of new thyroid hormones.', 'Propylthiouracil is a thiourea antithyroid agent. Grave''s disease is the most common cause of hyperthyroidism. It is an autoimmune disease where an individual''s own antibodies attach to thyroid stimulating hormone receptors within cells of the thyroid gland and then trigger overproduction of thyroid hormone. The two thyroid hormones manufactured by the thyroid gland, thyroxine (T4) and triiodothyronine (T3), are formed by combining iodine and a protein called thyroglobulin with the assistance of an enzyme called peroxidase. PTU inhibits iodine and peroxidase from their normal interactions with thyroglobulin to form T4 and T3. This action decreases thyroid hormone production. PTU also interferes with the conversion of T4 to T3, and, since T3 is more potent than T4, this also reduces the activity of thyroid hormones. The actions and use of propylthiouracil are similar to those of methimazole.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11399, 'Prime bronchi syrup 100 ml', 'برايم برونكاي شراب 100 مل', '39', NULL, 'Cough products', 'Thyme extract+primrose liquid root', 'Prime pharma', 'Syrup', 'شراب', '100 ml', '1', NULL, NULL, NULL, NULL, 894, '2024-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11401, 'Thyroxine 100mcg 100 tab.', 'ثيروكسين 100مكجم 100 قرص', '58', '42', 'Thyroid hormone', 'Levothyroxine', 'T3a pharma', 'Tab', 'أقراص', '100mcg', '1', 'يستخدم كعلاج بديل في قصور الغدة الدرقية الأولي (الغدة الدرقية) والثانوي (الغدة النخامية) والثالث (الوطاء) الخلقي أو المكتسب.', 'indication for use alone or in combination with antithyroid agents to treat hypothyroidism goiter chronic lymphocytic thyroiditis myxedema coma and stupor. mechanism of action levothyroxine acts like the endogenous thyroid hormone thyroxine (t4 a tetra-io', '6221508522816', NULL, 16168, '2024-07-25', 0, 'Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism. It is also indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.', 'Levothyroxine is a synthetically prepared levo-isomer of the thyroid hormone thyroxine (T<sub>4</sub>, a tetra-iodinated tyrosine derivative) that acts as a replacement in deficiency syndromes such as hypothyroidism. T<sub>4</sub> is the major hormone secreted from the thyroid gland and is chemically identical to the naturally secreted T<sub>4</sub>: it increases metabolic rate, decreases thyroid-stimulating hormone (TSH) production from the anterior lobe of the pituitary gland, and, in peripheral tissues, is converted to T<sub>3</sub>. Thyroxine is released from its precursor protein thyroglobulin through proteolysis and secreted into the blood where is it then peripherally deiodinated to form triiodothyronine (T<sub>3</sub>) which exerts a broad spectrum of stimulatory effects on cell metabolism. T<sub>4</sub> and T<sub>3</sub> have a relative potency of ~1:4. 



Thyroid hormone increases the metabolic rate of cells of all tissues in the body. In the fetus and newborn, thyroid hormone is important for the growth and development of all tissues including bones and the brain. In adults, thyroid hormone helps to maintain brain function, food metabolism, and body temperature, among other effects. The symptoms of thyroid deficiency relieved by levothyroxine include slow speech, lack of energy, weight gain, hair loss, dry thick skin and unusual sensitivity to cold.



The thyroid hormones have been shown to exert both genomic and non-genomic effects.[A179950] They exert their genomic effects by diffusing into the cell nucleus and binding to thyroid hormone receptors in DNA regions called thyroid hormone response elements (TREs) near genes.[A179605] This complex of T<sub>4</sub>, T<sub>3</sub>, DNA, and other coregulatory proteins causes a conformational change and a resulting shift in transcriptional regulation of nearby genes, synthesis of messenger RNA, and cytoplasmic protein production.[A179605,A179935] For example, in cardiac tissues T<sub>3</sub> has been shown to regulate the genes for α- and β-myosin heavy chains, production of the sarcoplasmic reticulum proteins calcium-activated ATPase (Ca2+-ATPase) and phospholamban, β-adrenergic receptors, guanine-nucleotide regulatory proteins, and adenylyl cyclase types V and VI as well as several plasma-membrane ion transporters, such as Na+/K+–ATPase, Na+/Ca2+ exchanger, and voltage-gated potassium channels, including Kv1.5, Kv4.2, and Kv4.3. [A179938] As a result, many cardiac functions including heart rate, cardiac output, and systemic vascular resistance are closely linked to thyroid status.



The non-genomic actions of the thyroid hormones have been shown to occur through binding to a plasma membrane receptor integrin aVb3 at the Arg-Gly-Asp recognition site.[A179959] From the cell-surface, T<sub>4</sub> binding to integrin results in down-stream effects including activation of mitogen-activated protein kinase (MAPK; ERK1/2) and causes subsequent effects on cellular/nuclear events including angiogenesis and tumor cell proliferation.[A179935, A179956]', 'Oral levothyroxine is a synthetic hormone that exerts the same physiologic effect as endogenous T<sub>4</sub>, thereby maintaining normal T<sub>4</sub> levels when a deficiency is present. 



Levothyroxine has a narrow therapeutic index and is titrated to maintain a euthyroid state with TSH (thyroid stimulating hormone) within a therapeutic range of 0.4–4.0 mIU/L.[A35722] Over- or under-treatment with levothyroxine may have negative effects on growth and development, cardiovascular function, bone metabolism, reproductive function, cognitive function, emotional state, gastrointestinal function and glucose and lipid metabolism. The dose of levothyroxine should be titrated slowly and carefully and patients should be monitored for their response to titration to avoid these effects. TSH levels should be monitored at least yearly to avoid over-treating with levothyroxine which can result in hyperthyroidism (TSH <0.1mIU/L) and symptoms of increased heart rate, diarrhea, tremor, hypercalcemia, and weakness to name a few.[F4636]



As many cardiac functions including heart rate, cardiac output, and systemic vascular resistance are closely linked to thyroid status,[A179938] over-treatment with levothyroxine may result in increases in heart rate, cardiac wall thickness, and cardiac contractility and may precipitate angina or arrhythmias, particularly in patients with cardiovascular disease and in elderly patients. In populations with any cardiac concerns, levothyroxine should be initiated at lower doses than those recommended in younger individuals or in patients without cardiac disease. Patients receiving concomitant levothyroxine and sympathomimetic agents should be monitored for signs and symptoms of coronary insufficiency. If cardiac symptoms develop or worsen, reduce the levothyroxine dose or withhold for one week and restart at a lower dose.[F4636]



Increased bone resorption and decreased bone mineral density may occur as a result of levothyroxine over-replacement, particularly in post-menopausal women. The increased bone resorption may be associated with increased serum levels and urinary excretion of calcium and phosphorous, elevations in bone alkaline phosphatase and suppressed serum parathyroid hormone levels. Administer the minimum dose of levothyroxine that achieves the desired clinical and biochemical response to mitigate this risk.



Addition of levothyroxine therapy in patients with diabetes mellitus may worsen glycemic control and result in increased antidiabetic agent or insulin requirements. Carefully monitor glycemic control after starting, changing or discontinuing levothyroxine.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11402, 'Westrino mouth wash 120 ml', 'ويسترينو غسول للفم 120 مل', '25', NULL, NULL, NULL, 'International medical guide', 'Mouth wash', 'غسول للفم', '120 ml', '1', NULL, NULL, NULL, NULL, 827, '2024-07-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11403, 'Iro-oley plus syrup 100 ml', 'ايرو اولي بلس شراب 100 مل', '70', '60', 'Multivitamin', 'Iron', 'Marvel', 'Syrup', 'شراب', '100 ml', '1', NULL, NULL, NULL, NULL, 741, '2025-08-04', 0, 'For treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Also used to replenish body iron stores in Non-Dialysis Dependent-Chronic Kidney Disease (NDD-CKD) patients receiving or not receiving erythropoietin and in Hemodialysis Dependent (HDD-CKD) and Peritoneal Dialysis Dependent (PDD-CKD) - Chronic Kidney Disease patients receiving an erythropoietin.', 'After iron dextran is injected, the circulating iron dextran is removed from the plasma by cells of the reticuloendothelial system, which split the complex into its components of iron and dextran. The iron is immediately bound to the available protein moieties to form hemosiderin or ferritin, the physiological forms of iron, or to a lesser extent to transferrin. This iron which is subject to physiological control replenishes hemoglobin and depleted iron stores.', 'Iron dextran is a dark brown, slightly viscous sterile liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. It is for treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Iron is essential to the formation of hemoglobin and to the function and formation of other heme and nonheme compounds. Untreated depletion of iron stores leads to iron-deficient erythropoiesis and, in turn, to iron deficiency anemia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11404, 'Proyan 50 gm cream', 'برويان كريم 50 جم', '120', NULL, 'Topical whitening cream', 'Skin care cream', 'Bme pharma', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, '6224009552108', NULL, 1005, '2024-07-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11406, 'Tibezole 500mg 3 f.c.tab.', 'تيبيزول 500مجم 3 اقراص', '10', NULL, 'Antiprotozoal', 'Ornidazole', 'Pharopharma', 'Tab', 'أقراص', '500mg', '1', 'مضاد للطفيليات', 'about ornidazole a nitro imidazole derivative antiprotozoal antibiotic antimicrobial. mechanism of action of ornidazole ornidazole is a nitro imidazole which has broad spectrum cidal activity against protozoa and some anaerobic bacteria. its selective tox', '6221094077530', NULL, 944, '2022-12-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11407, 'Tibezole 500mg 5 vaginal supp.', 'تيبيزول 500مجم 5 لبوس مهبلي', '14', NULL, 'Antiprotozoal', 'Ornidazole', 'Pharopharma', 'Supp', 'لبوس', '500mg', '1', 'مضاد للفطريات المهبلية -- تقليل الحكة والالتهابات -- الحفاظ علي البيئة الداخلية للمهبل', 'about ornidazole a nitro imidazole derivative antiprotozoal antibiotic antimicrobial. mechanism of action of ornidazole ornidazole is a nitro imidazole which has broad spectrum cidal activity against protozoa and some anaerobic bacteria. its selective tox', '6221094064950', NULL, 837, '2022-12-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11408, 'Tibolone 2.5mg 30 tab', 'تيبولون 2.5مجم 30 قرص', '60', NULL, 'Hormone replacement therapy', 'Tibolone', 'Adwia', 'Tab', 'أقراص', '2.5mg', '3', 'دواء بديل هرموني', 'about tibolone a synthetic steroid hormone selective tissue estrogenic activity regulator female sexual dysfunction drug. mechanism of action of tibolone the drug metabolized in a tissue selective manner in to three metabolites which have estrogenic proge', '6223002977772', NULL, 2081, '2023-01-18', 0, 'For the relief of post-menopausal symptoms and for the prevention of osteoporosis [L1724].', 'This drug''s effects are owed to the activity of its metabolites in various tissues [L1720].



Upon ingestion, tibolone is quickly converted into three major metabolites: _3 alpha- and 3 beta-hydroxy-tibolone_, which have oestrogenic effects, and the _Delta(4)-isomer_, which has progestogenic and androgenic effects. The specific tissue-selective effects of tibolone occur due to the metabolism, regulation of enzymes and receptor activation that varies in different tissues of the body.

 

The bone-conserving effects occur due to estradiol receptor activation, while the progesterone and androgen receptors are not involved in this process. Breast tissue of monkeys is not found to be stimulated after tibolone administration,  as occurs with estrogen plus progesterone used in combination. This is explained by the fact that tibolone and its metabolites inhibit _sulphatase and 17 beta-hydroxysteroid dehydrogenase_ (HSD) type I and _stimulate sulphotransferase and 17 beta-HSD type II_.  The combined effects of this process prevent the conversion to active estrogens.



In the uterus, the progestogenic activity of the _Delta(4)-metabolite_ and the effect on estrogen-inactivating enzymes prevent estrogenic stimulation. The mammary gland is not stimulated in currently used animal models. Tibolone has been shown to regulate estrogenic activity in several tissue types by influencing the availability of estrogenic compounds for the estradiol receptor in a selective manner [A32164].



Additionally, tibolone modulates cellular homeostasis in the breast by preventing breast tissue proliferation and stimulating cell apoptosis. Tibolone does not stimulate the endometrium because of the action of its highly stable progestogenic metabolite (Delta(4)-isomer) in combination with an effect on the sulfatase (inhibition)-sulfotransferase (stimulation) system. The estrogenic metabolites of tibolone have direct, favorable effects on the cardiovascular system and, in animal models, this drug has shown no adverse consequences. 





The tissue-selective effects of tibolone are the result of metabolism, enzyme regulation and receptor activation that vary in different tissues. The bone-preserving effects of tibolone are the result of estradiol receptor activation, while other steroid receptors, mainly the progesterone and androgen receptors, are not involved in this process. 



In a study of monkeys, breast tissue was not stimulated, which occurs with estrogen and progesterone, because tibolone and its metabolites inhibit _sulfatase and 17 beta-hydroxysteroid _dehydrogenase (HSD) type I and stimulate _sulfotransferase and 17 beta-HSD type II_. The simultaneous effects of this process halt conversion to active estrogens. Additionally, tibolone affects cellular homeostasis in the breast by preventing proliferation and stimulating apoptosis. Tibolone does not stimulate the endometrium due to the action of the highly stable progestogenic metabolite (Delta(4)-isomer) in combination with an effect on the sulphatase (inhibition)-sulphotransferase (stimulation) pathway [A32150].



The levels of tibolone metabolites and the alteration of hormonal activities vary according to the tissue type. In endometrial tissue the _Δ4-isomer_ functions as a progestagen, however, in the brain and liver, it shows androgenic effects. In breast tissue, the primary actions of tibolone are strong inhibition of sulfatase activity and weak inhibition of 17β-hydroxysteroid dehydrogenase activity, which leads to blocking the conversion estrone sulfate to E2 [L1720].', 'Tibolone prevents bone loss and treating post-menopausal symptoms without stimulating the endometrial tissues, which may lead to malignancy. Typical, drugs that treat post-menopausal symptoms such as estrogen, have a proliferative effect on the endometrium, increasing the risk of endometrial carcinoma [L1725]. The effects on the bone, brain and vaginal tissues can be explained by the estrogenic activity of tibolone.  It is important to note that activity is not expressed in the endometrium. Tibolone behaves differently from estrogen plus progesterone combinations on the breast. Therefore, tibolone can be characterized as a selective estrogen activity regulator [A32150].



Tibolone has been demonstrated to be an effective agent in treating symptoms associated with menopause. A 16 week trial in 1189 women examined the effect of tibolone 2.5 mg once daily on climacteric symptoms. Women treated with tibolone showed improvement from baseline in typical menopausal symptoms including hot flashes, sweating, insomnia, and anxiety [L1879].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11409, 'Dugoner 20 capsules', 'دوجونير 20 كبسولة', '280', NULL, 'Neuropathy management', 'Alpha lipoic acid 600 mg+benfotiamine 300 mg+methylcobalamin 1000 mcg+riboflavin sodium phosphate 4 mg+pyridoxine hcl 4 mg+folate 200 mcg+vitamin d3 800 i.u+vitamin c 200 mg', 'Duomed pharma', 'Capsule', 'كبسولة', NULL, '2', NULL, NULL, NULL, NULL, 3406, '2024-08-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11410, 'Ticanase 0.05% nasal spray 12 gm', 'تيكانيز بخاخة للانف 12 جم', '70', '45', 'Bronchodilator - glucocorticoid - anti-inflammatory', 'Fluticasone propionate', 'European pharmaceuticals', 'Spray', 'بخاخ', '0.05%', '1', 'موسع للشعب - كورتيزون - مضاد للالتهاب', 'about fluticasone synthetic topical glucocorticoid anti inflammatory and antipruritic in corticosteroid-responsive dermatoses; atopic dermatitis. mechanism of action of fluticasone it reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes b', '6221076160175', NULL, 7429, '2024-06-27', 0, 'Fluticasone propionate is indicated as an inhaler for the treatment and management of asthma by prophylaxis[FDA Label]as well as inflammatory and pruritic dermatoses[F4355]. Fluticasone propionate nasal spray is indicated for managing allergic and nonallergic rhinitis[L8309,F4358].', 'Fluticasone propionate works through an unknown mechanism to  affect the action of various cell types and mediators of inflammation[F4358]. Fluticasone propionate activates glucocorticoid receptors and inhibits lung eosinophilia in rats[F4358,F4355].', 'Systemically, fluticasone propionate activates glucocorticoid receptors, and inhibits lung eosinophilia in rats[F4358][FDA Label]. Fluticasone propionate as a topical formulation is also associated with vasoconstriction in the skin[F4355,A177118].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11415, 'Steps calcium 20 tabs', 'ستيبس كالسيوم 20 قرص', '85', NULL, 'Multivitamin', 'Calcium+magnesium+vitamin d3+vitamin k', 'Wea pharma', 'Tab', 'أقراص', NULL, '2', NULL, NULL, NULL, NULL, 1071, '2024-09-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11416, 'Tiger gel 100 ml', 'تايجر جل 100 مل', '175', NULL, 'Lubricant', 'Purified water+triethanolamine+hydroxymethyl cellulose+glycerin+propylene glycol+methyl paraben', 'Brother pharma', 'Gel', 'جل', '100 ml', '1', 'جل مرطب ويقضي على الروائح للسيدات', 'lubricant during sexual intercourse available in 3 flavours: chocolate - peach - strawberry', '6224000738013', NULL, 2332, '2022-12-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11418, 'Tiger plaster', 'لزقة ضهر النمر', '17', NULL, 'Analgesic', 'Counter irritant plaster', 'Alexandria', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, '6223000173992', NULL, 3666, '2023-02-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11420, 'Pantroglob 40mg powder for i.v. inf. vial', 'بانتروجلوب 40مجم فيال', '66', '45', 'Peptic ulcer.proton pump inhibitor', 'Pantoprazole', 'Global pharmaceutical industries', 'Vial', 'فيال', '40mg', '1', NULL, NULL, '6223004902062', NULL, 1390, '2024-11-12', 0, '

**Pantoprazole Injection**:



**Treatment of gastroesophageal reflux disease associated with a history of erosive esophagitis**



Pantoprazole for injection is indicated for short-term treatment (7-10 days) of patients having gastroesophageal reflux disease (GERD) with a history of erosive esophagitis, as an alternative to oral medication in patients who are unable to continue taking pantoprazole delayed-release tablets. _Safety and efficacy of pantoprazole injection as the initial treatment of patients having GERD with a history of erosive esophagitis have not been demonstrated at this time_.[FDA label]



**Pathological Hypersecretion Associated with Zollinger-Ellison Syndrome**



Pantoprazole for injection is indicated for the treatment of pathological hypersecretory conditions associated with Zollinger-Ellison Syndrome or other neoplastic conditions.[FDA label]



**Pantoprazole delayed-release oral suspension**:



**Short-Term Treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD)**



Indicated in adults and pediatric patients five years of age and above for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis. For adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole may be considered. Safety of treatment beyond 8 weeks in pediatric patients has not been determined.[F3202]



**Maintenance of healing of erosive esophagitis**



Indicated for maintenance of healing of erosive esophagitis and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD.[F3202]



**Pathological hypersecretory conditions including Zollinger-Ellison syndrome**



Indicated for the long-term treatment of the above conditions.[F3202]', 'Hydrochloric acid (HCl) secretion into the gastric lumen is a process regulated mainly by the H(+)/K(+)-ATPase of the proton pump, expressed in high quantities by the parietal cells of the stomach.[A174295] ATPase is an enzyme on the parietal cell membrane that facilitates hydrogen and potassium exchange through the cell, which normally results in the extrusion of potassium and formation of HCl (gastric acid). 



Proton pump inhibitors such as pantoprazole are substituted _benzimidazole_ derivatives, weak bases, which accumulate in the acidic space of the parietal cell before being converted in the _canaliculi_  (small canal) of the gastric parietal cell, an acidic environment, to active _sulfenamide_ derivatives. This active form then makes disulfide bonds with important cysteines on the gastric acid pump, inhibiting its function.[A174247] Specifically, pantoprazole binds to the _sulfhydryl group_ of H+, K+-ATPase, which is an enzyme implicated in accelerating the final step in the acid secretion pathway. The enzyme is inactivated, inhibiting gastric acid secretion.[A174253] The inhibition of gastric acid secretion is stronger with proton pump inhibitors such as pantoprazole and lasts longer than with the H(2) antagonists.[A174295] ', 'This drug acts to decrease gastric acid secretion, which reduces stomach acidity. Pantoprazole administration leads to long-lasting inhibition of gastric acid secretion.[F3193]



**General Effects**



Pantoprazole has been shown to reduce acid reflux-related symptoms, heal inflammation of the esophagus, and improve patient quality of life more effectively than histamine-2 receptor antagonists (H2 blockers). This drug has an excellent safety profile and a low incidence of drug interactions. It can be used safely in various high-risk patient populations, including the elderly and those with renal failure or moderate hepatic dysfunction.[A174226]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as pantoprazole have been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]



PPIs such as pantoprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes [A177577, A177580]. 



**A note on laboratory testing abnormalities**



During treatment with antisecretory medicinal products such as pantoprazole, serum gastrin (a peptide hormone that stimulates secretion of gastric acid) increases in response to the decreased acid secretion caused by proton pump inhibition. The increased gastrin level may interfere with investigations for neuroendocrine tumors. Published evidence suggests that proton pump inhibitors should be stopped 14 days before chromogranin A (CgA) measurements. This permits chromogranin A levels, that might be falsely elevated after proton pump inhibitor treatment, to return to the normal reference range.[F3217] 



Reports have been made of false-positive results in urine screening tests for tetrahydrocannabinol (THC) in patients receiving the majority of proton pump inhibitors, including pantoprazole. A confirmatory method should be used.[F3217]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11421, 'Iishou 36 cpasules', 'ليشو 36 كبسولة', '250', NULL, 'Weight loss', NULL, 'Company', 'Unknown', 'غير محدد', NULL, '1', 'علاج للسمنة وزيادة الوزن', NULL, '6932474320121', NULL, 864, '2023-01-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11422, 'Ivy tec-ac syrup 100 ml', 'ايفي تك شراب 100 مل', '60', '45', 'Cough product', 'Ivy extract', 'Company', 'Syrup', 'شراب', '100 ml', '1', NULL, NULL, NULL, NULL, 886, '2025-02-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11430, 'Timbestatin 10/20 mg 7 f.c. tab', 'تيمبيستاتين 10/20 مجم 7 قرص', '68', NULL, 'Antihyperlipidemic.cholesterol absorption inhibitors.combined with statin', 'Ezetimibe+simvastatin', 'Dbk pharma > royal group', 'Tab', 'أقراص', '20 mg', '1', 'يعمل على خفض الدهون والكوليسترول بالجسم.', NULL, NULL, NULL, 2762, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11431, 'Timogel 0.1% ophth. gel 5 ml', 'تيموجل 0.1% جل للعين 5 مل', '13', NULL, 'Antihypertensive.beta blocker.unselective', 'Timolol', 'Orchidia pharmaceutical industries', 'Gel', 'جل', '0.1%', '1', NULL, NULL, NULL, NULL, 977, '2022-11-23', 0, ' Ophthalmic timolol is indicated for the treatment of increased intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The oral form of this drug is used to treat high blood pressure.[L6724,L6727] In certain cases, timolol is used in the prevention of migraine headaches.[A179530,L6742] ', 'Timolol competes with adrenergic neurotransmitters for binding to beta(1)-adrenergic receptors in the heart and the beta(2)-receptors in the vascular and bronchial smooth muscle. This leads to diminished actions of catecholamines, which normally bind to adrenergic receptors and exert sympathetic effects leading to an increase in blood pressure and heart rate.[A179521] Beta(1)-receptor blockade by timolol leads to a decrease in both heart rate and cardiac output during rest and exercise, and a decrease in both systolic and diastolic blood pressure.[A179524,A179527] In addition to this, a reduction in reflex orthostatic hypotension may also occur. The blockade of beta(2) receptors by timolol in the blood vessels leads to a decrease in peripheral vascular resistance, reducing blood pressure.[L6724,L6727,L6733]



The exact mechanism by which timolol reduces ocular pressure is unknown at this time, however, it likely decreases the secretion of aqueous humor in the eye.[L6730] According to one study, the reduction of aqueous humor secretion may occur through the decreased blood supply to the ciliary body resulting from interference with the active transport system or interference with prostaglandin biosynthesis.[A179515]', 'Timolol, when administered by the ophthalmic route, rapidly reduces intraocular pressure. When administered in the tablet form, it reduces blood pressure, heart rate, and cardiac output, and decreases sympathetic activity.[A179506,A179509,A179512,L6727]. This drug has a fast onset of action, usually occurring within 20 minutes of the administration of an ophthalmic dose. Timolol maleate can exert pharmacological actions for as long as 24 hours if given in the 0.5% or 0.25% doses.[L6757]



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11432, 'Timogen 10mg/5ml syrup 120ml', 'تيموجين شراب 120 مل', '23', '14', 'Antispasmodic', 'Tiemonium methylsulphate', 'Delta pharma', 'Syrup', 'شراب', '10mg', '1', 'مضاد للتقلصات.', 'tiemonium methylsulfate - treatment of acute intense or refractory painful syndromes with a spasmodic component. the use of noramidopyrine is only justified when its activity confers a real advantage over other analgesics. indications: smooth muscle spasm', '6221163007222', NULL, 2867, '2024-09-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11433, 'Timolol-elnile 0.5% eye drops 5 ml (n/a)', 'تيمولول 0.5% قطرة عين 5 مل', '8', NULL, 'Antihypertensive.beta blocker.unselective', 'Timolol', 'El nile.', 'Drops', 'نقط', '0.5%', '1', NULL, 'about timolol nonselective beta adrenergic blocker ophthalmic- antiglaucoma antimigraine. mechanism of action of timolol timolol is a non selective beta blocker. it inhibits the beta receptors (beta-2) present in the eye such as in the ciliary body epithe', '6221077062515', NULL, 2217, '2022-12-13', 0, ' Ophthalmic timolol is indicated for the treatment of increased intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The oral form of this drug is used to treat high blood pressure.[L6724,L6727] In certain cases, timolol is used in the prevention of migraine headaches.[A179530,L6742] ', 'Timolol competes with adrenergic neurotransmitters for binding to beta(1)-adrenergic receptors in the heart and the beta(2)-receptors in the vascular and bronchial smooth muscle. This leads to diminished actions of catecholamines, which normally bind to adrenergic receptors and exert sympathetic effects leading to an increase in blood pressure and heart rate.[A179521] Beta(1)-receptor blockade by timolol leads to a decrease in both heart rate and cardiac output during rest and exercise, and a decrease in both systolic and diastolic blood pressure.[A179524,A179527] In addition to this, a reduction in reflex orthostatic hypotension may also occur. The blockade of beta(2) receptors by timolol in the blood vessels leads to a decrease in peripheral vascular resistance, reducing blood pressure.[L6724,L6727,L6733]



The exact mechanism by which timolol reduces ocular pressure is unknown at this time, however, it likely decreases the secretion of aqueous humor in the eye.[L6730] According to one study, the reduction of aqueous humor secretion may occur through the decreased blood supply to the ciliary body resulting from interference with the active transport system or interference with prostaglandin biosynthesis.[A179515]', 'Timolol, when administered by the ophthalmic route, rapidly reduces intraocular pressure. When administered in the tablet form, it reduces blood pressure, heart rate, and cardiac output, and decreases sympathetic activity.[A179506,A179509,A179512,L6727]. This drug has a fast onset of action, usually occurring within 20 minutes of the administration of an ophthalmic dose. Timolol maleate can exert pharmacological actions for as long as 24 hours if given in the 0.5% or 0.25% doses.[L6757]



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11435, 'Timolol maleate 0.5% eye drops 5 ml', 'تيمولول ماليات 0.5% قطرة عين 5 مل', '19', '14', 'Antihypertensive.beta blocker.unselective', 'Timolol', 'Eipico', 'Drops', 'نقط', '0.5%', '1', NULL, 'about timolol nonselective beta adrenergic blocker ophthalmic- antiglaucoma antimigraine. mechanism of action of timolol timolol is a non selective beta blocker. it inhibits the beta receptors (?2) present in the eye such as in the ciliary body epithelium', '6221032331267', NULL, 1216, '2025-04-29', 0, ' Ophthalmic timolol is indicated for the treatment of increased intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The oral form of this drug is used to treat high blood pressure.[L6724,L6727] In certain cases, timolol is used in the prevention of migraine headaches.[A179530,L6742] ', 'Timolol competes with adrenergic neurotransmitters for binding to beta(1)-adrenergic receptors in the heart and the beta(2)-receptors in the vascular and bronchial smooth muscle. This leads to diminished actions of catecholamines, which normally bind to adrenergic receptors and exert sympathetic effects leading to an increase in blood pressure and heart rate.[A179521] Beta(1)-receptor blockade by timolol leads to a decrease in both heart rate and cardiac output during rest and exercise, and a decrease in both systolic and diastolic blood pressure.[A179524,A179527] In addition to this, a reduction in reflex orthostatic hypotension may also occur. The blockade of beta(2) receptors by timolol in the blood vessels leads to a decrease in peripheral vascular resistance, reducing blood pressure.[L6724,L6727,L6733]



The exact mechanism by which timolol reduces ocular pressure is unknown at this time, however, it likely decreases the secretion of aqueous humor in the eye.[L6730] According to one study, the reduction of aqueous humor secretion may occur through the decreased blood supply to the ciliary body resulting from interference with the active transport system or interference with prostaglandin biosynthesis.[A179515]', 'Timolol, when administered by the ophthalmic route, rapidly reduces intraocular pressure. When administered in the tablet form, it reduces blood pressure, heart rate, and cardiac output, and decreases sympathetic activity.[A179506,A179509,A179512,L6727]. This drug has a fast onset of action, usually occurring within 20 minutes of the administration of an ophthalmic dose. Timolol maleate can exert pharmacological actions for as long as 24 hours if given in the 0.5% or 0.25% doses.[L6757]



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11443, 'Tineacure 1% top. cream 20 gm', 'تينياكيور كريم 20 جرام', '28', '13', 'Antifungal', 'Tioconazole', 'Kahira', 'Cream', 'كريم', '1%', '1', 'مضاد فطريات', 'about tolnaftate thiocarbamate derivative antifungal. mechanism of action of tolnaftate tolnaftate is a reversible noncompetitive inhibitor of squalene epoxidase enzyme of fungi. this epoxidase enzyme is useful for the conversion of squalene to sterols. i', '6221068603567', NULL, 3023, '2025-12-02', 0, 'For the local treatment of vulvovaginal candidiasis (moniliasis).', 'Tioconazole interacts with 14-&alpha; demethylase, a cytochrome P-450 enzyme that converts lanosterol to ergosterol, an essential component of the yeast membrane. In this way, tioconazole inhibits ergosterol synthesis, resulting in increased cellular permeability. Tioconazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms and the uptake of purine, impair triglyceride and/or phospholipid biosynthesis, and inhibit the movement of calcium and potassium ions across the cell membrane by blocking the ion transport pathway known as the Gardos channel.', 'Tioconazole is a broad-spectrum imidazole antifungal agent that inhibits the growth of human pathogenic yeasts. Tioconazole exhibits fungicidal activity in vitro against <i>Candida albicans</i>, other species of the genus Candida, and against <i>Torulopsis glabrata</i>. Tioconazole prevents the growth and function of some fungal organisms by interfering with the production of substances needed to preserve the cell membrane. In addition to its broad spectrum antifungal effects with tioconazole being effective against commonly occurring dermatophyte and yeast-like fungal species, tioconazole also has antibacterial effects on certain Gram-positive cocci bacteria.[L50166]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11445, 'Tineacure 1% paint 15 ml', 'تينياكيور مسة للجلد 15 مل', '16', '10', 'Antifungals.thiocarbamate', 'Tolnaftate', 'Kahira', 'Paint', 'مس/دهان', '1%', '1', NULL, 'about tolnaftate thiocarbamate derivative antifungal. mechanism of action of tolnaftate tolnaftate is a reversible noncompetitive inhibitor of squalene epoxidase enzyme of fungi. this epoxidase enzyme is useful for the conversion of squalene to sterols. i', '6221068503188', NULL, 959, '2025-01-09', 0, 'Tolnaftate topical is used to treat skin infections such as athlete''s foot, jock itch, and ringworm infections. Tolnaftate is also used, along with other antifungals, to treat infections of the nails, scalp, palms, and soles of the feet. The powder and powder aerosol may be used to prevent athlete''s foot.', 'Tolnaftate is a topical fungicide. Though its exact mechanism unknown, it is believed to prevent ergosterol biosynthesis by inhibiting squalene epoxidase. It has also been reported to distort the hyphae and to stunt mycelial growth in susceptible organisms.', 'Tolnaftate is a synthetic over-the-counter anti-fungal agent.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11446, 'Tinearest 1% topical cream 15 gm', 'تينياريست كريم 15جم', '23', '14.4', 'Antifungals.allylamines', 'Butenafine hydrochloride', 'Western pharmaceuticals industries', 'Cream', 'كريم', '1%', '1', 'كريم للفطريات -- تقليل الالتهابات الجلدية -- تقليل الالام و الاحمرار و الحكة', 'uses: this medication is used to treat a variety of fungal skin infections such as ringworm athlete s foot and jock itch. this medication is also used to treat a skin condition known as pityriasis (tinea versicolor) a fungal infection that causes a lighte', '6224007308493', NULL, 1638, '2025-10-19', 0, 'For the topical treatment of the following dermatologic infections: tinea (pityriasis) versicolor due to <i>M. furfur</i>, interdigital tinea pedis (athlete&rsquo;s foot), tinea corporis (ringworm) and tinea cruris (jock itch) due to <i>E. floccosum</i>, <i>T. mentagrophytes</i>, <i>T. rubrum</i>, and <i>T. tonsurans</i>.', 'Although the  mechanism of action has not been fully established, it has been suggested that butenafine, like allylamines, interferes with sterol biosynthesis (especially ergosterol) by inhibiting squalene monooxygenase, an enzyme responsible for converting squalene to 2,3-oxydo squalene. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Blockage of squalene monooxygenase also leads to a subsequent accumulation of squalene. When a high concentration of squalene is reached, it is thought to have an effect of directly kill fungal cells.', 'Butenafine is a synthetic antifungal agent that is structurally and pharmacologically related to allylamine antifungals. The exact mechanism of action has not been established, but it is suggested that butenafine''s antifungal activity is exerted through the alteration of cellular membranes, which results in increased membrane permeability, and growth inhibition. Butenafine is mainly active against dermatophytes and has superior fungicidal activity against this group of fungi when compared to that of terbinafine, naftifine, tolnaftate, clotrimazole, and bifonazole. It is also active against <i>Candida albicans</i> and this activity is superior to that of terbinafine and naftifine. Butenafine also generates low MICs for <i>Cryptococcus neoformans</i> and <i>Aspergillus spp.</i> as well.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (11448, 'Tinifloxacin 10 tab.', 'تنيفلوكساسين 10 اقراص', '76', '76', 'Antibiotic quinolone with antiprotozoal', 'Ciprofloxacin+tinidazole', 'Organopharma', 'Tab', 'أقراص', NULL, '1', 'علاج عدوي الجهاز البولي -- علاج عدوي الصدر والرئة -- علاج العدوي المهبلية والتهابات بطانة الرحم', 'about ciprofloxacin it is a broad spectrum fluoroquinolone with activity against pseudomonas aeruginosa. mechanism of action of ciprofloxacin ciprofloxacin is a bacteriostatic at low concentration and bactericidal at high concentration. it act by inhibiti', '200400906432', NULL, 10405, '2024-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
